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Abstract  
The preservative challenge test is a regulatory requirement specified in various pharmacopoeias 
to determine the efficacy of preservatives. However, such testing is a labour-intensive repetitive 
task and often requires days before results can be generated. Microbial biosensors have the 
potential to provide a rapid and automated alternative to the traditional viable counting currently 
in use. However, the selection of appropriate promoters is essential. The bioluminescent reporter 
strains used in the current study comprise the Photorhabdus luminescence lux CDABE reporter 
genes under the control of five individual constitutive Escherichia coli promoters: outer 
lipoprotein (lpp); twin arginine translocase (tatA); lysine decarboxylase (ldc); lysyl t-RNA 
(lysS); and ribosomal protein (spc). The promoter plus lux CDABE constructs were cloned, 
ligated into the plasmid vector pBR322 and transformed into E. coli ATCC 8739. The 
bioluminescence intensity in the decreasing order of constitutive promoter was lpp > spc> tatA> 
ldc > lysS. The five biosensor strains tested successfully in PET assays and demonstrated 
accuracy with a minimum detection limit of 10
3 
CFU/ml, a detection range of 6 orders 
magnitude, and yielded equivalent results to methods currently recommended by the 
pharmacopoeias. The bioluminescent biosensors were used to monitor the efficacy of 
preservatives; sorbic acid at concentrations of 0.031% to 0.2% at pH 5.0, and benzalkonium 
chloride at concentrations of 0.0062% to 0.00039% alone and in combination with 0.03% 
EDTA. The 99.9% percentage of bioluminescence reduction of tatA-lux, ldc-lux, lysS-lux, and 
spc-lux was statistically equivalent to the 3 log10 CFU/ml reduction as required by the 
Pharmacopeias’. Strong significant correlations between bioluminescence and the methods 
recommended by the pharmacopoeias were obtained when the biosensor strains were challenged 
with preservatives, for all except lpp-lux E. coli. The bioluminescence expressed by the lpp-lux 
biosensor was significantly lower during long-term stationary phase than it was for any of the 
other biosensors and was also significantly lower than for any of the other biosensors in the 
presence of preservatives. Since the plasmid copy number and viable counts for lpp-lux did not 
  
change under these conditions, it suggests that perhaps lpp-lux was down regulated under stress 
conditions. There were no statistically significant differences between the results of the 
bioluminescence assays and the results of the viable count and ATP chemiluminescence assay. 
Virtual foot printing (using Regulon DB database) demonstrated that two crp binding sites 
overlapping the -10 regions are located on the negative strand of the lysS promoter sequences 
and that one crp binding site is located in lpp.  The biosensor strains ldc-lux exhibited levels of 
bioluminescence per cell significantly lower than spc in the presence of preservatives whilst 
there was a significant increase in bioluminescence per cell by tatA-lux under alkaline conditions 
(pH 8.9) during long-term stationary phase. Amongst the five biosensor strains tested in the 
current work, it was determined that the spc-lux strain would be the most attractive candidate for 
further work, since the bioluminescence expressed per cell was significantly greater, by 10-1000 
times, than that expressed by the other four promoters when challenged with the preservatives 
tested with excellent significant correlations between bioluminescence expression and viable 
counts in the PET assays with the various preservatives in this study (R
2
: 8.79-1.00). The 
bioluminescent biosensor strains showed no statistical differences from the control strains 
(wildtype E.coli ATCC 8739 and E.coli carrying a promoterless [pBR322.lux] for adneylate 
energy charge (AEC), plasmid copy number (PCN) bioluminescence or viable counts over 28 
days. The emission of bioluminescence by the four bioreporter strains across 28 days is reflected 
by the stability of PCN with correlations of 0.78-0.90, except for lpp-lux with R
2
: 0.59. The 
following promoter elements were found likely to assist greater expression of bioluminescence: 
an A+T level of approximately 50% between the -40 and -60 regions (the UP element); a G+C 
level of approximately 50% within the -10 and +1 regions; the extended -10 region and -10 
region of  consensus sequence RpoD (σ70/D).  
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1 : General Introduction  
1.1 : Conventional and Rapid Methods for Detection and Enumeration of 
bacteria 
Microbiological testing is a critical tool in process monitoring control, quality control, surveillance, 
and in providing inputs to risk assessment (Hoorfar, 2011). It is a key process in the pharmaceutical, 
biotechnology, cosmetic, food and beverages industries (Meder et al., 2012). The importance of 
microbiological testing is to ensure the level of microorganisms encountered does not exceed a point 
where it becomes hazardous to health or the environment (Hoorfar, 2011). Conventional methods are 
the gold standard for the determination of microbiological quality as they are reliable, easy to carry 
out, demands no expensive infrastructure and are rather cheap in consumables. Nevertheless, these 
methods are time consuming procedures both in operation, data collection and labour intensive 
(Jasson et al., 2010). Moreover, they depend on the ability of microorganisms to yield visible 
colonies after an incubation period of typically 3 days, but can go up to 14 days (European & United 
States Pharmacopeia), and demands large volumes usage of liquid and solid media (Jasson et al., 
2010; Meder et al., 2012). There are various conventional methods employed, such as the 
conventional pour/spread plate method, culture turbidity and most probable number method (MPN) 
(Discussed in Section 1.1.1). These standardised classical culture methods are still in use by many 
labs, especially by regulatory agencies because they are regarded as harmonised methods and these 
are considered as important aspects in international trade and compliance testing. However, interest 
has risen in the development of more rapid methods during the last decades. The term ‘rapid 
methods’ is defined by Feng (1996) and Fung (1994) as ‘methods that significantly shorten the 
analysis time compared to conventional detection procedures’. Many rapid methods have been 
developed and marketed in recent years (Discussed in Section 1.1.2). 
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1.1.1 : Conventional Methods 
1.1.1.1 : Wet and Dry Cell Weight 
This method is widely used for the estimation of bacterial biomass as well as for basic calibration of 
other methods. Wet cell weight is determined after washing and centrifugation or filtration of cells. 
The wet weight method has high variability and is inaccurate. The dry weight of bacterial cells is 
obtained by either freeze drying or heating in an oven at 105 °C until no further weight change 
occurs (Hobson et al., 1996). The determination of bacterial biomass is achieved by converting 
bacterial volume into organic carbon. The conversion factor involved is calculated from values of 
buoyant density, the dry weight/wet weight ratio, and carbon weight/dry weight of bacterial cells. By 
using a conversion factor of 0.22 g of Ccm
-3
, the carbon content in bacterial biomass is estimated 
(Bratbak & Dundas, 1984). This method is simple, but it is laborious, inaccurate and unable to 
distinguish viable from dead cells. Furthermore, errors are introduced during the process in 
decomposition of biological materials (Hobson et al., 1996). Both are also susceptible to operator 
error in dilution or evaluation. At a minimum, neither method provides real-time information for 
process control. 
 
1.1.1.2 : Turbidity 
Turbidity is another widely used method for the estimation of cell density in suspension. The 
turbidity of a suspension can be determined by using a spectrophotometer to measure the loss of light 
from a beam due to scattering and absorption (Singh et al., 1994). The measurement of turbidity is 
affected by the osmotic potential across cell membranes, as this leads to changes in cell surface 
area/volume ratio and refractive index resulting in changes to the turbidity of cell suspension 
(Hobson et al., 1996). Turbidity measurements can usually be made without destroying or 
significantly disturbing the sample and results are easy to interpret. With that, turbidity 
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measurements are widely employed to monitor the growth rate of microbial cultures (Madigan & 
Martinko, 2006). However, turbidity measurements do not distinguish between viable and dead cells, 
therefore this method cannot be used to measure death kinetics of microbes. 
 
1.1.1.3 : Viable Counts 
Viable cell counting methods are widely used to estimate viable microbial populations. Evaluation of 
viable cell count is based upon the ability of the cells to grow and multiply in a liquid nutrient culture 
medium, on an agar gelled nutrient culture medium or on the surface of a membrane filter laid onto a 
nutrient agar medium. The plate count and membrane filter methods are examples of these 
techniques. These methods are highly recommended as they have been validated as one of the 
compendia methods (British & European Pharmacopeia). However, these methods are laborious, 
require high operating skills, and a long incubation period (24 – 72 hour) (Hobson et al., 1996). 
Roszak and Colwell (1987) demonstrated the plate counting procedure as an underestimation method 
for enumeration of viable cells, where counts were lower as compared to direct epifluorescence 
microscopy counts. 
 
1.1.1.4 : Plate Counting Methods 
There are a few plate counting methods such as the pour plate, agar droplet, spread plate, and surface 
drop. The common feature between these methods is that the bacterial suspensions are diluted 
(normally tenfold) in diluents such as ringers solution to ensure that the number of bacterial colonies 
are within a countable range (i.e. 30 to 300 colonies) on agar petri dishes. 
 
In the pour plate method, 1 ml of an appropriate dilution is dispensed into a petri dish, where molten 
nutrient agar is then poured, tempered to 50
ᵒ
C, and mixed carefully. Once the mixture solidifies, it is 
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incubated at an optimum temperature for the expected bacterial species (Thatcher & Clark, 1968). 
The agar droplet method is an improved version of the pour plate method. The dilutions of the 
bacterial suspensions are prepared directly in molten nutrient agar, instead of liquid diluents (Sharpe 
& Kilsby, 1971). The colonies are formed in the solidified droplets (0.1 ml) during incubation. The 
advantage of this method is that the preparation of agar can be done on the day to avoid potential 
contamination. 
 
The spread plate method involves the use of solidified pre-poured nutrient agar plates. Volumes 
(normally 0.1 ml) of the appropriate dilutions are spread evenly over the surface using a sterile L-
shaped glass rod. The spread plate method offers improved aeration for bacterial growth and minimal 
desegregation of colony formation (Pepper & Gerba, 2009). Furthermore, heat sensitive cells are not 
killed by the molten agar, which may occur in the pour plate and agar droplet methods when the 
temperature is too high. Secondly, the colonies developed on the surface of the agar and they can be 
easily observed and sub-cultured if needed.  
Meanwhile, the surface drop method is a modified method of the spread plate known as the Miles 
and Misra method. Calibrated pipettes dispensing 0.02 ml are used to dispense five separate droplets 
of diluted sample on solidified agar (Miles & Misra, 1938). 
 
1.1.1.5 : Membrane Filter Method 
The membrane filter method is based upon the use of a highly porous pore-size cellulose acetate 
membrane filter that hinders the passage of bacterial cells, which in turn allows the small number of 
cells that may be present in large volumes of water to be concentrated (Hobson et al., 1996). Bacteria 
that are retained by the filter are cultured by applying the filter to the surface of a solidified nutrient 
agar plate, followed by incubation at an optimum temperature after which the number of colonies 
formed are counted. The most common pore size for membrane filters used is 0.45µm (Hobson et al., 
  
28 
 
1996). The main advantage of the membrane filtration method over the plate count method is that 
large sample volumes containing low and dispersed cell populations can be processed (Jones, 1979). 
However, this technique can be very laborious and time consuming. 
 
1.1.1.6 : Most Probable Number (MPN) 
Most probable number (MPN) is a method used to estimate the concentration of viable 
microorganisms in a sample by growth in replicate volumes of liquid broth and is normally 
performed using ten-fold dilutions.  The inoculated samples are incubated and the number of tubes 
showing growth (turbidity) at each dilution is used to estimate the cell count by referring to a 
probability table (Meynell & Meynell, 1970). This method offers real advantages as an enumeration 
tool (Sutton, 2010) for the detection of microorganisms with low numbers and that grow poorly on 
agar plates. Unlike other direct quantitative procedures, MPN only measures live and active 
microbes. However, the drawbacks of MPN method are its poor selectiveness of growth for some 
microorganisms that have different nutritional, physiological requirements and incubation conditions 
used. The MPN method is not as accurate and precise as the plate count method (Hobson et al., 
1996).  
 
1.1.1.7 : Modified and Automated Conventional Methods 
Various improvements have been made to the laborious methods mentioned, in an attempt to 
increase their convenience and ease-of-use. Automation in enumeration methods can be very useful 
to reduce the time needed for various activities such as the preparation of media, serial dilutions, 
counting colonies. 
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The spiral plating method is an example of an automated system that can be used to obtain a viable 
cell count (Spiral Biotech). A stylus is used to spread a sample of liquid on the surface of a pre-
poured agar plate in an Archimedean spiral. This gives a concentration gradient starting from the 
centre and decreasing as the spiral progresses outward on the rotating plate (Fung, 2002). The agar 
plate is then incubated (24 – 72 hours) for the colonies to develop. The colonies that grow can be 
counted manually or electronically using a laser counter. The time required for plating is only several 
seconds as compared to minutes when conventional methods are used (Fung, 2002). 
 
In addition, chromogenic or fluorogenic substrates are also used in selective media for detection, 
enumeration, and identification of bacteria, where these procedures can be performed directly on an 
isolation plate (Manafi, 1996). These compounds yield brightly coloured or fluorogenic products 
when reacting with specific bacterial enzymes or bacterial metabolites for identification of bacteria 
species (Boer & Beumer, 1999).The incorporation of such fluorogenic or chromogenic enzyme 
substrates into a selective medium can eliminate the need for subculture and further biochemical tests 
to establish the identity of certain microorganisms (Manafi et al., 1991, Manafi, 1996).  
 
The SimPlate system (Biocontrol) automates the dispensing of samples into 84 wells (Fung, 2002). 
Once the sample is dispensed, rehydrated liquid nutrient medium is added into the wells. The 
mixture is distributed evenly into the wells by swirling the SimPlate. After incubation, the plate is 
placed under UV light. Wells which demonstrate fluorescence are counted and the number is 
converted into MPN by using standard MPN tables (Fung, 2002). TEMPO (Bio-Mérieux), and 
Colilert (IDEXX Laboratories) are examples of automated MPN principle of enumeration method 
(Jasson et al., 2010). 
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1.1.2 : Rapid/Alternative Enumeration Methods 
Rapid methods in this context can be interpreted as a shorter time for microbial detection and/or the 
capacity for handling large throughput of samples for the convenience of routine testing (Jasson et 
al., 2010). The main methods discussed are: biochemicals capture, and specialized equipment 
methods employed in rapid testing.  
 
1.1.2.1 : Biochemical Methods 
Biochemical methods are based on the measurement of biochemical properties or interactions of 
microorganisms. Key methods adopted in industries and research labs include ATP-
chemiluminescence, direct epifluorescence filter technique (DEFT), enzyme linked immunosorbent 
assay (ELISA), and fluorescence antibody technique. 
 
1.1.2.2 :  ATP-Chemiluminescence  
ATP-chemiluminescence is used to determine the approximate number of living organisms present in 
a sample by determining intracellular ATP present. The viable cell count is estimated by determining 
the usage of a conversion factor to quantitate the amount of ATP present in the sample, via the firefly 
luciferase assay (Sharma & Malik, 2012). ATP-chemiluminescence is dependent upon the viability 
of the cells in the sample, as ATP degrades rapidly after cell death (Deininger & Lee, 2001). ATP-
chemiluminescence is one of the most widely used rapid detection methods in microbiology 
(Sakakibara et al., 2003). The rapid response time makes this system very suitable for on-line 
monitoring in hazard analysis critical control point (HACCP) manufacturing protocols (Sharma & 
Malik, 2012).The ATP-chemiluminescence method reduces the test time to approximately one third 
of that required for traditional methods (PDA, 2000). The Commercial MicroStar system developed 
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by Millipore Corp (Benford, Mass., USA) combines the ATP-chemiluminescence technique with 
trapping bacteria on a specialized membrane filter (Milliflex). 
 
The ATP-chemiluminescence assay is an excellent and sensitive method requiring only a few 
minutes (Fung, 2002). However, the extraction process for intracellular ATP is regarded as a 
laborious method when conventional extraction methods are applied. The ATP-chemiluminescence 
method is prone to contamination during the extraction of intracellular ATP. Non-microbial sources 
of ATP in foodstuffs and bodily fluids could be measured indirectly. Desquamated human skin cells 
will also be present in most environments. Beggs et al. (2008) estimated that an adult sheds some 10
8 
cells in a 24 hour period. Furthermore, each cell is associated with about 100 bacteria. 
 
Hence, the ATP-chemiluminescence method does not differentiate intracellular microbial ATP from 
other forms of ATP.  Other limitations include sensitivity to pH (Boer & Beumer, 1999), temperature 
(Boer & Beumer, 1999) and the presence of quenchers (Wen et al., 2000) influences light emission. 
 
1.1.2.3 :  Direct Epifluorescence Filter Technique (DEFT) 
The direct epifluorescence filter technique (DEFT) is a direct method that is used for enumeration of 
microorganisms, and is based upon the binding properties of a fluorochrome such as acridine orange 
or DAPI. This technique utilizes the principle of membrane filtration where the samples are pre-
treated with detergents and proteolytic enzymes, and then stained with a fluorescent compound, 
followed by visualisation under fluorescence microscopy (Hobson et al., 1996).  
 
DAPI and acridine orange are able to permeable to cells, and they interact with DNA and RNA by 
intercalation or electrostatic attractions is visible under fluorescence microscopy. However, 
nonspecific binding of the fluorescent dyes such as DAPI and acridine orange in heterogeneous 
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matrix limits the benefits of this technique (Klauth et al., 2004). Recently, the application of novel 
nucleic acid dyes has shown a lot of potential in the replacement of DAPI and acridine orange. In 
comparison, there is a better signal to background ratio due to an increase in fluorescence, 
specifically during DNA binding (Klauth et al., 2004).  The new generation of nucleic acid dyes 
includes: SYBR Green; SYTOX; PICO green; and SYTO dyes (Klauth et al., 2004). Investigation of 
the viable but non culturable (VBNC) phenomenon using fluorescent redox dyes is on the increase 
(Besnard et al., 2000). 
 
The redox dye 5-cyano-2, 3-ditolyl tetrazolium chloride (CTC) has been used as an artificial electron 
acceptor that directly competes with molecular oxygen. The reducing power generated by the 
electron transport system converts the CTC into insoluble, fluorescent, CTC-formazon crystals (i.e. 
clearly visible with UV optics and epi-illumination) which accumulate in metabolically active 
bacteria (Besnard et al., 2000). 
 
Thus, the staining procedure is simple and when coupled with direct viable counts is able to 
demonstrate greater sensitive compared to plate counts (Rowan, 2004). However, this technique 
requires skilled personnel to operate the microscope. 
 
1.1.2.4 :  Enzyme-Linked Immunosorbent Assay (ELISA) 
Enzyme-linked immunosorbent assay (ELISA) is a diagnostic tool that uses antibodies and colour 
change to identify a substance, usually an antigen, in a sample (Gracias & McKillip, 2004). Although 
enzyme-linked immunosorbent assays (ELISA) are widely used in clinical and food analysis, it was 
not until recently that these methods were applied to pharmaceutical quality control. They are many 
ways to perform antigen-antibody reactions, but the most popular format in recent years is the 
‘Sandwiched’ ELISA test (Fung, 2002). This process involves a primary antibody which is specific 
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to go the target molecule sample. A secondary antibody is added, which forms a ‘sandwich’ of an 
antigen between two antibody molecules. When the assay is developed a colorimetric change is 
observed upon addition of substrate. Alternatively, the secondary antibody may be conjugated to a 
fluorophore and be observed by fluorescence excitation. Based on the principle of antibody-antigen 
interaction, this test allows for easy visualization of results and can be completed without the 
additional concern of radioactive materials use. 
 
ELISA has been successful for detection of whole cell antigens of pathogenic bacteria (Gracias & 
McKillip, 2004). The ELISA method is reported to be sensitive - with a minimum detection limit of 
10
3
- 10
4 
CFU/ml (Cox et al., 1987; Hobson et al., 1996). Many diagnostic companies such as 
BioControl, Organon, Tecra, and Molecular Circuitry have marketed ELISA test kits. The ELISA 
test kits are examples of automated systems, which can perform the entire ELISA procedure 
automatically and can complete an assay in minutes (Fung, 2002). However, the drawbacks of all of 
these methods are the requirement for skilled personnel and expensive equipment, which can render 
routine testing uneconomical. 
 
1.1.2.5 :  Fluorescent Antibody Technique 
The fluorescent-antibody technique can be used to enumerate specific groups of microorganisms in 
situ. The principle of this method is based on fluorescent probes designed to bind to specific target 
sites on or in cells. These fluorescent probes are usually antibodies which fluoresce when stimulated 
by an energy source (e.g. laser). The emission of fluorescence occurs extremely rapidly after the 
absorption of excitation light, upon conjugation of fluorescent antibody. This requires a short 
incubation time between probes and microorganisms. However, this method is costly and loss of 
fluorescence signal occurs over time. This method is widely used for bacterial enumeration in 
microbial ecology studies, and pathogen monitoring (Hobson et al., 1996). 
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1.1.2.6 : Capture Methods 
The capturing methods in this section involve molecular techniques and magnetic, super- 
paramagnetic particles and magnetization of microbial cells. 
 
1.1.2.7 : Molecular Techniques  
A range of molecular targets have been utilised in microbiological assays. Nucleic acid sequence- 
based methods target specific nucleic acid sequences of bacteria (Noble & Weisberg, 2005). 
Experiments utilising the polymerase chain reaction (PCR) have been used to detect DNA sequences 
and identify as well as enumerate bacterial species (Keer & Birch, 2003). The PCR-based methods 
for detection of foodborne microbial pathogens are recognized and standardised by International 
Organization for Standardization (ISO) guidelines (ISO, 2010). Other molecular techniques include 
reverse transcriptase polymerase chain reaction (RT-PCR), quantitative PCR (qPCR), nucleic acid 
sequence based amplification (NASBA), and microarrays. The applications of DNA microarrays (Ye 
et al., 2001) and peptide nucleic acid (PNA) probes (Stender et al., 2002) have been employed to 
increase the speed and specificity of detection of bacterial species present in a sample (Stender et al., 
2002; Tomas et al 2009; Ye et al., 2001). 
 
The International Standardization Organization (ISO) recently published standards which address the 
PCR based methodology for the detection of food-borne pathogens quality assurance of food-borne 
pathogens in food and dairy products. Monnet et al. (2006) have demonstrated the application of 
qPCR in quantifying Corynebacterium casei, which is present on the surface of cheese after ripening. 
In addition, the quantification of Penicillium roqueforti and Penicillium camemberti with qPCR was 
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used as a biomass indicator to monitor changes in fungal population growth during cheese ripening 
(Le Drean et al., 2010).  
 
However, the limit of quantification is approximately 10
3
-10
4
 CFU/ml (Jasson et al., 2010). This 
limit is achievable by other rapid methods and is insufficient for hygiene indicators under GMP 
conditions, as they require a minimum limit of 10 CFU/ml to a maximum of 10
4
 CFU/ml (Jasson et 
al., 2010).  
 
Nevertheless, the use of mRNA as a marker of viability is preferred as compared to DNA, for mRNA 
is a highly labile molecule with a very short half-life (seconds) and therefore should be more closely 
correlated with the viability of the status than DNA-based methods (Keer & Birch, 2003). Molecular 
recognition approaches have the potential to be for being more rapid, more sensitive and adaptable to 
a wider class of bacteria and pathogens. However, molecular approaches require careful optimisation 
of the experimental design which could be time consuming, in addition requires expensive reagents. 
 
1.1.2.8 : Magnetic, Super-Paramagnetic Method 
Many magnetic or magnetisable carriers are super paramagnetic, where they only exhibit magnetic 
properties in the presence of an external magnetic field. Since the particles are not magnetic in 
themselves, they are not attracted to each other and therefore they can be easily suspended into a 
homogeneous mixture in the absence of any external magnetic field (Lea et al., 1988). However, they 
can be easily removed from suspension by application of a magnetic field. This approach uses the 
paramagnetic beads as binding platforms or linkers between analytes and labels, which also allows 
for easy separation of target analytes from a mixed sample by simply using a magnet (Maalouf et al., 
2008). Impedance spectrometry has been used to monitor E. coli O157:H7 binding to antibodies 
conjugated to paramagnetic beads and captured on nanoporous membranes (Chan et al., 2012). This 
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method has demonstrated ultra-low sensitivity levels as low as 10 CFU/ml for E.coli O157: H7 
(Chan et al., 2012). However, these methods are not commonly used in routine testing, despite the 
level of sensitivity that can be achieved. 
 
1.1.2.9 :  Other Specialized Equipment for Bacterial Detection  
Since technology has advanced tremendously, a wide range of specialised equipment can now be 
used to detect bacteria. Examples of novel alternative rapid methods that can be used to detect and 
enumerate bacterial populations include: solid-phase flow cytometry (Marie et al., 1999); confocal 
scanning laser microscopy (CLSM) (Auty et al., 2001), and scanning electron microscopy (SEM) 
(Sanders et al., 2012). Amongst microscopy methods, a solid-phase cytometry method for 
conducting total direct counts of bacteria was found less biased, and it also performed significantly 
better, than the other microscopy methods tested (Lisle et al., 2004). 
 
Recent attempts to monitor cellular metabolism in bacterial cultures have employed nuclear magnetic 
resonance (NMR) spectroscopy, which relies on measuring phosphates in bacterial cultures as an 
indicator of cellular metabolism (Gupta et al., 2012). Short wavelength near infrared spectroscopy 
(Sonnleiter et al., 1992) and Fourier transform infrared spectroscopy (FTIR) (Davis & Mauer, 2010) 
have also been used to measure the metabolic state of microorganisms. In contrast, traditional plate 
count methods are unable to distinguish the metabolic state of microorganisms.  
 
Table 1.1 shows the many methods, both conventional and alternative, that have been reported and 
discussed to detect, enumerate, and screen microorganisms and compares the advantages and 
disadvantages of the conventional and alternative methods presented. The disadvantages include: 
requirement for either a long incubation time; highly skilled personnel; expensive reagents or 
equipment; and also possibly, limited suitability use in routine testing. These features could 
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potentially make a product more difficult to market to consumers. A method which circumvents the 
undesirable traits of current rapid methods would be advantageous in rapid microbiological testing.  
Hence, the application of reporter genes in a whole-cell microbial biosensor could potentially serve 
as a novel real-time rapid microbiological method. Whole-cell biosensors incorporating reporter 
genes offer faster responses than traditional plate count methods and can be used to monitor process 
critical control points in real time whilst being cost effective. 
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Table 1.1: A comparison of the advantages and disadvantages of the various conventional and 
alternative microbiological testing methods 
Method Advantage Disadvantage 
Wet and Dry cell weight  Cost effective Laborious, inaccurate, does not 
distinguish live and dead cells 
 
Turbidity   Cost effective, Easy interpretation of 
results 
Does not distinguish live and 
dead cells 
 
Viable counts Considered as a ‘gold standard’ and 
recognized by international consensus 
Long incubation time, laborious 
 
Membrane filter method Favorable for large sample volumes. Able 
to recover dispersed cell populations  
 
Laborious and time consuming 
Most probable Number 
method  
Able to recover low numbers of cells. 
Only measures live and active microbes 
 
Laborious, dependent upon 
special requirements 
ATP- bioluminescence Sensitive and rapid Background bioluminescence. 
Special conditions required for 
testing (e.g. pH, temperature, 
chemical). Prone to 
contamination 
 
Direct Epifluorescence 
Filter technique 
Sensitive in recovering small populations 
of microbes 
Prone to nonspecific binding 
Requires trained personnel 
 
ELISA Easy interpretation of results Expensive materials and 
equipment 
 
Fluorescent Antibody 
Technique 
High sensitivity and specificity in 
microbial ecology studies 
 
Expensive reagents and the need 
for antibody synthesis 
Molecular Techniques Specific and adaptable to a wider range of 
bacteria 
 
Requires optimisation of the 
experimental parameters  
Magnetic, super 
paramagnetic method 
Sensitive  Not applicable for routine 
testing 
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1.2 : Introduction to Biosensors 
The last two decades have witnessed remarkable progress in the development of biosensors and their 
application in areas such as environmental protection, biotechnology, medical diagnostics, drug 
screening, food safety and bioterrorism detection and protection. The word ‘biosensor’ has been 
defined in different ways in journals and text books. ‘Biosensor’ is defined by the International 
Union of Pure and Applied Chemistry (IUPAC) as “a compact analytical device incorporating a 
biological or biologically-derived sensing element either integrated within, or intimately associated 
with, a physiocochemical transducer”. 
 
Figure 1.1: Schematic diagram showing the layout of a biosensor. It consists of 3 parts; the biological 
detection element, a transducer and a signal processor. 
 
 
A biosensor consists of a biological sensing element, a transducer and a signal processor (Figure 
1.1). The biological sensing element acts as the sensing device which contains biological molecules 
such as whole cells, enzymes,  paramagnetic nanoparticles particles attached to whole cells (Maalouf 
et al., 2007), peptides, antibodies and enzymes (D’Souza, 2001).The biological sensing element is 
linked to a transducer which converts the signal from the sensor into a quantifiable signal (Figure 
  
40 
 
1.1). These signals are then amplified so that they can be processed and analysed (Mulchandani & 
Rogers, 1998).  
 
The variety of different types of transducers give rise to                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
different categories of biosensors such as potentiometric, amperometric, conductimetric, 
voltammetric, microbial fuel cell, optical and magnetic biosensors (Jianrong et al., 2004)        
(Discussed in Section 1.3). The application of biosensors has the capability to shorten the time 
between sampling and results, and potentially to save a proportion of the cost involved. The use of 
biosensors allows both miniaturization and automation. It also allows sample volumes in the range of 
microliter or less (Zhang et al., 2009). Commercial biosensors are rapid, reliable, compact and user-
friendly instruments. Examples of commercially available biosensors include glucose biosensors 
(MiniMed Paradigm® by Medtronic), pregnancy test (Clearblue®) and a recently developed HIV 
biosensor (OraQuick® In-Home HIV Test by OraSure). 
 
1.2.1 : Whole-cell Microbial Biosensors 
Microbial whole cells microbial have been used successfully in biosensors (De Souza, 2001; Lei et 
al., 2006; Su et al., 2011). Many studies have attempted to construct biosensors that incorporate 
microbial whole-cells within microfabricated devices, and significant progress has been made 
towards this goal over the past decade (Shiku et al., 2008). Microbes can be used in either a viable or 
a non-viable form, with viable cells becoming considerably more significant in the production and 
development of biosensors (Burlage & Kuo, 1994; Riedel et al., 1993; Arikawa et al., 1998; 
Simonian et al., 1998).  
 
Viable microbes have the ability to metabolise organic substrates, either anaerobically or aerobically, 
resulting in end products such as ammonia, carbon dioxide, and organic acids. These end products 
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can then be monitored as a proxy for the presence and concentration of the substrate or the metabolic 
activity of the cell. Viable whole-cell biosensors monitor the respiratory and metabolic functions of 
the cell, with the target analyte being either a substrate that enhances activity or an inhibitor that 
reduces it (D’Souza, 2001). Non-viable cells can also be an economical source of intracellular 
enzymes. These can be incorporated into simple biosensor applications which do not require 
metabolic respiratory activity or cofactor regeneration (Mulchandani & Rogers, 1998; Svitel et al., 
1998; D’Souza, 1999, 2001). Alternatively, classical analytical methods such as Affinity 
chromatography (AC), Ion exchange chromatography (IEC), Gas Chromatographic (GC) and High 
Pressure Liquid Chromatography (HPLC) methods are used to determine the concentration, and 
possibly identity of analyte/(s).  
 
The classical analytical methods require extraction and separation of the target analyte to be 
performed and, depending on the number of analytes tested, this process can take hours or even days 
for completion (Spier et al., 2012). Whole-cell biosensor methods permit the detection of specific 
target analytes by making specified genetic alterations to the cells, as well as enabling analysis to be 
completed in minutes.  
 
1.2.2 : Advantages of using Microorganisms as Bio-sensing Elements 
Microbes offer a number of advantages as biological sensing elements. These advantages include: 
I. Microbes are ubiquitous in the environment (Lei et al., 2006). Culturing of many 
microbial species is quick and inexpensive. 
II. Microbes consist of numerous enzymes and cofactors/coenzymes with the ability to 
respond to a wide range of chemicals, which means that they can potentially sense 
many different analytes (Su et al., 2011). 
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III. Microbes are amenable to genetic modification through mutation or recombinant 
DNA technology (Liu et al., 2005). This allows the construction of novel cells capable 
of sensing the substrate of interest (Su et al., 2011). 
IV. Microbes have a broad operating range for both pH and temperature, and can adapt 
their metabolism in response to the relative scarcity or excess of a particular resource 
(Salis et al., 2008). 
V. Microbes are able to respond to a wide range of environmental changes, which makes 
them suitable for ecotoxicity testing and environmental monitoring (Bentley et al., 
2001). 
VI. Microbes will accept the introduction of reporter genes in extrachromosomal DNA 
(plasmid) or chromosomal DNA, which they can replicate without losing 
physiological function. 
1.2.3 : Types of Whole-cell Microbial Biosensors 
Whole-cell microbial biosensors can be classified on the basis of the transducers used to process the 
signal from the sensing element. This signal can be further interpreted by an electronic device. There 
are two classifications of microbial biosensors; electrochemical microbial biosensors and optical 
microbial biosensors. 
 
1.2.3.1 : Amperometric Electrochemical Whole-cell Microbial Biosensors 
The basic principle of an amperometric whole-cell microbial biosensor is that it operates at a fixed 
electrical potential with respect to a reference electrode and output potential is correlated with the 
concentration of the target analyte. In an amperometric biosensor, the output current is generated by 
the oxidation or reduction of either cations or anions on the surface of the electrode (Lei et al., 2006). 
Amperometric biosensors are the most common form of electrochemical whole-cell microbial 
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biosensors. Amperometric whole-cell microbial biosensor have been extensively exploited for 
environmental applications (D’Souza, 2001), food and fermentation field analysis (D’ Souza, 2001). 
 
An example of a commonly used amperometric microbial biosensor is one that was developed to 
determine the biochemical oxygen demand (BOD) of a water sample; a value related to the 
concentration of biodegradable organic pollutants in aqueous solutions (Liu et al., 2000).The 
traditional method for the determination of BOD measures the microorganisms’ oxygen 
consumption/respiration over a period of 5 days (Chan et al., 1999) and is reported as BOD5. The 
time taken to process samples by conventional methods can be in the order of hours whilst the 
response time of an amperiometric biosensorto pollutants is of the order of minutes; for example a 
response time of 3-5 minutes was achieved by entrapping Pseudomonas syringae in a highly porous 
micro-cellular polymer conjugated with an oxygen electrode (Kara et al., 2009). 
 
Phenol and phenolic compounds are known to be very toxic, so there is an urgent need for innovative 
analytical tools or devices to facilitate the detection of these compounds. A fabA promoter fused to a 
reporter geneen coded β-galactosidase in an E.coli strain has been demonstrated to detect phenol 
between 1.6 and 16 ppm in 20 minutes (Neufeld et al., 2006). Other toxic chemicals such as 
pesticides can also potentially be found in wastewaters, and so hence the use of biosensors is 
increasing compared to chemical analysis in wasterwater testing. Evans et al. (1998) described the 
incorporation of activated sludge on the electrode for an amperometric biosensor to determine 
rapidly the toxicity of wastewaters. 
 
Amperometric microbial biosensors have also found uses in the food industry. Milk stored for 
prolonged periods becomes rancid. Rancidity in milk products is caused by the liberation of short-
chain fatty acids (C4-C12) from milk lipids by endogenous or microbial enzymatic activity. 
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Arthrobacter nicotianae has been shown to possess enzymes of the β-oxidation of fatty acid pathway 
with a high specificity towards short-chain fatty acids. These cells have been immobilized onto an 
oxygen electrode with calcium-alginate gel and can be used to analyse the concentrations of short-
chain free fatty acids in milk samples. This sensor does not require any form of pre-treatment and its 
response time is only 3 minutes (Schmidt et al., 1996). 
 
In addition, thiamine and tyrosine play important roles in maintaining a healthy nervous, 
cardiovascular functioning of the body and so are necessary supplements in food products. Despite 
their necessity for good health, it can also be a risk-factor of hypertension when consumed in large 
doses. Hence, levels of thiamine and tyrosine are monitored and determined in clinical analysis, food 
processing, pharmaceutical and biotechnological processes. Consequently, genetically modified 
Saccharomyces cerevisiae have been developed and coupled with an amperometric oxygen electrode 
for the detection of thiamine (Vitamin B1) and tyrosine (Akyilmaz et al., 2006; Di Paolantonio & 
Rechnitz, 1983) and have been shown to be more sensitive than classical analytical methods such as 
chromatography and spectrometry. 
  
1.2.3.2 : Potentiometric Electrochemical Whole Cell Microbial Biosensors 
Potentiometric microbial whole-cell biosensors have made use of a variety of microbial species to 
detect specific targets. Potentiometric microbial biosensors are dependent upon a change in electrical 
potential resulting from ion accumulation or depletion. The conventional potentiometric microbial 
whole-cell biosensors consist of an ion-selective electrode (e.g. pH, ammonium, chloride) coated 
with an immobilized microbe layer. A microbe consuming an analyte generates a change in potential 
resulting from ion accumulation or depletion. Potentiometric transducers then measure the difference 
between a working electrode and a reference electrode, with the difference being correlated to the 
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concentration of an analyte (Mulchandani & Rogers, 1998; Simonian et al., 1998). However, this 
method requires a very stable reference electrode, which can be a challenge. 
 
Organophosphorous compounds widely used as pesticides, insecticides and chemical warfare agents 
have created public concern because of their widespread use and toxicity. Potentiometric microbial 
whole-cell biosensors based on modification of a glass pH electrode with genetically modified E. 
coli that expresses intracellular organophosphorus hydrolase were able to detect up to 3 µM 
organophosphate (Brim et al., 2000; Gaberlein et al., 2000; Mulchandani et al., 1999; Simonian et 
al., 1998). The principle of detection is based upon the release of protons during hydrolysis of 
organophosphorus, and the concentration of protons released is directly correlated with the 
concentration of organophosphorus present in the sample. Similar potentiometric whole-cell 
microbial biosensors have been developed to monitor penicillin concentrations of up to 30 mM. To 
produce these biosensors the recombinant E.coli transformed with a plasmid encoding β-lactamase 
and penicillinase synthesis were incorporated into membranes comprising a mixture of gluten and 
acetylcellulose overlaid onto pH electrodes (Galindo et al., 1990 & Chan et al., 1999). Other target 
substrates that have been successfully analysed by biosensors include tryptophan, urea and 
trichloroethylene (Lei et al., 2006). 
 
While pH electrodes are the most widely used ion selective electrodes for microbial biosensors, other 
ion selective electrodes have also been utilized. For example, an ammonium ion selective electrode 
was coupled with urease-yielding Bacillus sp. isolated from soil to develop a disposable microbial 
biosensor for monitoring the presence of urea in milk (Verma & Singh, 2003). Similarly, a chloride 
(Cl
-
) ion selective electrode was modified with the trichloroethylene (TCE) degrading bacterium 
Pseudomonas aeruginosa JI104 for TCE monitoring in batch and continuous modes in wastewaters 
(Han et al., 2002). 
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1.2.3.3 : Microbial Fuel-Cell Electrochemical Whole- cell Microbial Biosensors 
Microbial fuel cell (MFC) technology harnesses energy stored in waste streams and organic-rich 
environments, providing electrons to an electrode by microorganisms (Bullen et al., 2006; Logan et 
al., 2006; Loveley, 2006). These microorganisms have the ability to donate electrons to an electrode 
under anoxic conditions to support oxidation of electron donors such as lactate, glucose, acetate and 
a number of mixed wastes (Rabaey & Verstraete, 2005). Currently, microbial fuel cells (MFC) have 
been used as biosensors for in situ analysis and monitoring of microbial respiration, as changes in the 
rate of respiration relate to the reduction in the concentration of a contaminant (Du et al., 2007; Li et 
al., 2011).  
 
Microbial fuel-cell electrochemical whole-cell biosensors can be applied to the monitoring of 
groundwater contaminant plumes undergoing natural attenuation or bioremediation, since this 
requires routine monitoring of various contaminant, biogeochemical, and water quality analyte. 
Furthermore, this provides information regarding contaminant flux and the processes that are central 
to contaminant remediation (Ling et al., 2003). Characterization of microbial respiration rates and 
delivery of reducing equivalents to affected areas would also improve the understanding of natural 
attenuation and bioremediation efforts. Therefore, the development of innovative sensor technologies 
could potentially reduce the costs of site monitoring, whilst meeting the informational needs of 
regulators and site managers. 
 
This is a platform in development of MFC-systems into a sensing technology for in situ water quality 
monitoring applications. MFC biosensor system for the detection of acetate has been developed 
(Tront et al., 2008). Geobacter sulfurreducens was used as an external electron acceptor for a system 
operated with an influent solution containing acetate at various concentrations and monitored for the 
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change of current generated indicated the change in acetate concentration. An excellent positive 
correlation between the acetate concentration and the electrical current (R
2
= 0.92) was reported 
(Tront et al., 2008). 
1.2.3.4 :  Optical Whole-cell Microbial Biosensors  
Optical detection is a technique commonly used in microbial biosensors. Optical detection is usually 
based on the measurement of luminescent, fluorescent, colorimetric, or other optical signals 
produced by the interaction of microorganisms with the analytes, correlating the observed optical 
signal with the concentration of target compounds. Genetically modified microorganisms are widely 
used as optical whole-cell microbial biosensors. 
 
Bio-reporter genes are the primary driver for optical microbial whole-cell biosensors. The signals 
produced may be detected by luminescent, fluorescent or colorimetric. Reporter gene technology 
involves controlling the expression of genes by defined cis-regulatory sequences (response 
elements), which correlates with changes in gene regulation and thus expression in host microbial 
cells (Figure 1.2).The principle behind this technology is relatively straightforward since changes in 
the abundance of the corresponding reporter protein(s) are indicative of the transcriptional activity of 
the promoter. The bioreporter genes discussed within these sections are: green fluorescence protein 
(gfp), firefly luciferase (luc), beta-galactosidase (β-gal), and bacterial luminescence (lux). 
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Figure 1.2: Schematic diagram of how a target molecule interacts with a reporter and generates a 
quantifiable signal.  
 
1.2.3.4.1 : Fluorescent Whole-cell Microbial Biosensors 
Green fluorescent protein (GFP) is one of the many bio-reporter genes commonly used in microbial 
whole-cell biosensors. GFP is a 27-kD protein from the jellyfish, Aequorea Victoria, which exhibits 
bright green fluorescence when folded correctly as polypeptide chain. Residues; Ser65, Tyr66, and 
Gly67 form an extended and rigidly encapsulated conjugated ᴨ system that results in bright green 
fluorescence (Jackson et al., 2006). The emission of fluorescence requires no addition of any 
substrate or cofactor, hence it can be used in many species for live cell detection (Jackson et al., 
2006). GFP is very stable under a variety of conditions; however this stability limits its application in 
transcriptional induction studies since the fluorescence may decline at a much slower rate than 
transcription (Li et al., 1998). Recent efforts have sought to decrease the half-life of GFP, so as to 
increase its suitability for real time analysis (Matthysse et al., 2006). In biosensor systems, 
expression of gfp is influenced by changes in the transcriptional activity of the promoter which 
correlated with the concentration of the target analyte. For example, detection of zinc has been 
achieved developed by the transformation of Bacillus megaterium with enhanced green fluorescent 
protein (egfp) under the transcriptional control of the promoter for the smt operon (Date et al., 2010). 
The detection range for this biosensor was from 10
-6
 to 10
-4
M of the analyte. Monitoring the levels of 
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uranium in water is vital due to the toxicity, especially in the marine environments. This was 
undertaken by using a GFP reporter attached to an inducible urcA promoter in a Caulobacter 
crescentus biosensor strain which would then exhibit fluorescence in the presence of uranium 
(Hillson et al., 2007). 
 
1.2.3.4.2 :  Colourimetric Whole-cell Microbial Biosensor 
Colourimetric whole-cell microbial biosensors utilise the generation of a coloured compound as a 
signal which can be measured and correlated with the concentration of analyte present in a sample. 
The coloured product can be distinguished by the naked eye or by spectrophotometry readings. This 
method gives an easy-to-interpret response, a high turnover rate, is stable, and is easy to quantify; 
however it may require the addition of a chromogenic substrate. 
 
One example of a colourmetric system is based upon the 464 kDa  β-galactosidase enzyme extracted 
from E.coli (Naylor, 1999). The activity of the enzyme can be demonstrated by using the chromogen 
ortho-nitrophenyl-β-D-galactopyranoside (ONPG) which is an artificial substrate for the enzyme. 
ONPG is colourless, while its product, orthonitrophenol (ONP) is yellow (λmax= 420 nm). Therefore, 
enzyme activity can be measured by the abundance of yellow colour using a spectrophotometer. In 
addition, the artificial substrate X-gal can be used to β-galactosidase activity.The substrate X- gal 
also forms an intense blue when it is cleaved by β-galactosidase (Naylor, 1999). X-gal is commonly 
used to monitor β- galactosidase expression in bacterial colonies on agar whilst ONPG is employed 
for quantifications in solution. Ramanathan et al. (1997) successfully demonstrated the detection of 
arsenite by monitoring the activity of β- galactosidase, whilst Shin (2012) showed the expression of 
β- galactosidase in the presence of phenolic compounds. 
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The discovery of novel colorimetric compounds broadens the scope for colorimetric applications. 
The detection and quantification of arsenite is performed by the construction of the promoter region 
of the ars operon and the arsinite resistance gene (ArsR) cloned from E.coli, were conjugated to the 
crtA gene from photosynthetic bacterium, Rhodovulum sulfidophilum (Fujimoto et al., 2006). The 
crtA gene is responsible for carotenoid synthesis, and so the biosensor strains will change colour 
from yellow to red in the presence of arsinite (Fujimoto et al., 2006). The limit of detection for this 
biosensor was reported to be 5 µg/L arsenite (Fujimoto et al., 2006). 
 
1.2.3.4.3 :  Bioluminescent Whole- cell Microbial Biosensor 
A bioluminescent microbial whole-cell biosensor is associated with the emission of light by living 
microorganisms. The bioluminescence expression acts as a reporter for gene expression, a feature 
which marks the widest application in molecular genetics (Nordeen, 1988; Schauer, 1988). The lux 
genes that control luminescence are arranged in a single polycistronic operon, lux CDABE (Meighen, 
1991). 
 
 
Figure 1.3: Arrangement of lux CDABE open reading frames and a single polycistronic operon 
(Adapted from Lin and Meighen, 2009). 
 
Bacterial luciferase is a heterodimeric enzyme (αβ) of 78k-Da containing two non-identical subunits, 
α and β, located in a polycistronic operon as shown in Figure 1.3. luxA and luxB, the genes encoding 
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α and β subunits, possess 30% sequence identity (Meighen, 1994). Bacterial luciferase oxidizes a 
long chain aldehyde (RCHO) in the presence of reduced flavin mononucleotide (FMNH2) to produce 
a long chain fatty acid and blue-green light at 490nm (Meighen, 1991). The FMNH2 is readily 
provided from the electron transport chain in all bacteria. Although the biosynthesis of riboflavin and 
FMN is carried out in multiple steps by enzymes that are not encoded by the lux gene system, these 
enzymes are generally present in bacteria as riboflavin and FMN syntheses are required for bacterial 
growth. 
 
This reaction is highly specific for FMNH2 and any modifications to the flavin ring or removal of the 
phosphate group decreases its activity significantly (Meighen, 1991). The reduced flavin, FMNH2, 
binds to the enzyme, and reacts with oxygen (O2) to form a peroxyflavin. This complex interacts 
with aldehyde to form a highly stable intermediate which decays slowly. This results in the emission 
of light along with the oxidation of the substrates. The luciferase enzymes undergoes a single 
catalytic cycle as the rate of chemical oxidation of FMNH2 is higher than the turnover rate of 
luciferase in the bioluminescence reaction, resulting in a decay of luminescence with time in a first-
order process that reflects the turnover number of the enzyme under the assay conditions (Meighen, 
1991). The production of the reduced substrates FMNH2 requires an electron transport system which 
is driven by the central reactions of carbon and energy metabolism. Any perturbation of these 
processes or of electron transport would have an effect on bioluminescence intensity. Consequently, 
monitoring of changes in bioluminescence intensity provides a direct assessment of the perturbant 
effect on microbial metabolism (Scheerer et al., 2006). Furthermore recent studies have been 
demonstrated that the bioluminescence emission of a reporter gene under stress conditions correlated 
to gene expression in host strain using real-time PCR (Burton et al., 2010; Kim & Gu, 2006) and 
cDNA microarray techniques (Kim & Gu, 2006). Bacterial bioluminescence expression is real-time 
where monitoring of bioluminescence occurs with time frame of measurements of 3 to 5 minutes. 
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Additional advantages include very low background noise, high sensitivity and a wide dynamic 
range which enables very weak to very strong rranscriptional activity to be measured (Sunya et al., 
2012). 
 
 
Figure 1.4: The fatty acid reduction pathway catalysed by luxD, luxE, luxC gene products (Meighen, 
1994). 
 
 
The synthesis of aldehydes for the bioluminescence reaction is catalyzed by a multienzyme fatty acid 
reductase complex containing three proteins; a reductase (lux C), a transferase (lux D) and a 
synthetase (lux E) (Figure 1.5). lux CDE encodes the fatty acid reductase complex involved in 
synthesis of the aldehyde substrate (Figure 1.4). Lux D, the first thioesterase, cleaves tetradecanoyl- 
Acyl-carrier protein (ACP). The fatty acid product is activated by luxE with ATP to form fatty acyl-
AMP. In the presence of Lux C, the acyl group is transferred from acyl-AMP to LuxE, consequently 
LuxC finally reduces the acyl-AMP to fatty aldehyde (Meighen, 1991). These fatty acid reductase 
genes make the lux-operon ‘self-sufficient’ with no additional reagents required.  
 
On the contrary, a recent study by Yagur-Kroll and Belkin (2011) demonstrated an improved version 
of bioluminescent bioreporter is done by splitting luxCDABE genes of Photorhabdus luminescens, 
into two smaller functional units: luxAB encodes luciferase enzyme and luxCDE encodes enzymatic 
complex responsible for synthesis of aldehyde proved to be superior to the native luxCDABE 
configuration. This suggests that there is an improved efficiency in the transcription and translation 
of two subunits rather than a large gene. The best combination was of an inducible luxAB and a 
constitutive luxCDE due to aldehybe being a limiting factor in the bioluminescence system (Yagur-
Kroll &Belkin, 2011).  However, mathematical modelling studies byWelham and Stekel (2009) 
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contradict the findings of Yagur-Kroll and Belkin (2011) indicating optimal performances by 
constitutive luxAB and inducible luxCDE. The studies of upgrading bioluminescence expressions by 
splitting lux cassette is novel in contrast to traditional attempts to improve whole-cell sensors’ output 
by reducing background emission level, promoter strength and manipulation of host cells (membrane 
permeability) (Yagur-Kroll & Belkin, 2011).  However, until recently, only a few research dealing 
with the splitting of lux genes have been studied (Welham & Stekel, 2009; Yagur-Kroll & Belkin, 
2011).  
Today there are eleven bioluminescent bacterial species classified into four genera. Three genus are 
of marine origin: Vibrio, Photobacterium and Alteromonas. The fourth, more recently discovered 
one is of terrestrial origin: Photorhabdus (ex Xenorhabdus) (Meighen & Szittner, 1992). Amongst 
the species known V. ﬁscheri, V. harveyi, and Photorhabdus luminescens appear to have usable 
thermal stability to temperatures of 30, 37 and 42
ᵒ
C, respectively, with P. luminescens having a half-
life of 3 h at 45
ᵒ
C (Meighen, 1991). Furthermore, the entire luxCDABE operon for V. harveyi and P. 
luminescens emits strong bioluminescence signals expressed in E. coli at 37
ᵒ
C (Meighen & Szittner, 
1990). A comparison between V.harveyi and P.luminscence indicates a total loss of luciferase 
activity in V.harveyi, whilst P. luminescens retained 100% activity at 37
ᵒ
C (Meighen & Szittner, 
1990). This indicates that the P. luminescenes lux operon is the most suitable from the three genera 
for further study and incorporation into whole-cell biosensor constructs. 
 
Very effective bioluminescent microbial biosensors have been developed for environmental toxicity 
monitoring (Liu et al., 2011). Of the several possible bio-reporter systems (Kohler et al., 2000; 
Magrisso et al., 2008), the use of bacterial bioluminescence genes (luxCDABE) is most favoured due 
to the high sensitivity conferred by enzymatic photon generation, the capacity for continuous online 
monitoring (Marincs, 2000), and independence from an exogeneous substrate supply. There is no 
prerequisite for any special genotypes in the recipient strain in order to obtain expression, while the 
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response of bioluminescence is obtained in real time without cell disruption (Steward, 1990).  More 
importantly, the emission of bioluminescence is proportional to the rate of transcription of lux, hence 
this meets the requirements for a whole-cell biosensors and also gene expression studies. 
Furthermore, whole-cell bioluminescence not only correlates to growth but also reflects on the 
metabolic status of the cell (Ellison et al., 1994b; Hill., 1993; Marincs, 2000; Stewart, 1990, 1993 
1997; Stewart & Williams, 1992, 1993; Stewart et al., 1991, 1993, 1996, 1997). This implies that any 
stress responses that directly or indirectly affect the production of intracellular FMNH2 can be 
monitored in lux-recombinant bacteria in the form of light output per cell (Stewart, 1990). This 
attribute acts as an indication of global changes in intracellular biochemistry reflecting detrimental 
changes in bioluminescence (Stewart, 1990). This feature is regarded as important in monitoring the 
real-time recovery of microbial cells from sub-lethal injury, which is of immense importance to the 
enumeration of microorganisms in food and environment (Stewart, 1990). Previous studies also 
demonstrated that the recovery of S. typhimurium cells from freeze injury can be observed in real-
time using bioluminescence (Ellison et al., 1991a). However, gene expression using lux gene fusions 
under anaerobic conditions are limited by the need of oxygen and flavin mononucleotide (Meighen, 
1991).Contrary to this, Phillip-Jones (2000) demonstrated successful construction of lux AB to 
aerotolerant anaerobe Clostridium perfringens in monitoring expression of  cpa (virulence gene). 
Today, the application of bioluminescence genes has extended to the medical field. Recent studies on 
the application of bioluminescence as a rapid screening method for acute myeloid leukaemia (AML) 
patients before undergoing chemotherapy presented in the study by Alloush et al., 2010. 
 
The current most widely used bioluminescent microbial toxicity testing system is marketed as 
Microtox
TM
 and is based upon the wild-type bioluminescent bacteria, Vibrio fischeri. In the last 18 
years, the Microtox® system has been used by several agencies to assess the impact of chemicals in 
the environment. Toxic agents that affect metabolism or compromise bacterial viability cause a 
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reduction in light output. The results are expressed as effective concentration values at which there is 
a 50% decrease in light emission (EC50) (Sinclair et al., 1999). However, the use of V.fisheri in 
toxicity testing has also some limitations: due to the marine origin of bacteria, which requires high 
salinity (2% NaCl) and bioluminescence expression is unstable above 30
o
 degrees (Close et al., 
2010). In addition, Gellert et al. (2000) demonstrated that V.fisheri growth was weakened in the 
presence of nutrient broth. Due to the disadvantages, luciferase genes, luxCDABE genes from 
Photorhabdus luminescens has been often a better alternative used for recombinant luminescent 
bioreporters and bioluminescence expression is stable up to 40
o
 degrees (Meighen, 1991).  
 
Over the past decade, a new contaminant has found its way into water supplies around the world. 
Oestrogen comes from multiple sources, both natural and synthetic. This has raised concerns about 
possible health effects when consuming drinking water from contaminated sources. Most water 
treatment plants have not implemented any processes to remove oestrogen (Dery, 2009). Therefore it 
is likely that routine measurement of oestrogen in water supplies is likely to be implemented in the 
relatively near future. A bioluminescent whole-cell biosensor that is able to detect oestrogen has 
been constructed in S. cerevisiae (Hollis et al., 2000). Both reporter genes lux and lacZ have been 
successfully constructed into biosensors for screening, chemical sensing, and real time monitoring of 
oestrogen compounds and endocrine disrupting chemicals in the environment (Sanseverino et al., 
2005). 
 
A wide range of bacteria has been transformed with bioluminescent reporter constructs in which the 
lux operon has been placed under the control of an inducible promoter to create analyte-specific 
bioluminescent biosensors. These biosensors have demonstrated great value in determining the 
presence and concentration of specific pollutants. For example, Pseudomonas fluorescence HK44 
carrying the nah-lux reporter plasmid, which is capable of degrading both salicylate and naphthalene, 
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has been developed as a bioassay to assess the bioavailability of naphthalene and salicylate in 
contaminated soils (Burlage et al., 1990; King et al., 1990). Similarly, a biosensor in which a fusion 
of the Tn21 mercury resistance promoter (mer) with lux operon was constructed to detect inorganic 
Hg (II) in natural water in the 0.1 to 200 ppb range (Selifonova et al., 1993). Moreover, 
bioluminescent microbial biosensors to detect chlorophenols (Sinclair et al., 1999), nitrate (Preston et 
al., 2000), cadmium and lead (Tauriainen et al., 1998) have been developed and tested. A new 
generation of bioluminescent microbial biosensor of genetically modified spores of Bacillus subtilis 
is able to induce bioluminescence upon germination. This enables screening of many preservatives to 
be carried out rapidly and in real-time mode and also further evaluate inhibitory actions of the 
preservatives (Ciarciagline et al., 2000). Bioluminescence offers benefits over other reporter systems, 
where it has been shown to yield a faster and more sensitive measure and related compounds in 
samples when compared to fluorescence (Liu et al., 2011).  
 
In addition, firefly (luc) genes can also be utilized in luminescent reporters for measures of 
chemibioluminescence. The Firefly luciferase (LUC) is a 62 kDa protein from the firefly Photinus 
pyralis (DeWet et al., 1985). Firefly luciferase catalyses the oxidative decarboxylation of luciferin to 
oxyluciferin in the presence of ATP, magnesium ions, and oxygen  producing an emission of photons 
at 562nm wavelength (Lippincott-Schwartz & Patterson, 2003). The advantage of this reaction is 
applicable to broad range of species (including mammalian cells). However, this reaction involves 
the addition of reagents, and oxygen and magnesium ions are also required (Naylor, 1999).  
 
One of the greatest limitations of whole-cell biosensors is the availability of strong constitutive 
promoters or ones that respond only to the relevant stimuli (induced promoters) (Sorensen et al., 
2006). To circumvent this obstacle, more knowledge on gene regulatory networks in bacteria is 
needed. Linking transcriptomic studies and metatranscriptome analysis in microbial cells could 
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provide an immense source of new regulatory elements in the future (Cases & De Lorenzo, 2005). 
An alternative approach is to synthesize ‘super promoters’ based on consensus sequences obtained 
from comparative genomic studies of different promoters in known regulatory networks (Dreier et 
al., 2002). 
 
Therefore, the aim of the study described in this thesis is to investigate the application, sensitivity, 
stability of lux as a reporter system in Escherichia coli ATCC 8739 when controlled by 5 different 
constitutive promoters. 
 
1.3 : Gene Expression and Promoter Functions 
Gene expression is a process by which information from a gene is used in the synthesis of a 
functional gene product. Regulation of gene expression gives the cell control over both its structure 
and its functions. Gene expression in bacteria is controlled by the action of the multi subunit RNA 
polymerase, which catalyses DNA template-dependent RNA synthesis (Lee et al., 2012) illustrated 
in Figure 1.5. 
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Figure 1.5: Schematic representation of RNA polymerase interactions at the promoter and the initial 
steps to transcription initiation.  
(a): The process of transcription begins when RNA polymerase recognizes and binds to DNA 
elements within a promoter sequence.  
(b): Isomeriation to the open complex is signified by unwinding of the duplex DNA around the 
transcription start site.  
(c): Formation of transcript, with addition of nucleoside triphosphate (NTP) Adapted from Browning 
& Busby, 2004. 
 
In bacteria, RNA polymerase is composed of a core of multiple subunits (ββ’α1α2ώ) that is tightly 
associated with a sigma (σ) factor (Browning & Busby, 2004) (Figure 1.5). The core contains the 
active site for polymerase activity, and is thus capable of synthesizing mRNA whilst the associated 
sigma factor controls when and where transcription is initiated. Transcription initiation requires the 
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interaction of RNA polymerase with promoter DNA and the formation of an open complex, in which 
the duplex DNA a round the transcript start-point is unwound (De Haseth et al., 1998). Synthesis of 
the DNA template-directed RNA chain then begins with the formation of the first phosphodiester 
bond between the initiating and adjacent nucleoside triphosphates (Figure 1.5 c). After this initiation 
phase, RNA polymerase is moved into the elongation complex, which is responsible for RNA-chain 
extension (Figure 1.5). The main step in initiation is promoter recognition by RNA polymerase and 
the different DNA sequence elements that are responsible for this have been studied intensively 
(Gross et al., 1998; Busby & Ebright, 1994). Four different sequence elements have been identified. 
The two principal elements are the -10 hexamer and the -35 hexamer, which are located 10 and 35 
base pairs (bp) upstream from the transcript start site respectively. 
 
Table 1.2:  Functions of E.coli σ factors 
Organism σ factor Gene  Function  
Escherichia coli σ 70(σ D) rpoD Housekeeping genes 
 σ 32 (σ H) rpoH Heat shock  
 σ 24 (σ E) rpoE Periplasmic Stress 
 σ 28(σH) fliA Flagellar-based motility 
 σ 38(σS) rpoS Stationary/starvation phase 
 σ 54(σN) rpoN Nitrogen-regulated gene 
 σfecI fecI Ferric citrate uptake (ECF) 
The text in blue indicates the second family of sigma factors 
 
The highest intracellular concentration of the σ factors belongs to the σ70 family, reflecting their 
relationship to the principal σ factor of Escherichia coli, σ70 regulating housekeeping genes (Table 
1.2 in black). A second family of σ factors, the σ54 family, comprises proteins that are functionally 
similar to, but structurally distinct from, σ70 of E. coli. For the purposes of this thesis, we will limit 
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our discussion to the σ70 family.σ70 can be divided into four major regions (regions 1, 2, 3, and 4) 
(Browning & Busby, 2004). Prokaryotes have multiple sigma factors; a primary σ factor that is 
needed for the expression of housekeeping genes during exponential growth and alternate σ factors 
that are used under certain conditions of growth or stress (Gruber & Gross, 2003; Paget & Helmann, 
2003).  As the metabolic state of the cell changes, other sigma factors can dominate and control 
transcription (Table 1.2). 
 
 
Figure 1.6: Schematic diagram of the structural Characteristic of the E.coli σ70. 
 (a) The promoter DNA sequence has been divided into four distinct regions that are recognized by σ 
factors. 
(b) A model based on crystallographic analysis for the interaction of RNA polymerase holoenzyme 
(containing β, β’, 2α, ώ subunit in addition to the σ factor) with promoter DNA and holoenzyme-
model DNA complexes. Adapted from Young et al. 2002 
 
Promoter region -10 elements are recognized by region 2 of the RNA polymerase σ subunit 
(region2.3 and 2.4) (Figure 1.6). The subregion 2.3 is thought to interact primarily with single 
stranded DNA in the open complex (dashed arrow in Figure 1.6). The promoter region -35 element is 
recognized by region 4 (subregion 4.2) of the RNA polymerase σ subunit. The two other important 
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promoter elements are the extended –10 element and the UP element (-40 to -60). The extended –10 
element is a 3 to 4 bp motif located immediately upstream of the –10 hexamer, which is recognized 
by region 3 of the RNA polymerase σ subunit (Murakami et al., 2002a; Bown et al., 1994; Sanderson 
et al., 2003). Whilst,  UP element is a ∼20 bp sequence located upstream of the promoter region –35 
hexamer, which  is recognized by the C-terminal domains of the RNA polymerase α subunits (Ross 
et al., 2001).The discovery that the σ3-σ4 linker is located in the RNA exit channel of the RNA 
polymerase suggests a mechanism of promoter clearance that involves the nascent RNA displacing 
the linker, in turn weakening the interaction between the core RNA polymerase and the σ4 domain 
and ultimately the rest of the σ factor (Murakami et al., 2002a; Vassylyev et al., 2002). 
 
Promoters can also be categorized by their strength; with strong promoters generating high levels of 
transcription whilst weak promoters generate low levels of transcription. In general, strong promoters 
have sequences that are similar to the consensus sequence (Pribnow, 1975). However, studies 
conducted by Hook-Barnard & Hinton (2007) indicate that the direct and indirect interactions of σ 
factor (s) with bases within the consensus elements (i.e. UP elements, -35 region, and -10 region) 
contribute to the strength of promoters. 
 
There are two groups of promoters commonly employed in whole-cells bio-sensing; these are 
constitutive and inducible promoters. Biosensor systems based upon these two types of promoters 
which have different benefits and limitations in bio-sensing (Gu et al., 2004). The use of constitutive 
expression relies upon a promoter that is highly expressed under normal conditions, where the 
expression levels of the bio-reporter signal will change directly with the addition of chemicals of 
interest (Figure 1.7a). Constitutive systems provide an overall picture of the metabolic state of 
individual cells. On the other hand, inducible promoters respond to specific analytes of interest and 
the bio-reporter signals increase when the target analyte is detected (Gu et al., 2004) (Figure 1.7b). 
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Compared to the constitutive systems, inducible systems provides a more sophisticated and specific 
detection of a certain compound. However, the target analyte is restricted to the specific promoter 
gene. 
 
Figure 1.7: The functional behaviour of inducible and constitutive promoters. 
A: The reporter gene fused to a constitutive promoter (Pconst) has high expression levels under normal 
conditions, whilst reporter protein activity decreases when exposed to stress. 
B: is an inducible biosensor fused to an inducible promoter (PInduce) responding to a stress agent 
inducing a stress response. The reporter protein is expressed at high levels under stress conditions, 
but is low or nil under normal conditions. 
 
1.4 : Biological Functions of Promoters 
There are many constitutive promoters that are used for gene expression studies and in biosensors. 
Amongst the many constitutive promoters, five constitutive promoters were selected for the study 
described in this thesis. These promoters were lysyl tRNA synthetase (lysS), ribosomal protein (spc), 
outer membrane lipoprotein (lpp), twin arginine translocase (tatA), and lysine decarboxylase (ldc). 
The biological functions are discussed below. 
 
A 
B 
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1.4.1 : Lysyl-tRNA Synthetase (lysS) 
The role of aminoacyl-tRNA synthetases plays a key role in protein synthesis by catalysing the 
covalent attachment of amino acids to the 3’ end of tRNAs (Chan & Bingham, 1991). Lysyl-
tRNAsynthetase catalyses the formation of lysyl-transfer RNA, and transfers lysine in to 
polypeptides (Freist & Gauss, 1995). Lysine is important for proteins since it is one of only two 
proteinogenic amino acids carrying an alkaline functional group (Freist & Gauss, 1995). In E.coli 
there are two lysyl-tRNAsynthetases encoded by lysS (VanBogelen et al., 1983) and lysU (Emmerich 
et al., 1987). The lysS gene is expressed constitutively (Hirshfield et al., 1984) whilst lysU can be 
induced under selective conditions (i.e. in the presence of L-leucine, L-alanine, or glycyl-L-leucine, 
D-fructose and also at elevated temperature (Hirshfield et al., 1984). The lysS promoter was chosen 
due to its constitutive expression under all growth conditions because of its essential role in protein 
synthesis.  
 
1.4.2 : Ribosomal Protein (spc) 
The genes encoding the 52 ribosomal proteins (r-proteins) of Escherichia coli are organized into 
approximately 19 operons scattered throughout the chromosome (Cerreti et al., 1983). One of these, 
the spc operon, contains the genes for eleven ribosomal proteins including secY (Zengel & Lindahl, 
1994); L14; L24; L5; S14; S8; L6; L18; S5; L30 and L15 (rp1N, rp1X, rp1E, rpsN, rpsH, rp1F, 
rp1R, rpsE, rpmD, and rp1O) (Cerreti et al., 1983).The spc promoter has a long sequence of 2 fold 
symmetry centred within the Pribnow box (Leonard et al.,1978). The spc promoter was chosen due 
to its important role in E.coli, where the synthesis of ribosomal proteins is subjected to tight control 
and regulates ribosome biosynthesis (Leonard et al., 1978). The crucial role of spc in metabolism, 
and its high levels of expression, indicates that it would make an effective constitutive promoter for a 
bioluminescent reporter strain that could be used to monitor toxicity in samples. 
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1.4.3 : Outer membrane lipoprotein (lpp) 
The E.coli outer membrane contains approximately 7.5 x 10
5 
molecules of lipoprotein, which is the 
most abundant protein found in E.coli (Inouye & Inouye, 1985). The strong expression of the gene 
lpp from its promoter contributes to the abundance of the lipoprotein in E. coli (Nakamura & Inouye, 
1982), as does the stability of the lpp mRNA (Hirashima & Inouye, 1972) and the efficient 
translation of the lpp mRNA (Nakamura et al., 1980). The lpp gene is expressed constitutively and 
has an A-T rich promoter region (-45 bp), which suggests it would be an excellent candidate for a 
biosensor (Nakamura & Inouye, 1982).  
 
1.4.4 : Twin-Arginine Translocase (tatA) 
The twin-arginine translocation (tatABCE) operon encodes an export pathway which is found in the 
cytoplasmic membranes of most bacteria (Berks et al., 2003). This functions as an export pathway of 
pre-folded proteins and translocates redox enzymes into the E.coli periplasm (Santini et et al., 1998). 
The tatA gene are expressed constitutively, indicating a requirement for the Tat export machinery 
under all growth conditions. Hence, this suggests it could make a suitable promoter for a whole-cell 
biosensor for monitoring viability. 
 
1.4.5 :  Lysine Decarboxylase (ldcc) 
There are two lysine decarboxylases, one of which is an inducible decarboxylase (CadA) and the 
other is a constitutive decarboxylase (LdcC) (Lemonnier & Lana, 1998). The function of 
constitutive-expressed ldcc is to catalyse the synthesis of putrescine and spermidine, which are 
polyamines that are needed for ribosomal functions and growth (Tabor & Tabor, 1985). 
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Stewart (1990) noted that the speedy response of bioluminescent bacteria to the action of 
antimicrobial substances brings close to reality the prospect of on-line microbial assays for those 
agents. Thus the purpose of the work described in this thesis was to examine the effectiveness of the 
five bioluminescent biosensor constructs towards monitoring the levels of preservatives 
 
1.5 : Preservative Efficacy Testing 
Antimicrobial preservatives are substances added to multi-use products to protect the products from 
microbial contamination and spoilage. Microbes can be introduced inadvertently during 
manufacturing or during the repeated use of a product. The test for Antimicrobial efficacy is used to 
demonstrate the effectiveness of any added antimicrobial preservative(s). This test, also known as the 
preservative efficacy test (PET), is performed to determine if the chosen preservative is appropriate 
for a product formulation. Testing is performed according to compendial requirements of the 
European Pharmacopoeia Section 5.1.3 to evaluate the antimicrobial effectiveness of a product. The 
effectiveness of the preservative is evaluated by comparing the reduction in viable counts of 
microorganisms from their initial level, and is tested at various stipulated time intervals over a period 
of 28 days storage at room temperature. 
1.5.1 : Preservative Efficacy Testing in Accordance with European and British 
Pharmacopeia Regulations 
 
Over the last 20 years or so, a number of alternatives to traditional colony counts methods have been 
developed to enumerate viable microbial cells in foods, pharmaceuticals and cosmetics (Connolly et 
al., 1994). Antimicrobial preservatives are used to prevent or inhibit the growth of microorganisms 
that could present a risk of infection to patients and consumers, or degradation of medicinal and 
other products (Beveridge, 1999). There are many factors that affect the efficacy of a preservative 
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which include the concentration, pH, temperature and chemical composition of the product, the 
physiological condition of the contaminant microorganisms, the presence or absence of interfering 
substances, and the possible chemical interactions of a preservative with containers and closures. 
These aspects must be considered when choosing a suitable antimicrobial agent as a preservative, as 
it is an integral part of a pharmaceutical formulation’s early development (Russell, 2003). However, 
it is difficult to predict accurately the ultimate effectiveness of a preservative in any pharmaceutical 
formulation. Therefore, it is necessary to assess the preservative efficacy in order to provide 
assurance that the product is adequately protected.  
 
The pharmacopoeia published by different authorities, e.g. European Pharmacopeia (EP), British 
Pharmacopoeia (BP), Japanese Pharmacopeia (JP) and United States Pharmacopoeia (USP), each 
describe methods that are intended to assess the efficacy of an antimicrobial preservative. The 
methods vary only slightly from one pharmacopeia to another and they all share basic similarities 
with the same aim. 
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The organisms specified for testing purposes in the current BP (British Pharmacopoeia), USP 
(United States Pharmacopoeia) and EP (European Pharmacopoeia) are standard species and strains. 
The test microorganisms that are to be used are Pseudomonas aeruginosa ATCC 9027 (EP, USP, 
JP), Staphylococcus aureus ATCC 6538 (EP, USP, JP), Candida albicans ATCC 10231(EP, USP, 
JP), Aspergillus niger ATCC 16404 (EP, USP, JP), Zygosaccharomyces rouxii (EP, JP), and 
Escherichia coli ATCC 8739 (EP (oral preparations), USP, JP). 
 
The accepted evaluation is dependent on the type of preparations (i.e. Parenteral and ophthalmic, 
topical, and oral) as shown in in Tables 1.3, 1.4 and 1.5. There are two categories of criteria for 
acceptance described, these are the target (EP-A) and acceptable (EP-B) level criteria. Efficacy 
results at the EP-B level are acceptable if there are good reasons for EP-A levels not being fulfilled. 
 
Table 1.3:  The criteria for evaluating preservative effectiveness in topical formulations as defined by 
the European Pharmacopeia 
  Log10reduction  
  2d 7d 14d 28d 
Bacteria  A 2 3 - NI 
 B - - 3 NI 
Fungi A - - 2 NI 
 B - - 1 NI  
NI = No Increase  
 
 
 
 
 
  
68 
 
Table 1.4:  The criteria for evaluating preservative effectiveness in parenteral and ophthalmic 
formulations as defined by the European Pharmacopeia 
   Log10reduction  
  6 h 24h 7d 14d 28d 
Bacteria  A 2 3 - - NI 
 B - 1 1 3 NI 
Fungi A - - 2 - NI 
 B - - - 1 NI  
NI = No Increase  
Table 1.5:  The criteria for evaluating preservative effectiveness in oral formulations as defined by 
the European Pharmacopeia 
  Log10reduction  
  14d 28d 
Bacteria  A 3 NI 
Fungi A 1 NI 
NI = No Increase  
 
The criteria for evaluating preservative effectiveness for topical formulations indicates that the target 
for reduction (A) of bacterial viable counts is 2 log10 CFU/ml from the initial count at 2 days and 3 
log10 CFU/ml at 7 days with no increase permitted at 28 days, whist the reduction in fungal viable 
counts must be 3 log10 CFU/ml from the initial count at 14 days with no increase permitted at 28 
days. 
 
 For parenteral and ophthalmic preparations, the target reduction (A) for bacterial viable counts is 2 
log10 CFU/ml from the initial count at 6 hours and 3 log10 CFU/ml at 24 hours with no increase in 
counts after 28 days whilst the fungal viable counts must be reduced by2 log10 CFU/ml from the 
initial count at 14 days with no increase at 28 days. In contrast, the criteria for oral formulations do 
not provide target and acceptable criteria. For bacteria, oral products require a 3 log10 CFU/ml 
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reduction in viable counts from the initial count at 14 days and no increase at 28 days, whilst for 
fungi a 1 log10 CFU/ml reduction and no increase is permitted  at 28 days. 
 
Since plate count methods require several days of incubation to yield visible colonies, then viable 
count methods can be time-consuming  (Chollet et al., 2008). Many companies these days 
manufacture products under tight time constraints, and delays in laboratory testing can significantly 
increase the cost of production. Moreover, traditional microbiological techniques require skilled 
personnel for sample handling and interpretation of results  (Morris, 1998). Consequently, 
bioluminescent reporter strains could prove to be an effective alternative to viable counts for 
monitoring changes in microbial population density, and thus find potential applications in 
antimicrobial efficacy testing (Marincs, 2000). 
 
Bioluminescent reporters have the potential to provide continuous real-time results, which means 
that formulations failing the PET acceptance criteria can be identified early on in the process – 
therefore potentially saving a lot of time. Bioluminescent reporters can also be used as a rapid 
screening tool for the selection and development of novel formulations, antimicrobial products and 
preservatives (Naseby, 2006). A constitutive promoter fused to the lux bio-reporter transformed in to 
biosensor microorganisms could serve as a rapid system for preservative efficacy screening. High 
levels of bioluminescence would indicate the presence of a large number of viable microbial cells 
and vice versa under normal conditions. In the presence of preservatives, a reduction in 
bioluminescence would indicate a reduction in the number of viable cells. Consequently, the research 
described in this thesis set out to assess the various features of five novel E. coli biosensor strains in 
monitoring PET constructed at the University of Hertfordshire in testing a selection of preservatives 
with unique modes of antimicrobial action. This work will be described further in chapters 4 and 5. 
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1.6 : Rationale of Study 
The rationale behind this study was to investigate and assess lux bio-reporter constructs controlled by 
five different constitutive promoters transformed into Escherichia coli ATCC 8739 for the 
application as a rapid microbiological method in preservative efficacy test (PET). Stewart (1989) 
stated that the speedy response of bioluminescent signals encoded by lux operon, therefore brings the 
prospect of on-line microbial assays closer to reality. Hence, the hypothesis of this study is that the 
ability of the whole-cell bioluminescence method to replace the traditional plate counting method. 
Therefore, successful evaluation of whole-cell bioluminescent method would make a great 
contribution as a real-time monitoring system in PET.  
 
The promoters play an important role in regulating the bioluminescence gene expression within the 
lux operon. Thus, the promoters’ sequences were analysed, in relation to the level of 
bioluminescence expression and consensus sequences of sigma factors. Sorensen et al. (2006) 
remarked that one of the greatest limitations of whole-cell biosensors is the strength of the promoter. 
Thus, a comparison of the sequence of the five selected promoters with the consensus sequence 
could indicate whether promoter strength was affected by similarity, or otherwise.  
 
In this study, five Escherichia coli ATCC 8739 transformed with five different constructs were 
validated as novel rapid microbiological method according to the regulations recommended by the 
British Pharmacopeia Vol 5 SC IV L & European Pharmacopeia 5.1.6, Section 31, for preservative 
efficacy applications. The criteria of accuracy, precision, reliability, linearity, limit and range of 
detection were assessed. The five E.coli constructs and two control strains were evaluated and 
compared to four other current microbiological testing methods: Plate counting; ATP chemi-
luminescence; Fluorescence Spectrometry; and Epifluorescence Microscopy (Chapter 2). The 
promoter sequences within the -60 to +1 regions of the constructs were analyzed, and compared to 
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the consensus sequences of different σ-factors.  Measurements of whole-cell bioluminescence, 
adenylate energy charge (AEC) and viable counts were evaluated throughout the 28 days of 
incubation to further characterize the constructs. The plasmid copy number (PCN) was determined 
by quantitative polymerase chain reaction (qPCR), to assess the number of plasmid copies/cell 
throughout the incubation period This was performed to ensure that any changes in bioluminescence 
expression levels over the extended incubation periods were not a result of changes to the plasmid 
copy number per cell (Chapter 3). 
 
The constructs were further challenged with two different preservatives in accordance to the British 
Pharmacopeia Appendix XVI C and European Pharmacopeia Section 5.1.3 regulations to assess the 
value of a bioluminescent biosensor as an alternative testing method to conventional microbiological 
approaches (Chapter 4 and 5). 
 
1.7 : Aim 
1) The aim of this project was to assess five genetically modified E.coli constructs as novel 
rapid real time reporters for their application in preservative efficacy studies (PET) studies in 
replacement of conventional plate counting method. 
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Chapter 2 
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2 : The Validation of the Five Bioluminescent reporter strains E. coli 
Constructs- as a Rapid Real Time Microbiological Testing Method. 
 
2.1 : Introduction  
Microbial analysis of food, cosmetic, and pharmaceutical products are an integral part of the 
management of microbial safety. Both control authorities and individual business operators monitor 
microbial levels in order to detect emerging microbial risks. Microbial analysis is also a valuable tool 
for compliance testing to define microbiological criteria or to assess the performance of management 
strategies based upon Hazard Analysis Critical Control Points (HACCP). Standardized methods (e.g. 
ISO and Pharmacopoeia methods) are acknowledged to be the gold-standard analytical methods for 
assessment of microbial load (Jasson et al., 2010). These standardization methods involve classical 
culturing methods using broth and media to grow, isolate or enumerate bacterial cells. These 
methods have been developed historically based upon expertise and decided upon by international 
consensus (Jasson et al., 2010). These classical culture methods are still used by many labs, and 
especially by regulatory agencies, because they are harmonized methods. However, a serious 
drawback is that they are laborious, demand large volumes of liquid, solid media and reagents, and 
involve time consuming procedures-both in operation and data collection. The term ‘rapid method’ 
can be defined as any method or system that reduces the time taken to obtain a microbiological result 
(Feng, 1996; Fung, 1994). In addition, rapid methods may also be automated to improve efficiency 
in handling multiple/large samples.  
 
Because of the many rapid microbiological methods available, it is important to develop a 
comprehensive and holistic approach for the validation process to ensure that a given rapid 
microbiological testing method is suitable for its intended use. Rigorous scientific validation is a 
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critical part of obtaining regulatory approval for a rapid microbiological testing method (Riley, 
2004). A new method should be at least equivalent to the existing methods. Since the existing 
methods are predominantly the microbial growth based compendia methods, a comparison should be 
made between the new and the compendia methods. In order to determine validity between the old 
and new methods, this is discussed in the following text (British & European Pharmacopeia).  
 
2.1.1 : Validation Criterias’ set by the Pharmacopoeia Regulations  
The essential criteria for validation of a method are its accuracy, precision, specificity, limit of 
detection, range, linearity, and robustness (British & European Pharmacopoeia; PDA, 2000). 
 
Accuracy is defined as the closeness between the results of a new test method with the compendia 
methods (British & European Pharmacopoeia; PDA, 2000). Since the expected results are usually 
based on the existing method, a test of accuracy is essentially a comparison between the old and new 
methods. The accepted criterion is that the new method should give equivalent or better results than 
the current method. A standard deviation of ± 0.3 is accepted for a new microbiological method 
(British & European Pharmacopoeia; PDA, 2000). The accepted criterion is at least 70% recovery 
(British & European Pharmacopoeia; PDA, 2000). 
 
Precision is defined as the degree of agreement among individual test results when the procedure is 
applied repeatedly to multiple samplings or suspensions across the range of test. Precision can be a 
measure of either the degree of reproducibility or the repeatability of the new microbiological 
method under optimum conditions. The recommended statistical method of comparing the precision 
of the two methods is the application of the F value.  If the calculated ratio for that degree of freedom 
exceeds the value in the F distribution table, a significant difference exists between the precision of 
the two methods (British & European Pharmacopoeia; PDA, 2000). 
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Limit of detection is the lowest number of microorganism in a sample that can be detected or 
counted. The limit of detection is particularly important for qualitative tests. 
The working range of assay is defined as the interval between the upper and lower levels of 
microorganisms that have can be determined with precision, accuracy, and linearity with the new 
microbiological method.  
 
The linearity of a microbiological test method is its ability to furnish results which are proportional 
to the concentration of microorganisms present in the sample, within a given working range. The 
criterion for acceptable criterion of correlation of coefficient is 0.9 or better.  
 
 The robustness/ ruggedness of an assay is defined as its ability to tolerate slight deviations in test 
parameters and still provide accurate results.  
 
An ideal rapid method would enable a ‘real time’ measurement of microbial content in a sample. 
Furthermore, rapid tests are very useful tools in hazard analysis and critical control points (HACCP) 
programmes and in conditions where microbial analysis is required, instead of relying on laborious 
methods that take hours or days to yield results.  
2.2 : Rational of Chapter 2 
 
This chapter focuses on the validation process for a whole-cell bioluminescence method, to be used 
as an alternative rapid method against the compendia method (i.e. conventional plate counting). 
Validation was performed following the guidelines of the Parenteral Drug Association (PDA) 
Technical Report No 33 ‘Evaluation, Validation, and Implementations of New Microbiological 
Testing Methods’, as described by the British Pharmacopoeia Volume 5 SC IV L and European 
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Pharmacopoeia Chapter 5.1.6.  The validation criteria examined were accuracy, precision, limit of 
detection, linearity, range and equivalence. Three other current methods: ATP-bioluminescence; 
fluorescence spectrometry; and epifluorescence microscopy were performed for comparison with the 
whole-cell bioluminescence method. The bioluminescence expression levels exhibited by the five 
bioluminescent reporter strains E. coli strains were evaluated. The promoter regions of the five 
promoters were identified and compared with the consensus sequences of RpoD (σ70/D). The aim of 
this was to determine whether the promoter strength of the five constructs was affected by similarity, 
or otherwise, to the consensus sequence.  
 
 
Figure 2.1: Summarises the various steps employed in chapter 2 
 
 
 
Validation of Genetically 
modified E.coli as a Rapid 
Microbiological Method 
1) Accuracy 
2) Precision 
3) Equilvalence 
4) Lineraity 
5) Limit of Detection 
6) Range  
Comparison with 
conventional and alternative 
methods 
Conventional Plate count 
ATP Bioluminescence 
Fluorescence 
Spectrometry 
Epifluorescence 
Microscopy 
Comparison with RpoD 
(σ70/D)  consensus seqeunces  
1) -10 & -35 regions 
2) -60 to -40 region 
3) Inter space regions 
between -10 & +1 
4) Inter space between -10 
& -35 regions 
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2.3 : Objectives 
1) To validate the five constructs for their accuracy, precision, equivalence, linearity, range and 
limit of detection in accordance to the European and British Pharmacopoeia as a rapid 
microbiology method for future preservative efficacy test  
2) To compare and contrast the whole-cell bioluminescence method with the plate count 
method, ATP-bioluminescence, fluorescence spectrometry, and epifluorescence microscopy 
counts. 
3) To identify the promoter regions, and to compare them with the RpoD (σ70/D) consensus 
regions of -10 and -35, the spacer lengths between -10 and -35, AT (%) of -60 to -40 regions, 
and GC (%) between the -10 and +1 regions are analysed. 
 
  
78 
 
2.4 : Materials and Methods  
2.4.1 : Construction of Bioluminescent Reporter Strains E. coli 
The E. coli ATCC 8739 constitutive promoters used in this study are shown in Table 2.1. The plasmid 
pSB417, containing a 5.8kbp lux cassette, was obtained from Dr. Michael Winson (Winson et al., 1998). 
The lux cassette was flanked at either end by an EcoR1 and BamH1 restriction site. The lux cassette was 
also excised by double restriction; using a total volume of 20 µl that consisted of 1 x Multicore buffer 
(Promega), 1.5 µg pSB417, 2 µg BSA, 10 U EcoR1 (Invitrogen) and 10 U BamH1 (Promega). Reactions 
were carried out at 37
ᵒ
C for 4 hours, and restriction enzymes were inactivated at 80
ᵒ 
C for 10 minutes. 
Success of the reaction was determined by 1.0 % (w/v) agarose gel electrophoresis, and the 5.8 kbp 
fragment was purified using the QIAquick Gel Extraction Kit (Qiagen) as outlined in the manufacturer’s 
protocol.  
 
Plasmid pBR322 was obtained from Promega and restricted with restriction enzymes EcoR1 and 
BamH1 using the procedure described above for pSB417. Plasmid pBR322/lux was constructed by 
ligation of the purified 5.8 kbp lux cassette from pSB417 to the restricted pBR322. After the addition of 
0.2 U of T4 DNA ligase (Invitrogen) and 1 x ligase buffer (Invitrogen) to give a final reaction volume of 
20 µl, the pBR322/lux mix was heated to 65
ᵒ 
C and cooled rapidly to 4
o 
C for 16 h. 
 
Constitutive promoters were isolated using the primers shown in Table 2.1. The forward primers had an 
artificial EcoR1 restriction site designed into the 5’end. An ‘in frame’ artificial stop codon and a SnaB1 
restriction site were designed into the 5’end of each reverse primer. The promoter regions were 
amplified by PCR with addition of the following reagents: 200 µM of each deoxynucleoside 
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triphosphate (dNTP); 0.5 µM of each reverse and forward primers; 2.5 mM MgCl2; 1 x PCR buffer; 1 U 
platinum Taq DNA polymerase (Invitrogen), and 5 µl of genomic template. The thermal cycling 
conditions for the PCR reactions were initial denaturation at 94°C for 2 minutes, followed by 35 cycles 
of denaturation at 94°C for 30s, annealing at 60°C for 30s and extension at 72°C for 30s. A final 
extension at 72°C for 10 minutes was then performed. The PCR products were analysed by 1.0% (w/v) 
agarose gel electrophoresis and stained with ethidium bromide. 
 
Plasmid p322/lux (0.9ug) was digested in a 50 ul reaction consisting of 25 U of EcoR1 (Invitrogen) and 
SnaB1 (New England Biolabs), 1 x Multicore buffer (Promega) and 5 ug BSA (New England Biolabs). 
Approximately 0.5 ug of each of the purified promoter regions described above were also digested in a 
total reaction volume of 50 ul consisting of 25 U of EcoR1 and SnaB1, 1 x Multicore buffer and 5ug 
BSA. Each digestion reaction was performed at 37
o
C for 4 h followed by inactivation of the enzymes at 
80
o
C for 10 min. The pBR322/lux construct was restricted and each of the individual promoters was 
then ligated with it using DNA ligase. The plasmid pBR322/lux constructs were then transformed by 
electroporation into electrocompetent E. coli ATCC 8739 cells. The transformation was performed using 
a Gene-Pulser system (Bio-Rad) under the following conditions: 25µF; 2.5 kV; and 200 ohms. Figure 
2.2 illustrates the construct. 
 
To perform DNA sequencing of the constructs, the plasmid was extracted from the transformed E. coli 
ATCC 8739 using the QIAprep Spin Miniprep kit (Qiagen). The forward primer sequence 5’-
ACAAATAGGGGTTCCGCGCA-3’ and the reverse primer sequence 5’-
TCACGAATGTATGTCCTGCGTC-3’ were used for the DNA sequencing analysis of the construct 
promoter regions with PCR conditions of; initial denaturation at 94°C for 2 min followed by 35 cycles 
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of denaturation at 94°C for 30 s, annealing at 50°C for 30 s and extension at 72°C for 1 min. A final 
extension at 72°C for 10 min was then performed. Sequencing was performed in accordance with the 
protocol of GATC biotech sequencing. The E. coli ATCC 8739 biosensor strains were constructed by Dr 
Daniel Hoeffl in 2007. 
 
 
Table 2.1: Forward and reverse primers used for amplification of the constitutive promoters 
 
Promoter region  Forward Primer (5’-3’) Reverse Primer (5’-3’) 
PlysS (Lysyl tRNA 
synthetase) 
CTTCAAGAATTCATGTCG 
ATACCGCCCTCTGG
1
 
CTGATTACGTAGTCATTC 
CGTGAGGTCCTGAATGGGA
2
 
Pspc (Ribosomal Protein 
operon) 
CTTCAAGAATTCTTGAAA 
TCCGCGGAATGCCGT 
CTGATTACGTAGTCAGTT 
GTCGGCGACGTTCAGCA 
Plpp (Outer Membrane 
Lipoprotein) 
CTTCAAGAATTCTGTATA 
TCGAAGCGCCCTGATG 
CTGATTACGTAGTCATGC 
CAGCAGAGTAGAACCCAGGA 
PtatA (Twin-arginine 
Translocase) 
CTTCAAGAATTCACATTC 
TTGTTGGTCAGCCGA 
CTGATTACGTAGTCAATC 
GGAACCGATGGAGCCGAGC 
Pldc (Lysine 
Decarboxylase) 
CTTCAAGAATTCTGATCG 
ACTCCATCATCCCGGA 
CTGATTACGTAGTCACG 
ACTCCAGTTCTTTGATGGGCTC 
1 
Underlined sequences indicate either EcoR1 sites (for the forward primers) or SnaB1 sites (for the reverse 
primers). 
2
 Bold sequences indicate an artificial ‘in frame’ stop codon 
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Figure 2.2: a) A diagram of the modified pBR322 vector into which the bioluminescent reporter cassette 
was inserted. b) A schematic diagram of the bioluminescent reporter construct denoted as [1]. P denotes 
the promoter, and can represent either lpp, tatA, ldc, lysS or spc. The promoter and lux operon fusion 
was ligated into position 1 of the plasmid in Figure 2.2a. 
 
2.4.2 : Media and Solutions  
The transformed E. coli strains were maintained on tryptone soy agar (TSA) (Oxoid) with the addition 
of 100 µg/ml ampicillin. A single colony of each culture was inoculated into 10 ml tryptone soy broth 
(TSB) and grown overnight aerobically at 32
o
C to produce a starter culture for the experiments (as 
specified by the E.P & B.P). For all experiments, a 50µl volume of the overnight starter culture of each 
strain was inoculated into 50 ml of TSB supplemented with 100 µg/ml ampicillin, except for the 
untransformed E. coli ATCC 8739 parental strain. The bioluminescent reporter strains E. coli strains: E. 
coli [pBR322. lpp-lux] (which will be referred to as lpp-lux E. coli through the remainder of the text); E. 
BamH1 EcoR1 SnaB1 
luxC luxD luxA luxB luxE P 
a) 
 
b
) 
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coli [pBR322. tatA-lux] (tatA-lux E. coli); E. coli [pBR322. ldc-lux] (ldc-lux E. coli); E. coli [pBR322. 
lysS-lux] (lysS-lux E. coli); E. coli [pBR322. spc-lux]) (spc-lux E. coli); and also the control E. coli 
ATCC 8739 [pBR322.lux] and E. coli ATCC 8739 strains were incubated aerobically on an orbital 
shaker (Thermo Scientific) at 100 rpm, 32 
o
C for 24 hours. Cultures were diluted tenfold in buffered 
peptone water (10
-1
 to 10
-8
) (BPW) (Oxoid) in readiness for the experiments described in section 2.4.3, 
2.4.4, 2.4.5, 2.4.6, and 2.4.7. This was carried out in five replicates. 
 
2.4.3 : Bioluminescence Determination  
Relative light units (RLU) were measured using a Celsis Advance Luminometer. The Celsis Advance 
Luminometer is designed to run bioluminescence assays using an automated sampling system. 
 
Volumes (1.0 ml) of each dilution, prepared in section 2.4.2 above, were transferred to culture tubes 
(Fischer Brand disposable borosilicate glass culture tubes 12 x 75 mm) and the bioluminescence 
readings measured with the Celsis Advance Luminometer. This experiment was repeated 5 times. A 
blank control containing buffered peptone water was used. The true bioluminescence readings were 
calculated by subtracting the blank value from the found value and then division of the result by the 
dilution factor as in equation 2.1. 
 
                          
   
  
               
               
………………………….. Equation 2.1 
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Figure 2.3: The Celsis Advance Luminometer (http://www.celsis.com/rapid/celsis-systems/advance-
system/advance-luminometer) 
 
2.4.4 : Viable Counts Determination 
The viable counts of the E. coli strains were determined by spread-plating 100µl of the 10
-7
 and 10
-8
 
diluted culture, prepared as described in section 2.4.1 above, onto TSA agar containing 100 µg/ml  
ampicillin. Colonies were counted after incubation at 32 
ᵒ
C for 72 hours. CFU/ml counts was calculated 
based on the average of five replicates divided by the dilution factor and multiplied by the inverse of the 
volume used (0.1 ml) as in equation 2.2. 
 
                              
               
         ………………………………….. Equation 2.2 
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2.4.5 : ATP-Chemiluminescence Determination  
2.4.5.1 : Preparation of samples 
Volumes (1.0ml) of the bacterial suspension, prepared as described in section 2.4.1 above, were 
centrifuged at 8000 xg for 4 minutes (Accu Spin Micro, Fisher Scientific). Supernatant of culture were 
discarded and cell pellet was washed by resuspending and centrifugation with 1.0ml of cold sterile 
deionized water to get rid of any broth, three times repetitively. Pellets were resuspended and vortexed 
with 1.0ml of dilution buffer (Roche). Subsequently, a 500µl volume of cell lysis reagent (Roche) was 
added to the resuspended pellets, and the mixture incubated for 5 minutes at 20 ± 2.5
ᵒ
C.  After mixing, 
the samples were centrifuged for 2 minutes at 8000 xg. Finally, 500µl of the supernatant was transferred 
to a sterile culture tube and kept on ice until measurement was performed. 
 
The ATP Bioluminescence Assay Kit HS II (Roche) was used for the ATP chemiluminescence 
determination. Lyophilised ATP (Roche) was diluted (1:10) in dilution buffer, and concentrations 
ranging from 10.8 fg/ml to 108 µg/ml were prepared – these were expressed as -log mg/ml. Controls for 
background luminescence (Dilution Buffer) were run using Celsis Advanced luminomter, and these 
readings were subtracted from the sample readings. 30.0ml of dilution buffer was added to the 
lyophilized luciferin-luciferase enzyme mix. The Celsis Advanced luminometer was programmed to 
dispense 200µl of luciferin-luciferase reagent (Roche) into each experimental sample. The luminometer 
injector was washed with 70% ethanol and rinsed twice with sterile distilled water before use. All ATP 
preparations were carried out in a BIOMAT
2
 Class Microbiological Safety Cabinet to maintain sterility. 
Gloves were worn at all times to avoid any exogenous ATP contamination of the reagents. Reagents and 
samples were kept on ice at all times to avoid loss of enzymic activity. The luciferase enzyme was 
mixed by inversion and not by vortexing, as required by the manufacturer’s protocol. 
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2.4.6 : Determination of Fluorescence readings of Viable Cells Using LIVE/DEAD stains 
A 1.0 ml volume of each dilution (10
0
- 10
-6
), prepared as described in section 2.4.1 above, was 
centrifuged (13,000 xg) for 2 minutes (Accu Spin, Fisher Scientific) and resuspended with 1.0 ml of 
0.85% NaCl. A 1ml volume of the cell suspension was stained with 1 μl of fluorochrome dyes (0.5 μl of 
each) SYTO-9 and propidium iodide (PI) (BacLight Live/Dead kit, Molecular Probes). The mixture was 
incubated for 15 minutes in the dark at 20 
o
C, before 200 μl of each sample was pipetted into separated 
wells of a 96-well black/white microtiter plate. The fluorescence of the samples was measured using a 
Promega GloMax detection system with blue filters (excitation at 490 nm, emission at 510-570 nm) and 
green filters (excitation at 525 nm, emission at 510-570 nm). A control with sterile deionized water was 
used to determine the background fluorescence. True fluorescence readings were calculated by the 
deduction of the control readings from the sample readings and division of the result by the dilution 
factor and multiplication by the volume used (0.2 ml) as in equation 2.3.  This was repeated 5 times for 
each sample. 
 
                           
               
          ……………………….. Equation 2.3 
2.4.7 : Epifluorescence Microscopy Counts 
 
Samples of the 10
-1 
- 10
-3
 bacterial suspensions, prepared as described in section 2.4.1 above, and mixed 
with the BacLight Live/Dead dyes were enumerated using an Improved Neubauer haemocytometer and 
a fluorescence microscope (Nikon EFD-3) with UV lamp (Nikon Hg lamp), under the following 
conditions: excitation at 410-490nm, emission at 505-520nm; and 1000x magnification . The bright 
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green viable cells were counted within a total of 20 (0.005cm x 0.005 cm) with   a  relevant  dilution  
which yielded  5  to  20  bacteria  per small  square squares (volume of each: 0.25 x 10
-6
 cm
3
. The 
calculation of total viable cells were done by taking the total of  30 squares divided by the proportion of 
chamber counted and multiplied by the volume of the chamber (4.0 x 10
-6
 cm
3
). The final total viable 
cell count (TVC) was obtained by dividing the count by the dilution factor as in equation 2.4. 
 
                       
                                        
   
 
               
 …………………………….. Equation 2.4  
 
2.4.8 : Statistical Analyses 
 
Initially, a Shapiro-Wilk normality test was carried out for all data obtained in sections 2.4.1 to 2.4.7 
whereby the alpha value tested was α=0.05. The null hypothesis was that the population tested was 
normally distributed.  The P value obtained was less than 0.05 indicating that the null hypothesis should 
be rejected. Thus the raw count data were found to be not normally distributed. Consequently, all 
readings were log-transformed to ensure that they conformed to a normal distribution before performing 
further statistical analyses. Two way ANOVA; Post Hoc Tukey analysis and Pearson’s Correlation 
analysis (α= 0.05) of the data were performed using IBM SPSS statistics Version 20. Standard means of 
errors (SEM) were calculated by standard deviations (S.D) of replicates divide square root of replicates 
(n). 
 
  
……………………………………………….. Equation 2.5 
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2.4.9 : Validation  
The novel bioluminescent method was validated and compared with the four current microbial analytical 
methods to determine the reliability of the whole-cell bioluminescent method for microbial analysis: the 
standard plate counting method; ATP chemiluminescence; fluorescence spectrometry; and 
epifluorescence microscopy. The following parameters were evaluated for the validation: accuracy; 
precision; equivalence; limit of detection; linearity; and range (B.P & E.P). 
1. The accuracy of the whole-cell bioluminescence assay and conventional plate counting method 
were determined by preparing a suspension of the microorganism at the upper and lower end of 
the working range for the assay. The whole-cell bioluminescence and colony forming unit 
readings were obtained upon the testing of 10
8 
CFU/ml as the upper limit and a 10
4
 CFU/ml as 
the lower limit. The readings obtained were regarded as the actual result (100%). A further 
dilution in BPW of (i.e. 75%, 50%, 25%, and 10%) made from the upper and lower range, were 
regarded as the expected result. The expected results were divided by the dilution factor (i.e. 
75%, 50%, 25%, and 10%). The recovery results for both range were obtained by the ratio of 
expected to the actual reading multiplied by hundred per cent.  The average recoveries of the 
upper and lower limit were deduced.  
 
2. The range of precision was determined at suspension of whole-cell bioluminescence (RLU/ml) to 
plate counts at 10
8
, 10
7
. 10
6
, 10
5 
and 10
4
 CFU/ml. The SEM was calculated of whole-cell 
bioluminescence readings and plate counts; a relative standard deviation in the 15% to 30% 
range is acceptable according to the Pharmacopoeia standards. Statistical analysis was performed 
using the F-test to obtain the F value for precision comparisons between the whole-cell 
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bioluminescence and conventional plate counting method. The F value obtained was then 
compared to the  expected F value in the F-distribution table. 
 
3. The equivalence of the novel bioluminescent reporter to the standard test methods was tested at 
the range of suspensions (10
8
, 10
7
. 10
6
, 10
5
, 10
4 
and 10
3 
CFU/ml) as above in the precision 
section. The results of the whole-cell bioluminescence assay and the conventional plate count 
method were compared by two-way ANOVA (α= 0.05). 
 
4. The minimum limit of detection (MDL) of the ATP-chemiluminescence, fluorescence 
spectrometry and epifluorescence microscopy method was determined by producing serial 
dilutions of the bacterial suspensions graph and plotted against whole-cell bioluminescence 
readings. The lowest level of whole-cell bioluminescence was deduced and incorporated to the 
y=mx+c equations in the whole-cell bioluminescence vs CFU counts graph to obtain the MDL in 
CFU counts. 
 
5. The linearity was determined by calculating the correlation coefficient of whole-cell 
bioluminescence, ATP chemiluminescence, fluorescence spectrometry and epifluorescence 
microscopy readings and CFU counts; linearity of whole-cell bioluminescence and ATP-
chemiluminescence, fluorescence spectrometry and epifluorescence microscopy were obtained 
by Pearson`s correlation.  
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6. The range was determined from the lowest limit of detection (CFU/ml) to the highest limit of 
detection (CFU/ml) for whole-cell bioluminescence, ATP chemiluminescence, fluorescence 
spectrometry and epifluorescence microscopy methods. 
 
The time taken per sample analysis (minutes), preparation time per sample (minutes) and incubation 
time (hours) were recorded throughout this study. The average time to perform the procedure was 
calculated from the times taken to perform each method 10 times. The time taken per sample 
analysis included the time taken: to prepare the dilutions; by the equipment processing the samples; 
and incubation times for the ATP-chemiluminescence, fluorescence spectrometry and 
epifluorescence microscopy methods. The preparation time also included the time needed to prepare 
the universal bottles, pipette tips, eppendorf tubes, diluents, and agar for autoclaving. 
 
2.4.10 : Bioinformatics Analysis of the Promoter Regions 
The GATC sequencing results obtained were analysed using the BPROM Softberry programme. The 
Softberry programme allows tabulation of sequences specifically on the bacterial -10 and -35 promoter 
regions (http://www.softberry.com). Other promoter regions were also tabulated concurrently (the -40 & 
-60 regions, the inter-regions between -10 and +1, and the inter-regions between -10 and -35). 
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2.5 : Results 
This results section contains experimental results for the validation process, and bioinformatics 
tabulation of promoter sequences 
Sections 2.5.1, 2.5.2, 2.5.3, 2.5.4, 2.5.5, and 2.5.6 contain data for the validation of the bioluminescent 
reporter strains constructs, whilst section 2.5.7 relates the promoter strength to the consensus sequences 
of RpoD (σ70/D). 
 
2.5.1 : Recovery Determination of Bioluminescence and Plate Counting  
Bioluminescence recoveries (%) were higher than plate count recoveries at high bacterial suspensions 
(Table 2.2) for tatA-lux and lysS-lux (125.61% and 135.19%), whilst lpp-lux, ldc-lux, and spc-lux 
(87.18%, 86.17%, and 87.18%) showed recoveries similar to the conventional method at high bacterial 
suspension (87.71 – 99.60%). The range of recoveries for the whole-cell bioluminescence at high 
concentration was 86.71-135.19 %, compared to 82.1-133.19% for the conventional plate counting 
method. 
 
At low bacterial suspensions, the plate count method resulted in a greater percentage of recovery 
(102.21% - 139.17%) compared to the whole-cell bioluminescence method (78.17 – 112.68%). The 
overall recoveries percentages of the bioluminescence method were 78.71 – 135.19% which was similar 
to the plate count method (82.10-139.17%). 
 
No significant difference was found in the recoveries of the whole-cell bioluminescent and conventional 
plate count method for both concentrations. 
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Table 2.2: The average recoveries (%) obtained for the whole-cell bioluminescence and conventional 
plate count methods in high (10
8
 CFU/ml) and low (10
4
 CFU/ml) bacterial concentration 
 
Bioluminescent 
reporter strains E. coli 
Strain 
High bacterial concentration Low bacterial concentration 
 Average 
Bioluminescence 
Recovery (%)
#
 
Average Conventional 
Plate count Recovery 
(%)
#
 
Average 
Bioluminescence 
Recovery (%)
#
 
Average Conventional 
Plate count Recovery 
(%)
#
 
Lpp-lux 87.18(±0.125)
 ns
 99.6(±0.075)
 ns
 83.76(±0.075)
 ns
 137.01(±0.14)
 ns
 
TatA-lux 125.61(±0.125)
 ns
 98.81(±0.01)
 ns
 112.68(±0.01)
 ns
 139.17(±0.15)
 ns
 
Ldc-lux 86.71(±0.12)
 ns
 87.65(±0.02)
 ns
 79.38(±0.01)
 ns
 128.81(±0.12)
 ns
 
LysS-lux 135.19(±0.15)
 ns
 82.10(±0.02)
 ns
 78.71(±0.08)
 ns
 114.39(±0.08)
 ns
 
Spc-lux 87.18(±0.125)
 ns
 87.71(±0.08)
 ns
 81.70(±0.08)
 ns
 125.56(±0.01)
 ns
 
E. coli [pBR322-lux] n/a 133.19(±0.03) n/a 129.86(±0.05) 
Wildtype E. coli 
ATCC 8739 
n/a 101.28(±0.04) n/a 102.21(±0.03) 
# 
The average bioluminescent/ plate count recoveries of high (10
8
CFU/ml) / low (10
4
CFU/ml)/ bacterial suspensions at 75%, 
50%, 25%, and 10%. (n=5, ± S.E.M) 
ns
 denotes no significant difference between the whole-cell bioluminescence and conventional plate count methods
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2.5.2 : Determination Of The Precision And Equivalence Of The Whole-Cell 
Bioluminescence Method And Compared To The Conventional Plate Counting 
Method  
 
To determine the precision of the whole-cell bioluminescence method in comparison with the plate 
counting method, the F-test was applied and the results of this analysis are shown in Table 2.3 The 
critical value obtained from F distribution, F4,18;0.05=2.93. The calculated F values obtained were, in 
increasing order tatA (F= 1.715), lpp (F=1.717), ldc (F=1.849), spc (F=1.884), and lysS (F=2.656). The 
most precise construct is tatA followed by lpp, ldc, spc, and lysS. The F values obtained by the 
bioluminescent reporter strains strains were lower than the critical value (F=2.93) from the F distribution 
signifying no significant difference between the two methods 
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Table 2.3: The Precision analysis of the Whole-Cell Bioluminescence Method Compared to the Plate Count 
Method over a Range of Concentrations. 
Bioluminescent 
reporter strains E. coli 
Strain 
 Serial dilution of Bacterial Suspension Statistical 
Analysis  
Dilution 
Factor 
Bioluminescence (Average 
log10 RLU/ml)
 #
 
Plate count (Average log10 
CFU/ml)
 #
 
F-Value
+
 (P-
value)
++
 
     
lpp-lux 
 
10 
0
 7.36 (±0.04) 8.5(±0.05) 1.717, (p= 0.18) 
10
-1
 7.32(±0.01) 7.5(±0.05) 
10
-2
 6.54(±0.05 6.5(±0.05) 
10
-3
 5.65(±0.01) 5.5(±0.05) 
10
-4
 4.69(±0.02) 4.5(±0.05) 
 10
-5
 3.72(±0.02) 3.5(±0.05)  
tatA-lux 10 
0
 6.37(±0.02) 8.53(±0.08) 1.715,  (p=0.15) 
 10
-1
 6.40(±0.05) 7.53(±0.08) 
10
-2
 5.50(±0.05) 6.53(±0.08) 
10
-3
 4.60(±0.03) 5.53(±0.08) 
10
-4
 3.61(±0.008) 4.53(±0.08) 
 10
-5
 2.71(±0.02) 3.53(±0.08)  
ldc-lux 10 
0
 5.99(±0.03) 8.58(±0.08) 1.849, (p=0.12) 
 10
-1
 6.12(±0.02) 7.58(±0.08) 
10
-2
 5.18(±0.06) 6.58(±0.08) 
10
-3
 4.24(±0.01) 5.58(±0.08) 
10
-4
 3.32(±0.01) 4.58(±0.08) 
 10
-5
 2.42(±0.012) 3.58(±0.08)  
lysS-lux 10 
0
 5.87(±0.03) 8.65(±0.08) 2.656, (p=0.09) 
 10
-1
 5.95(±0.04) 7.65(±0.05) 
10
-2
 5.02(±0.03) 6.65(±0.05) 
10
-3
 4.12(±0.03) 5.65(±0.05) 
10
-4
 3.27(±0.10) 4.65(±0.05) 
 10
-5
 2.33(±0.12) 3.65(±0.05)  
spc-lux 10 
0
 6.57(±0.04) 8.64(±0.09) 1.884, (p=0.1) 
 10
-1
 6.71(±0.08) 7.64(±0.09) 
10
-2
 5.86(±0.05) 6.64(±0.09) 
10
-3
 4.92(±0.05) 5.64(±0.09) 
10
-4
 4.02(±0.07) 4.64(±0.09) 
 10
-5
 3.06(±0.03) 3.64(±0.09)  
# The average bioluminescent and plate count in a tenfold dilution series (n=5 ± S.E.M)) 
+The degrees of freedom analysed were F4,18;0.05=2.93, no significant difference 
++ P value obtained from ANOVA at α=0.05 
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Figure 2.4 (a): The relationship between bioluminescence and viable counts for each of the biosensor strains. 
The equations for each of the lines are as follows: lpp y=0.8857x+1.042; tatA y=0.794x+1.064; ldc 
y=0.9271x+0.9455; lysS y=0.9254x+1.0143; spc y=0.8987x+0.8448. The correlation coefficient for each was 
lpp R
2
 = 0.976; tatA R
2
 = 0.988, ldc R
2
 = 0.968, lysS R
2
 = 0.963and spc R
2
 = 0.971. 
 
 
Figure 2.4 (b): The relationship between ATP-chemiluminescence and viable counts for each of the biosensor 
strains. The correlation coefficient for each was lpp R
2
 = 0.965; tatA R
2
 = 0.954; ldc R
2
 = 0.917; lysS R
2
 = 
0.939; spc R
2
 = 0.881; E. coli [pBR-322.lux] R
2
 = 0.848; and E. coli ATCC 8739 R
2
 = 0.848. 
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Figure 2.4 (c):  The relationship between fluorescence values and viable counts. The correlation coefficient for 
each was lpp r
2
 = 0.936; tatA R
2
 = 0.914; ldc R
2
 = 0.856; lysS R
2
 = 0.766; spc R
2
 = 0.851; E. coli [pBR-322.lux] 
R
2
 = 0.864; and,E. coliATCC 8739 R
2
 = 0.864. 
 
 
 
Figure 2.4 (d):  Relationship between total viable count (TVC) from microscopic counts using LIVE/DEAD 
stains and viable counts (plate counting method ) of all constructs and strains. The correlation coefficients (r
2 
Lpp=1.00, TatA=1.00, Ldc=1.00 LysS= 1.00 and Spc= 1.00, E. coli [pBR-322.lux]=1.00, E. coli ATCC 
8739=1.00). 
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2.5.3 : Trends and relation to conventional plating method 
Figures 2.4 (a, b, c, and d) show the relationships of CFU against four microbial quantification methods. 
(i.e. Whole-cell Bioluminescence, ATP-chemiluminescence, Fluorescence spectrometry, and 
epifluorescence microscopy). Bioluminescence readings was lower at high populations (8.5 ± 0.05 log10 
CFU/ml), compared to bioluminescence readings at 7.5 ± 0.05 log10 CFU/ml. Never the less, strong 
correlations were obtained for bioluminescence readings of five bioluminescent reporter strains 
constructs (R
2
= 0.963-0.988) against the compendia plate counting method. The ATP-bioluminescence 
method displayed strong correlations in relation to conventional plate count method (|R
2
= 0.881-0.965). 
At low concentration of CFU/ml, the ATP bioluminescence levels were concentrated at about 10
4
 
RLU/ml, for the bioluminescent reporter strains constructs and control strains. The relation of 
fluorescence spectrometry method and conventional plate count method follows a sigmoid curve where 
the reading plateaus at mid CFU concentration (10
6
 CFU/ml) with significant correlation readings of 
R
2
= 0.776-0.936 (P ≤ 0.05, Pearson Correlation). The epifluorescence method resulted in correlation 
coefficient of R
2
= 1.00 throughout all constructs and control strains.  
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Figure 2.5 (a):  The relationshiop between bioluminescence and fluorescence values for each of the 
biosensor strains. The correlation coefficient for each was (lpp R
2
= 0.978; tatA R
2
= 0.948; ldc R
2
= 
0.900; lysS R
2
= 0.827; and spc R
2
= 0.971. 
 
 
Figure 2.5 (b):  The relationship between bioluminescence and ATP-chemiluminescence for each of the 
biosensor strains. The correlation coefficient for each was lpp R
2
 = 0.993; tatA R
2
 = 0.976; ldc R
2
 = 
0.957; lysS R
2
 = 0.955; and spc R
2
 = 0.907. 
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Figure 2.5 (c):  The relationship between bioluminescence and viable counts from microscopic counts 
using LIVE/DEAD stains for each of the biosensor strains. The correlation coefficient for each was (lpp 
R
2
 =0.976; tatA R
2
 =0.988; ldc R
2
 =0.968; lysS R
2
 = 0.963; and spc R
2
 = 0.971). 
 
2.5.4 : Trends and relation to Bioluminescence Method 
There was an increasing trend of ATP-bioluminescence, fluorescence units, and total viable counts 
observed in all the methods, with increasing bioluminescence (RLU/ml) (Figures 2.5 (a, b, c, and d)).  
Bioluminescence readings increased proportionally with relative fluorescence measured. At low 
concentration of RLU/ml, the fluorescence readings were concentrated at approximately 10
3
 RLU/ml, 
similarly in Figure 2.4 (c). There was a proportional increase in ATP-bioluminescence and 
bioluminescence for all five bioluminescent reporter strains constructs E. coli. Strong significant 
correlations of bioluminescence were obtained between these methods ATP bioluminescence (R
2
= 
0.907-0.993) (Pearson Correlation), fluorescence spectrometry (R
2
= 0.827-0.978) (Pearson 
Correlation)., epifluroscence microscopy (R
2
= 0.963-0.988) (Pearson Correlation). The range of 
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correlations values obtained between the fluorescence method and the whole-cell bioluminescence 
method was higher in comparison to the ATP-bioluminescence and epifluorescence methods.
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2.5.5 : Minimum Limit Of Detection And Working Range Of Methods Employed 
The minimum limit of detection for each method employed was determined from whole-cell bioluminescence relations from Figures 2.5 (a, b, 
c, and d), were converted to CFU/ml using y= mx + c equations in Figure 2.4 (a) for ATP-bioluminescence, fluorescence spectrometry, and 
epifluorescence microscopy methods. 
 
Table 2.4: The minimum detection limit of (MDL) and range of the methods employed 
Bioluminescent 
reporter strains E. 
coli Strain 
Bioluminescence Method  ATP-Bioluminescence Method Fluorescence spectrometry 
Method  
EpiFluorescence 
Microscopy 
 MDL
#
 Range  MDL Range  MDL Range  MDL Range  
 
6-7orders 
of 
magnitude 
 
lpp-lux 3.16 x 10
3
 6 orders of 
magnitude 
5.22 x 10
2
 8-7 orders of 
magnitude 
3.70x10
4
 5-6 orders 
of 
magnitude 
 
4.44x 10
3
 
tatA-lux 3.80x 10
3
 1.25x 10
2
 3.76x 10
3
 4.42 x 10
2
 
ldc-lux 3.80 x 10
3
 5.10 x 10
1
 3.19 x 10
3
 3.39 x 10
2
 
lysS-lux 4.46 x 10
3
 4.40 x 10
1
 1.41 x 10
3
 5.08 x 10
2
 
spc-lux 3.36 x 10
3
 3.88 x 10
2
 5.75 x 10
4
 4.95 x 10
3
 
# The MDL was determined from Figures 2.5 (a, b, c, & d) and converted to CFU/ml using regression equations in Figure 2.4 (a) to permit expression in terms of the 
viable count (CFU/ml) 
 
The minimum detection limit (MDL) for the whole-cell bioluminescence method ranged from 3.16 - 4.46 x 10
3 
CFU/ml, depending upon the 
biosensor strain, and each displayed a 6 orders of magnitude working range. The MDL for each biosensor strain was the lowest when the 
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ATP-chemiluminescence method was employed, ranging from 4.40 x 10
1
 – 5.22 x 102 CFU/ml, and displayed a 7 – 8 orders of magnitude 
working range. The MDL for each biosensor strain when the Epifluorescence method was employed ranged from 3.39 x 10
2
 - 4.95 x 10
3
 
CFU/ml, and displayed a 6-7 orders of magnitude working range. The highest MDL measured in this study was observed when fluorescence 
spectrometry was employed, ranging from 1.41 x 10
3
 - 5.75 x 10
4 
CFU/ml
 
and displaying a 5-6 orders of magnitude working range.  
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2.5.6 : Comparison of Time Required to Undertake Each Method  
The time required to prepare the samples for the ATP-chemiluminescence, fluorescence spectrometry, 
epifluorescence microscopy, and whole-cell bioluminescence method was 15 minutes, whilst the plate 
method required 30 minutes of preparation time. The plate count method was the only one that required 
an incubation time of 72 hours, whilst the other four microbial enumeration methods did not require any 
overnight incubation time. Amongst the analytical methods employed, the whole-cell bioluminescence 
and fluorescence spectrometry methods required the least time for sample analysis, at only 15 minutes, 
whilst the epifluorescence microscopy method required the longest at an hour (Figure 2.6). On the other 
hand, the ATP-chemiluminescence method required 30 minutes for sample analysis and the plate count 
method required 35 minutes per sample. 
 
Figure 2.6: The preparation time (minutes), incubation time (hours), and sample analysis time (minutes) 
per sample for each of the analytical methods employed. 
# SEM for preparation time did not exceed 3 min for each method 
# SEM for sampling analysis time did not exceed 1 min for each method 
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2.5.7 : Analysis of Promoter Strength of the Five Constructs  
 
Figure 2.7: Constitutive promoter strength measured as the ratio (RLU:CFU) for each biosensor 
construct, determined at a high bacterial cell density (10
8 
CFU/ml) 
a,b,c,d
 Letters within a column indicate significant differences at P ≤ 0.05, n=5, with error bars 
representing SEM 
 
 
At 24 hours of incubation the bioluminescence expression per cell (RLU:CFU) for the lpp-lux (0.0732) 
was statistically significantly greater than for each of the other constructs (P ≤0.001, Tukey Post Hoc) 
followed by spc-lux (0.0086) construct expressed significantly (P ≤0.001, Tukey Post Hoc)  greater 
bioluminescence per cell than the tatA-lux (0.0069) construct (P ≤0.01, Tukey Post Hoc). ldc-lux 
(0.0025) and lysS-lux (0.00169) were statistically significantly lower (P ≤ 0.001, Tukey Post Hoc) to 
lpp-lux, tatA-lux, and spc-lux at 24 hours and both expressed the lowest bioluminescence per cell.  
0 
0.01 
0.02 
0.03 
0.04 
0.05 
0.06 
0.07 
0.08 
Lpp TatA LdcC LysS Spc 
B
io
lu
m
in
es
ce
n
ce
 t
o
 V
ia
b
le
 C
o
u
n
t 
R
at
io
 
(R
LU
:C
FU
) 
Constrcut 
b 
ab ab 
c 
d 
  
104 
 
Table 2.5: A comparison of sequences within the promoter regions of the promoters used in the bioluminescent reporter strains with the E. coli RpoD 
(σ70/D) consensus sequence 
 
Promoter  Extended 
-15
TGn
-13
 
element 
-10 region 
sequence 
Number of spacers (nt) 
between the -35 and -10 
regions 
-35 region 
sequence 
A+T (%) 
in UP element 
G+C (%)between 
 -10 and +1 regions 
Outer Membrane 
Lipoprotein (lpp) 
 
TGT AATACT 15 TTCTCA 65 34 
Twin Arginine Translocase 
(tatA) 
 
ACG TATAAT 19 TTCATC 40 38 
Lysine Decarboxylase (ldc) 
 
GGC TATGAT 17 TTTTTA 50 44 
Lysyl-tRNASynthetase 
(lysS) 
 
GAA GAAAAT 13 TTTATG 50 52 
Ribosomal Protein (spc) 
 
TGT TATAAT 18 TTTCTA 45 50 
*E. coli σ70 consensus 
sequence  
TGn TATAAT 17 TTGACA   
* (Pribnow, 1975)  
Positions -15,-14,-13, (extended element). Positions -12,-11,-10,-9,-8,-7 reads from left to right for -10 regions. Positions -35,-34,-33,-32,-31,-30 
(left to right) 
Ind    Indicates differences from the σ70 E. coli consensus sequence 
          
         Indicates differences from the consensus in spacer length (nt), between the -35 regions and -10 regions 
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The lpp promoter strength was greatest, followed by spc, tatA, ldc and lysS, in terms of the 
bioluminescence per cell (RLU:CFU) (Figure 2.7). The bioluminescence expressed by lpp-lux was 43- 
fold greater than that expressed by any of the other constructs (lysS-lux, ldc-lux, tatA-lux, and spc-lux). 
The sequences of the five constitutive promoters employed were compared to the E. coli global 
consensus sequence (Table 2.5).  
 
The regions analysed were the extended -10 elements, the -10 region, the number of spacers between the 
-35 and -10, the -35 region, and the UP elements (-40 to -60 regions). Lpp and Spc display consensus 
sequences at positions -15 and -14 which is T and G.  
 
The RpoD (σ70/D) -10 region consensus sequence is TATAAT. Both spc and tatA exhibited the same 
sequence as the consensus sequence in the -10 region, whilst lpp and lysS have the T at position -12 of 
the consensus sequence with a nucleotide replacement of an A and a G, respectively. In contrast, 
position -10 of lysS has an A instead of a T, whilst ldc has a nucleotide replacement of a G instead of the 
consensus T at the -9 position. Lpp has a nucleotide replacement of a C instead of the consensus T at the 
-8 position. 
 
The spacer length between the -35 and -10 regions is smallest for lysS compared to the other four 
promoters. The ldc promoter has the same number of spacers between the -35 and -10 regions as the 
consensus sequence. 
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At position -33, in the -35 region, there is a C substituted for a G in the lpp and tatA promoters whilst for 
ldc, lysS, and spc a T is replaced. The consensus of the -35 region is TTGACA. At position -30, there 
are nucleotide replacement of a C in tatA and G in lysS instead to the consensus A whilst at position -31, 
constructs tatA-lux, ldc-lux, lysS-lux and spc-lux showed a T instead of the C consensus. At position -32, 
there is a substitution of a T for into the lpp and ldc promoter sequences, whilst a C is substituted for 
spc. At position -33, all constructs showed a nucleotide difference to the consensus G whilst nucleotide 
sequence at positions -34 and -35 agreed with consensus for all 5 constructs. 
 
The percentages of A+T in the UP elements and G+C in the regions between -10 and +1 were within the 
ranges of 45-65% and 34-52% respectively. The rank order for A+T percentage of the UP elements was 
as follows lpp>ldc=lysS>spc>tatA, whilst the rank order for G+C percentage between the -10 and +1 
regions was as follows lysS>spc>ldc>tatA>lpp. 
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2.6 : Discussion  
2.6.1 : Validation of the Five Bioluminescent Constructs as a Rapid Microbiological 
Method In Comparison With Traditional Plate Counting  
The five bioluminescent reporter E. coli strains demonstrated an accuracy level which is expressed as 
the percentage recovery of bioluminescence exhibited by the constructs in the whole-cell 
bioluminescence assay. The accuracy of the whole-cell bioluminescence method is the closeness of 
the actual test results obtained by the current compendial method which is the conventional plate 
counts (PDA, 2000) 
 
The average bioluminescence recovery was between 78.71 and 135.19 %, whilst the average 
recovery for the conventional plate count methods were between 82.10 and 139.17% with no 
significant difference (Table 2.2) for both high and low concentrations of cells. This demonstrates 
that the bioluminescence method has similar accuracy to the plate counting method. In addition, 
recovery values obtained from the bioluminescence method were higher as compared to recovery 
values obtained from ATP-chemiluminescence method as shown in Kramer et al (2008) especially at 
low concentration. This suggests that the whole-cell bioluminescence method has higher accuracy as 
compared to ATP-chemiluminescence method. 
 
Numerous studies of whole-cell bioluminescent measurement have demonstrated prospects of 
replacing the conventional plate count method (Ellison et al., 1994a & b; Hill et al., 1993; Marincs, 
2000; Stewart, 1990, 1993, 1997; Stewart & Williams, 1992,; Stewart et al., 1991, 1993, 1996, 
1997). However, to the author`s best knowledge, previous studies have not demonstrated the 
evaluation of accuracy of the whole-cell bioluminescent method as a rapid microbiological testing 
method (PDA, 2000).  
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The F values suggest that there was a greater variance between the whole-cell bioluminescence 
method and the conventional plate counting method for lysS-lux, with F=2.656, than for ldc-lux (F= 
1.849), spc-lux (F= 1.884), tatA-lux (F= 1.715), and lpp-lux (F=1.717), as shown in Table 2.2. 
However, the calculated ratios did not exceed the critical F value obtained in the F distribution, 
which is 2.93. Therefore, according to the technical report No 33 of evaluation, validation, and 
implementation of new microbiological testing methods, there is no significance difference (P ≤ 
0.05, ANOVA) between the precision of the bioluminescence method and the conventional plate 
counting method.  
 
The whole-cell bioluminescence recorded when the viable counts were 8.5 log10 CFU/ml was not 10 
fold higher than the whole-cell bioluminescence recorded when the viable counts were 7.5 log10 
CFU/ml. This could be explained by scattering of the light by the high cell density of the bacterial 
culture resulting in less light per cell being detected by the luminometer. Konstantinov et al. (1993) 
demonstrated that bioluminescent cultures not only emit light but also absorb and scatter and the 
light extinction effect, known as the “inner filter effect,” is significant in high-density cultures. This 
phenomenon is observed in the whole-cell bioluminescence method at 8.5 log10 CFU/ml which is 
well above the working concentration required by the Pharmacopeial regulations. Nevertheless, at 
cell densities below 8.5 log10 CFU/ml the bioluminescence method showed great linearity supported 
with excellent correlation with the conventional plate count method (Figure 2.4 (a)). 
 
The correlation coefficients for the whole-cell bioluminescence from the five bioluminescent 
reporter strains compared with the conventional plate counts were significantly higher compared to 
the correlation coefficients for the ATP-chemiluminescence  versus plate counts values of (R
2
 = 
0.968-0.988 and R
2
 = 0.881-0.965, respectively; Figures 2.4 (a) and (b), respectively). The 
underlining relationship between the bioluminescence and viability involves the oxidation of reduced 
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FMNH2 and an aldehyde molecule by molecular oxygen (Meighen, 1991). The production of 
FMHN2 is dependent on the electron transport thus only live cells are able to produce 
bioluminescence (Stewart, 1997). The relationship between whole-cell bioluminescence readings 
versus plate counts is  significantly higher compared to the correlation coefficients of fluorescence 
spectrometry readings versus plate counts for the biosensor strains (R
2
 = 0.968-0.988 and R
2
= 0.776-
0.936, respectively; Figures 2.4 (a) and (c), respectively. This demonstrates that the whole-cell 
bioluminescence method showed greater correlation with the plate counts than ATP-
chemiluminescence or fluorescence spectrometry. However, the epifluorescence microscopy method 
demonstrated the greatest correlation with the conventional plate count method (R
2
 = 1.00; Figure 
2.4 (d). 
 
Roszak and Colwell (1987) demonstrated that plate counts would the viable count of a bacterial 
population, whilst direct viable counts determined by microscopy would overestimate the viable 
count. However, in the study described in this thesis, direct microscopic viable counts yielded very 
similar viable counts to the plate count method, with correlation coefficients of R
2
= 1.00 for each of 
the constructs. This could be due to the enumeration of E. coli cells at early stationary phase, when 
all the cells could have been viable and culturable in comparison to the natural water sample in 
Roszak and Colwell (1987). Therefore the comparison of the direct microscopic counts between the 
whole-cell bioluminescent method lead to high correlation of R
2
= 0.963-0.976 (Figure 2.5 (c).  
 
The correlations between ATP-chemiluminescence and whole-cell bioluminescence for the five 
constructs were significantly excellent at R
2
= 0.907-0.993 (Figure 2.5 (b)). The ATP-
chemiluminescence method has been validated by Kramer et al. (2008) and has been recognized by 
the Pharmacopoiea as a rapid microbiological testing method for the preservative efficacy test (PET). 
The ATP-chemiluminescence method has been widely applied in the food industry for bacterial 
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enumeration (Griffiths, 1993; Siragusa et al., 1996; Sharma & Malik, 2012). There are many easy-to-
use kits, with pre dispensed reagents, which can be used with relatively low cost hand-held 
luminometers for rapid determination of ATP levels and so to estimate the microbial load (Sharma & 
Malik, 2012). The ATP-chemiluminescence method is no doubt very rapid however there is the 
potential of extracellular ATP affecting the readings, creating  false positive (Dostalek & Branyik, 
2005). Furthermore, the ATP-chemiluminescence method can potentially suffer ‘quenching’ due to 
the presence of cations and anions which can cause significant decreases or even increases in the 
light emission (Wen et al., 2001; Dostalek & Branyik, 2005).  
 
The use of SYTO 9 and propidium iodide (PI) stains has grown tremendously. SYTO 9 stains all 
bacteria in a population, even those with damaged membranes (Armstrong & He, 2001). In contrast, 
PI only penetrates bacteria with damaged membranes. It quenches the green fluorescence of SYTO 9 
and replaces it with its own red fluorescence (Armstrong & He, 2001). Microscopically, the green 
and red cells can be distinguished easily (Armstrong & He, 2001) whilst the fluorescence intensity 
can be measured using a fluorescence spectrometer. The correlation coefficients between the whole-
cell bioluminescence and the fluorescence spectrometry for the five biosensor strains were poorer 
than for any of the other assay methods, since they gave the largest range (R
2
= 0.827-0.978; Figure 
2.5 (a) with no significant difference). This could have resulted from inconsistent diffusion of the 
dye across the cell membranes. Previous studies have shown that the outer membrane in stationary 
phase cells of E. coli can act as a barrier to SYTO 9 (Berney et al., 2007). This phenomenon seems to 
be specific to gram negative cells and so may be related to the presence of an outer membrane 
(Berney et al., 2007). In addition, SYTO 9 binds non-specifically to any DNA-containing 
contaminants for example lysed cells (Klauth et al., 2004). Previous studies have found it difficult to 
distinguish microbial cells from other features of a similar shape and size, and this could have 
implications for the use of epifluorescence with pharmaceutical products (Nunan et al., 2001). The 
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SYTO 9 stain is widely used in epifluorescence microscopy for the enumeration of bacteria (Joux & 
Lebaron, 2000; Klauth et al., 2004). However this technique requires extensive training and a high 
technical skills proficiency, especially in the loading and handling of the haemocytometer as operator 
errors can introduce non-random distribution of cells across its surface and it is very fragile. 
Moreover, fixing the cells on haemocytometer can results in cell shrinkage and so can induce biased 
light-scattering measurements which can lead to a decrease in fluorescence emissions for SYTO dyes 
(Del Giorgio et al., 1997).  
 
Despite the use of the same fluorochromes (SYTO 9 and propidium iodide (PI)) in both the 
epifluorescence microscopy and the fluorescence spectrometry, the minimum detection limit (MDL) 
for epifluorescence microscopy in the current study was 10
2
-10
3
 CFU/ml, which was a log unit lower 
than for the fluorescence spectrometry method at 10
3
-10
4
 CFU/ml. This could be due to limits to the 
sensitivity of the spectrometry equipment, whereas the haemocytometer has the potential to manage 
samples with low viable counts. The limit of detection for epifluorescence microscopy determined in 
the current study agrees with that determined by Pettifer (1983). On the other hand, epifluorescence 
microscopy studies conducted by Lemarchand et al. (2001) using microbial cells labelled with SYBR 
green II found the detection limit to be considerably higher than the current study at 10
4
 cells/ml. 
 
The MDL for the whole-cell bioluminescence method is 3.16-4.46 x 10
3
 CFU/ml (Table 2.3) with 
working range of 5-6 orders of magnitude. The MDL obtained were in line with previous work 
carried out by Rattray et al., 1990. The genetically engineered E.coli DH1 [pUCD607.luxCDABE],   
E.coli MM294 [pBTK5.luxRICDABE], E.coli MM294 [pEJ205.luxABE], E.coli MM294 
[pEMR1.luxABE],   deduced a limit of detection between 5.0 x 10
1
 – 1.211 x 103 CFU/ml in liquid 
culture. The variation that was obtained was due to the fact that the bioluminescence measurements 
carried out in Rattray et al. (1990) was during exponential phase and the different vector and portions 
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of the lux cassette ligated. In contrary to the bioluminescence measurements at stationary phase 
carried out in this study yet, the MDL falls within the range of 10
3 
CFU/ml. 
 
 In contrast, the minimum detection limit (MDL) for the ATP-chemiluminescence method was the 
lowest of all those tested at 4.40 x 10
1
 – 5.22 x 102 CFU/ml, and it also the greatest working range 
(7-8 orders of magnitude) (Table 2.4). This agrees with the minimum detection limit for ATP-
chemiluminescence as determined by Kramer et al. (2008). However, the MDL obtained by the 
whole-cell bioluminescent method is equipped for the preservative efficacy testing (PET) which 
requires that at least a 3 log10 reduction in the viable counts from an initial viable count of 6 log10 
CFU/ml occurs, then both of these methods would have a sufficient working range and minimum 
detection limit to be used in PET.  
 
Amongst the five analytical methods assessed in the current study, the epifluorescence method 
required the longest time for sample analysis, at an hour (Figure 2.6). The time taken to view and 
count each sample is strenuous, and does not allow the rapid screening of multiple samples which 
could be classified as a disadvantage for a rapid method. The fluorescence spectrometry method 
required 20 minutes to complete the analysis of each sample, which was 5 minutes more than the 
whole-cell bioluminescence method. The extra time required for fluorescence spectrometry is due to 
the incubation process of the stains in the dark, before the data were obtained. The ATP-
bioluminescence method required five minutes less the plate counting method. The plate counting 
method involved serial dilution, followed by plating on solid agar and the counting of colonies after 
an extensive incubation period. On the other hand, although the ATP-bioluminescence method also 
involved a serial dilution, along with the additional time required for the extraction of intracellular 
ATP and the time taken to measure the chemiluminescence from the luciferin-luciferase reaction it 
did not require an extensive incubation period. The use of a kit minimized the time needed for the 
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extraction process, but conventional extraction , when kits are not available or affordable, involve the 
use of boiling buffers or ice cold acid which can be very time consuming. 
 
However, the ATP bioluminescence assay kit HS II and the BacLight LIVE/DEAD kits are both 
costly, whereas the whole-cell bioluminescence method has minimal costs (Appendix 2). Moreover, 
the ATP extraction process requires a sterile environment to prevent contamination with exogenous 
ATP-rich cells, which can be difficult to maintain. On the other hand, despite the minimal cost for 
agar and diluent buffers, the plate count method required a 72 hour incubation time plus 30 minutes 
for sample preparation which makes it much slower in yielding results and this can have an impact 
on the rate at which product can be cleared for market by a pharmaceutical manufacturer. 
Conventional plate counts require 15 minutes more preparation time than the whole-cell 
bioluminescence method because of the time taken to prepare the agar plates. Consequently, the 
whole-cell bioluminescence method needed only a short time for sample preparation and analysis, 
with no incubation time required, as well as requiring only low-cost materials (Appendix 2). 
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2.6.2 : Evaluation of the Promoter Strength, And Its Relationship with Bioluminescence 
Expression 
Amongst the five constitutive promoters tested for their suitability as a whole-cell bioluminescent 
method, lpp-lux exhibited the highest bioluminescence output per colony forming unit whilst lysS-lux 
exhibited the lowest, after 24 hours of incubation (Figure 2.7). To permit comparison between the 
bioluminescent biosensor constructs, the light per CFU was converted to a percentage value, with the 
light output from lpp-lux normalised to 100% as it gave the highest light output. Consequently, spc-lux 
expressed 11.7% of the light output of lpp-lux, followed by tatA-lux with 9.45%, ldc-lux with 3.52%, 
and lysS-lux with 2.3% gave the lowest light output. Therefore the rank order for the promoter strength 
of each of the constructs under standard culture conditions was as follows; lpp> spc>tatA>ldc>lysS.  
 
The outer membrane lipoprotein (lpp) promoter controls the expression of the enzymes which produce 
outer membrane lipoprotein, and thus is directly responsible for the levels of lipoprotein present.  Since 
lipoprotein is the most abundant protein in E. coli, with approximately 7.5 x 10
5
 molecules per cell 
(Inouye & Inouye, 1985), this could explain why the intensity of bioluminescence per CFU from the 
lpp-lux strain was significantly the greatest. The spc operon encodes the ribosomal protein which is 
regulated at the translational level (Merianos et al., 2004), demonstrating constitutive characteristic of  
11.7% bioluminescence per cell whilst the tatA promoter controls the protein transport pathway in 
cytoplasmic membranes (Jack et al., 2001) and ldc promoter controls the decarboxylation of lysine, a 
basic amino acid (Lemonnier & Lane, 1998) with 9.45% and 3.52% bioluminescence per cell .The lysS 
promoter controls the expression of aminoacyl- tRNA synthetase in protein synthesis expressing 
bioluminescence per cell at 2.3%. The five promoters chosen imply the constitutive levels at varying 
levels as a whole-cell bioluminescent biosensor. Since after 24 hours of incubation, the culture had 
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reached early stationary phase it may be that a large amount of outer membrane lipoprotein is required at 
this stage and so greater levels of expression occur to provide this. In comparison it may be that the 
expression of ribosomal protein, protein transportation and synthesis, and decarboxylation of basic 
amino acid does not need to be so strong at this stage of growth. Nakamura and Inouye (1982) 
demonstrated a 30 times stronger expression in lpp promoter than lac promoter when inserted upstream 
of β- galactosidase gene. 
 
The strength of promoter activation is dependent upon the binding affinity of the RNA polymerase to the 
promoter regions (Ishihama, 1988; Jensen & Hammer, 1997) it was decided to perform a bioinformatics 
analysis of the promoter regions to understand promoter strength (Table 2.4). 
 
Gene expression in bacteria is due to the action of RNA polymerase that catalyses DNA template-
dependent RNA synthesis. In order to recognize promoters, RNA polymerase must associate with a 
sigma (σ) factor, which is directly responsible for binding of the RNA polymerase complex to the 
promoter sequence elements (Lee et al., 2012). Formation of a ‘close complex’ occurs when the sigma 
(σ) factor is in contact with subregions of 2.4 and 4.2 to interact with the -10 and -35 promoter DNA 
elements. The sigma (σ) factor orchestrates the transcription process. The sigma subunit of bacterial 
RNA polymerase is strictly required for promoter recognition. The primary (housekeeping) sigma factor 
of Escherichia coli, sigma RpoD (σ70/D), is responsible for most gene expression (Gregory et al., 2005). 
 
One of the regions recognized by RpoD (σ70/D), is the -15TGn-13 motif, also known as the extended -10 
sequence (Keilty & Rosenberg, 1987). Optimal expression activity requires the presence of both the -15 
T and -14 G (Keilty & Rosenberg, 1987). Extended regions of spc and lpp promoters have both of the 
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nucleotides suggesting the potential for strong promoter activity with RpoD (σ70/D). The amino terminal 
part of region 3 of RpoD (σ70/D) makes contact with the conserved -15TGn-13 in the extended -10 element 
is in contact with the amino terminal part of region 3 of RpoD (σ70/D) and so mediates recognition of the 
-10 region and melting of the DNA (Paget & Helmann, 2003). This potential for strong promoter 
activity is reflected in the greater emission of light at early stationary phase by the spc-lux and lpp-lux 
constructs in comparison with the others. Barne et al. (1997) and Campbell et al., (2002) reported that 
promoters which conformed to the consensus sequence of 
-15
TGn
-13
 may not require a -35 region or have 
-35 regions that deviate significantly from the consensus sequence.  
 
Mutagenesis studies carried out by Inouye and Inouye (1985) demonstrated an increase in expression 
activity when the -10 region of a promoter was the same as the consensus sequence of TATAAT. Both 
tatA and spc have a -10 sequence that conforms to the consensus sequence (Table 2.4). However the 
highest expression levels of light were seen with the lpp-lux construct. The -10 region interacts 
intimately with subregions 2.3 and 2.4 of sigma factor which corresponds to the α-helix in region 2 of 
RpoD (σ70/D) (Paget & Helmann, 2003). The -12 position of the lysS promoter is the only encoding a G. 
Several studies have shown that suppression in subregion 2.4 of the σ70 can occur when there is a G at 
the -12 position, this indicates possible suppression of the promoter activity in this region (Waldburger 
et al., 1990; Siegele et al., 1989). In addition, Dombroski, (1997) demonstrated that within the -10 
region, only mutations at positions -12, -11, and -10 were deleterious for binding by σ70. Since lysS had 
the highest number of differences in the -12, -11, and -10 positions (Table 2.5), this could explain the 
low levels of light expression per cell from this construct compared to the other four (Figure 2.7). 
Weakened recognition of the promoter by the RNA polymerase and σ subunit, due to a reduction in their 
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ability to unwind the DNA strand and generate an open complex for initiation of transcription could 
offer the explanation for this observation (Browning & Busby, 2004). 
 
At positions -11 and -7 of the -10 region, there were no nucleotide differences between the constitutive 
promoter sequences and the consensus sequence. The -11A and -7T positions interact with RNA 
polymerase (Liu et al., 2011). The -11A and -7T are flipped out of the base stack, with their bases buried 
in pockets on the protein surface (Liu et al., 2011).  This recognition of the bases at -11 and -7 are 
specific and conserved (Liu et al., 2011). The five constructs did not show any difference to the 
consensus at positions -11 and -7 therefore there is relative strength in bioluminescence expression for 
all constructs, despite the various strengths.  
 
The -35 element of the promoter forms a helix-turn-helix motif when in contact with the carboxy-
terminal part of region 4 (subregion 4.2) of RpoD (σ70/D). The consensus sequence for the -35 region is 
TTGACA, and both lpp and tatA differ from the consensus by encoding a C instead of a G at position -
33. Interestingly, other studies have shown that transcription occurs more frequently when the non-
consensus A or C bases are found at the -33 position than the more highly conserved G (Keener & 
Nomura, 1993). This could be one of the factors influencing the high expressions of lpp.  
 
The conserved regions between -40 and -60 are known as the UP region. Studies have revealed that an 
A+T-rich sequence of the UP element was enough to significantly enhance transcription from some 
promoters (Chan & Busby, 1989). The percentage of A+T in the UP region of lpp was the highest at 
65%, followed by ldc and lysS with 50%, spc with 45%, and tatA with 40%. These regions are bound 
specifically by the C-terminal domain of the α-subunits of the polymerase complex (Gaal et al., 1996; 
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Ross et al., 1993). This region is in contact through minor grooves of the promoter DNA at position -42 
and interacts directly with region 4 of the σ subunit bound to the -35 element (Naryshkin et al., 2000; 
Ross et al., 2001). Moran et al. (1981) demonstrated that the AT rich sequences in the UP region are 
known to play a role in promoter strength. 
 
The lpp promoter has the highest percentage of A+T within the UP elements. This suggests that the high 
expression of lpp could be influenced greater expression levels compared with the other four promoters. 
Recent structural studies from Feklistov and Darst (2011) show that interactions between the σ factor 
and the -10 element take place only after promoter melting. This coincides with the initial encounter of 
the polymerase with the promoter, involving the promoter UP element and -35 elements, along with the 
downstream elements. This suggests that there is a strong relation between the -35 element and UP 
element for gene expression levels, and has implications for the choice of promoter for an efficient 
whole-cell biosensor, where high levels of expression may be desirable. 
 
The levels of G+C in the region between -10 and +1 influences the kinetic stabilization of the open 
complexes at the promoter. Consequently, since lpp had lower G+C levels in this region, the stability of 
the open complexes may have been lower and allowed for quicker formation of the first phosphodiester 
bond when transcribing the lux gene (De Haseth et al., 1998). The ldc, tatA, spc and lysS promoters all 
have a higher G+C percentage than lpp, which suggests that the high levels of bioluminescence 
expression by lpp in the early stationary phase could partly have been due to the lower energy needed 
for the formation of phosphodiester bonds. 
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The number of spacers between the -35 and -10 regions is important for promoter recognition by RNA 
polymerase (Hawley & McClure, 1980). This distance is set, in part, by the interaction of RpoD (D/70) 
in domain 4 with the core structure called the ββ’ flap at domain 4, which functions to contact at the –35 
region (Kuznedelov et al. 2002; Murakami et al. 2002b; Vassylyev et al. 2002). Amongst the promoters, 
lpp, tatA, and spc have 18 and 16 base pairs of spacers between the -35 and -10 regions, whilst ldc has 
the consensus length of 17 nucleotides and lysS has lowest length of 13 nucleotides. Promoters with a 
spacer length close to 17 have been shown to have a stronger activity in vitro as well as in vivo, 
compared with those that have shorter or longer spacers (Ayers et al., 1989; Mulligan et al.,1985; 
Stefano et al.,1982). However, Harley and Reynolds, (1987) demonstrated that inter region spacing of 
16 and 18 bp should not affect the promoter activity compared to the consensus sequence which is 17bp 
suggesting that the promoter activity of lpp, tatA, and spc were not affected. In contrast, the number of 
spacers between the -35 and -10 region was the least for lysS suggesting that this could been important 
factor in the lower levels of bioluminescence expressions from this promoter. 
 
It is clear that the activity of the promoter is not reliant on any single particular conserved region, but the 
sum of the interactions between the RNA polymerase with all the conserved regions. In this study, the 
presence of a sequence similar to the consensus sequence in the extended region, along with high A+T% 
in the UP regions and low GC levels within the -10 and +1 region in lpp could together have resulted in 
high expression levels from this promoter.  In contrast, the small number of spacers, only 13 nucleotides 
between the -35 and -10 regions could have resulted in the low levels of bioluminescence expression by 
lysS-lux. Nevertheless, bioluminescence expression by all five of the biosensor constructs demonstrated 
a good correlation with all of the methods tested (i.e. conventional plate counting, ATP-
chemiluminescence, and direct epifluoresence microscopy).  
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The decay of bacterial luminescence with time is a first-order process and reflects the turnover 
number of the luciferase enzyme (Meighen, 1991) with a half time between 1s and 20 s at room 
temperature (Meighen, 1993). This attribute of bacteria luciferase is real time whereby the production 
light is dependent on the metabolic activity and physiology state of the bacteria (Meighen, 1993). 
Furthermore, the bacterial bioluminescence is known as real-time and non-invasive bio-reporter (Carmi 
et al., 1987). Therefore this real-time system could allow continuous monitoring of bacterial suspension 
and growing bacterial cultures, without the need for any external substances to be added which are 
prerequisites for a number of other rapid microbiological testing methods (Marincs, 2000).  
 
Consequently, this is a platform for the introduction of lux genes into other Pharmacopoiea bacterial and 
fungi strains (Naseby, 2006). The use of whole-cell bioluminescent strains could find significant 
applications in both minimum inhibitory concentration (MIC) and preservative efficacy testing (PET). 
The whole-cell bioluminescent constructs could serve approve to be good alternatives to laborious and 
time-consuming conventional methods. 
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2.7 : Conclusions  
 
1) The bioluminescent reporter strains E. coli demonstrated a level of accuracy, precision, linearity, 
and equivalence to the conventional plate count method, and proved to have a minimum 
detection limit of 10
3
 CFU/ml with a 6 order of magnitude working range, (European 
Pharmacopoiea 5.1.6) to suggest they were suitable as a rapid microbiological testing method.  
 
2) Amongst the five constructs tested, the rank order for bioluminescence expression was as 
follows: lpp-lux E. coli> spc-lux E. coli > tatA-lux E. coli > ldc-lux E. coli >lysS-lux E. coli. The 
promoter regions play an important role in the expression of bioluminescence by these 
constructs. In this study, the similarity of the -10 and the extended -10 region nucleotide 
sequences with the consensus promoter sequence, along with a high AT% within the UP 
elements, may influence bioluminescence expression to a positive extent at early stationary 
phase.  
 
 
3) The whole-cell bioluminescence method required a shorter time for preparation and sample 
analysis, with no incubation time required, compared with the other methods tested. In addition, 
the low cost of the materials needed gives it an additional advantage over the ATP-
chemiluminescence, fluorescence spectrometry, and epifluorescence methods. 
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Chapter 3 
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3 Comparisons of Bioluminescence, Growth, Adenylate Energy Charge 
(AEC), and Plasmid Copy Number over Extended Incubation period 
3.1 : Introduction 
3.1.1 : Bacterial Growth and Survival Phases 
 
Bacterial growth is defined as an increase in the cell number of a population, which occurs through cell 
growth and division. In this chapter, the cell viability (measured as CFU/ml) of Escherichia coli 
growing in optimal laboratory conditions (rich medium, 32
ᵒ
C and agitation) revealed a characteristic 
growth pattern comprised of five phases which agrees with the work done by Zambrano and Kolter 
(1996); Finkel (2006). This is in contrast to the standard textbook description of the bacterial life cycle 
which comprises of just three phases. 
 
Figure 3.1: Stages of bacterial growth. Phase 1= lag; 2= exponential; 3= stationary; 4=death phase; 5= 
long term stationary phase (the red, magenta, purple, blue and cyan dotted lines) (Finkel, 2006) 
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Phase 1 is the lag phase. During lag phase, cells undergo intracellular changes in an effort to adjust to a 
new environment, and little or no cell reproduction takes place (Yates & Smotzer, 2007). This phase is 
characterized by metabolic reprogramming of the cell that enables it to thrive in the current 
environment, and the length of the lag phase is determined by several factors such as the bacterial 
species, the shifting environmental parameters, and also the incubation time of inoculum before (Pin & 
Baranya, 2008). Once cells have adapted to a new environment, they start to grow and divide 
exponentially; a state known as exponential phase (Phase 2). Cells divide asexually by binary fission at a 
constant rate during exponential phase. The growth rate of a bacterial population is known as the 
doubling time per hour. This rate varies depending on the environmental conditions with, for example, a 
slower rate in nutrient-poor media and faster in nutrient-rich media. The primary sigma factor RpoD 
(σ70/D) is essential for general transcription in exponential phase, and can also be replaced by alternative 
sigma factors to coordinate gene expression under particular conditions. This includes diverse functions, 
such as stress responses, and morphological development (Paget & Helmann, 2003).  
 
In exponential phase, bacterial growth exhausts the nutrient resources available, and eventually the 
population enters stationary phase (phase 3) when no further increase in cell number is observed. In 
Gram negative bacteria, the metabolic status of bacterial cells changes over time, during the transition 
from exponential to stationary phase.  Starvation triggers accumulation of the alternative sigma factor 
RpoS (σS/38) which controls 10% of E. coli genes, these genes prepare the cell for survival in stress 
settings (Lacour & Landini, 2004). Nutrient depletion in stationary phase leads to the accumulation of 
waste products, whilst a lack of nutrients then leads on into the death phase (phase 4) and the number of 
viable cells (CFU/ml) decreases. Escherichia coli cells will tend to enter death phase after around 3 days 
of uninterrupted incubation (Finkel, 2006). In this phase, 90%-99% of the cell population can die, which 
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can release nutrients back into the nutrient depleted medium, and this can be used subsequently by the 
remaining cells. The number of viable cells in older bacterial populations can remain constant for 
months or even years, and this is termed as long-term stationary phase (phase 5) (Finkel, 2006). The 
balance between dying and growing cells provides a dynamic equilibrium where the final output is a 
stable number of viable cells in the population. 
 
3.1.2 : Plasmid Copy Number  
The plasmid copy number (PCN) is defined as the number of copies of a plasmid present per copy of the 
chromosome in a bacterial cell (Gerhardt et al., 1994).  Chromosome replication is tightly coordinated 
with the cell cycle such that all origins are initiated synchronously at the same cell mass per cell cycle 
whilst plasmid replication is independent (Nordstrom & Dasgupta, 2006). However, plasmid replication 
can mimic growth curve or otherwise. Control of the plasmid copy-number within cells is achieved by 
either limiting the supply of initiation factors (RNA or protein) or by inactivating the initiator through 
dimerization or regulation of iteron complexes (Nordstrom, 1990). 
 
The plasmid pBR322 was selected as the vector for the lux operon bio-reporter. The widespread use of 
pBR322 in recombinant studies has revealed that it has three important features as an effective cloning 
vector. These are that the plasmid is: stably-maintained within cells; offers reliable selection options for 
recombinants; and is versatile in accommodating recombinants genes (Balbas et al., 1986). Chiang and 
Bremer (1988) have also noted that there was no indication of the accumulation multimers which is 
known to interfere with the stability of pBR322. Plasmid multimers are able to confuse the intracellular 
control circuits which can lead to a decrease in the number of plasmids within the cell. Plasmid 
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multimers out-replicate monomeric plasmids and accumulate within the cell, resulting in populations 
with a significantly-increased rate of plasmid loss (Summers, 1998). 
 
The plasmid copy number is important for recombinant studies, as the level of gene expression within 
the host cell correlates with it. Consequently, a number of methods to determine plasmid copy number 
have been devised. Most of the methods available to determine the plasmid copy number are known to 
be laborious, resulting in low reproducibility and a narrow dynamic range (Schmidt et al., 1996). The 
methods available include caesium chloride-ethidium bromide (CsCl-EtBr) centrifugation (Weisblum et 
al., 1979), gel electrophoresis (Projan et al., 1983), and high-performance liquid chromatography 
(Coppella et al., 1987). Quantitative real-time PCR has demonstrated excellent sensitivity to plasmid 
copy number and so it was used in this study to quantify the number of intracellular pBR322 plasmid 
copies. This method is well established and widely used for detecting the copy number of genes, and has 
been established to determine the plasmid copy number (Lee et al., 2006a; Lee et al., 2006b). 
Quantitative PCR (qPCR) extends the usefulness of PCR technology by permitting reliable 
determination of the starting DNA or RNA template concentration. It offers simultaneous detection and 
quantification of DNA or RNA in one reaction. The most significant advantage over conventional 
approaches is its superiority in terms of accuracy, sensitivity, and in the elimination of post-PCR steps. 
 
The most common qPCR protocols are either the Taqman probe or the SYBR green I fluorophore. The 
Taqman probe is based on the specific hybridization of a double dye oligonucleotide probe target to a 
DNA or RNA molecule. Whilst SYBR green real time PCR assay is based on binding of the fluorescent 
dye SYBR green I to the minor groove of the double stranded PCR product (Hernandez et al., 2003; 
Howell et al., 1999; Ririe et al., 1997; Wittwer et al., 1997).  
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Figure 3.2: The principle of the SYBR green-based qPCR assay: step A is the denaturation stage when 
the dsDNA is melted; step B is the annealing stage where the primers anneal to the ssDNA; step C is the 
elongation stage when dNTPs are added to the nascent strand; and step D is the completion stage, when 
the SYBR green binds to the dsDNA and will emit a fluorescent signal 
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.  
SYBR green I exhibits a baseline fluorescence intensity when irradiated with the excitation wavelength 
when unbound in solution, but it will emit a much stronger fluorescence signal after it has bound to 
dsDNA (Figure 3.2). In qPCR, the fluorescence is measured at the end of the elongation step of each 
PCR cycle to measure DNA amplification. The advantage of using this method for qPCR is that it is 
relatively cheap, since it can be used with any pair of primers for any target DNA. However, since the 
dye will bind to any dsDNA present and so yield fluorescence, the specificity of this assay will be 
greatly reduced by amplification of non-specific products and also primer-dimers. However, a melting 
curve analysis can be used to distinguish a specific PCR product from non-specific contaminants 
(Wittwer et al., 1997), and thus to identify and eliminate contamination. It was decided to use the SYBR 
green assay to investigate plasmid copy number in the work described in this thesis. 
 
There are two quantification strategies that are applied to analyse quantitative PCR, which are absolute 
and relative quantification of the PCR product (Pfaffl, 2012). Absolute quantification relates the PCR 
signal to plasmid copy number by means of a calibration curve using known concentrations of the gene 
of interest (Pfaffl, 2012). Absolute quantification is dependent on the reliability and validity of the 
standard curve. In this study, absolute quantification of PCN was chosen as the generation of a standard 
curve can allow highly specific, sensitive and reproducible quantification data (Pfaffl, 2012). Bustin and 
Nolan (2004) noted that this approach is more accurate but often more labour intensive due to the 
construction of standard curves for every time point evaluated. Relative quantification instead compares 
changes in the expression levels of two or more gene targets. In relative quantification, the difference in 
expression levels between the target gene and the reference gene gives a measure of gene expression. 
Hence, two general mathematical models can be used for relative quantifications, one of which is based 
on the ‘delta delta ct model’ (Livak & Schmittgen, 2001) and the other on the ‘efficiently corrected 
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model’ (Pfaffl, 2001).  To ensure the integrity of the scientific literature, promote consistency between 
laboratories, and to increase experimental transparency when performing qPCR the Minimum 
Information of Quantitative Real-time PCR Experiments (MIQE) Guidelines were developed (Bustin et 
al., 2009). The important parameters for qPCR quantification include: qPCR efficiency; linear dynamic 
range; limit of detection; and precision (Bustin et al., 2009). 
 
3.1.3 :  ATP as a Prime Energy Source for Bacteria 
Adenosine triphosphate (ATP) is the principle energy carrier for all living organisms. It is in this form 
that cells expend energy on all processes that require it, including cellular energetics, intracellular 
signalling, metabolic regulation, motility and various homeostasis functions. 
 
The catalyses the synthesis of ATP involes  adenosine diphosphate (ADP) and inorganic phosphate 
which are driven by a flux of protons across the membrane down the proton gradient known as proton 
motive force (pmf), generated by electron transfer. The flux creates an electrochemical potential from 
the potential difference across the cytoplasmic membranes catalyzed by ATP synthase. This reaction is 
fully reversible, so ATP hydrolysis generates a proton gradient by a reversal of this flux (Boyer, 1988).  
      
 
      
The importance of the adenine nucleotides as major regulatory factors in controlling metabolic processes as 
a result of their influence on key regulatory enzymes has been well established. Comparison of the effects 
exerted on individual enzymes in vivo with regulation of metabolism by the energy state of the cell is 
facilitated by use of the adenylate energy charge (AEC) (Ball & Atkinson, 1975). The adenylate energy 
charge is defined as [(ATP) + 1/2(ADP)]/ [(ATP) + (ADP) + (AMP)], is a linear measure of the amount 
of metabolic energy stored in the adenine nucleotide pool and represents the relative saturation of the 
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adenylate pool expressed as a ratio (Atkinson & Walton, 1967; Ball & Atkinson, 1975). The methods 
that are most frequently employed for adenine nucleotide determinations involve enzymatic conversions 
of ADP and AMP to equivalent levels of ATP followed by a quantitative analysis of ATP via the firefly 
chemibioluminescence reaction.  
 
To the best of this author’s knowledge previous studies have not demonstrated the AEC levels of 
genetically modified bioluminescent bioreporter strains (thereby transformation of plasmids carrying 
bioreporter genes lux to host cell) and wildtype microorganism. The lux operon is regarded as an energy 
expanding system as the primary reaction of fatty acid reductase requires ATP (Meighen, 1993). In 
addition, Galluzzi and Karp (2007) and Koga et al. (2005) investigated bioluminescence expressions 
from plasmid-based lux fusion and have concluded that intracellular redox pool affects bioluminescence 
expressions. Therefore, this could lead to the hypothesis that the genetically modified bioluminescent 
E.coli constructs could possibly utilize higher energy levels possibly resulting in lower AEC values than 
the wildtype organism. Thereby, in this chapter, the analysis of AEC of the genetically modified 
bioluminescent constructs and control strains ([pBR322.lux]. E.coli and E.coli ATCC 8739) throughout 
the growth cycle is carried out in this chapter to bridge the gap of knowledge. 
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3.2 : Rational of Chapter 3 
In this chapter, a detailed investigation of the physiology and behaviour of the five E. coli constructs and 
also the control strains was undertaken throughout the course of a full growth cycle. This was achieved 
by measuring whole-cell bioluminescence (RLU/ml), viable counts (CFU/ml), the adenylate energy 
charge (AEC) and the plasmid copy number (PCN) over 28 days of incubation. In addition, the 
morphology of the genetically modified bioluminescent bioreporter strains and the control strains was 
determined by fluorescence microscopy over the 28 days of incubation. Furthermore a comparison of 
the promoter sequences for the bioreporters with the consensus sequences for RpoS (σ38/S), RpoE (σ24/E), 
and RpoF (σ28/F) was performed to understand the activity of the promoter sequences for the five strains 
in the different growth phases. 
 
The adenylate energy charge (AEC) was determined over the 28 days of incubation by using the 
luciferin-firefly luciferase assay for ATP combined with enzymatic conversion of AMP to ADP to ATP. 
The aim of this was to relate the levels of bioluminescence expressed by the bioreporter strains to the 
AEC during the phases different of growth. To examine the stability of the plasmid copy number for the 
five constructs, and to permit this to be related to bioluminescence expression by the bioreporter strains, 
over the 28 days of incubation the plasmid copy number was quantified by using quantitative real-time 
polymerase chain reaction (qPCR). 
 
The relationship between the different elements of the research described in this chapter is summarised 
in figure 3.3 
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Figure 3.3: Summarises the various studies in this chapter in characterising the five constructs 
 
3.3 : Objectives 
 
1) To perform bioluminescence and viable count growth curve analyses for both the five 
bioluminescent bioreporter strains and also the control E. coli strains, over 28 days of incubation. 
2) To determine, using qPCR, the plasmid copy number for the five bioreporter strains over 28 days 
of incubation. 
3) To measure the adenylate energy charge (AEC) of the five bioreporter strains and also the 
control E. coli strains over 28 days of incubation. 
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3.4 : Materials and Methods  
 
3.4.1 : Construction of Growth Curves 
 
Inoculum preparation and inoculation of the experimental cultures was carried out as described in 
Section 2.4.1.  Whole-cell bioluminescence readings and the viable counts for the five 
bioluminescent bioreporter strains and the control strains during 28 days of incubation were 
measured as described in sections 2.4.3 and 2.4.4. The measurements were taken every hour for the 
first 5 hours of incubation, and then subsequently every half an hour until the 20
th
 hour of incubation. 
From the 20
th
 hour of incubation, measurements were taken every hour until the 30
th
 hour, followed 
by every 2 hours until the 40
th
 hour, and then every 4 hours till the 48
th
 hour of incubation. However, 
the viable counts (CFU/ml) for the control strains were determined every hour until the 24
th
 hour, 
followed by every 4 hours until the 48
th
 hour of incubation. This was followed by the long term 
incubation periods at 7 days (168 hours), 14 days (336 hours), 21 days (504 hours), and 28 days (672 
hours). The ratio of RLU divided CFU were denoted as bioluminescence per cell (RLU:CFU) across 
all time points for all five bioreporter E.coli strains. The average pH of the growth medium for each 
of the E. coli strains was measured using a calibrated pH meter (Toledo Mettler) upon inoculation (0 
hour), and thereafter at 6 h, 24 h, 168 h (7 days), 336 h (14 days), 504 h (21 days) and 672 h (28 
days) of incubation.  
3.4.2 : Fluorescence Imaging  
 
Samples of the cultures (1.0 ml) taken at 0, 6, 24, 168, 336, 504 and 672 hours of incubation were 
centrifuged (13,000 xg) for 2 minutes (Accu Spin, Fisher Scientific), and resuspended with 0.85% 
NaCl. The suspensions were stained according to the methods described in section 2.4.6, and viewed 
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microscopically as described in section 2.4.7. The images were observed at a total magnification of 
1000X using a fluorescence microscope (excitation at 450-490nm, emission at 505-520nm, Nikon 
EFD-3) with a mercury lamp (Nikon), whilst images were taken using a GX-CAM scientific imaging 
camera and pictures were edited with GX capture software. 
3.4.3 : Plasmid Copy Number (PCN) Determination 
A brief flow chart of the procedure that was followed to determine the PCN of the five constructs is 
shown below (Figure 3.4) and the procedure is described in greater detail in the following sections; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: A flow chart describing the methodology steps involved in plasmid copy number 
quantification  
 
2) Gel Electrophoresis 1) Extraction of genomic and plasmid 
DNA 
4) Gel Electrophoresis 
3) Polymerase Chain 
Reaction (PCR) of 
a) Genomic DNA target 
(dxs) 
b) Plasmid target (bla) 
 
5) Quantitative PCR (qPCR) 
a) Serial Dilution for construction 
of Standard Curves 
b) Standardized amount of 2ng/µl 
gDNA and pDNA 
 
6) Analysis of plasmid copies 
from standard curves 
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3.4.3.1 : Extraction of Genomic DNA (gDNA) and Plasmid DNA (pDNA) 
 
Genomic DNA (noted as gDNA) and plasmid DNA (noted as pDNA) were extracted from the 
cultures immediately after inoculation (0 hours), and then again at 6, 24, 168, 336, 504 and 672 hours 
of incubation. The Gen Elute bacterial genomic DNA kit (Sigma-Aldrich) and the Gen Elute HP 
Plasmid Miniprep kit (Sigma-Aldrich) were used to extract the genomic and plasmid DNA from the 
cells following the manufacturer’s protocol. The concentration of extracted DNA was measured 
using biophotometer (Eppendorf). The DNA samples were diluted and transferred into quartz 
cuvettes, and then the absorbance was measured using the biophotometer at wavelengths (λ) of 
260nm and 280 nm. The quality and yield of the DNA extract was determined by the OD ratio 
(260/280). A high ratio (1.8-2.0) indicates a relatively pure sample, with little protein contamination. 
The DNA concentration was estimated, after the non-nucleic acid absorbance (measured at 320 nm) 
had been deducted, using equation 3.1 below; 
 
DNA Purity (A260/A280) = 
              –             
              –            
  ……. Equation 3.1 
 
3.4.3.2 : Gel Electrophoresis  
Genomic and plasmid DNA samples and also the standard DNA molecular weight markers (1 kbp 
and 100 bp, Promega) were prepared by adding gel loading dye (10% Ficoll 400, 20% sucrose, 
10mM EDTA and 0.25% bromophenol blue) to the DNA at a ratio of 1:5 respectively and loaded 
onto the gels as carefully as possible. The 1 kbp DNA markers were used when gDNA and pDNA 
was loaded, whilst for PCR products, a 100 bp ladder was used. Genomic DNA and plasmid DNA 
samples were loaded on a 0.8% agarose gel (Invitrogen) in 5µl aliquots.  The gel was placed in a gel 
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tank containing 250ml of TBE buffer (0.09M Tris/HCl, 0.09M boric acid, and 2.5mM EDTA, pH 
8.2).  
  
The gels were run at 110V for 60 minutes for genomic/plasmid DNA whilst 45 minutes for PCR 
products. The gels were subsequently stained with ethidium bromide solution (5 mg/mL) for 15 
minutes and then de-stained with sterile distilled water for 5 minutes before visualizing under UV 
irradiation using a UV-transilluminator (Ingenius Syngene Bioimaging) to ensure that extracted 
DNA had not been degraded. 
 
3.4.3.3 : Design of primer sets for Polymerase Chain Reaction (PCR) and Quantitative 
Polymerase Chain Reaction (qPCR) 
 
Two primer sets specific to the beta-galactosidase gene and to D-deoxyxylulose-5-phosphate 
synthetase (dxs) used were as cited in previous studies in Lee et al., 2006; Rozen & Skaletsky, 2000 
denoted as bla and dxs primers were purchased from Invitrogen. The bla is present in single copy in 
pBR322 (Watson, 1998) whilst the dxs is present in single copy in the E. coli chromosome (Hahn et 
al., 2001). Consequently, quantification of the bla and dxs content of the samples indicates the 
corresponding amounts of pBR322 plasmid, and E. coli chromosomal, DNA present in the samples. 
Prior to the obtaining the optimal concentrations of magnesium chloride and annealing temperature, 
magnesium chloride concentrations of 3.5mM, 3mM, 2mM, 1.5mM and 1mM were optimized by 
using a temperature gradient from 50 ºC to 60ºC for optimal temperature. 
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Table 3.1:  Primer sequences for bla and dxs 
Gene  Accession 
no. 
Primers (5’->3’)n Length 
(nt) 
Product 
size (bp) 
Tm 
(⁰C) 
GC %  
bla  J10749 F: CTACGATACGGGAGGGCTTA 20 81 54 55 
  R: ATAAATCTGGAGCCGGTGAG 20 52 50 
dxs  AF035440 F: CGAGAAACTGGCGATCCTTA 20 113 52 50 
  R: CTTCATCAAGCGGTTTCACA 20 50 45 
n 
F and R denote the forward and reverse primers, respectively 
 
Upon resuspension of the freeze dried primers in 100µl TE buffer pH 8. 5 µl of each of the primer 
suspensions was run on a 1.0% agarose gel at 100 V for 60 min, followed by staining with 5 mg/ml 
ethidium bromide and UV illumination, to check for the presence of the primers before the 
commencement of PCR. 
 
3.4.3.4 : Polymerase Chain Reaction (PCR) 
 
The extracted genomic and plasmid DNA samples were used as the template for PCR. Initial 
working solutions of 25 µM of primers were prepared. Both the stock solutions and the working 
solutions of the primers were stored at -20
o
C until required. Reaction buffer, magnesium chloride 
(MgCl2), deoxynucleotides (DNTPs), and taq polymerase were all purchased from Promega Ltd. The 
following reagents as stated in Table 3.2 were added give a total volume of 25 µL. The reaction 
tubes were placed in the Gradient PCR thermocycler (Eppendorf Mastercycler Gradient). The 
reaction conditions and the volumes used for PCR are listed in table 3.2. The PCR products were 
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analysed by gel electrophoresis using a 2.0% agarose gel following the procedure described in 
section 3.7.1. 
 
Table 3.2: Volume of reagents required and PCR conditions for bla and dxs amplification after 
optimization 
Reagent Volume 
(µL) 
Steps  Temperature 
(⁰C) 
Duration 
(minutes)  
10x Reaction buffer 2.5 Initial 
Denaturation  
95.0 5  
50mM MgCl2 1.5 Denaturation  95.0 0.5 
10mM dNTP 0.5 Annealing  58.0 0.5 
25µM Forward primer 1 Extension 72.0 1.0 
25 µM Reverse primer 1 Final extension  72.0 5.0 
5U/ µM Taq polymerase 0.2 Hold  4.0 Until 
electrophoresis  
DNA template 5    
Sterile water 13.3 n/a   
Total volume  25 n/a   
     
     
3.4.3.5 : Real Time Quantitative PCR (qPCR) using SYBR Green I Dye 
Real time qPCR amplification was performed using a Chromo4 detector attached to a DNA engine 
(Bio-Rad) and analysis was done using MJ DNA engine software (Version 3.1; Bio-Rad). Low 
profile 0.2 ml PCR tube strips with optical flat caps (Bio-Rad), were used to contain the qPCR 
reactions. DNA extracted as described in Section 3.6.3.1 was used as the template. Platinum SYBR 
Green qPCR SuperMix-UDG kit purchased from Invitrogen. The volumes and conditions used for 
each qPCR reaction are given in table 3.3. 
 
40 cycles  
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Table 3.3: Volume of reagents required and conditions for qPCR analysis 
 
Reagent  Volume 
(µl) 
 
 
Steps  Temperature 
(
o
C)  
Duration 
(minutes) 
Platinum SYBR Green qPCR 
SuperMix-UDG 
25.0  Initial 
Denaturation  
95.0 10 
Forward primer (25µM) 1.0  Denaturation  95.0 0.17 
Reverse primer (25µM) 1.0  Annealing  58.0 0.17 
Magnesium Cloride (50mM) 1.5  Extension 72.0 0.17 
DNA Template (normalized to 
2ng/µl) 
 
x     
Sterile distilled water  11.5-x  n/a   
Total volume  40.0  n/a   
 
 
After amplification, a melting curve analysis with a temperature gradient of 0.1⁰C/s from 70⁰C to 
95.0⁰C was performed to confirm that only the products of specific interest had been amplified. 
Finally, the samples were cooled down to 40⁰C for 30 s. Negative controls, where no DNA was 
added, were included in each run. The concentration of the DNA template (gDNA and pDNA) was 
standardised to 2 ng/µl for all samples. The analyses were carried out in triplicate. 
 
 
 
 
 
40 cycles  
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3.4.3.6 : Construction of Standard Curves of Genomic DNA and Plasmid DNA 
 
Samples of gDNA and pDNA taken at each time point of 0, 4, 6, 24, 168, 336, 504 and 672 hours 
were 10-fold serially diluted (1:10, 1:100 and 1:1000) 10-fold serially diluted whereby 2µl of serially 
diluted DNA was added to the master mix as indicated on table 3.3 to prepare a standard curve of CT 
values against copy numbers. The preparation of the standard curves complied with the MIQE 
requirements for a linear dynamic range of least 3 orders of magnitude, and CT values ≥ 40 were 
disregarded as these imply low efficiency of qPCR reaction and can indicate a false positive (Bustin 
et al., 2009). The efficiency (E) of qPCR reaction is calculated as= 10 
(-1/slope)
-1 (multiplied to 100%). 
The range and linearity of standard curve were determined by using the correlation coefficient (R
2
) 
between the CT values and copy numbers. The minimum limit of detection (MDL) was ensured that 
ct values (Y-axis) are within 95% of log copies axis (x-axis) to allow accurate quantification of 
plasmid copy numbers whilst precision of qPCR reaction was interpreted as the calculated SEM. 
 
The initial copy numbers for the Deoxy-Xylulose-5-Phosphate gene (dxs) and ampicillin resistance 
gene (bla) were calculated using the following formula:  
 
             
    
   
              
                                           
..................................................................Equation 3.2 
  (Argyropoulos & Savva, 1997) 
 
Escherichia coli 8739 has a genome of 4746218 bp (NCBI Reference sequence NC_010468), whilst 
pBR322 with the lux operon insert is 10184 bp. The region promoter size varies according to the 
individual biosensor construct. The sizes of the promoter regions were as follows: lpp = 373bp; tatA 
= 300bp; ldc = 300bp; lysS = 273 bp; and spc = 310bp. The bla and dxs are single copy genes found 
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in pBR 322 and E. coli genomic DNA, respectively. Consequently, the ratio of bla to dxs is equal to 
the plasmid copy number of pBR322. Absolute quantification was performed using the standard 
curves constructed. The ratio of bla to dxs in the plasmid DNA and genomic DNA were determined 
from the corresponding standard curves using the CT values.  
3.4.4 : Adenosine Measurements 
3.4.4.1 : Adenosine Triphosphate Chemiluminescence Assay  
Cell contents were extracted in triplicates described in section 2.4.5.1 for ATP, ADP, and AMP 
measurements. The ATP chemiluminescence assay was performed as described in Section 2.4.5.1. 
3.4.4.2 : ADP Measurement  
The ADP in the cell extract was first converted to ATP by the addition of 200 µl of a solution 
mixture of 25 mM HEPES (Sigma-Aldrich), 10 mM MgSO4 (Fisher Scientific) and 10 mM KCl 
(Fisher Scientific) adjusted to pH 7.0, 0.4mg/ml of phosphoenolpyruvate (PEP) and 10 µl of 
pyruvate kinase in ammonium sulphate (32 mg/ml) (Sigma-Aldrich)) to 500µl of cell extract. This 
was then incubated at 30ᵒC for 30 minutes and the total amount of ATP in the samples was then 
measured as described in Section 2.4.5.1. This value for total ATP content is the product of the ATP 
+ ADP content of the sample. The luminescence readings of ADP present was finally calculated by 
deducting the ATP content, determined in section 3.6.4.1, from the total ATP+ADP content. This 
was repeated three times. 
 
3.4.4.3 : AMP Measurement  
The AMP and ADP in the cell extract were converted to ATP by the addition of 200 µl of mixture 
solution of 25mM of HEPES, Sigma-Aldrich, 10mM MgSO4 (Fisher Scientific), 10mM KCl (Fischer 
Scientific) adjusted to pH 7.0, 0.4 mg/ml of phosphoenolpyruvate (PEP), 10 µl of pyruvate kinase in 
ammonium sulphate (Sigma-Aldrich) and 100µl of adenylate kinase (28mg/ml) (Sigma-Aldrich)) to 
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500µl of cell extract. This was then incubated for 30 minutes at 30ᵒC and the total amount of ATP 
present in the samples was then measured as described in Section 2.4.5.1. This value for total ATP 
content is the product of the ATP+ADP+AMP content of the sample. The bioluminescence readings 
of AMP present was finally calculated by deducting the ATP and ADP bioluminescence readings, 
determined in section 3.6.4.2, from the total ATP+ADP+AMP content. This was repeated three 
times. 
 
3.4.4.4 : Calculation of Adenylate Energy Charge (AEC) 
The adenylate energy charge (AEC) was calculated from the mean ATP, ADP and AMP content of 
the cells, as determined in sections 3.6.4.1-3, using the formula given in equation 3.3.  
 
     
               
              
....................................................................................................Equation 3.3 
(Atkinson, 1968) 
 
3.4.5 : Statistical Analysis 
Statistical Analysis was carried out as described in Section 2.4.8.  Pearson correlation analysis was 
performed to compare plasmid copy number (PCN) with bioluminescence per cell (RLU:CFU). 
Standard error of means (SEM) is obtained by SPSS program. 
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3.5 : Results  
This results section contains four experimental parts. 
Section 3.7.1 reports the bioluminescence and population kinetics. Section 3.7.2 reports the 
morphology of the E. coli strains over the 28 days of incubation. Section 3.7.3 reports the plasmid 
copy numbers present in each of the bioreporter strains. Section 3.7.4 reports the adenylate energy 
charge (AEC) within the five bioreporter strains and also the control strains over the 28 days of 
incubation. 
 
3.5.1 : Bioluminescence and viable count Kinetics in the Growth and Survival Curve  
3.5.1.1 : Bioluminescence Kinetics in the Growth and Survival Curve  
 
Figure 3.5 (a) shows the bioluminescence kinetics across 48 hours. The initial bioluminescence 
(RLU/ml) expressed by each of the 5 bioluminescent bioreporter strains was on average between 
4.16 ± 0.03 log10 RLU/ml at 0 hour. The strains carrying the lpp-lux and spc-lux constructs yielded 
the highest initial bioluminescence, measured at 4.3 ± 0.02 log10 RLU/ml. The initial 
bioluminescence expressed by the other bioreporter strains, in increasing order, was as follows: tatA-
lux, 4 ± 0.03  log10 RLU/ml; ldc-lux, 4.03 ± 0.04   log10 RLU/ml; lysS-lux, 4.2 ± 0.01  log10 RLU/ml; 
spc-lux and lpp-lux, 4.3 ± 0.04  log10 RLU/ml. Each of the 5 bioreporter strains exhibited a decrease 
in bioluminescence expression, of an average of 0.4 ± 0.07 log10 RLU/ml, with no significant 
difference between the strains, and remained at that level in the first three hours of incubation. The 
bioluminescence expressed by each of the bioreporter strains began to increase from the 4
th
 hour up 
to the 6
th
 hour of incubation, at a rate approximately 2.3 ± 0.13   log10 RLU per hour. A Tukey Post 
hoc analysis revealed there was a significant increase (P ≤ 0.05, ANOVA) for bioreporter strains; 
lpp-lux, tatA-lux, ldc-lux lysS-lux and spc-lux between the 5
th
 and 6
th
 hour of incubation from 0h 
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inoculation time with a significant (P≤ 0.05, ANOVA) increase of 2.21 ± 0.05 log10 RLU/ml, whilst 
tatA-lux increased significantly (P ≤ 0.05, Tukey Post Hoc) by 1 ± 0.04 log10 RLU/ml, spc-lux 
significantly by 0.71 ± 0.07 log10 RLU/ml, ldc-lux by 0.655 ± 0.1 log10 RLU/ml and lysS-lux by 
0.586 ± 0.01  log10  RLU/ml. At the 5.5
th
 hour of incubation, the bioluminescence peaked the highest 
with spc-lux (8.70 ± 0.04 log10 RLU/ml), followed by lpp-lux (8.64 ± 0.05 log10 RLU/ml), tatA-lux 
(8.19 ± 0.04 log10 RLU/ml), ldc-lux (7.65 ± 0.06 log10 RLU/ml), lysS-lux (7.56 ± .03 log10 RLU/ml)  
 
In total, the bioluminescence expressed by the bioreporter strain carrying the lpp-lux construct 
increased significantly (P ≤ 0.05, Tukey Post Hoc) by 4.31 ± 0.1 log10 RLU/ml over the first 6 h of 
incubation. The bioluminescence expressed by the spc-lux increased significantly (P = 0.00, Tukey 
Post Hoc) by 4.4 ± 0.15  log10 RLU/ml over the first 6 h of incubation whilst that expressed by the 
tatA-lux strain increased significantly (P = 0.00, Tukey Post Hoc) by 4.19 ± 0.1  log10 RLU/ml, that 
expressed significantly (P = 0.00, Tukey Post Hoc) by the ldc-lux strain increased by 3.62 ± 0.2  
log10 RLU/ml, and that expressed significantly (P = 0.00, Tukey Post Hoc) by the lysS-lux strain 
increased by 3.36 ± 0.23  log10 RLU/ml (Figure 3.3a). Overall, Tukey Post Hoc analysis revealed 
that there was no significant difference between the high bioluminescence readings of spc-lux and 
lpp-lux (P= 0.900, Tukey Post Hoc analysis) whilst a significant difference between tatA-lux, ldc-lux 
and lysS-lux (P= 0.00, 0.00, 0.00, Tukey Post Hoc analysis 
Approaching stationary phase, the level of bioluminescence expressed by each of the bioluminescent 
bioreporter strains remained relatively stable from the 7.5
th
 hour to the 40
th
 hour for all five 
constructs with no significant difference. During the stationary phase, the level of bioluminescence 
expressed by the bioreporter carrying the lpp-lux was the highest up to 35
th
 hour of incubation, after 
which the bioluminescence decreased to levels similar to the other 4 constructs. After the 40
th
 hour of 
incubation, there was a decrease significantly (P ≥ 0.05, ANOVA) in the level of bioluminescence 
expressed of around 1-2 log10 RLU/ml. The level of bioluminescence expressed by the control strains 
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E. coli ATCC 8739 [pBR322.lux] and the negative control, E. coli ATCC 8739, remained unchanged 
at 0 log10 RLU/ml. The overall standard error of the means (SEM) of the bioluminescence kinetics is 
0.065 (Figure 3.3 (a)). 
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Figure 3.5 (a): Bioluminescence expression by the five bioluminescent E. coli ATCC 8739 bioreporter strains (lpp-lux, tatA-lux, ldc-lux, lysS-lux, and spc-lux) 
over 48 hours of incubation n=3. # The overall SEM of each is 0.065 at 95% confidence interval. 
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3.5.1.2 : Viable Counts Kinetics in the Growth and Survival Curve  
The initial viable counts for the five bioreporter strains were approximately 5.88 ± 0.07 log10 
CFU/ml whilst the initial viable counts for the control strains were approximately 5.53 ± 0.06  log10 
CFU/ml with no significant difference between the biosensor and control strains (Figure 3.5 (b)). 
Each of the strains demonstrated a lag during the first 2 hours of incubation, and there was a slight 
decrease in the viable counts between 0.25 ± 0.03 log10 CFU/ml with no significant difference, 
during that period. After 4 h of incubation, the cultures entered exponential phase, and continued to 
multiply at a rate of approximately 1.5 ± 0.07 log10 CFU/ml every hour until the 7.5
th
 hour. At the 
7.5
th
 hour, the viable counts of the bioluminescent bioreporter strains were between 9.8 ± 0.1 log10 
CFU/ml whilst 9.66 ± 0.1 log10 CFU/ml those of the E.coli strains were significantly increased (P ≤ 
0.05, ANOVA) from the initial incubation time for all E.coli strains. From the 10
th
 hour until the 40
th
 
hour of incubation, the viable counts remained statistically unchanged. From the 40
th
 to 48
th
 hour of 
incubation, there was a decreased significantly (P ≤ 0.05, ANOVA) of 1.5  ± 0.1 log10 CFU/ml in the 
viable counts with no significant difference between the E.coli strains. The SEM for the population 
kinetics in Figure 3.3 (b) is 0.083. The significant correlation coefficients between the RLU and the 
CFU throughout the 48 hours of incubation were: lpp-lux R
2
 = 0.82; tatA-lux R
2
 = 0.85; ldc-lux R
2
 = 
0.89; lysS-lux R
2
 = 0.92; and spc-lux R
2
 = 0.81, whilst the F value obtained overall for the growth 
curves across 48 hours was F (228, 21, 0.05) = 3.88. 
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Figure 3.5 (b): Viable counts of the five bioluminescent E. coli ATCC 8739 bioreporter strains (lpp-lux, tatA-lux, ldc-lux, lysS-lux, and spc-lux) and controls 
(E.coli [pBR322.lux] and wildtype ATCC 8739 over 48 hours of incubation n=3. # The overall SEM is exceed 0.083 at 95% confidence interval. RLU vs CFU 
correlation coefficients: lpp-lux R
2
 = 0.82; tatA-lux R
2
 = 0.85; ldc-lux R
2
 = 0.89; lysS-lux R
2
 = 0.92; and spc-lux R
2
 = 0.81; F test of (228, 21, 0.05)= 3.88 
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3.5.1.3 :Ratio of Bioluminescence to Viable Counts (RLU: CFU) in the Growth and 
Survival Curve 
The ratio of bioluminescence to viable counts (RLU: CFU), gives an indication of the level of 
bioluminescence expressed per cell (Figure 3.5 (c). The RLU: CFU ratio was relatively low for all of 
the bioreporter strains carrying bioluminescent constructs on average 0.055 ± 0.13 during the first 3 
hours of incubation.  In contrast, the RLU: CFU ratio reached a peak between at the 5.5
th
 hour of 
incubation. The bioreporter strain carrying the lpp-lux construct demonstrated the highest peak ratio 
of RLU: CFU of 5.884, and this was followed by the spc-lux strain with an RLU: CFU peak of 5.01, 
then tatA-lux at 1.59, and ldc-lux at 0.51, whilst the lowest RLU: CFU ratio was exhibited by lysS-
lux at 0.46. A Tukey post hoc statistical analysis revealed that there is a statistical significance (P ≤ 
0.05, Tukey Post Hoc) increase of RLU:CFU for lpp-lux, and spc-lux between the 5
th
 and 6
th
 hour of 
incubation. From the 6.5 hour to 10
th
 hour of incubation, the RLU:CFU ratios decreased significantly 
(P ≤ 0.05, ANOVA). Finally, between the 10th and the 48th hour of incubation, the RLU: CFU ratio 
for each of the five strains was low averaging at 0.008 ± 0.3 with no statistical differences between 
the E.coli strains in figure 3.3 (c)).  
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Figure 3.5 (c): The bioluminescence to viable count ratio (RLU:CFU) of the five E. coli ATCC 8739 bioreporter strains (lpp-lux, tatA-lux, ldc-lux, lysS-lux and 
spc-lux) over 48 hours of incubation n=3. # The overall SEM is 0.19 at 95% confidence interval. 
0 
1 
2 
3 
4 
5 
6 
7 
0 5 10 15 20 25 30 35 40 45 50 
B
io
lu
m
in
es
ce
n
ce
 t
o
 v
ia
b
le
 c
o
u
n
t 
ra
ti
o
 (
R
L
U
:C
F
U
) 
Time (Hours) 
lpp-lux  
tatA-lux 
ldc-lux 
lysS -lux 
spc-lux 
  
151 
 
3.5.1.4 : Bioluminescence, Viable Counts And Bioluminescence Per Cell (RLU: CFU) For 
The Bioreporter Strains Over 28 Days Of Incubation 
The bioluminescence and viable counts were determined at 1, 2, 7, 14, 21, and 28 days of incubation 
(denoted as hours for graphical purposes) (Figures 3.6 a & b). Bioluminescence and population 
levels at 24 hours were on average 7.71± 0.03 log10 RLU/ml and 10.10± 0.02 log10 CFU/ml exhibited 
by the five constructs. Bioluminescence and population counts decreased at the 48
th
 hour 
significantly, whilst sustaining levels of bioluminescence in terms of bioluminescence per cell 
(RLU:CFU) and populations across the  significantly from the 48
th
 hour to 168
th
 hour.   
 
The bioluminescence readings in the 168
th
 hour decreased significantly to between 4.99 and 6.22 
log10 RLU/ml; with Spc-lux retaining the highest bioluminescence at 6.22 ± 0.01 log10 RLU/ml, 
followed by tatA-lux (5.66 ± 0.013 log10 RLU/ml), lysS-lux (5.51 ± 0.02 log10 RLU/ml), ldc-lux (5.45 
log10 ± 0.03 RLU/ml), and lpp-lux (4.99 ± 0.009 log10 RLU/ml) from the 48
th
 hour. Whilst, viable 
counts decreased to an average 7.9 ± 0.008 log10 CFU/ml at 168 hours for all five constructs.  
 
 After the 336
th
 hour of incubation, the bioluminescence levels decreases significant (P = 0.00, Tukey 
Post Hoc), in increasing order; Lpp-lux construct declined to 2.42 ± 0.001 log10 RLU/ml, lyss 3.42 
log10 ± 0.02 RLU/ml, tatA-lux 4.10 ± 0.03  log10 RLU/ml, followed by ldc-lux to 4.89 ± 0.009  log10 
RLU/ml, and spc-lux to 5.17 ± 0.001  log10 RLU/ml. Viable counts for all strains declined to an 
average of 0.2 ± 0.001  log10 CFU/ml measured at 336
th
 hour with significantly (P ≥ 0.05, Tukey Post 
Hoc).  
 
At the 504
th
 hour, bioluminescence levels of the four out of the five constructs increased from 336
th
 
hour by tatA-lux significantly (P ≤ 0.05, Tukey Post Hoc) as compared to ldc-lux lysS-lux, spc-lux 
and lpp-lux. Lpp-lux continued to decrease significantly sharply from the 504
th
 hour to 2 log10 
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RLU/ml at the 672
th
 hour. Simultaneously, viable counts further decreased from 336
th
 to the 672
th
 
hours with no significant differences. Bioluminescence per cell (RLU:CFU) expressed by tatA-lux 
were significantly higher at the 504
th
 hour compared to ldc-lux, lpp-lux, spc-lux and lysS-lux. 
 
Overall, a Tukey post doc test revealed the RLU:CFU exhibited by lpp-lux showed a significantly 
lower bioluminescent (P = 0.0, Tukey Post Hoc) compared to all the other four bioluminescent 
bioreporter stains in the extended phase of growth whilst no significant difference between tatA-lux, 
ldc-lux, lysS-lux and spc-lux. Statistically significant correlation coefficients between RLU vs CFU; 
Lpp-lux= 0.62; TatA-lux= 0.75; Ldc-lux= 0.74; LysS-lux= 0.95 and Spc-lux = 0.96 over extended 
period in Figure 3.6 (a & b). 
  
The SEM for bioluminescence readings over the extended periods was 0.005, whilst the viable 
counts SEM was 0.014 (Figures 3.6 (a & b)). 
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Figure 3.6 (a): Bioluminescence expression of bioreporter strains over extended incubation periods 
(1, 2, 7, 14,21and 28 d of incubation. n=3 #The overall SEM is 0.005 at 95% confidence interval    
 
 
Figure 3.6 (b): Viable Counts of constructs and control strains over extended incubation periods (1, 
2, 7, 14,21and 28 d of incubation. #The overall SEM of each biosensor does not exceed 0.014 at 95% 
confidence interval. n=3 
# Correlation coefficients RLU vs CFU; lpp-lux= 0.62; tatA-lux= 0.75; ldc-lux= 0.74; lysS-lux= 0.95 
and spc-lux = 0.96 over extended period 
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Figure 3.6 (c): The bioluminescence to viable count ratio (RLU:CFU) of the five E. coli ATCC 8739 
bioreporter strains over incubation periods (1, 2, 7, 14,21 and 28 d of incubation (lpp-lux, tatA-lux, 
ldc-lux, lysS-lux and spc-lux) over 28 days of incubation. n=3 
#  The SEM for RLU:CFU is 0.01 at 95% confidence Interval 
 
 
Figure 3.7: The average pH of the growth medium in the cultures at 0, 1, 2, 7, 14, 21 and 28 days of 
incubation during long-term culture of the E. coli strains. n=3 
# The SEM for pH in the media did not exceed 0.003 for each E.coli strain 
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3.5.1.5 : Culture Medium pH During Long-Term Incubation of 28 Days 
The pH of the initial growth medium was pH 7, and this increased to pH 8.2 ± 0.001 after 24 hours 
of incubation with the bacterial cultures of all seven strains (Figure 3.7). The pH was between 8.53-
8.49 ± 0.003 at 48 to 7 days (168 hours) of incubation, and continued increasing until pH 8.9 ± 0.001 
at 28 days (672 hours) of incubation. The pH of the culture medium did not differ significantly 
between the E. coli strains at any of the time points. 
 
3.5.2 : Morphological and Physiological Changes to the Bacterial Cell Over Extended 
period of 28 days 
The E. coli bioreporter strains and also the control strains when examined microscopically 
immediately after inoculation were rod shaped (indicated by the blue arrows in figure 3.8 (a)). After 
24 hours of incubation there was a mixture of cell morphologies, with almost 60% of cells 
demonstrating a spherical morphology (indicated by the red arrows in figure 3.8 (b) and 
approximately 40% of cells remaining rod-shaped (indicated by the blue arrows in figure 3.8 (b)). In 
contrast, all of the E. coli cells in incubated for 7, 14, 21 and 28 days demonstrated a spherical 
morphology (figures 3.8 (c), (d), (e), & (f) showed by the red arrows). The images here are 
representative of all of the E. coli strains grown. 
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Figures 3.8 (a) – (f): Fluorescence micrographs showing examples of E. coli cells, stained with 
SYTO-9 dye and captured at x1000 magnification. (a) the lpp-lux culture immediately after 
inoculation; (b) the ldc-lux at culture after 1 day of incubation; (c) the lpp-lux culture after 7 days; (d) 
the E. coli [pBr-322.lux] culture after 14 days; (e) the lysS-lux culture after 21 days; (f) the lysS-lux 
culture after 28 days. 
                Blue arrow indicates rod shaped E. coli 
                Red arrow indicates spherical E. coli 
a b 
c d 
e f 
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3.5.3 : Plasmid Copy Numbers (PCN) Determination 
Figures 3.9 (a) & (b) are representative of the graphical output from the MJ DNA software showing 
fluorescence intensity against cycle number in a serial dilution of gDNA and pDNA. Figure 3.9 (a) 
shows an example of the cycle number (CT value) versus fluorescence for the dxs target, whilst 
figure 3.7(b) shows an example of the cycle number (CT value) versus fluorescence for the bla target. 
 
The CT values for the dxs and bla amplicons from each of the bioluminescent bioreporter strains 
were plotted against log10 gene copy number, and there was excellent correlation between CT value 
and copy number for each (figure 3.10 (a), (b), (c), (d) & (e)) for all construct E. coli strains up to 24 
hours of incubation with ≥ 4 orders of magnitude as determined by the MIQE guidelines. The linear 
equations for the calibration curves at 0 hour, 4 hour, 6 hour, 7 days, 14 days, 21 days and 28 days of 
incubation are reported in appendix III. 
 
The slope for the relationship between CT value and copy number (both for dxs and bla) were -2.5 to 
-3, which correspond to qPCR efficiencies of 110% to 150% for 0 hours and 4 hours of incubation, 
respectively (Appendix 3). Whilst slopes of between -3.6 and -2.8 were obtained at between 6 hours 
and 28 days of incubation, correspond to qPCR efficiencies of between 90% to 127% (Figures 3.10 
(a), (b), (c), (d) & (e), and Appendix 3). The standard curves were within the dynamic range of 5 or 6 
log10 magnitude order and PCN were tabulated within the 95% of log copies axis (x-axis) vs CT 
values (Y-axis) and this was recommended by the MIQE guidelines (Bustin et al., 2009) across all 
time points. This demonstrates precision and reliability of quantification data. However, the qPCR 
efficiencies at 0 and 4 hours were between 110% to 150% for all constructs, which was higher than 
efficiencies obtained at 6 hours, 24 hours, 168 hours, 336 hours, 504 hours and 672 hours of all five 
constructs. This could be due to the lower DNA purity (1.5-1.69) (Appendix 3) extracted for 
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construction of standard curve at 0 and 4 hours. The correlation coefficients (R
2
) for ct value versus 
copy number (both for dxs and bla) were between 0.87-0.99 from 0 hours to 4 hours incubation 
whilst the R
2
 values obtained from 6 hours to 28 days of incubation were between 0.9-0.99. The 
SEM of the qPCR reaction obtained at all time points was between 0.005 and 0.05. 
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Figure 3.9 (a) & (b): qPCR curves for serial dilutions of gDNA and pDNA versus cycle number (CT) for dxs 
and bla). 
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Figure 3.10 (a): Standard curves of CT value versus log10 number of gene copies for both the dxs and 
bla amplification from lpp-lux Esherichia coli 8739. The CT values showed an excellent correlation 
with the gene copy number for both the dxs and the bla genes n=3 (R
2
>0.99 with qPCR efficiencies 
92.38%, 94.31% respectively).  
 
 
Figure 3.10 (b); Standard curves of CT value versus log10 number of gene copies for both the dxs and 
bla amplification from tatA-lux Esherichia coli 8739. The CT values showed an excellent correlation 
with the gene copy number for both the dxs and the bla genes n=3 (R
2
>0.99 with efficiencies 
101.16%, 105.67% respectively). 
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Figure 3.10 (c); Standard curves of CT value versus log10 number of gene copies for both the dxs and 
bla amplification from ldc-lux Esherichia coli 8739. The CT values showed an excellent correlation 
with the gene copy number for both the dxs and the bla genes n=3 (R
2
>0.99 with efficiencies 
97.53%, 101.26% respectively). 
 
 
Figure 3.10 (d); Standard curves of CT value versus log10 number of gene copies for both the dxs and 
bla amplification from lysS-lux Esherichia coli 8739. The CT values showed an excellent correlation 
with the gene copy number for both the dxs and the bla genes n=3 (R
2
> 0.99 with efficiencies 
104.07%, 115.46% respectively).  
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Figure 3.10 (e): Standard curves of CT value versus log10 number of gene copies for both the dxs and 
bla amplification from spc-lux Esherichia coli 8739. The CT values showed an excellent correlation 
with the gene copy number for both the dxs and the bla genes, n=3 (R
2
> 0.99 with efficiencies 
81.38%, 114.51% respectively).  
 
The standard curve equations at other time points (i.e. 0, 4, 6, 168, 336, 504, and 672 hours can be 
referred in appendix 3 
3.5.3.1 : Melting Curve and Fluorescence Intensity Curves  
The melting curve generated by the qPCR instrument (Bio Rad) yields two items of information: 
these are the relative intensity of fluorescence (red arrow in figures 3.11 (a) & (b)); and fluorescence 
derivative (-dI/dT) (blue arrow in figures 3.7(a) & (b)). 
 
The melting temperature for the dxs amplicon was 83.6 ± 0.05°C (Figure 3.11 (a)). Alongside figure 
3.11 (a) is a photograph of a 2.0% agarose gel in which the reaction products were run: lane 1 shows 
the molecular weight markers (100bp ladder); lane 2 shows the dxs PCR product (113 bp).  The 
melting temperature for the bla amplicon was 84.2 ± 0.05°C (figure 3.7 (b)). Alongside Figure 3.11 
(b) is a photograph of a 2.0% agarose gel in which the reaction products were run: lane 1 shows the 
molecular weight markers (100bp ladder); lane 2 shows the bla PCR product (81 bp).   
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Figure 3.11 (a); Melting curve for serial dilutions of the gDNA extracted from E. coli 8739 ldc-lux 
after 24 hours of incubation. Peak (1) is due to melting of the dxs amplicons (at 83.6 ± 0.05
o
C). 
The picture alongside shows the dxs PCR product run on a 2.0% agarose gel along with a 100 bp 
ladder. The dxs product size is 114 bp 
 
 
 
 
Figure 3.11 (b); Melting curves for serial dilutions of the pDNA extracted from E. coli 8739 ldc-lux 
after 24 hours of incubation. Peak (2) is due to melting of the bla amplicons at (84.2± 0.05
o
C). 
The picture alongside shows the bla PCR product run on a 2.0% agarose gel along with a 100 bp 
ladder. The bla product size is 81 bp. 
1 
2 
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3.5.3.2 : Plasmid Copy Number (PCN) for the Bioluminescent Constructs Within the E. 
coli Bioreporter Strains over 28 days of Incubation 
 
 
Figure 3.12: Plasmid copy numbers (PCN) of the five bioluminescent constructs within the E. coli 
strains over a 28 day incubation period, n=3 ± SEM. 
 
Figure 3.12 shows the plasmid copy number (PCN) for the bioluminescent constructs in E. coli at 
each time point during 28 days of incubation. Immediately after inoculation (0 hour), the PCN for the 
lysS-lux construct was 49 copies per cell. The PCN at 0 h for ldc-lux was 41; for tatA-lux it was 38; 
for lpp-lux it was 35; and for spc-lux it was 34 with no significant difference amongst the constructs. 
The PCN in all of the bioreporter strains was statistically significantly lower at the 4
th
 hour of 
incubation, in all of the strains, at approximately 18 to 32 copies/cell (P ≤ 0.05, Tukey Post Hoc) 
After 6 hours of incubation, the PCN had recovered significantly to between 55 and 67 copies/cell. 
Tukey post hoc test revealed that there was statistically significant higher (P ≤ 0.05, Tukey Post Hoc 
than PCN at 0, 4, 168, 336, 504, 672 hours. After 24 hours of incubation the PCN was between 49 
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and 58 copies/cell. A Tukey post-hoc test revealed that at 24 hour, there was statistically 
significantly higher (P ≤ 0.05, Tukey Post Hoc) than 168, 336, 504 and 672 hours compared to 0, 4, 
and 6 hours.  
 
The highest PCN at 24 h was demonstrated by spc-lux with 58, followed by lpp-lux with a PCN of 
54, lysS-lux with a PCN of 53, tatA-lux with a PCN of 50, and last of all ldc-lux with a PCN 49. The 
PCN decreased significantly after 24 hours for all constructs and remained between 15-29 copies 
from 1 day to 28 days of incubation (P ≤ 0.05, Tukey Post Hoc) 
 
The coefficient of correlation between the RLU:CFU and the PCN values for each bioreporter strain 
was as follows: lpp-lux R
2
 = 0.59; tatA-lux R
2
 = 0.90; ldc-lux R
2
 = 0.84; lysS-lux R
2
 = 0.78; and spc-
lux R
2
 = 0.80. 
 
3.5.4 : ATP standard 
 
Figure 3.13: Standard curve of ATP concentration versus Chemiluminescence for the ATP-
Chemiluminescence assay using luciferin-luciferase 
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The concentration of ATP in the standard solutions ranged from 10.8 fg/ml to 108µg/ml, which 
yields chemiluminescence of 3-8 log10 RLU/ml in the ATP-chemiluminescence assay.  The 
chemiluminescence showed excellent correlation with the ATP concentration, over a range of 6 
orders of magnitude (R
2
: 0.9858). 
 
3.5.4.1 : Intracellular ATP Content of the E. coli Bioreporter Strains Over 28 Days of 
Incubation 
 
Figure 3.14: The intracellular ATP Concentration of the E. coli bioreporter and control strains over 
an extended incubation period of 28 days.# The overall SEM is 0.006 at 95% confidence interval, 
n=3 
 
The amount of ATP present in each cell is expressed as log10 RLU/ml output from the ATP-
bioluminescence assay. The range of initial ATP-chemiluminescence levels were between 4-4.9 log10 
RLU/ml for the five constructs and the control strains. The amount of ATP present in the cells, as 
demonstrated by ATP-bioluminescence assay, peaked at the 6
th
 hour of incubation for all strains 
between on 4.67-4.99 log10 RLU/ml with no statistical differences at this point. The amount of ATP 
present in all strains decreased significantly (P ≥ 0.05, ANOVA) between 6 to 24 hours of 
incubation, as demonstrated by a 1.0-1.3 log10 RLU decrease in ATP-chemiluminescence; by all E. 
coli strains. From 168
th
 to 672
th
 hour of incubation, the levels of ATP chemiluminescence were on 
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average 3.6 ± 0.05 log10 RLU/ml by the five construct and control strains with no statistical 
differences.  
 
The chemiluminescence readings for ADP and AMP and the levels of ATP, ADP and AMP readings 
were converted mg/ml from the standard curve obtained in figure 3.13. Due to the huge amount of 
figures obtained, the readings are located in the appendix 3. 
 
3.5.4.2 : Adenylate Electron Charge (AEC) of the E. coli Bioreporter Strains Over 28 Days 
of Incubation 
 
 
Figure 3.15: The Adenylate Energy Charge (AEC) of the E. coli bioreporter and control strains over 
an extended incubation period of 28 days. # The overall SEM is 0.003 at 95% confidence interval, 
n=3 
 
The AEC peaked after 6 hours of incubation and, overall, followed the same trend as that shown by 
the ATP levels (Figure 3.10 versus Figure 3.11). Immediately after inoculation, the AEC was 
between 0.74 and 0.86 for each the five bioreporter and control strains, with no significant difference 
between the E.coli strains. At the 6
th
 hour of incubation, the AEC values were between 0.85 and 0.91 
for all of the E. coli strains with no significant difference. The AEC decrease significantly (P ≤ 0.05, 
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Tukey Post Hoc) from 6
th
 hour to 24
th
 hour, the AEC values were between 0.60 and 0.75 for all of 
the E. coli strains. From the 7
th
 to 28
th
 day of incubation, the AEC of all of the E. coli strains fell 
steeply by between 0.5 and 0.57. A Tukey post-hoc test revealed no significant difference in the 
AEC levels from 24 hours to 168 hours. 
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3.6  Discussions  
3.6.1 : Physiology, Morphology, Metabolic Status, And Plasmid Copy Number Of The 
Five E. Coli Biosensor Strains And The Control E. Coli Strains 
 
The bioluminescence emission patterns resulting from lux expression by five constructs in the 
bioreporter strains followed the classical bacterial growth curve of a lag, an exponential, a stationary 
and a death phase. The lag phase is the period during which the microbial population adapts to its 
environment when it is changed suddenly, leading to a delay in the commencement of growth 
(Swinnen et al., 2004). The results obtained in this chapter reveals the lag phase of the 
bioluminescence, viable counts and bioluminescence per cell profiles lasted for the first 4 h of 
incubation (Figure 3.5 (a, b & c)) with no significant differences. During this adaptation phase the E. 
coli cells undergo intracellular changes to adjust to the nutrients in the new medium in order to 
initiate exponential growth, and at the same time little cell reproduction occurs (Buchman & 
Cygnarowics, 1990; Yates & Smotzer, 2007). Consequently, the limited growth and bioluminescence 
expression during the first 4 h of incubation in the experiments described in this thesis fits well with 
expectations. The reduction in bioluminescence expressions is also the result from the requirement of 
reduced cofactors during the adaptation process, during the lag phase in accordance with transient 
changes of internal metabolite concentrations (e.g. ATP; NADP; NADH; intracellular glucose, 
phosphoenolpyruvate; glucose-6-phosphate) (Buchholz et al., 2002; Hoque et al., 2005).  During the 
lag phase,  the housekeeping sigma subunit RpoD (σ70/D) expression has been shown to produce a 2-
fold increase during lag phase, beginning at about 20 minutes, and continuing into the exponential 
phase of growth (Rolfe et al., 2012). RNA synthesis during the lag phase is a prerequisite for the 
production of proteins required to equip the bacteria for exponential growth. It has been reported that 
the intracellular concentration of the core RNA polymerase (RNAP) remains constant during the 
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exponential and stationary phase, at around 2,000 complexes per chromosome equivalent in E. coli 
(Ishihama, 2000), with the activity of the RNAP being modulated by competition between the 
different sigma factors (Grigorova et al., 2006). 
 
In this phase, the plasmid copies demonstrated lower copies during the first 4 hour of incubation, the 
plasmid copy number decreased to 18 - 32 copies at 4 hours decreased significantly (P ≥ 0.05, Tukey 
Post Hoc) compared with 34 - 49 copies per cell initially (Figure 3.12). Previous studies by Lee et al 
(2006a) demonstrated lower PCN during lag phase due to the adjustment to the changes in the 
environment with minimal cell growth and DNA replication. This also coincides with previous 
studies carried out by Chao-Lin and Bremer (1986), and Klumpp (2011) where plasmid copy number 
of pBR322 is proportional to the doubling time of growth. During lag phase, the growth rate 
decreases as shown in this study and hence there is higher competition of RNA polymerase for 
plasmid and genomic replication (Klumpp, 2011) resulting in lower PCN, CFU and RLU as 
demonstrated in Figures 3.5 (a & b). Additional tabulation of the growth rate was carried out to 
demonstrate the relation between growth rate and PCN (Appendix 3).  
 
The relation of bioluminescence expression and growth requires energy, the amount of metabolically 
available energy is stored in the adenylate system denote as adenylate energy charge (AEC) 
(Chapman et al., 1971). There was no statistical difference between the AEC levels between the five 
bioluminescent bioreporter strains and the control E.coli strains throughout the 28 days (Figure 3.15). 
Although initially, it was a concern that the biochemical pathway involving the oxidation of reduced  
FMNH2 and aldehyde by molecular oxygen controlled by constitutive expressions would increase 
levels of kinase activity resulting in higher metabolic turnovers by the constructs with lower AEC 
values. Therefore, it is clear that the same metabolic load is exerted throughout 28 days and this 
demonstrated the suitability of the bioluminescent measurement exhibited by the bioreporter E.coli 
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ATCC 8739 strains when challenged in PET instead of the conventional plate counting method. In 
addition, previous report cited that luminometer (Multi-Lite, Biotrance Ltd) was capable of detecting 
30 fg ATP, moreover, the celsis luminometer was able to obtain a lower detection of 10.8 fg ATP. 
Nevertheless, the amount of ATP per E.coli cell measured by the Celsis luminometer agreed with the 
measurements made by Multi-Lite which is approximately 3 fg per colony forming unit (Kyriakides 
& Patel, 1994). 
 
The bioluminescence reached mid-exponential phase 30 minutes earlier than the viable counts at 5-6 
hours (Figures 3.5 (a) & (b)). This resulted in large peaks in bioluminescence per cell (Figure 3.5 (c)) 
around mid-exponential phase. Previous study have demonstrated increased bioluminescence 
expressions resulting from the sudden change of metabolic activity from a non-limited glucose 
growth to a glucose limited condition led to  higher concentration of FMNH2 and consequently an 
strong and sharp signal of bioluminescence (Sunya et al., 2012). Bioluminescence levels per CFU 
(RLU:CFU) were significantly higher for lpp-lux and spc-lux than ldc-lux, lysS-lux and tatA-lux 
(Figure 3.5 (c)). The increased of constitutive expression for lpp and spc compared to the other three 
promoters were due to the expression levels contributed by the binding affinity of promoter regions 
with sigma factors (Jensen & Hammer, 1998) and also the possibility of the native promoter 
functions which this will be discussed in detail in the next section. On the contrary, recent study from 
Sunya et al. (2012) showed that the strong bioluminescence expressions is not dependent on the 
strains or on the type of promoter-lux fusions but is rather dependent on the metabolic activity of the 
cells and the biochemistry of bioluminescence. Hence, this study therefore presents the relation of 
bioluminescence expressions with combined effect of various constitutive promoters, metabolic 
activity and biochemistry of bioluminescence.  
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The increased bioluminescence and bioluminescence per cell is related to the significant increase of 
PCN from 0 hour to the 6
th
 hour of incubation resulted in plasmid copies per cell of 55 to 67 
copies/cell. The significant increase of PCN coupled with CFU  at the 5
th
 to 6
th
 hour lead to a greater 
proportions of bioluminescence per cell expressed and  possibly because a large proportion of the rod 
cells were elongated prior to septation and cell division at this point in time (Figures 3.8 (b)). 
Therefore, bioluminescence output per cell (RLU:CFU)  is expected to be greater between the 5
th
 and 
6
th
 hour. Previous studies by Amin-Hanjani et al. (1993) reported similar phenomenon of high copy 
number contributed to the higher luminescence per cell. This was supported by relation of 
correlations values (R
2
: 0.59-0.9) between bioluminescence per cell levels and PCN for the five 
constructs except lpp-lux which is discussed in the later test.  Similar analysis in studies conducted 
by Rattray et al. (1990) demonstrated bioluminescence per cell exhibited by E.coli DH1 
[pUCD607.lux CDABE],   E.coli MM294 [pBTK5.lux RICDABE] at exponential phase was 0.13 
(RLU:CFU). According to Rattray et al. (1990), the variation levels of bioluminescence between 
plasmids (i.e.pUCD607 and pBTK5) were reflected by the differences in plasmid copy number and 
constitutive promoter expressing bioluminescence. Hence, in this study, the bioluminescence per cell 
(RLU:CFU) was higher (0.467 - 5.88) in the exponential phase than in the stationary phase (0.001-
0.0009) for each of the biosensor strains. This suggests that the five promoter chosen have higher 
constitutive activity in expressing high bioluminescence levels and stable plasmid copy number.  
 
Proceeding on to exponential phase, there were approximately 55-67 copies of pBR322 in the five E. 
coli bioreporter strains, which corresponds well with previous observations that E. coli harbours 
between 30 and 70 copies of pBR322  (Atlung et al., 1999; Lee et al., 2006a). pBR322 replication is 
regulated by the ratio of its self-encoded promoters, RNA I and RNA II, where RNA II is known as 
an initiation preprimer. The high copy number of pBR322 during exponential phase would suggest 
that high levels of RNA II, which initiates replication efficiently, are present in the cell, and at the 
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same time it suggests and absence of the RNA I/RNAII duplex, to inhibit plasmid replication (Atlung 
et al., 1999).  
 
Exponential bacterial growth and replication involves multiple rounds of DNA synthesis, coupled 
with transcription and translation, to synthesize the necessary macromolecules. In the exponential 
stage, there is a high demand for energy, hence the AEC for all of the E. coli strains in exponential 
phase was between 0.9 and 0.93, which compares well and agrees with previous studies that 
demonstrated that growth was possible with an AEC of 0.8 or above in E.coli (Chapman et al., 
1971). The increase in the energy status of the cell, as reflected in a rise in the AEC is due to the 
increased amount of phosphoenolpyruvate that is converted to pyruvate and oxaloacetate for use in 
the biosynthetic pathways and for energy production through glycolysis, the tricarboxylic acid cycle 
(TCA), electron transport and oxidative phosphorlyation (Liao & Atkinson, 1971). Furthermore, 
bioluminescence emission, CFU counts and PCN are at their highest during exponential phase, when 
replication of the chromosome and the plasmid are also at their maximum. 
 
The plateau in the bioluminescence and viable counts from 7.5 to 40 hours of incubation, is typical 
of the stationary phase. During this phase, no increase was observed in either the bioluminescence or 
the viable counts. The depletion of nutrients and the accumulation of bacterial waste products (eg 
ammonium cation) resulted in an increase of the pH of the growth from 7 to 8.5 by 48 hours of 
incubation.  Clifton (1937) reported the pH of E.coli cultures have rapidly shifted to alkaline values 
reporting at pH 8.4 or higher in peptone medium. At high pH E. coli requires a greater import of 
protons to counteract the alkaline stress on cytoplasmic pH (Maurer et al., 2005) which could lead to 
death phase.  
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The death phase occurred from the 40
th
 hour to 48
th
 hour of incubation during which there was a 
significant decline of 1-2 log10 CFU/ml. During the death phase, dead cells are lysed and release 
nutrients in to the depleted growth medium that can then be exploited by the surviving population of 
E. coli (Navarro Llorens et al., 2010). As mentioned in chapter 1, the light emitting reaction involves 
an intracellular, luciferase catalysed by oxidation of reduced FMNH2, molecular oxygen and 
aldehyde. Since reduced FMNH2 production depends upon fractional electron transport, only live 
cells are able of producing light. With strong correlations obtained during the growth curve, this 
confidently demonstrated the relationship between cellular viability and light that endows 
bioluminescence with the ‘reporting’ power on the viability status. This attribute of invivo 
bioluminescence as a bioreporter of viability has been demonstrated in many past studies (Hill et al., 
1993; Ellison et al., 1994a & b; Marincs, 2000; Steward, 1990, 1993; Stewart & Williams, 1992,; 
Stewart et al., 1991, 1993, 1996, 1997).  
 
During long term stationary phase, from 7 to 28 days of incubation, the AEC values were between 
0.50 and 0.58, with no significant difference between the E. coli bioreporter and control strains. This 
agrees with the work carried out by Chapman et al. (1971) which showed that cell viability could be 
maintained, but that growth was not possible, at AECs of between 0.5 and 0.8. The significantly 
lowered AEC from 24 hours to the extended incubation time of 7 to 28 days suggest that there will 
be less energy available for transcription process of the lux cassette to produce bioluminescence 
(Figure 3.15). This coincides with the significant decrease of PCN from 24 hours to 7, 14, 21 and 28 
days in long term stationary phase. Therefore, the combined effect of less energy and lowered PCN 
values in the extended time frame resulted in the decreased bioluminescence. 
 
The bioluminescence and viable counts were lower between 7 and 14 days of incubation, which may 
result from the specific targeting of the reduced metabolic activity upon maintenance of cell viability 
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by, for example repairing the macromolecular damage accumulated in stationary phase (Rolfe et al., 
2012).  Between the 14
th
 and 21
st 
days of incubation, there was an increase significantly in 
bioluminescence levels from both the tatA-lux E. coli and the ldc-lux E. coli.  The greater increase of 
bioluminescence expression with resulted in the higher RLU:CFU for tatA-lux E. coli at the between 
the 14
th
 and 21
st
 day. Previous studies from Maurer et al (2005) demonstrated a significant increase 
in tatA expression at pH 8.7 whilst the pH recorded in this study was pH 8.89 between day 14 and 21 
(Figure 3.7). This suggests the potential of tatA constitutive promoter to remain high 
bioluminescence intensity  in high alkaline conditions.   
 
The fluorescence microscopy images suggest that during long term stationary phase (from 7 to 28 
days) the E. coli cells undergo both physical and morphological changes, becoming smaller and more 
spherical (Figure 3.8 (a-f). Loewen and Hengge-Aronis (1994) showed that this move to a coccoid 
morphology was a result of induction of the bolA gene. The cytoplasm becomes condensed, while 
the volume of the periplasm increases. The composition of the cell membrane is altered to produce a 
less fluid membrane and the nucleoid becomes condensed by replacement of some DNA-binding 
proteins with other species of DNA binding protein, which results in a multi-resistant state, when the 
cells become more thermotolerant and more resistant to oxidative, acid, and osmotic stresses than 
when they are in exponential phase (Loewen & Hengge-Aronis, 1994). There is also an increase in 
the amount of DnaA protein, which is required for initiation of chromosome replication in the late 
stationary phase (Talukder et al., 1999). Under these conditions, E. coli cells with a growth 
advantage in the stationary phase (GASP) phenotype may grow within the culture to either coexist 
with the parental majority or displace the parent (Zambrano et al., 1993).  
 
This attribute is important to ensure the bioluminescence readings reflect the viability across the  
PET time frame. Furthermore, the plasmid copy numbers measured for the five constructs 
  
176 
 
demonstrated stability across the PET time frame. This chapter covers the extensive study of the 
bioluminescent bioreporter strains where there are no statistical differences between the 
bioluminescence, viable counts, AEC, and PCN across 28 days which thereby demonstrated 
legitimate of the PET application in the proceeding chapters. 
  
3.6.2 : Relationship Between Extended Stationary phase and Bioluminescence  
Along growth and survival phase, the E.coli strains spend a considerably long amount of time in 
stationary phase where there is no significant increase in viable counts. In stationary/starvation 
phase, the expression of genes of both the RpoS (encoding σ38/S) and the RpoD (encoding σ70/D) 
regulons are important, as both σ factors compete for the core polymerase since they both regulate 
expression of genes required for  survival in stationary/starvation phase (Finkel, 2006). However, the 
levels of active RpoS (encoding σ38/S) are extremely low during exponential growth (Jishage et al., 
1996), and increases by up a 3 to 6 fold increase in RpoS mRNA levels occurs during the transition 
from the exponential to stationary phase (Yamashino et al., 1995) and RpoS regulates more than 30 
genes (Hengge-Aronis, 1996; Nystrom, 1994). Consequently, a different set of recognition sequences 
is required for genes to be expressed in stationary phase than is required in exponential phase. 
Furthermore, anti-sigma factors have been identified, such as the anti-RpoD (σ70/D) factor, and so it is 
possible that the activity of RpoD (σ70/D) is controlled to permit RpoS (σ38/S) to up-regulate 
transcription of the genes that it regulates more effectively (Hughes & Mathee, 1998). 
 
RpoS (σS/38) regulates expression in stationary/starvation phase by recognition of particular promoter 
regions. The -10 region consensus sequence is identical for both RpoS (σS/38) and RpoD (σD/70) 
except that in the -8 position the adenine (A) of RpoD (σD/70) is replaced with a cytosine (C) in RpoS 
(σS/38). At the-8 position, tatA, ldc, lysS and spc carried an adenine (A), whilst lpp carried a cytosine 
(C) which is the consensus of RpoS (σS/38). This did not significantly affect the bioluminescence 
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levels of tatA-lux, ldc-lux, lysS-lux, and spc-lux throughout stationary phase except for lpp-lux. RpoS 
(σS/38) has a preference for either a T or G nucleotide at position -14, and since spc and lpp have a G 
this suggests they would have an increased affinity for σS during starvation/stationary phase (Becker 
& Hengge-Aronis, 2001). However, bioluminescence expression by spc-lux was not significantly 
increased during the long term stationary phase. Never the less, bioluminescence expression from the 
lpp-lux E. coli decreased significantly more rapidly than it did from the lysS-lux, ldc-lux, tatA-lux, 
and spc-lux under long-term incubation in comparison to the bioluminescence expression exhibited 
by lpp-lux in early stationary phase.  
 
Becker and Hengge-Aronis (2001) reported that the difference in the extended regions of RpoD 
(σD/70) to RpoS (σS/38) is the preference of G at the -13 position (Table 2.4) to a C at position -13 of 
RpoS (σS/38). This relates to accommodation of gene expression at different phase of growth for  
RpoD (σD/70)-controlled promoters during exponential phase whilst expression of genes regulated by 
RpoS (σS/38) is acquired under conditions of low or no growth (in stress conditions).  RpoS (σS/38) 
and RpoD (σD/70) diverged relatively recently in evolutionary terms, and are still relatively similar, 
but different selective pressures have been acting upon RpoS (σS/38) and RpoD (σD/70) mediated gene 
expressions (Becker & Hengge-Aronis, 2001). This selective pressure of sigma factors of RpoS 
(σS/38) and RpoD (σD/70) during the growth phase (i.e. lag, exponential, stationary phases) could be 
one of the factors which could influence the expression of bioluminescence, more significantly 
during starvation/stress periods.  
In relation to the bioluminescence per cell expressed over 28 days, bioluminescence per cell 
exhibited by lpp-lux E. coli was significantly much lower than from the other four constructs over 
the extended incubation period. The significant (P ≤ 0.05, Tukey Post Hoc) reduction in the lux 
expression for lpp may suggests down-regulation of this promoter during long-term stationary phase, 
which has not previously been reported in the literature. Previous studies have demonstrated strong 
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induction of starvation lipoprotein, slp, in response to entry to stationary phase (Alexander & St 
John, 1994). It has been demonstrated that the slp promoter resembles the consensus sequence for σ70 
(-35 region: ATGAAA, -10 region: TATTAT) (Alexander & St John, 1994). In addition, the slp 
promoter contains a region that has interrupted dyad symmetry between -36 and +5. The region 
modulates the expression of slp during periods of growth and starvation (Alexander &St John, 1994).  
The role of slp is to maintain the structural integrity of the cell surface layers and help stabilize the 
outer membrane of E. coli during carbon starvation and the stationary phase (Alexander & St John, 
1994).  
Amongst the other four bioreporter strains, tatA-lux strains exhibited significantly higher 
bioluminescence per cell relatively (Figure 3.6 (c)) compared to ldc-lux, spc-lux and lysS-lux in the 
extended phase in alkaline pH.  The biological function of tatA is in exporting pre-folded proteins 
from the cytoplasmic membrane to periplasm (Santini et al., 1998). Therefore, this relates the levels 
of bioluminescence expressions to the biological functions of tatA, where in starvation/stationary 
phase, this suggest that there would be an increased need to export proteins for viability 
maintenance. The biological function of ldc is to synthesize polyamines which are needed for 
ribosomal functions and growth (Tabor & Tabor, 1985). In addition, cells respond to starvation by 
reduced biosynthesis in ribosomal proteins and DNA replication (Llorens et al., 2010), hence 
expressions of spc and lysS would be expected to reduce in extended incubation period. Neusser et 
al., (2010) denoted that mRNA levels of lysyl- t-RNA synthetase enzyme (lysS) decreased during 
stationary phase which would explain lowest RLU:CFU after lpp-lux in the extended phase. 
Regulation of an alternative lipoprotein, slp was known to be regulated under long term stationary 
phase (Alexander & St John, 1994) which explains the significant decreased in bioluminescence 
levels. Meanwhile, high amount mRNA levels of spc operon were expressed during exponential 
phase (Wei et al., 2001) which agrees with the results obtain in exponential phase. Therefore there is 
an indispensable relation between the biological function of the promoter and sigma factor 
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competitions which relates to expression levels bioluminescence at different growth and survival 
phases. 
In summary, the E. coli bioluminescent biosensor strains have demonstrated similar physiology to 
control strains, in terms of the growth and survival curves, and adenosine energy charge. The relative 
stability of the plasmid copy number per cell over the 28 days of incubation contradicts the 
suggestion made by Turdean (2011) which mentioned that one of the disadvantages of whole-cell 
biosensors is a lack of stability due to the loss of plasmids from the bioreporter cells. However, the 
PCN results in this study have shown otherwise, indicating no significant decrease of PCN after 7 
days to 28 days of incubation. However, studies from Bechor et al. (2002) showed decrease 
bioluminescence intensity measured from plasmid based lux strain compared to chromosomal 
integration strain. Therefore, despite the use of plasmid strain in this study, low bioluminescence 
background were also measured under glucose limited condition for biosensor and control strains; 
promoter-less lux E.coli ATCC 8739 strain, in contrary to  rpoS controlled promoter in Notley and 
Ferenci, (1996). 
 Furthermore, Turdean (2011) also stated that the experimental conditions such as medium pH, 
incubation time, and buffer and reagent composition could have affect bioluminescence expression, 
and thus biosensor performance. However, the excellent stability of the bioluminescence exhibited 
by the biosensor strains over 28 days of incubation under changing conditions, such as increasing 
pH, again contradicts Turdean (2011). Hence, it would seem that these bioluminescent constructs 
with the chosen constitutive promoters have the potential to succeed in whole-cell microbial 
biosensors. 
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3.7 : Conclusions 
1) The growth curves indicate that the four biosensor constructs are indeed expressed 
constitutively with strong correlations (R
2
: 0.74-0.92) values were obtained between RLU 
and CFU across 28 days for all constructs. However, the expression of bioluminescence by 
the lpp-lux E. coli decreased more rapidly than it did in the other four strains.  
2) There is no statistical differences between the bioluminescence, viable counts, AEC, and 
PCN across 28 days which thereby demonstrated legitimate of the PET application in the 
proceeding chapters. 
3) There was no significant difference in the total AEC in either the five bioreporter strains or 
the E. coli control strains over 28 days demonstrating equal metabolic load. 
4) There is an indispensable relation between the biological function of the promoter and sigma 
factor competitions which relates to expression levels bioluminescence at different growth 
and survival phases. 
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Chapter 4 
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4 Whole-Cell Bioluminescence Evaluation Using Sorbic Acid 
 
4.1 : Sorbic Acid as a Preservative 
Sorbic acid (2,4-hexadienoic acid) is a straight chain unsaturated fatty acid with a molecular weight 
of 112.13 g/mol and the formula: CH3- CH = CH - CH = CH – COOH (Figure 4.1) (Sofos & 
Busta,1981).  
 
Figure 4.1: Chemical Structure of Sorbic acid 
 
 Sorbic acid is commercially produced in powder or granule form; it has a characteristic acrid odour 
and acid taste (Sofos & Busta, 1981). The carboxyl (COOH) group in sorbic acid is very reactive and 
can form salts with calcium, sodium and potassium (Sofos & Busta, 1981).  A.W. Van Hoffman first 
isolated sorbic acid from berries of the mountain ash tree in 1859 (Sofos & Busta, 1981) and the 
antimicrobial properties of sorbic acid were first recognized in the 1940's. Exposure to sorbate results 
in an extension of the lag phase, regardless of the growth rate of the bacterial culture (Chung & Lee, 
1982, Greer, 1982; Larocco & Martin, 1981; Tsay & Chou, 1989; Zamora & Zaritzky, 1987). The 
effectiveness of sorbate salts against bacteria, yeasts and molds gave rise to its extensive use in 
foods, cosmetic products, and ophthalmic products (Sofos & Busta, 1981). The addition of small 
amounts of sorbic acid to food also does not alter the taste, flavour and nutrient content of the food.  
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4.1.1 : Mode of Action  
The primary mode of action of sorbic acid is a result of the partial dissociation of a weak acid. Weak 
acids exist in varying mixtures of dissociated and undissociated molecules in aqueous solutions. The 
undissociated form of a weak acid can readily permeate the plasma membrane of microbial cells and 
is therefore able to diffuse freely into the cytoplasm (Booth & Kroll, 1986) (Figure 4.2). This 
diffusion of undissociated acid reaches an equilibrium when the internal and external concentrations 
become equal. Most neutralophilic microbes maintain a pH gradient across their cytoplasmic 
membranes, with the internal pH higher than the external. Consequently, the acid molecules will tend 
to undergo dissociation once they have diffused into the cell until the pKa is achieved. This means 
that further undissociated acid molecules will diffuse into the cell in order to achieve equilibrium, so 
fuelling further increases in the dissociated acid anion and proton concentrations. The accumulated 
high levels of charged weak acid in the cytoplasm results in a decrease in internal pH (pHi). This 
drives the proton translocation activity of the H
+
-ATPase, in order to expel hydrogen ions and 
maintain pHi homeostasis (Bracey et al., 1998; Cole & Keenan, 1987; Eraso & Gancedo, 1987; 
Salmond et al., 1984). The maintenance of pHi homeostasis can be energetically expensive (Eraso & 
Gancedo, 1987; Serrano, 1980, 1984), and can result in consumption of 40%-60% of the total 
intracellular ATP by the membrane H
+
-ATPase (Serrano, 1991). Therefore, the maintenance of pHi 
homeostasis in the presence of weak acids preservatives may deplete intracellular ATP levels 
significantly (Cole & Keenan, 1987). Such depletion of the ATP would result in growth restriction 
and an indirect result of growth inhibition by weak acids may be to cause membrane disruption 
(Bracey et al., 1998; Freese et al., 1973; Stratford & Anslow, 1998), leading to a disturbance in 
essential cell functions such as ATP synthesis, active transport of nutrients, cytoplasmic regulation, 
inhibition of essential metabolic enzymes  (Krebs et al., 1983), cell growth cycle arrest  (Booth et 
al.,1989; Cole et al., 1987; Krebs et al., 1983), and the accumulation of toxic anions (Eklund, 1983). 
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Sorbic acid was chosen to challenge the bioluminescent E. coli bioreporter strains, as it requires an 
energy-dependent response to counteract the detrimental effect of sorbic acid (Plumridge et al., 2004). 
Sorbic acid is considered to be very effective against E. coli and it has been ranked as the third most 
effective, after disodium sulfite and benzoic acid, against E. coli O157:H7 amongst the weak acid 
antimicrobials E. coli (Lu et al., 2011). However, sorbic acid is less toxic than benzoic acid against 
humans and animals (Turantas et al., 1999), and so is preferred as a preservative. The multiple effects of 
sorbate upon the microbial cell such as the depletion of cellular energy therefore present a particular 
challenge to the biosensor system because of its potential impact upon the expression of 
bioluminescence. 
 
Figure 4.2: A schematic diagram of the mode of action of sorbic acid. Uncharged molecules (HA) 
diffuse through the plasma membrane and can dissociate to protons (H
+
) and anions (A
-
) in the 
cytoplasm. The charged protons are expelled by the membrane H
+
ATPase, leaving the acid anions 
within the cytoplasm (Piper et al., 1998). 
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4.2 : Rationale of Chapter 4 
This chapter describes an investigation into the application of whole-cell biosensors as a rapid 
microbiological method in preservative efficacy studies. The inocula were standardised in 
accordance with the requirements set out by the British & European Pharmacopoeias, as were the 
reductions in viable counts when exposed to the preservatives tested. The whole-cell 
bioluminescence method was employed to screen a range of concentrations of 0.2% to 0.0031% at 
pH 5.0.  The whole-cell bioluminescence method was performed concurrently with two other 
methods that are described by the pharmacopoeias: the conventional plate count method; and the 
ATP chemiluminescence method. The aim of the work described in this chapter was to determine 
the accuracy and reproducibility of the whole-cell bioluminescence method in comparison with the 
currently accepted methods. 
 
The chapter that follows covers the following comparisons;  
 
Comparison of preservative 
efficacy testing (PET) 
methods using Sorbic Acid 
Conventional plate count 
Rapid ATP-
chemiluminescence 
Rapid bioluminescence 
Comparison of promoter 
activity when challanged with 
sorbic acid 
1) lpp (outer membrane 
lipoprotein) 
2) tatA (twin arginine 
translocase) 
3) ldc (lysine decarboxylase) 
4) lysS (lysyl-tRNA) 
5) spc (ribosomal protein) 
Calculations of  the 
concentrations of 
Undissociated sorbic acid and 
dissociated sorbate anion 
Henderson–
Hasselbalch equation 
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4.3 : Objectives  
1) To compare the response of the 5 bioluminescent bioreporter strains after exposure to sorbic 
acid at 0.2% to 0.031% at pH 5.0 
2) To compare the response of the bioluminescent reporter strains to sorbic acid, at 0.2% to 
0.031% at pH 5.0, with the existing methods prescribed by the British and European 
pharmacopoeias. 
3) To rationalize and compare the five promoters, expressing bioluminescence in sorbic acid 
efficacy test at pH 5. 
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4.4 : Materials and Methods 
4.4.1 : Preparation of Bacterial Initial Inoculum and Preservative Solutions 
1.0 g of sorbic acid (Sigma-Aldrich) was weighed and dissolved in 150ml of deionized water. The 
pH of the solution was adjusted to pH 5.0 by adding 0.1M NaOH. This solution was then topped up 
with deionized water to 250.0 ml in the volumetric flask to produce a 0.4% stock solution. 60ml of 
the stock 0.4% (w/v) sorbic acid solution was then sterilized by filtering through a 0.2 µm Millipore 
Minisart syringe filter. Twofold serial dilutions of the 0.4 % (v/v) sorbic acid stock solution were 
made using sterile deionized water to obtain the following range of concentrations: 0.2% (v/v); 0.1% 
(v/v); 0.05% (v/v); 0,025% (v/v); 0.0125% (v/v); 0.062% (v/v); and 0.0031% (v/v). 
 
The five bioluminescent E. coli bioreporter strains and control strains (E.coli [pBR322.lux] and 
E.coli ATCC 8739 were grown overnight as described in Section 2.2 to provide an initial inoculum. 
10ml of the overnight culture was centrifuged at 20,000 g (Sorvall, RC 5B with SS-34 rotor) for 20 
minutes, at 4
ᵒ 
C. The supernatant was removed and the cell pellet was washed by resuspending and 
centrifugation with 10ml of sterile deionized water three times. The resulting cell pellet was finally 
resuspended with 10ml of sterile deionized water. Ten-fold serial dilutions of the washed bacterial 
suspension were prepared using sterile buffer peptone water (Sigma), to obtain an initial cell density 
of ~ 10
8
 CFU/ml. This was determined by pre-constructed standard curves from chapter 2. A 30µl 
aliquot of the prepared 10
8
 CFU/ml initial inoculum was inoculated into 2970µl of the sorbic acid 
dilutions (0.4%-0.0031%) prepared as described above along with a negative control of sterile 
double distilled water (ddH20). This resulted in an initial population of ~ 10
6
 CFU/ml (USP, E.P & 
B.P). Ten-fold serial dilutions were prepared with samples of each of the bacterial suspensions 
exposed to preservative and these were spread onto TSA plates, which had been supplemented with 
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100 µg/ml ampicillin for those plates inoculated with transformed E. coli strains, to confirm the 
initial counts. 
 
4.4.2 : Preservative Efficacy Testing (PET) 
The sorbic acid dilutions, inoculated with bacterial suspensions as described above, were incubated 
at 20ºC ± 2.5 ºC for a period of 28 days. The viable counts (as described in Section 2.4.4), 
bioluminescence (as described Section 2.4.3) and ATP chemiluminescence (as described in Section 
2.4.5) were evaluated at 0 hours, 1 day, 2 days, 7 days, 14 days, 21 days, and 28 days after 
inoculation as prescribed by the European Pharmacopoeia –A criteria (for topical, ophthalmic and 
parenteral preparations. Both the British and European Pharmacopoeia require a minimum reduction 
in viable counts of 2 log10 CFU/ml after 2 days of exposure to a preservative, and a minimum 
reduction in viable counts of 3 log10 CFU/ml after 7 days of exposure for topical preparations. 
Whilst, a minimum reduction in viable counts of a 2 log10 CFU/ml after 6 hours of exposure and a 
minimum reduction in viable counts of 3 log10 CFU/ml after 24 hours of exposure for parenteral and 
ophthalmic preparations. Lastly a minimum reduction in viable counts of 3 log10 CFU/ml after 14 
days of exposure is required for oral preparations.  The experiments were performed in triplicate. 
The time taken to achieve a viable count of ≤ 3 log10 CFU/ml, a bioluminescence of ≤ 3 log10 
RLU/ml and an ATP-chemiluminescence of ≤ 3 log10 RLU/ml was recorded for each of the five 
bioluminescent biosensor strains and control strains. 
 
4.4.3 : Determination of the Minimum Inhibitory Concentration (MIC) of Sorbic acid 
A stock solution of sorbic acid was prepared as described in section 4.5.1. Twofold serial dilutions 
were prepared using TSB to yield working concentrations of 0.2%, 0.1%, 0.05%, 0,025%, 0.0125%, 
0.062%, and 0.0031%. Initial inocula of the E. coli biosensor and control strains were prepared as 
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described in section 4.5.1, inoculated into the sorbic acid solutions and incubated at 32 °C. The 
initial optical density of the bacterial suspensions was determined at 620nm (Cecil CE1011 1000 
series), as was the initial bioluminescence of the suspensions before the preservatives were added. 
The optical density and bioluminescence were again determined after 24 hours’ exposure to the 
sorbic acid dilutions. The MIC was defined as the lowest concentration of sorbic acid that 
demonstrated no growth of the bacterial culture. Plate counting was carried out before addition of 
preservatives and at the MIC concentration to confirm a 99.9% reduction. 
 
4.4.4 :  Calculation of the Intracellular Undissociated Acid and Dissociated Acid Anion 
Concentration Present in the Experiments 
The pKa of sorbic acid is 4.76 (Cowles, 1941; Cerruti et al., 1990; Freese et al., 1973; Hoffamn et 
al., 1944; Sofos & Busta, 1981; Rahn & Conn, 1944; Pethybridge et al.,1983), the pH of cytoplasm is 
6.8 (Salmond et al., 1984) and the pH of the sorbic acid solution was measured at 5.0. The 
concentrations of undissociated sorbic acid molecules and also dissociated sorbate anions of were 
calculated at both pH 5.0 and pH 6.8 using the Henderson-Hasselbalch equation (equation 4.1).  
 
           
    
……………………………………………………………Equation 4.1 
The sorbic acid concentrations calculated were as indicated in section 4.4.1. 
 
4.4.5 : Statistical Analysis 
Statistical analysis was performed as described in section 2.4.8. The bioluminescence, viable counts 
and ATP chemiluminescence were compared by Pearson correlation analysis. 
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4.5 : Results 
The results section contains two experimental parts; 
Section 4.6.1 presents the undissociated acid and dissociated acid anion concentrations calculated using 
the Henderson-Hasselbalch equation. Section 4.6.2 presents the MIC of sorbic acid determined by 
bioluminescence and turbidity methods, whilst sections 4.6.3, 4.6.4, and 4.6.5 evaluate various features 
of sorbic acid (SA) in preservative efficacy testing (PET). 
 
4.5.1 : Concentrations of the undissociated and dissociated forms of sorbic acid in solution 
and in the cytoplasm, calculated according to Henderson-Hasselbalch equation 
Table 4.10 shows the ratio of the un-dissociated and the dissociated form (anion) to the total 
concentration of sorbic acid at pH 5.0, as calculated according to the Henderson-Hasselbalch equation 
for sorbic acid concentrations of 35.65mM, 17.84mM, 8.92mM, 4.46mM, 2.23mM, 1.12mM, 0.56mM 
and 0.28mM (i.e. 0.2%, 0.1%, 0.05%, 0.0025%, 0.00125%, 0.00062% and 0.0031%). At a pH of 5.0, the 
ratio of undissociated to total sorbic acid was 0.37, whilst the ratio of dissociated anion to total sorbic 
acid was 0.63. 
 
The ratio of the undissociated and the dissociated form (anion) to the total concentration of sorbic acid at 
the cytoplasmic pH of 6.8 were also calculated. At a pH of 6.8, the ratio of undissociated to total sorbic 
acid was 0.01, whilst the ratio of dissociated anion to total sorbic acid was 0.99. 
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Table 4.10: Concentrations of the undissociated and dissociated forms of sorbic acid in solution and in the cytoplasm, calculated according to the 
Henderson-Hasselbalch equation 
 
Concentration 
of sorbic acid 
Concentration of 
undissociated acid in solution 
[HA]  
Concentration of discociated 
acid in solution [A
-
]  
Concentration of dissociated 
acid in cytoplasm  
Concentration of remaining 
 undissociated acid in 
 cyctoplasm  
 
 
 
(mM)* (mM)  
 
(Ratio)
1
 (mM) (Ratio)
2
 (mM) (Ratio)
3
 (mM) (Ratio)
4
 
17.84 6.51 0.37 11.33 0.63 6.45 0.99 0.06 0.01 
8.92 3.25 0.37 5.67 0.63 3.23 0.99 0.03 0.01 
4.46 1.62 0.37 2.84 0.63 1.62 0.99 0.015 0.01 
2.23 0.81 0.37 1.42 0.63 0.81 0.99 0.008 0.01 
1.12 0.40 0.37 0.71 0.63 0.41 0.99 0.004 0.01 
0.56 0.20 0.37 0.36 0.63 0.21 0.99 0.002 0.01 
0.28 0.10 0.37 0.18 0.63 0.11 0.99 0.001 0.01 
*The concentrations of 0.2%, 0.1%, 0.05%, 0.025%, 0.0125%, 0.0062%, and 0.0031% were converted to mM 
1
 ratio of [undissociated]/[total sorbic acid (SA)] at pH 5.0 
2
 ratio of [dissociated]/[total SA] at pH 5.0 
3 
ratio of [undissociated]/[total SA at pH 6.80 
4
 ratio of [dissociated]/[total SA at pH 6.8 
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Concentration of undissociated acid [HA] in the medium 
 
pH = pKa + log [A-] / [HA] 
5.00 = 4.76 + log [A-] / [HA]  
1.74 = [A-] / [HA]   (Ratio of HA to A
-
 is 1/2.74 or 37%) 
Therefore, [HA] = (1/2.74)   (Concentration of sorbic acid) 
[HA] = (1/2.74) x (35.67mM) 
[HA] = 13.01mM  
 
Concentration of dissociated acid anion[A
-
] in the medium  
 
pH = pKa + log [A-] / [HA] 
5.00 = 4.76 + log [A-] / [HA]  
1.74 =  [A
-
] / [HA]   (Ratio of A
- 
 to HA is 1.74 /2.74 or 63%)  
Therefore, [A
-
] = (1.74 /2.74)   (Concentration of sorbic acid) 
[A
-
] = (1.74 /2.74) x (35.67mM) 
[A
-
] = 22.65 mM  
 
Concentration of dissociated acid anion and protons [A
-
] + [H
+
] in cytoplasm 
 
pH = pKa + log [A-] / [HA] 
6.80 = 4.76 + log [A-] / [HA]  
109.64  =  [A-] / [HA]   (Ratio of [A
-
] to HA is 109.64 /110.64 or 99% in cytoplasm) 
[A
-
]/[H
+
] = (109.64 /110.64) x (13.01mM)   (HA dissociates to anions and protons) 
[A
-
]/[H
+
]=  12.89 Mm 
 
Concentration of undissociated acid [HA] remaining in cytoplasm 
 
pH = pKa + log [A-] / [HA] 
6.80 = 4.76 + log [A-] / [HA]                                                                  
109.64 =  [A-]/[HA]   (Ratio of [HA]  to [A
-
]  is 1/109.64 or 1% to in solution) 
[HA] = (1/109.64) x (13.01 mM)   (HA remaining after dissociation in cytoplasm)                                                                         
[HA] = 0.11 mM 
 
  
 
 
 
Table 4.2: Example mathematical calculation for the ratio of undissociated to dissociated sorbic acid 
using the Henderson-Hasselbalch equation. 
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4.5.2 : Minimum Inhibitory Concentration (MIC) of Sorbic Acid 
Initially the absorbance of the culture was 0.05 ± 0.07 A.U.  for all of the cultures (without SA), whilst 
the bioluminescence of the biosensor culture was between 4.25 ± 0.08  log10 RLU/ml. After 24 hours of 
incubation, the culture density was high, at 0.95± 0.07 A.U. when the cells of the E.coli strains exposed 
to sorbic acid concentration at concentrations; 0%, 0.05%, 0.025%, 0.0125%, 0.0062%, and 0.0031%, 
and significantly (P = 0.001, Tukey Post Hoc analysis) at 0.05 ± 0.007 A.U.  at  0.1% and 0.2% SA, 
after 24 hours of incubation. The response to exposure to sorbic acid was the same for each of the 
biosensor and control strains (Figure 4.3 (a)). 
 
 
Figures 4.3 (a): Effect of sorbic acid upon culture density (absorbance at 620 nm) after 24 hours of 
incubation in its presence in order to determine the Minimum Inhibitory Concentration (MIC) 
# The SEM for each individual biosensor strain in Figures 4.3 (a) did not exceed 0.007 
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 The bioluminescence expressed by each of the biosensor strains was also high, between 6.5 to 7.00 ± 
0.10 log10 RLU/ml at sorbic acid concentrations; 0.05%, 0.025%, 0.0125%, 0.0062%, 0.0031%, or 0%, 
and significantly (P = 0.02, Tukey Post Hoc analysis) decreased to 0.75 ± 0.07 log10 RLU/ml at sorbic 
acid concentrations; 0.1% and 0.2% (Figures 4.3 (b)).   
 
Figures 4.3 (b): Effect of sorbic acid upon bioluminescence after 24 hours of incubation in its presence 
in order to determine the Minimum Inhibitory Concentration (MIC) 
# The SEM for each individual biosensor strain in Figures 4.3 (b) did not exceed 0.10 
 
# The correlation coefficients for bioluminescence versus absorbance readings for each of the biosensors 
were as follows: lpp-lux R
2
 = 0.9798; tatA-lux R
2
 = 0.9553; ldc-lux R
2
 = 0.9917; lysS-lux R
2
 = 0.9748; 
spc-lux R
2
 = 0.9727 
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The control strains, E. coli [pBR-322.lux] and E. coli ATCC 8739 did not exhibit any bioluminescence 
(Figure 4.3 (b)). Strong correlations were found between the absorbance and the bioluminescence (R
2
= 
0.9553-0.9917) for each of the 5 biosensor strains exposed to differing sorbic acid concentrations. 
 
The MIC of sorbic acid was determined to be 0.1 % SA. This was confirmed by using plate counts 
which demonstrated a 99.9% reduction of viable counts from those present in the initial innoculum. 
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4.5.3 : Bioluminescence and Viable Counts of the Preservative-Free Negative Controls 
Immediately after inoculation of the experiments, the bioluminescence was 5.9 + 0.1 log10 RLU/ml for lpp-lux, 
5.5+ 0.04 log10 RLU/ml for tatA-lux, 5.18+ 0.1 log10 RLU/ml for ldc-lux, 5.02+ 0.002 log10 RLU/ml for lysS-lux 
and 5.5+ 0.03 log10 RLU/ml for spc-lux (Figure 4.4 (a)). The bioluminescence expressed by each biosensor 
strain decreased by approximately 0.3 log10 RLU/ml between inoculation and day 2 of incubation with no 
significant differences. On the other hand, between day 7 and day 28 of incubation, the bioluminescence 
expressed by lpp-lux and lysS-lux decreased to approximately 3.0 + 0.1 log10 RLU/ml.  
 
Figure 4.4 (a): Bioluminescence of  the biosensor strains were incubated without preservative for up to 28 days, 
in triplicates n=3 
 
# The SEM for each individual biosensor strain in Figures 5.6 (a) did not exceed 0.15 
 
The initial viable counts (log10 CFU/ml) of the five bioreporter strains and wildtype ATCC 8739 strain were 6.0 
+ 0.5 log10 CFU/ml, and remained broadly unchanged with up to 2 days of incubation with no significant 
difference. After 7 days of incubation the viable counts had declined slightly but this was not statistically 
significant. The viable counts of all bioreporter strains had reduced by approximately 1.00 + 0.02 log10 CFU/ml 
at day 14 of the incubation and a further 0.5 + 0.05 log10 CFU/ml at day 21. Between 21 and 28 days of 
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incubation, there was no significant difference between (Figure 4.4 (b)). Although the viable counts decreased 
significantly with incubation, there were no significant differences between the viable counts of the five E. coli 
biosensor strains and the control strains at any given time point between inoculation and 28 days of incubation. 
 
Figure 4.4 (b): Viable counts of the biosensor strains were incubated without preservative for up to 28 days, in 
triplicates n=3 
 
# The SEM for each individual biosensor strain in Figures 5.6 (b) did not exceed 0.10 
 
 
The bioluminescence per cell (RLU:CFU) was the highest for lpp-lux immediately after inoculation (0 hour) (at 
0.79 + 0.2), followed by spc-lux (at 0.31+ 0.3), tatA-lux (at 0.2 + 0.4), ldc-lux (at 0.15 + 0.3), and lysS-lux (at 
0.10 + 0.1). At day 1 of incubation the RLU:CFU was, in descending order, lpp-lux (at 0.52+ 0.1), followed by 
spc-lux (at 0.28 + 0.1), tatA-lux (at 0.16 + 0.1), ldc-lux (at 0.10 + 0.15), and finally lysS-lux (at 0.10 + 0.08). At 
day 2 of incubation the RLU:CFU for lpp-lux (at 0.26 + 0.1) was similar to that spc-lux (at 0.2 + 0.09), whilst 
tatA-lux, ldc-lux, and lysS-lux demonstrated an RLU:CFU of between 0.07 and 0.1. From day 7 to day 28 of 
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incubation, the RLU:CFU for spc-lux from day 7 to day 28 of incubation were between 0.22-0.37. In contrast 
the RLU:CFU for ldc-lux and tatA-lux was on average 0.15 ± 0.05, whilst for lpp-lux and lysS-lux it was on 
average 0.056 ± 0.05. There was no statistical difference in the bioluminescence expressed by tatA-lux, ldc-lux 
and spc-lux although it declined significantly in each case (P = 0.002, 0.000, 0.000, Tukey Post Hoc). 
 
 
Figure 4.4 (a, b, & c): Bioluminescence per cell (RLU:CFU) when the biosensor strains were incubated without 
preservative for up to 28 days, in triplicates n=3 
 
# The SEM for each individual biosensor strain in Figures 5.6 (c) did not exceed 0.1 
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4.5.4 : Effect of Sorbic Acid on Bioluminescence, Viable Counts and ATP-
Chemiluminescence for the Five Biosensor Strains and the Control Strains of E. coli 
ATCC 8739 in a Preservative Efficacy Test 
The bioluminescence expressed by the five bio-reporter strains, and also the intracellular ATP levels (as 
demonstrated by the chemiluminescence assay), decreased significantly (P = 0.003, 0.001, 0.008, Tukey 
Post Hoc analysis) between inoculation and 24 hours of incubation when cultures were exposed to high 
concentrations of sorbic acid (0.2%, and 0.1%) (Figures 4.5, 4.6 and 4.8). At sorbic acid concentrations 
at 0.2% to 0.1%, the reduction in E. coli viable counts to undetectable levels between 0 h and day 1 of 
incubation exceeded the European Pharmacopoeia-A criteria for preservatives in oral, topical 
ophthalmic and parenteral preparations. The bioluminescence per cell was  in ascending orders was; spc 
(0.0018 ± 0.002),  lpp (0.0005 ± 0.002), ldc (0.0001 ± 0.005), tatA (0.001 ± 0.006), and  lysS (0.001± 
0.0001) at 0 h in 0.2% SA and remained zero at each of the time points tested up to 28 days of 
incubation, for the five biosensor strains at 0.2 % SA. Whilst the average bioluminescence per cell for 
the five biosensors at 0.1% SA at  0 hr of incubation in ascending orders was; lpp (0.008 ± 0.001), spc 
(0.0022± 0.002), ldc (0.00138 ± 0.002), tatA (0.00126 ± 0.003), and  lysS (0.00126± 0.001) was reduced 
to zero between 0 hr and 24 hours of incubation, resembling the bioluminescence, ATP-
chemiluminescence and plate counts with no significant differences. 
 
When exposed to concentrations of sorbic acid of 0.05%, 0.0125%, 0.0062%, and 0.0031% SA, the 
bioluminescence expressed by the lpp-lux biosensor strain showed a significant reduction (P = 0.01, 
ANOVA) of at least 5 of magnitude after 7 days of incubation, and there was no subsequent recovery in 
bioluminescence up to 28 days of incubation (P = 0.01, ANOVA). The bioluminescence per cell were  
on average 0.00003 ± 0.34  after 7 d for 0.0125%, 0.0062%, and 0.0031%, SA. 
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The bioluminescence levels (log10 RLU/ml), viable counts (log10 CFU/ml) and ATP-chemiluminescence 
(RLU/ml) of each of the E. coli biosensor strains except lpp-lux reduced significantly (P = 0.00, 
ANOVA) by 3 orders of magnitude between 2 and 7 days when exposed to 0.05% SA, whilst at 0.025% 
SA reduction of bioluminescence (log10 RLU/ml), viable counts (log10 CFU/ml) and ATP-
chemiluminescence (RLU/ml) of each of the E. coli biosensor strains except lpp-lux  reduced decreased 
significantly by at least 3 orders of magnitude between 7 and  14 days of incubation with no significant 
differences between the methods. The average bioluminescence per cell from the biosensor strains at the 
reduction of 3 orders of magnitude at concentrations 0.05% and 0.025% SA was as follows (in 
ascending order): lysS (0.01± 0); ldc (0.28 ± 0.7); tatA (0.44 ± 0.60) and spc-lux (0.66 ± 0.22). 
 
When exposed to concentration 0.0125% SA, the bioluminescence levels expressed by lysS-lux  
decreased significantly (P = 0.00, ANOVA)  to at least 3 orders of magnitude between 7 and 14 days 
whilst bioluminescence levels expressed by ldc-lux and tatA-lux biosensors strains decreased 
significantly (P = 0.00, ANOVA) between 14 and 21 days of incubation when exposed to 0.0125% SA. 
Bioluminescence expression by Spc-lux reduced by 1.10 ± 0.36 log10 RLU/ml from 0 h to 28 days in 
0.0125% SA. The bioluminescence per cell obtained at these time points were in ascending order of 
were ldc (0.022 ± 0.07); lyss (0.026 ± 0.02); tatA (0.03 ± 0.05) and spc (0.39 ± 0.05). Plate counts and 
ATP chemiluminescence readings at 0.0125% SA reduced significantly (P = 0.00, ANOVA) by 1.21 ± 
0.20 log 10 CFU/ml  and 1.205 ± 0.25 log 10 RLU/ml   from 0 h to 28 days. 
 
In sorbic acid concentrations of 0.0062% and 0.0031% a significant reduction in bioluminescence 
expression of at least 3 orders of magnitude was demonstrated by the tatA-lux, ldc-lux, and lysS-lux 
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biosensor strains from 0 h to 28 days of incubation, whilst bioluminescence expression by Spc-lux 
reduced on average 1.075 ± 0.36 log 10 RLU/ml from 0 h to 28 days in 0.0062% and 0.0031% SA. The 
bioluminescence per cell obtained at these time points were in ascending order of were ldc (0.0018 ± 
0.07); lyss (0.0018 ± 0.03); tatA (0.007 ± 0.09) and spc (0.50 ± 0.07). Whilst, the plate counts and ATP 
chemiluminescence readings at 0.0062% and 0.0031% SA reduced significantly (P= 0.00, 0.000, Tukey 
Post Hoc) on average by 1.00 ± 0.22 log 10 CFU/ml  and 0.60 ± 0.27 log 10 RLU/ml  from 0 h to 28 days. 
 
Overall, there is a significant decreased (P= 0.146, Tukey Post Hoc) between bioluminescence readings 
exhibited by lpp-lux and lysS-lux to bioluminescence readings exhibited by ldc-lux (P= 0.026, Tukey 
Post Hoc), tatA-lux (P= 0.006, Tukey Post Hoc) and spc-lux (P= 0.00, Tukey Post Hoc) whilst no 
significant difference between bioluminescence readings exhibited by spc-lux to ldc-lux (P= 0.299, 
Tukey Post Hoc), and tatA-lux (P= 0.882, Tukey Post Hoc) across the 28 days. 
 
 Importantly, a reduction in viable counts of 3 orders of magnitude correlated significantly with a at least 
more than 99.9% reduction in bioluminescence for each of the bio-reporter strains (P ≤ 0.05, ANOVA) 
(Table 4.3). The correlation coefficients between the viable counts (log10 CFU/ml) and bioluminescence 
(log10 RLU/ml) were significant (P ≤ 0.05, Pearson Correlation); lpp-lux (R
2
=0.55-1.00); tatA-lux 
(R
2
=0.886-1.00); ldc-lux (R
2
=0.833-1.00); lysS-lux (R
2
=0.811-1.00); and spc-lux (R
2
=0.879-1.00) (Table 
4.3). In addition, the correlation coefficients between the bioluminescence (log10 RLU/ml) and ATP-
chemiluminescence (log10 RLU/ml) were; lpp-lux (R
2
=0.676-1.00); tatA-lux (R
2
=0.806-1.00); ldc-lux 
(R
2
=0.854-1.00); lysS-lux (R
2
=0.827-1.00); and spc-lux (R
2
=0.8733-1.00) (Table 4.3). 
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In table 4.3 illustrates the tabulation for suitability of the range of sorbic acid tested in this study in 
accordance to EP-A criteria. This revealed that sorbic acid at concentrations; 0.2% and 0.1% were 
proved to be effective for oral, parenteral, and topical pharmaceutical preparations, whilst at 
concentration 0.05% SA was suitable for oral and tropical preparation and finally at concentration 
0.025% was suitable for only oral preparations. On the other hand, concentrations of SA at 0.0125%, 
0.0062%, and 0.0031% were not effective for any pharmaceutical preparations. The E.coli strains 
demonstrate the same effect against sorbic acid concentrations. 
 
 The overall standard error of means was lower for whole-cell bioluminescence readings by over an 
order of magnitude (0.011), in comparison to CFU (0.127) and was approximately half  that of ATP- 
bioluminescence (0.056). The recommended statistical method of comparing the precision is the 
application of the F-test. The variance of each method is estimated, and the ratio of the largest to the 
smallest variance is calculated and compared to the tabulated values for an F distribution. The calculated 
ratio (by statistical programme, SPSS) is F (258, 35, 0.05) = 1.404, which less than the critical value of 1.62, 
indicates no significant difference exists between the precision of the methods (PDA, Technical Report 
No. 33) between the whole-cell bioluminescence compared to traditional plate count, and ATP 
chemiluminescence method. 
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Figure 4.5 Bioluminescence expression (log10 RLU/ml) by the five biosensor strains when challenged with sorbic acid (the concentrations of sorbic 
acid are presented in ascending order (A to G) from left to right, and were: 0.0031%; 0.0062%; 0.0125%; 0.025%; 0.05%; 0.1%; and 0.2% for each 
biosensor strain) at pH 5.0 over 28 days of incubation. # The overall SEM is 0.011 at 95% confidence interval. 
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Figure 4.6: Viable counts (log10 CFU/ml) for the five biosensor strains and also the control strain when challenged with sorbic acid (the 
concentrations of sorbic acid are presented in ascending order (A to G) from left to right, and were: 0.0031%; 0.0062%; 0.0125%; 0.025%; 0.05%; 
0.1%; and 0.2% for each biosensor strain) at  pH 5.0 over 28 days of incubation. # The overall SEM is  0.127 at 95% confidence interval 
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Figure 4.7: Bioluminescence per cell (RLU:CFU) for the five biosensor strains when challenged with sorbic acid (the concentrations of sorbic acid 
are presented in ascending order (A to G) from left to right, and were 0.0031%; 0.0062%; 0.0125%; 0.025%; 0.05%; 0.1%; and 0.2% for each 
biosensor strain) at pH 5.0 over 28 days. # The overall SEM is 0.012 at 95% confidence interval 
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Figure 4.8: ATP-chemiluminescence (log10 RLU/ml) measurements for the five biosensor strains and also the control strain when challenged with sorbic 
acid (the concentrations of sorbic acid are presented in ascending order (A to G) from left to right, and were 0.0031%; 0.0062%; 0.0125%; 0.025%; 0.05%; 
0.1%; and 0.2% for each biosensor strain) at pH 5.0 over 28 days of incubation. # The overall SEM is 0.056 at 95% confidence interval 
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Table 4.3: Analysis of the viable counts, ATP-chemiluminescence, bioluminescence and the suitability of sorbic acid  for different 
pharmaceutical preparations in accordance to European and British Pharmacopeia  
 
Biosensor 
strain 
[Sorbic 
acid] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of 
sorbic acid for 
different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
Lpp-lux 0.2 1  1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.1 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.05 7 7 1 99.9 0.790 0.973 0.961 O, T 
 0.025 14 14 1 99.9 0.558 0.958 0.676 O 
 0.0125 n/a n/a 7 99.9 0.745 0.968 0.748 Non-effective 
 0.0062 n/a n/a 7 99.9 0.796 0.885 0.742 Non-effective 
 0.0031 n/a n/a 7 99.9 0.684 0.850
 
 0.720 Non-effective 
tatA-lux 0.2 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 
 
 
0.1 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 
  
208 
 
Biosensor 
strain 
[Sorbic 
acid] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of 
sorbic acid for 
different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
tatA-lux 0.025 14 14 14 99.9 0.929 0.977 0.937 O 
 0.0125 n/a n/a 21 n/a 0.877 0.870 0.837 Non-effective 
 0.0062 n/a n/a 28 n/a 0.886 0.807 0.806 Non-effective 
 
 
 
0.0031 n/a n/a 28 n/a 0.966 0.955 0.919 Non-effective 
 
ldc-lux 0.2 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.1 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.05  7 7 7 99.9 0.973 0.906 0.962 O, T 
 0.025 14 14 14 99.9 0.988 0.909 0.962 O 
 0.0125 n/a n/a 21 n/a 0.903 0.863 0.984 Non-effective 
 0.0062 n/a n/a 28 n/a 0.948 0.992 0.930 Non-effective 
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Biosensor 
strain 
[Sorbic 
acid] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of 
sorbic acid for 
different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
 0.0031 n/a n/a 28 n/a 0.833 0.985 0.854 Non-effective 
lysS-lux 0.2 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.1 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.05 7 7 7 99.9 0.82 0.822 0.981 O, T 
 0.025 14 14 14 99.9 0.811 0.925 0.914 O 
 0.0125 n/a n/a 14 99.9 0.803 0.959 0.949 Non-effective 
 0.0062 n/a n/a 28 n/a 0.886 0.949 0.956 Non-effective 
 0.0031 n/a n/a 28 n/a 0.963 0.901 0.827 Non-effective 
spc-lux 0.2 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.1 1 1 1 99.9 1.000 1.000 1.000 O, P, T 
 0.05 7 7 7 99.9 0.82 0.822 0.981 O, T 
 0.025 14 14 14 99.9 0.871 0.925 0.914 O 
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Biosensor 
strain 
[Sorbic 
acid] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of 
sorbic acid for 
different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
 0.0062 n/a n/a n/a n/a 0.896 0.939 0.954 Non-effective 
 0.0031 n/a n/a n/a n/a 0.963 0.921 0.927 Non-effective 
E.coli [pBR-
322.lux] 
         
 0.2 1 1 n/a n/a n/a 0.945 n/a O, P, T 
 0.1 1 1 n/a n/a n/a 0.973 n/a O, P, T 
 0.05 7 7 n/a n/a n/a 0.990 n/a O, T 
 0.025 14 14 n/a n/a n/a 0.874 n/a O 
 0.0125 n/a n/a n/a n/a n/a 0.882 n/a Non-effective 
 0.0062 n/a n/a n/a n/a n/a 0.805 n/a Non-effective 
 0.0031 n/a n/a n/a n/a n/a 0.945 n/a Non-effective 
E.coli ATCC  0.2 1 1 n/a n/a n/a 0.945 n/a O, P, T 
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Biosensor 
strain 
[Sorbic 
acid] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of 
sorbic acid for 
different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
 0.1 1 1 n/a n/a n/a 0.973 n/a O, P, T 
 0.05 7 7 n/a n/a n/a 0.991 n/a O, T 
E.coli 
ATCC 
8739 
0.0125 n/a n/a n/a n/a n/a 0.886 n/a Non-effective 
 0.0062 n/a n/a n/a n/a n/a 0.813 n/a Non-effective 
 0.0031 n/a n/a n/a n/a n/a 0.847 n/a Non-effective 
# O, P and T denote the effectiveness of sorbic acid according to  Pharmacopeia guidelines of Oral, Parenteral and ophthalmic, Topical preparation 
n/a: not applicable 
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4.6 : Discussions  
4.6.1 : Minimum Inhibitory Concentration (MIC) of Sorbic Acid 
Organic acids have a long history of being utilized as food additives and preservatives for preventing 
food deterioration and extending the shelf life of food. These compounds primarily include saturated 
straight–chain monocarboxylic acids, often referred to as fatty acids, volatile fatty acids and weak acids 
(Ricke, 2003). Sorbic acid is one of the most widely used antimicrobial agents for food preservation 
worldwide, and it is used to preserve food, animal feed, pharmaceuticals, and cosmetics (Sofos et al., 
1986). 
 
The high correlations obtained between bioluminescence and culture density (absorbance) in the MIC 
assay described above (R
2
: 0.9553-0.9917; Figures 4.3 (a) & (b)) suggest that each of the five constructs 
biosensor strains were equivalent to measuring growth by determining the turbidity of culture. 
Furthermore, on the basis of these results, each of the five biosensor strains could be considered for use 
in preservative MIC assays and to screen preservatives in preservative efficacy tests by measuring the 
emission of bioluminescence instead of turbidity. 
 
The broth dilution assay is one of the earliest and most commonly used antimicrobial susceptibility 
testing methods (Wiegand et al., 2008). The advantages of using either turbidity or bioluminescence to 
estimate the effect of a preservative are the ability to produce rapid quantitative results using them. 
However, the principal disadvantage of measuring turbidity is the inability to determine the metabolic 
activity of the target cell(s). Mixtures of broth and high concentrations of certain preservatives (e.g. 
benzalkonium chloride) can result in a cloudy solution, and so the measurement of turbidity could be 
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yield a false positive result. However, the turbidity or otherwise of the culture medium is not a 
significant issue when measuring bioluminescence and so an assay based upon it would not be 
particularly affected by medium turbidity. 
 
The MIC of sorbic acid was found to be at 0.1% in this study. This correlates well with previous work in 
which E. coli ML308-225 was challenged with sorbic acid at pH 5.0 and resulted in an MIC of 0.112% 
(Eklund, 1983). The same MIC was found for each of the biosensor and control strains in the work 
described in this thesis, which implies that the genetic manipulation of E. coli did not affect its 
susceptibility to sorbic acid. Sorbic acid is a six-carbon monocarboxylic acid, unsaturated at position 2 
and 4. Other six-carbon acids, alcohols and aldehydes analogues have been found to have similar MIC to 
sorbic acid, despite different levels of saturation (Stratford & Anslow, 1998). Consequently, it is 
possible that these bioluminescent biosensor strains could be applied to preservative efficacy testing for 
all six-carbon sorbic acid analogues. 
 
The work described in this thesis represents, to the best of this author’s knowledge, the first attempt to 
investigate the use of E. coli transformed to a bioluminescent phenotype, using bioluminescent 
bioreporter constructs with constitutive promoters, as a rapid microbiological method for preservative 
efficacy testing (PET). Sorbic acid was prepared at pH 5.0 due to the potential for increased oxidation of 
sorbic acid at lower pH values (Stopforth et al., 2005) and also to mimic the pH often used in 
pharmaceutical preparations, food and cosmetic products. The E. coli biosensor strains, as well as 
control strains were, challenged with sorbic acid and their response was studied by monitoring 
bioluminescence in comparison with two methods recommended by the British and European 
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Pharmacopeias’ (i.e. plate count and ATP chemiluminescence) to evaluate the effectiveness of sorbic 
acid as a preservative. 
 
4.6.2 : Calculation of Undissociated and Dissociated levels of Sorbic Acid by Henderson-
Hasselbalch Equation  
The log acid dissociation (-log10 Ka) (pKa) represents the degree of dissociation for a weak acid; sorbic 
acid is a weak acid, and its pKa is 4.76 (Cowles, 1941; Cerruti et al., 1990; Freese et al., 1973; Hoffamn 
et al., 1944; Sofos & Busta, 1981; Rahn & Conn, 1944; Pethybridge et al.,1983). This means that the 
concentration of undissociated sorbic acid molecules is equimolar to the dissociated form at a pH of 
4.76. Whilst the concentration of undissociated molecules increases with decreasing pH, in contrast the 
concentration of undissociated molecules decreases with increasing pH levels (Simon & Beevers, 1951). 
Acetic acid has a pKa value of 4.76, which is the same sorbic acid. However, the MIC required to inhibit 
the growth of Saccharomyces cerrevisiae by acetic acid was 30 times higher than the MIC of sorbic acid 
(Stratford & Anslow 1998). This indicates that sorbic acid has more than one mode of action, for 
example it may act as a membrane-active compound (Stratford & Anslow, 1998) in addition to the weak 
acid effect of reducing intracellular pH. 
 
The undissociated form of sorbic acid (C6H11COOH) is membrane permeable by passive diffusion, and 
at the pH of 5.0 used in the current experiments 37% of the sorbic acid molecules would be in the 
undissociated form at pH 5.0 (Booth & Kroll, 1989). However, within the cytoplasm of a bacterial cell, 
the pH is approximately pH 6.8, the increased pH will favour the dissociation of the undissociated acid 
molecules entering the cell. Within the cytoplasm, 99% of the acid molecules will be in the dissociated 
form, releasing protons (H3O
+
) and anions (C6H11COO
-
) according to the Henderson-Hasselbalch 
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equation (Table 4.1). The calculated percentage of undissociated molecules of sorbic acid (pH 5.0) in 
table 4.1 agrees with Sofos and Busta (1981). Since the vast majority of the intracellular sorbic acid will 
be in the dissociated form, but 37% of the extracellular acid will be in the undissociated form, a 
concentration gradient will ensue and lead to further diffusion of the undissociated form into the cell. 
 
Acidification of the cytoplasm due to the release of protons, due to the dissociated sorbic acid, to 
prevent E. coli growth (Salmond et al., 1984). Both the undissociated and dissociated forms of acid 
cause the intracellular pH to fall (Salmond et al., 1984). However, on the contrary, Eklund (1983) 
proposed that growth inhibition requires the undissociated form of acid, which is approximately 10-600 
times more effective as an inhibitor than the dissociated acid. Yet, the principle of inhibitory effect of 
weak acids is to reduce pHi, which leads to the translocation of protons using H
+
-ATPase which drains 
cells’ energy (Salmond et al., 1984). The accumulation of the 99% of protons from the 37% 
undissociated SA entering the cytoplasm causes further acidification. 
 
4.6.3 : Effect of Sorbic Acid on Bioluminescence, Viable Counts and ATP-
Chemiluminescence of Biosensor and Control E. coli ATCC 8739 Strains in 
Preservative Efficacy Test (PET) 
When challenged with 0.2% and 0.1% sorbic acid, the populations of E.coli biosensor strains and also 
the control strains (wildtype E. coli ATCC 8739 and E. coli [pBR322.lux]) had been reduced to 
undetectable levels between 0 h and 1 day of exposure (Figure 4.6). This related to the high 
concentrations calculated of undissociated form of SA calculated by the Handerson-Hasselbalch 
equation which dissociates to protons and anions in the cytoplasm (Table 4.1) resulting in cell death 
between 0 h and day 1. The high intracellular levels of dissociated sorbic acid leads to a pH difference 
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across the cell membrane (ΔpH) and forms a proton potential (Δp). Consequently the cell is required to 
expend energy to restore the intracellular pH to normal physiological levels. Under weak acid stress, 
ATPase activity requires 40% to 60% of total cellular ATP to restore internal pH of the cytoplasm 
(Holyoak et al., 1996; Serrano, 1991) in contrast to normal growth, the H
+
-ATPase is estimated to use 
10% to 15% of the total ATP produced. In addition, Plumridge et al. (2004) monitored NMR spectra to 
demonstrate rapid depletion of intracellular ATP under sorbic acid stress. Furthermore, it has been 
suggested that the concentration of intracellular anions can also lead to an osmotic imbalance within the 
cell and thus lead to an increase in cell turgor pressure (McLaggan et al., 1994). The combined effects of 
both accumulated protons and acid anions lead to the lethal effect of sorbic acid upon E. coli (Brown & 
Booth, 1991). Furthermore, the inhibition of metabolic enzymes such as fumarase and aspartase may be 
an indirect effect of sorbic acid, contributing to its antimicrobial activity (Beales, 2004; Liewen & 
Marth, 1985) at concentrations of 0.2%, and 0.1%SA. Sorbic acid has been demonstrated to covalently 
bind with, and inactivate, the sulphydryl groups of these enzymes (Denyer & Stewart, 1998; Eklund, 
1989). Additionally, sorbic acid can also result in: interference with nutrient transport; cytoplasmic 
membrane damage; and disruption of outer membrane permeability (Beales, 2003; Freese et al., 1973; 
Liewen & Marth, 1985; Startford & Anslow, 1996). Finally, changes in pHi can also affect control of the 
cell cycle (Anand & Prasad, 1989) resulting in decreased rates of DNA and RNA synthesis (Madshus, 
1988). Thus sorbic acid can have multiple inimical effects upon the microbial cell. 
 
The significant decrease in bioluminescence expression by the five biosensor strains when exposed to 
high concentration of SA (0.2% and 0.1%) was the result of exhaustion of the intracellular ATP levels in 
an attempt to restore of internal pH of the cell via the export of protons by the membrane H
+
-ATPase 
(Holyoak et al., 1996) with undetectable levels of viable counts and low ATP-chemiluminescence 
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(Figures 4.6 & 4.8)). Furthermore, strong correlations between bioluminescence versus ATP 
chemiluminescence; and bioluminescence versus viable counts at these concentrations (R
2
: 1.00). This 
reflects the light emission by the bioreporter strains is an indicative of the active state of cells whilst a 
reduced metabolism reflects on decreased bioluminescence (Unge et al., 1999). Consequently, dead 
bacteria do not produced light (Hastings et al., 1985). 
 
Data tabulation of at least 3 orders of magnitude of viable counts (log10 CFU/ml), ATP-
chemiluminescence (log10 RLU/ml) and bioluminescence (log10 RLU/ml) were employed in this study in 
compliance with the Pharmacopoeia requirements. The decrease of viable counts upon exposure to 0.2% 
and 0.1% SA between 0 h and 24 h for all E.coli strains exceeded the European Pharmacopoeia-A 
criteria and these concentrations are effective in oral, topical ophthalmic and parenteral preparations.  
 
In 0.05% and 0.025% SA exposure, the dissociation of sorbic acid resulted in a decrease of viable counts 
of more or at least 3 or more orders of magnitude between 2 and 7 days in 0.05% SA whilst between 7 
and 14 days respectively for all five constructs and control strains (wildtype E. coli ATCC 8739 and E. 
coli [pBR322.lux]).The antimicrobial activity at 0.05% and 0.025% SA took a longer time for a 99.9% 
decrease in viable counts. This suggests that, the driven H
+
-ATPase activity was able to adequately 
pump protons, for restoration of internal pH at 0.05% and 0.025% SA, however the depletion of energy 
within the cells fail to sustain the activity at day 7 and 14 respectively for all five constructs and control 
strains (wildtype E. coli ATCC 8739 and E. coli [pBR322.lux] in which case wasn’t able to pump 
protons out of the cell adequately).  
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The bioluminescence expressed by the lpp-lux strain was reduced by at least 3 orders of magnitude after 
1 day of exposure.  However, it was not until 7 days of exposure to 0.05% sorbic acid, and 14 days of 
exposure to 0.025% sorbic acid, that there was a corresponding reduction in bioluminescence expression 
of at least 3 orders of magnitude by the tatA-lux, ldc-lux, lysS-lux and spc-lux biosensor strains. There 
was a simultaneous decrease in the bioluminescence (log10 RLU/ml), viable counts (log10 CFU/ml), and 
ATP-chemiluminescence (log10 RLU/ml) from the tatA-lux, ldc-lux, lysS-lux and spc-lux biosensor 
strains at sorbic acid concentrations of 0.05 % and 0.025%. It has previously been reported that sorbic 
acid did not appear to have a major effect on the total glycolytic or respiratory flux, under any of the 
conditions tested, as the total CO2 production and O2 consumption were not affected (Holyoak et al., 
1996). Consequently, it is likely that the intracellular supply of substrates to drive the bioluminescence 
pathway is independent of any energy depletion caused by the sorbate weak acid effect. This suggests 
that these biosensor strains with the appropriate constitutive promoter could be perfectly effective for a 
PET assay and that bioluminescence is not affected by SA and so can be used as a proxy for viable 
counts in PET (Ellison et al., 1994 a & b, Hill et al., 1993; Marincs, 2000; Steward, 1990, 1993; Stewart 
& Williams, 1992, 1993; Stewart et al., 1991, 1993, 1996, 1997). 
 
However, at low concentrations of sorbic acid (i.e. 0.0125%, 0.0062%, and 0.0031%), the 
concentrations of dissociated SA (Table 4.1) from the undissociated form were proved to be less 
effective to E. coli populations for all five biosensor strains as well as the wildtype E. coli strains. This 
suggests that, at lower concentrations of sorbic acid, the H
+
-ATPase activity of E.coli may have been 
able to pump protons out from the cell to a sufficient extent to control the internal pH of E. coli cells 
(Eraso & Gancedo, 1987; Salmond et al., 1984; Errano, 1980; Serrano, 1984; Plumridge et al., 2004). 
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The threshold concentration of intracellular undissociated sorbic acid that would result in a reduction of 
viable counts of at least 3 or more orders of magnitude was 0.81mM or 0.009% (Table 4.1).  
 
The bioluminescence (log10 RLU/ml) expressed by the lpp-lux biosensor strain was decreased by more 
than 3 orders of magnitude after 7 days of exposure. In contrast, the viable counts did not decline by 
more than 3 orders of magnitude, even by the 28
th
  day of exposure to these concentrations of sorbic acid 
(Table 4.3) for all E.coli strains. At a sorbic acid concentration of 0.0125%, the bioluminescence 
expressed by the lysS-lux biosensor strain had decreased by 3 orders of magnitude between 7 and 14 
days of exposure. In contrast, at an sorbic acid concentration of 0.0125% it took 14 and 21 days of 
exposure before the bioluminescence expressed by the ldc-lux, and tatA-lux biosensor strains had 
decreased by 3 orders of magnitude. At a sorbic acid concentration of 0.0031% it took 28 days of 
exposure for the bioluminescence expressed by lysS-lux, ldc-lux, and tatA-lux to be reduced by more 
than 3 orders of magnitude. This suggests that the metabolic activity of the lysS-lux, ldc-lux and tatA-lux 
biosensor strains decreased more rapidly than the viable counts. Never the less, the correlations between 
the bioluminescence and viable counts for these three biosensors were high (tatA-lux; R
2
=0.877-0.966; 
ldc-lux; R
2
=0.833-0.948, lysS-lux; R
2
=0.803-0.963). Hence, the lowest SA concentration to inhibit E.coli 
growth is 0.1% which coincides with previous study by Eklund (1983) which reiterates that below this 
concentration is unable to cause a 3 orders of magnitude reduction. This agrees with the reduction of 
viable counts at 0.0125%, 0.0062%, and 0.0031% in this study. This implies that lpp, lysS, ldc, and tatA 
promoter constructs yielded a quicker bioluminescence reduction which could likely that the differences 
between the bioluminescence expressed by the five biosensor strains were brought about as a result of 
using the different constitutive promoters to control bioluminescence expression, and this will be 
discussed further in Section 4.7.3.  
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In contrast, at concentrations; 0.0125%, 0.0062%, and 0.0031% sorbic acid, the bioluminescence 
expressed by the spc-lux biosensor strains did not demonstrate a reduction of 3 orders of magnitude at 
any time over the 28 days of incubation, which matches the observation for viable counts and ATP 
chemiluminescence. Moreover, the bioluminescence per cell (RLU:CFU) was significantly higher  at 
low SA concentrations expressed by spc-lux biosensor strain, as compared  to tatA-lux, ldc-lux, lysS-lux 
and lpp-lux biosensor strains . It seems reasonable that a higher expression of bioluminescence per cell 
would offer greater flexibility for antimicrobial testing due to the wider working range of 
bioluminescence between maximal bioluminescence expression and zero. Consequently, it would seem 
reasonable that spc-lux would be a particularly good candidate for further evaluation in “real-life” 
preservative efficacy testing, more so than the other biosensor strains tested here. This conclusion is 
further supported by the excellent correlation coefficients between bioluminescence and viable counts 
obtained (R
2
= 0.879-1.00) in the trial of sorbic acid PET. 
 
It is noteworthy that a residual low level of bioluminescence was observed from the five biosensor 
strains even when viable counts were undetectable in the presence of 0.2%, and 0.1% sorbic acid, which 
suggests two potential possibilities. The first is that there may be a small population that is below the 
MDL limit whilst a large population of injured cells that are luminescing sub-maximally (Dodd et al., 
1997). The residual ATP measured within the cells (Figure 4.5) could promote the residual 
bioluminescence, but be insufficient for growth. A second explanation is that the residual luminescence 
may represent viable but non culturable (VBNC) state of E. coli cells at high SA concentrations. 
Previous efficacy studies of pharmaceutical oils have demonstrated that E. coli 8739 enters into a viable 
but non culturable (VBNC) state which can be demonstrated by measurement of a signal using solid-
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phase cytometry (SPC), whilst viable counts are undetectable (Prijck et al., 2008). In addition, Duncan et 
al. (1994) was able to detect the presence and activity of viable but non culturable cells utilizing 
luminescence genes luxAB. Although, VBNC cells show very limited metabolic activity (Oliver, 2005), 
and therefore there may not be sufficient FMNH available, or aldehyde produced, to drive measurable 
bioluminescence.  
 
It is recommended by both the European and British Pharmacopeias that E. coli ATCC 8739 only be 
used PET assays for oral preparations. However, the United States Pharmacopeia still permits E. coli 
ATCC 8739 to be used for PET assays of different pharmaceutical preparations. Sorbic acid was 
effective at reducing both the bioluminescence and viable counts of all of the E. coli ATCC 8739 
biosensor strains by more than 3 orders of magnitude at concentrations of 0.2%, 0.1%, 0.05% and 
0.025%. The viable counts and bioluminescence expressed by the lpp-lux, tatA-lux, ldc-lux, lysS-lux and 
spc-lux biosensor strains was reduced by 99.9% (3 orders of magnitude) at sorbic acid concentrations of 
0.2%, 0.1%, 0.05% and 0.025% concentrations which demonstrates that bioluminescence yields results 
that are directly comparable with the Pharmacopoeial requirement for a reduction in viable counts of at 
least 3 orders of magnitude.  
 
4.6.4 :  The Overall Comparisons between the Constitutive Promoters Expression 
Bioluminescence to the ATP-Chemiluminescence and Viable Counts Methods 
F values result signifies the equivalence and precision of the whole-cell bioluminescence as a rapid 
microbiological method in comparisons to the pharmacopeia certified methods; plate counting and ATP 
chemiluminescent method. This implies that the success of whole-cell bioluminescence method to 
monitor E.coli viability in diverse preservatives. The SEM obtained for the whole-cell bioluminescent 
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method was an order lower than the plate counting method, and half that of to ATP chemiluminescence. 
These SEM obtained for the three methods were in line with the SEM which were less than 0.3 (PDA, 
2000).  This further justifies the application of the whole-cell bioluminescence method as a rapid real 
time microbiological method instead of viable counts for PET. 
 
Previously ATP measurements have been used as an alternative to viable counts (Kremer et al., 2008), 
and this has subsequently been validated and incorporated into the Pharmacopoeia as the first alternative 
method for PET that has been accepted by the regulatory authorities. ATP-chemiluminescence has been 
demonstrated to yield equivalent results to traditional viable counting when E. coli ATCC 8739 was 
challenged with methyl parahydroxybenzoate (MHB) (Kramer et al., 2008). Similarly, in the current 
experiments, ATP-chemiluminescence demonstrated excellent correlations (R
2 
= 0.806-1.00) with viable 
counts for each of the biosensor and control strains for all of the concentrations of sorbic acid tested, 
from 0.2% to 0.031%. Moreover, in this study, there was excellent correlation (R
2 
= 0.806-1.00) 
between the bioluminescence expressed by the tatA-lux, ldc-lux, lysS-lux and spc-lux biosensor strains 
and ATP-chemiluminescence measured using Pharmacopoeial methods which indicates the equivalence 
of these two methods for PET assays of sorbic acid. However, lpp-lux biosensor strain yield a lower 
correlation coefficient (R
2
:0.676-1.00) between ATP-chemiluminescence and bioluminescence. 
 
In addition to bioluminescence versus ATP-chemiluminescence, the correlation between 
bioluminescence and viable counts was also excellent for each of the biosensor strains (for tatA-lux, R
2
 
= 0.886-1.00; for ldc-lux, R
2
 = 0.833-1.00; for lysS-lux R
2
 = 0.811-1.00; and for spc-Lux R
2
 = 0.879-
1.00). Furthermore, the result of F test implies equivalence in precision of the whole-cell bioluminescent 
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method to the traditional plate count method and ATP chemiluminescence as they are regarded as valid 
microbial enumeration methods for PET as defined by the Pharmacopeia.  
 
Although sorbic acid presents a substantial inimical challenge to the target cells, and this was 
hypothesised to affect intracellular ATP levels due to the requirement to excrete protons, the 
bioluminescence was found to correlate well with both the viable counts and the ATP-
chemiluminescence The results found in this study prove otherwise. On the other hand, at low 
concentrations of sorbic acid, the viable counts, bioluminescence and ATP chemiluminescence 
decreased proportionally and were strongly-correlated amongst the methods except for lpp-lux. 
 
Amongst the five biosensor strains tested, that using the lpp promoter to drive luxCDABE did not exhibit 
any bioluminescence after day 2 of exposure to even relatively low concentrations of sorbic acid, whilst 
ldc-lux, lysS-lux and spc-lux all exhibited bioluminescence at lower sorbic acid concentrations. Studies 
have indicated increased expression of Slp (lipoprotein), (Arnold et al., 2001) and pal (lipoprotein 
associated with peptidoglycan) (Maurer et al., 2005) by E. coli cells under acidic conditions at pH 5.0. 
These genes all function to protect against protein damage which is caused by the intracellular 
dissociation of weak organic acids that have diffused into the cell in the undissociated form (Mates et 
al., 2007). In this study, it is possible that lpp expression was down-regulated under sorbic acid stress. 
This is suggested by the decrease in when exposed to low concentrations of sorbic acid, even when the 
viable counts and ATP-chemiluminescence levels remained relatively unchanged. Production of an 
alternative lipoprotein using the slp gene product, is up-regulated to provide outer membrane lipoprotein 
when cells are stressed by starvation (Mates et al., 2007) and its role is to limit penetration of organic 
acids across the outer membrane or as part of a signal transduction mechanism that activates an organic 
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acid protection system (Castanie-Cornet et al., 2006). It has been noted that the maintenance of pH 
homeostasis under mild acid shock induces changes in the composition of outer membrane proteins and 
also to cell surface hydrophobicity (Dilworth and Glenn, 1999). Hence, due to the possible up-regulated 
products of outer membrane lipoprotein as demonstrated in previous studies, it is likely that the 
expression of lpp would have been switched off under starvation stress, as seen in the drastic decrease in 
bioluminescence.  
4.6.5  Bioluminescence Expression in Relation to the Promoters Employed 
Under acidic condition, it has been revealed previously that the stationary phase sigma factor RpoS 
(σ38/S), is required for weak acid tolerance induced by microbial growth at nonlethal acidic pH (Arnold 
et al., 2001). The RpoS (σ38/S) regulon constitutes of a large regulatory network with a hierarchical 
(cascade-like) expression of regulatory genes under the control of RpoS (σ38/S) in acidic conditions (pH 
5) (Richard & Foster, 2003; Weber et al., 2005).  
 
A virtual foot printing analysis (Regulon DB) was carried out, and this indicated that a crp binding site 
was present in the negative strand of the lpp promoter within the -10 regions (Score: 5.07) (Appendix 4)  
A PWM's score is the sum of log-likelihoods, which corresponds to the presence of crp binding site 
present. In addition, two crp binding sites were found located on the negative strand of the lysS promoter 
sequence (Scores: 6.00, and 6.55). When bound at tandem binding sites within the UP (-60 and -40 
positions) elements, crp functions synergistically with cyclic adenosine monophosphate (cAMP) as an 
activator when there is an upstream crp binding site located in contact with α-CTD which contributes to 
the stability of the RNA polymerase (Czarniekci et al., 1997; Gaal et al., 1996; Tang et al., 1994). 
However, when there is/are crp binding site (s) that overlaps or located within the downstream of the 
transcription sites between the -10 and +1 regions, this acts a repressor (s) (Busby &Ebright, 1994; Lee 
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& Busby, 2012; Weber et al., 2005).  This suggests that the location of the crp regulators within the -10 
elements results in a possibility of down-regulation in promoter activity of lpp and lysS in the presence 
of repressor (Busby & Ebright, 1994). Marques et al (2006) reveals the obstacles concerning the 
presence of regulons which leads to repression of bioreporter gene expressions in whole-cell biosensor. 
Hence, the use of the virtual foot printing software could detect possible regulons for future constructs 
of biosensors for possible reasoning for lower/higher promoter strength. 
 
Despite finding two crp loci within the lysS promoter, as opposed to only one in the lpp promoter, 
bioluminescence was not so strongly affected by acid stress as it was in lpp. However, Rhodius and 
Mutalik (2010) have described a scoring system position weight matrix (PMW) that could predict 
inaccurate transcription binding sites where the interactions are weak or inactive under physiological 
conditions, and false predictions (Rhodius & Mutalik, 2010). Consequently, virtual foot printing tool can 
be used to identify potential presence of repressors within the promoter sequences of biosensors which 
could explain the lowered expression levels under stress (i.e. nutrients and acid). However, further 
studies to identify these repressors. 
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4.6.6 : Selected Promoters under Acidic Conditions at pH 5.0 
The apparent down-regulation of lpp during the sorbic acid challenge experiments described here 
suggests that the lpp promoter is not suitable for use in a biosensor for PET assays. Amongst the four 
other promoters tested, expression of bioluminescence by lysS was the weakest which resulted in a 
significantly lower bioluminescence expression under sorbic acid challenge than was observed for the 
other bioreporter strains. It is possible that the crp locus within the promoter region may have influenced 
this behavior. In contrast, both the tatA-lux and ldc-lux constructs both yielded bioluminescence levels 
per cell that were almost 100-1000 times higher than lpp, when challenged with low concentrations 
(0.0125%, 0.0062%, and 0.0031%) of sorbic acid at pH 5.0. Previous studies have shown that an RpoS-
dependent mechanism regulates ldc in the stationary phase (Kikuchi et al., 1998). However, the 
expressions of bioluminescence per cell of ldc was significantly lower to spc. Whilst, tatA demonstrated 
approximately half the intensity significantly of bioluminescence per cell at low SA concentrations 
(0.0125%, 0.0062%, and 0.0031%) compared to spc  In addition, the increased levels of 
bioluminescence per cell were observed in alkaline pH (Chapter 3) demonstrates a potential of the 
application of tatA constitutive promoter in alkaline preservatives. Therefore, it is concluded that spc is 
the most appropriate promoter, from amongst the five tested, for use in sorbic acid, pH 5 from 0.2% to 
0.0031%, since the bioluminescence expressed per cell was 10-1000 times greater than that exhibited by 
the other four promoters. The spc-lux biosensor demonstrates a stronger correlation in with the 
consensus sequences the extended -10 region and -10 region of spc is the exact consensus sequence of 
RpoD (σ70) (Cowing, 1985) and only a -8 nucleotide difference to the consensus of RpoS (σ38) (Becker 
& Hengge-Aronis, 2001). These resemblance of the spc nucleotide in the promoter regions to the 
consensus sequences of RpoD (σ70) and RpoS (σ38) could suggest that these consensus sequences 
contributes to a high bioluminescence per cell under sorbic acid regulation. 
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Moreover, the fact that there were no significant differences between the bioluminescence results, and 
the viable counts and ATP-chemiluminescence levels, demonstrates that bioluminescence shows great 
potential for application in preservative efficacy studies.  Rapid methods to determine preservative 
efficacy are also in high demand in areas of monitoring, where results need to be supplied in minutes. 
Consequently, the application of lux constructs provides much more than a convenient bioreporter for 
gene expression but also an alternative rapid method to the conventional plate counting method. The 
ability to monitor in real-time microbial population dynamics means that the time taken to determine the 
activity of antimicrobials in food, cosmetic and pharmaceutical products can be significantly reduced.  
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4.7 : Conclusions 
 
1) There was a strong correlation between the bioluminescence expressed by the spc-lux, tatA-
lux, lysS-lux and ldc-lux biosensor strains and the viable count and ATP-chemiluminescence 
compliance methods from by the Pharmacopoeias. 
2) There did not appear to be any factors in the tatA, ldc and spc promoters that might affect the 
expression of bioluminescence, whilst potential repressor sequences were identified in both 
lpp and lysS. 
3) Expression of the lpp promoter was found to be down-regulated under acidic conditions, 
since bioluminescence was significantly reduced after 7 days of exposure to low 
concentrations of sorbic acid whilst the viable counts and ATP-chemiluminescence were 
unchanged. 
4) The spc promoter is the best candidate for further testing of bioluminescence as a rapid 
whole-cell method for PET assays, since there was a 10-1000 times greater bioluminescence 
per cell than that exhibited by the other four promoters, when challenged in sorbic acid, pH 
5.0. 
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5 Evaluation of Whole-Cell Bioluminescence Using Benzalkonium 
Chloride (BAK) 
 
5.1 : Benzalkonium Chloride as a Preservative 
Quaternary ammonium compounds (QACs) such as benzalkonium chloride (BAK) are used in a wide 
range of applications such as disinfectants, pharmaceutical antiseptics, cosmetics, oral, parenteral, nasal, 
and ophthalmic products. The aims of its use are to kill microorganisms (bactericidal effect) and/or 
prevent microbial growth (bacteriostatic effect) (Brown & Norton, 1965; Eriksen, 1970). 
 
BAK is also used in alcohol-free hand sanitizers (Dyer et al., 1998). The use of alcohol in hand 
sanitizers frequently causes dryness and can lead to subsequent micro abrasions to the skin (Dyer et al., 
1998). This therefore, increases the susceptibility of the skin surface to infection by members of the 
transient microflora. The use of BAK complements, rather than compromises, the natural barrier 
function of the skin much better than alcohol (Dyer et al., 1998). In addition, the use of BAK as an 
antiseptic causes less of a ‘burning’ sensation on any wounds than alcohol or hydrogen peroxide do. 
BAK is effective in inhibiting the growth of bacteria, yeast, and moulds (Dyer et al., 1998). 
Low concentrations 
Velandia et al. (1995) demonstrated the inhibition of HIV particles by 0.05% BAK. Formulations using 
BAK and other QAC derivatives have also been shown to possess antiviral properties. Overall, the use 
of BAK is favoured for skin sanitizers and disinfectants due to its neutral to slightly alkaline nature, non-
metal corrosive and non-flammable characteristics. In addition, it is safe to use on washable surfaces. 
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BAK has been used to preserve ophthalmic medications since the late 1940s. Microbial contamination 
has been found to be present in approximately 29% of all in-use ophthalmic containers (Geyer et al., 
1995; Schein et al., 1992). Therefore, BAK is commonly added to ophthalmic care products to prevent 
contamination by microbes that might potentially cause physicochemical deterioration of a multi-dose 
ophthalmic solution, or pose a risk of further infection to the patient. Such potential contamination may 
occur either during the preparation of a medication or during its application into the eye (Furrer et al., 
2001). However, the use of BAK for sanitisation of soft contact lenses is limited due to binding of BAK 
to the lens material which can lead to ocular irritation (Doughty, 1994). Overall, the maximum 
concentration of BAK recommended for ophthalmic and parenteral procedures is 0.02% (Furrer et al., 
2001). 
5.1.1 : Mode of Action 
 
Figure 5.1: The chemical structure of BAK. 
 
Chemically, benzalkonium chloride (BAK) is a mixture of alkylbenzyldimethylammonium chloride 
which is strongly positively charged and has a slight hydrophobic property which is contributed by the 
hydrocarbon chain (Figure 5.1). The inimical activity of BAK is initiated by the attraction of opposite 
charges between BAK and the bacterial cell. The structure of the outermost layer of bacterial cells 
universally carries a net negative charge associated with the cytoplasmic membrane and also the 
lipopolysaccharide of the cell wall of Gram negative bacteria. The attraction of charges results in a high 
Hydrocarbon 
chain 
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binding affinity and the effect of BAK leads to destabilisation of the cell membrane, resulting in a loss 
of proton motive force (pmf) and also the leakage of cell contents resulting in growth arrest as depiced 
in Figure 5.2. Bacterial cell walls are often stabilized by the presence of divalent cations such as Mg
2+
 or 
Ca
2+
 (Figure 5.2).  Consequently the action of BAK can be enhanced by the addition of chelating agents 
such as EDTA that perturb the membrane structure through the sequestration of stabilizing metal cations 
(Gilbert & Moore, 2005). Therefore, synergistic relationship between BAK and EDTA that can enhance 
the antimicrobial activity of BAK has been reported. 
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Figure 5.2: The progressive adsorption of the quaternary head group of acidic phospholipids into the 
bacterial cell membrane, leading to the decreased fluidity of the bilayer, and to the creation of 
hydrophilic voids within the membrane. Protein function is also perturbed by BAK, and eventually 
phospholipids and proteins will bud off into phospholipid micelles that will lead to cell lysis (adapted 
from Gilbert & Moore, 2005). 
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5.2 : Rationale of Chapter 5 
This chapter describes an investigation into the application of a whole-cell biolumiscent biosensor as an 
alternative rapid microbiological method to test the efficacy of a quanternary ammonium compound 
preservative. In this chapter, the whole-cell bioluminescence method was employed to screen a range of 
concentrations of benzalkonium chloride (BAK) from 0.00125% to 0.00039% at a pH of 7.0, in 
accordance with the requirements set out by the British & European Pharmacopoeias. The reductions in 
the viable counts of the experimental organisms, when exposed to the preservatives tested, were also 
determined in accordance with the requirements of the British & European Pharmacopoeias. 
Furthermore the whole-cell bioluminescent biosensors were also used to investigate the synergistic 
relationship between EDTA and BAK in the work described in this chapter. In addition to monitoring 
the viable counts of E. coli in the presence of the preservative using bioluminescence, viable counts and 
ATP-chemiluminescence were also used to monitor viability as described by the pharmacopoeias. The 
aim of the work described in this chapter was to determine the accuracy and reproducibility of whole-
cell bioluminescence as a biosensor to screen the activity of BAK in comparison with the currently-
accepted methods. 
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This chapter covers the following comparisons: 
 
 
 
5.3 : Objectives 
 
1) To compare the response of the 5 bioluminescent reporter strains to exposure to benzalkonium 
chloride at a range of concentrations from 0.00125% to 0.00039% at a pH of 7.0, and in the 
presence or absence of EDTA. 
2) To compare the response of the bioluminescent reporter strains to benzalkonium chloride, at a 
range of concentrations from 0.00125% to 0.00039% at a pH of 7.0 and with the addition of 
EDTA, to the existing methods prescribed by the British and European pharmacopoeias. 
3) To compare the antimicrobial activity of BAK in the presence and absence of EDTA.
Comparison of methods for 
Preservative Efficacy Testing 
(PET) ofBenzalkonium 
Chloride 
Conventional Plate 
Counts 
Rapid ATP-
Chemibioumiscence 
Rapid Whole-Cell 
Bioluminescence 
Comparison of promoter 
activity when challenged 
with BAK  
1) lpp (Outer Membrane 
lipoprotein) 
2) tatA (Twin arginine 
translocase) 
3) ldc (Lysine Decarboxylase) 
4) lysS (Lysyl- tRNA) 
5) spc (Ribosomal Protein) 
The Antimicrobial Acitivty 
of BAK  
Comparison of the 
antimicrobial activity of 
BAK in the presence and 
absence of EDTA 
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5.4 : Materials and Methods  
5.4.1 :  Preparation of Bacterial Initial Inoculum and Preservative Solutions 
The initial inocula of the five biosensors and also the control strains were prepared as described in 
Section 4.5.1. 
5.4.2 : Preparation of Preservative Solutions 
5.4.2.1 :  Preparation of buffer solution without BAK 
2.50 g of Sodium Chloride (Fisher Scientific), 2.50g of Potassium Chloride (Fisher Scientific), 2.50 ml 
of Glycerol (Sigma-Aldrich), 1.25 ml of Propylene Glycol (Sigma-Aldrich)  and volumes of BAK as 
indicated in 5.2.2.2 were dissolved in 150.0 ml of deionized water. The pH of the solution was adjusted 
to neutrality (pH 6.9-7.1) by the dropwise addition of 0.1M HCl. The solution was then topped up with 
deionized water to a final volume of 250.0 ml (Table 5.1). This buffer solution composition was based 
on moisturizing and lubricating eye solution without addition of preservatives. 
 
Table 5.1: Composition of the buffer solution for the PET assays 
Chemical  Concentration in Percentage (%) 
Sodium Chloride 1.0 w/v 
Potassium Chloride 1.0 w/v 
Glycerol 1.0 v/v 
Propylene Glycol 0.5 v/v 
 
 237 
 
 
5.4.2.2 :  BAK solutions 
1.0g of benzalkonium chloride (Sigma-Aldrich) was weighed out and dissolved in 10ml of sterile 
distilled water to obtain a 10.0% stock solution which kept at 4°C until use. To prepare the working 
solution of BAK, 15.6µl of the 10% BAK stock was added to the buffer solution indicated in Section 
5.2.2 for the final concentration of the BAK was 0.0062%. 
 
For the working concentrations of 0.0031% (v/v), 0.0016% (v/v) (round up to 2 significant figures), 
0.00078% (v/v) and 0.00039% (v/v)– 78.1 µl, 39.1 µl, 19.5 µl and 9.7 µl of BAK 10% – were added to 
250 ml of buffer solution to yield the concentrations noted above. The volume of BAK stock solution, 
concentration of BAK stock solution and final working concentration of BAK solution produced are as 
indicated in Table 5.2. 
 
Table 5.2: Amounts of BAK required for respective final working concentrations 
Volume of stock BAK solution 
(µl) 
Concentration of stock BAK 
solution (% v/v) 
Final working concentration of 
BAK (% v/v) 
15.6 10 0.0062 
78.1 10 0.0031 
39.1 10 0.0016 
19.5 10 0.00078 
9.7 10 0.00039 
 
The aliquots of BAK stock solution were individually added to buffer solutions, and then filtered 
through 0.22 µm Millipore Minisart syringe filters to produce the sterile working solutions. 
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5.4.2.3 : Benzalkonium chloride with 0.03% EDTA Formulations 
7.5g of EDTA (Sigma-Aldrich) was added to 250 ml buffer solutions to yield a final concentration of 
0.03% (w/v). The 0.03% EDTA in basal salt formulation was then used to prepare the BAK solutions as 
described in Table 5.2. The final BAK concentrations used in combination with 0.03% EDTA were 
0.0062% (v/v), 0.0031% (v/v), 0.0016% (v/v), 0.00078% (v/v) and 0.00039% (v/v). 
5.4.3 : Preservative Efficacy Test 
Preservative efficacy testing of the various preservative solutions, prepared as described in section 5.2.2, 
was carried out as described previously in section 4.5.2. 
 
5.4.4 : Determination of the Minimum Inhibitory Concentration (MIC) ofBenzalkonium 
Chloride (BAK), BAK +0.03% EDTA, and EDTA 
Stock concentrations of the benzalkonium chloride, and also the initial bacterial inocula, for the 
experiments to determine the MIC of BAK were made up as described in Section 4.5.1. Initially, a ten-
fold dilution was made in TSB from the 1% BAK stock solution to yield an initial working 
concentration of 0.1% BAK and then two-fold serial dilutions were subsequently carried out to give 
final working concentrations of BAK of 0.05%, 0.025%, 0.0125%, 0.0063%, 0.0031%, 0.0016%, 
0.00078%, and 0.00039%. In a second set of MIC tests, 0.03% EDTA was added  to the TSB and a ten-
fold of 0.1%, and  then two-fold serial dilutions were subsequently carried out to give final working 
concentrations of BAK with 0.03% EDTA of 0.05%, 0.025%, 0.0125%, 0.0063%, 0.0031%, 0.0016%, 
0.00078%, and 0.00039%. In a third set of MIC tests EDTA alone was used, 900µl of the 1% stock 
solution was added to a 99.1 ml volume of TSB, and then three-fold dilutions were performed to achieve 
the final working concentrations of 0.09%, 0.03%, and 0.01% EDTA. 
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The initial optical density of the bacterial suspension, the bioluminescence throughout the course of the 
experiment, and the MIC were all determined as described in Section 4.5.3. The viable counts of the 
bacterial cultures were determined before addition of the preservatives and also from the concentration 
determined to be the MIC. 
 
5.4.5 : Statistical Analysis 
Statistical analyses were performed as described in Section 4.5.3 
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5.5 : Results 
This results section contains three experimental parts. 
 
The first experimental part, described in section 5.3.1 presents the MIC of benzalkonium chloride 
(BAK) alone, BAK with 0.03% EDTA and of EDTA alone evaluated using both the bioluminescence 
and the turbidity method. The second experimental part, described in sections 5.3.2, 5.3.3 and 5.3.4 
evaluates BAK in the preservative efficacy test (PET) using bioluminescence, viable counts and ATP-
chemiluminescence. The final experimental part, described in sections 5.3.5 and 5.3.6, evaluates the 
combination of BAK and EDTA in the preservative efficacy test (PET) using bioluminescence, viable 
counts and ATP-chemiluminescence. 
 
5.5.1 : Minimum Inhibitory Concentration (MIC) Benzalkonium Chloride (BAK) 
The mean + SEM (viable count of the initial inoculum before the addition of preservatives was 
approximately 2 ± 0.1 x 10
6
 CFU/ml for all E.coli strains. The mean + SEM absorbance of the initial 
inoculum was 0.05 ± 0.01 A.U. across BAK concentrations ranging from 0.00039% to 0.025%, whilst 
for 0.05% BAK it was significantly higher at 0.3 ± 0.02 AU. The mean + SEM initial bioluminescence 
readings were between 6.79 to 4.25 ± 0.10 log10 RLU/ml (this was done as described in Section 4.6.2). 
 
After 24 h exposure to the BAK, the mean + SEM culture density was 0.96 ± 0.05 A.U. with no 
statistical significant differences at BAK concentrations of 0%, 0.00039% and 0.00078%, and was 
significantly lower with a mean of 0.02 ± 0.70 A.U. at BAK concentrations of 0.0016%, 0.0031%, 
0.0063%, 0.0125% and 0.025% (P = 0.00, ANOVA) (Figure 5.3(a)). However, the mean + SEM 
absorbance of the culture after exposure to 0.05% BAK (0.37 ± 0.06 A.U.) was significantly higher than 
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after exposure to 0.025% BAK (0.05 ± 0.01 A.U.) (P = 0.00, Tukey Kramer Post Hoc) (Figure 5.3(a)). 
The same effect was observed for each of the E.coli strains. 
 
 
Figures 5.3 (a): Effect of Benzalkonium Chloride upon culture density after 24 hours of incubation in its 
presence, in order to determine the Minimum Inhibitory Concentration (MIC) 
# The SEM for each individual biosensor strain in Figure 5.3 (a) did not exceed 0.005 
 
The bioluminescence + SEM was between 5.04 to 6.69 ± 0.2 log10 RLU/ml at 0% BAK, 0.00039% BAK 
and 0.00078% BAK after 24 h incubation. The mean + SEM bioluminescence was significantly lower 
after 24 hours of incubation with BAK concentrations of 0.0016%, 0.0031%, 0.0063%, 0.0125%, 
0.025% and 0.05%, than with 0%, 0.00039% or 0.00078% (P= .000, ANOVA) (Figure 5.3b). Neither of 
the control strains, E.coli [pBR-322. lux] and E.coli ATCC 8739, expressed any bioluminescence. 
Strong significant correlations were found between the absorbance and the bioluminescence (R
2
 = 
0.9362-0.9774) (P= 0.001) in the determination of the BAK MIC. 
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The MIC of BAK was determined to be 0.0016 %, from the change in bioluminescence expression as 
well as the OD, and this was confirmed by the plate counts with a statistically significant (P =0.000, 
ANOVA) ≥ 99.9% reduction in the viable counts from a mean of 6.2 ± 0.3 CFU/ml in the initial inocula 
to a final value of approximately 2 ± 0.1 x 10
3 
CFU/ml at 0.0016% BAK and greater (P =0.000, 
ANOVA). 
 
 
Figures 5.3 (b): Effect of Benzalkonium Chloride upon bioluminescence, after 24 hours of incubation in 
its presence, in order to determine the Minimum Inhibitory Concentration (MIC) 
# The SEM for each individual biosensor strain in Figure 5.3 (b) did not exceed 0.11 
Correlation coefficients between bioluminescence and absorbance readings were: lpp-lux R
2 
= 0.9774; 
tatA-lux R
2
 = 0.9362; ldc-lux R
2
 = 0.9497, lysS-lux R
2
 = 0.9564; spc-lux R
2
 = 0.9752 
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5.5.2 : Minimum Inhibitory Concentration (MIC) of Benzalkonium Chloride (BAK) when 
Supplemented with 0.03% EDTA 
When the cultures were exposed to 0% and 0.00039% BAK supplemented with 0.03% EDTA the mean 
+ SEM cell density, at 0.96 ± 0.05 A.U. was statistically significantly higher than when exposed to 
0.00078%, 0.0016%, 0.0031%, 0.0063%, 0.00125% and 0.025% after 24 hour incubation (P = 0.002, 
ANOVA) (Figure 5.4 (a)). The initial O.D and bioluminescence were as mentioned in Section 5.3.1.  
When cultures were exposed to 0.05% BAK supplemented with 0.03% EDTA the mean cell density was 
0.278 ± 0.14 A.U. which was statistically significantly higher than for cultures exposed to 0.025% BAK 
supplemented with 0.03% EDTA when the mean cell density was 0.025 ± 0.01 A.U. after 24 hours of 
incubation (P = 0.02, Tukey-Kramer post hoc analysis) (Figure 5.4 (a)). 
 
 
 
Figures 5.4 (a): Effect of Benzalkonium Chloride upon culture density when supplemented with 0.03% 
EDTA, after 24 hours of incubation in their presence in order to determine the Minimum Inhibitory 
Concentration (MIC) 
# The SEM for each individual biosensor strain in Figures 5.4 (a) did not exceed 0.003. 
 
The bioluminescence + SEM from the cultures exposed to 0.00078%, 0.0016%, 0.0031%, 0.0063%, 
0.00125%, 0.025% and 0.05% BAK supplemented with 0.03% EDTA was between significantly lower (P= 
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0.002, ANOVA) than that from the cultures exposed to 0% or 0.00035% BAK supplemented with 0.03% 
EDTA, for all five biosensor (Figure 5.4 (b)). 
 
The mean bioluminescence expressed by the cultures exposed across the concentrations of BAK, 
supplemented with 0.03% EDTA, showed a significant statistical correlation (P = 0.001) with the cell 
density (R
2
= 0.9556-0.9855).  
 
Figures 5.4 (b): Effect of Benzalkonium Chloride upon bioluminescence, when supplemented with 0.03% 
EDTA, after 24 hours of incubation in their presence in order to determine the Minimum Inhibitory 
Concentration (MIC) 
# The SEM for each individual biosensor strain in Figures 5.4 (b) did not exceed 0.09. 
# Correlation coefficients between bioluminescence and absorbance readings were: lpp-lux,R
2
= 0.9645; 
tatA-lux R
2
 = 0.9644, ldc-lux-R
2
 = 0.9247, lysS-lux R
2
 = 0.971; spc-lux R
2
 = 0.960 
 
 
The MIC of BAK, when supplemented with 0.03% EDTA, was determined from the change in 
bioluminescence expression as well as the OD to be 0.00078 % BAK. This was confirmed by the change in 
the viable counts which demonstrated a 99.9% reduction of viable counts from a mean of 6.2± 0.3 CFU/ml 
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in the initial inocula to a final value of approximately 3.4 ± 0.3 log 10
 
CFU/ml at 0.00078% BAK and 
greater (P = 0.000, ANOVA).  
 
 
5.5.3 : Minimum Inhibitory Concentration (MIC) of EDTA 
The initial bioluminescence and O.D readings before the addition of EDTA are as follows from Section 
5.3.1. 
 
There were no significant differences between the mean densities of the cultures exposed for 24 h to any of 
the concentrations of EDTA tested (P = 1.00 in each case, Tukey-Kramer post hoc analysis). The mean + 
SEM culture density in the presence of 0% EDTA after 24 h incubation was 0.90 A.U. ± 0.005., whilst at 
0.01% EDTA it was 0.92 ± 0.001 A.U., at 0.03% EDTA it was 0.93 + 0.015 A.U., and at 0.09% EDTA it 
was 0.97 ± 0.02 A.U. The bioluminescence expressed by the five biosensors after 24 hour incubation with 
EDTA showed a significant correlation with the culture density (P= 0.000) (R
2 
= 0.8414-0.99), with a OD + 
SEM of between 0.92-0.97 ± 0.01 A.U. and bioluminescence + SEM of between 7.4 to8.3 + 0.5 log10 
RLU/ml being recorded (Figures 5.5 (a) & (b)). The bioluminescence expression by either of the control 
strains - E.coli [pBR-322.lux] or E.coli ATCC 8739 – was 0 log10 RLU/ml. 
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Figures 5.5 (a & b): Effect of EDTA upon culture density (absorbance measured at 620 nm) and 
bioluminescence after 24 hours of incubation in its presence in order to determine the Minimum 
Inhibitory Concentration (MIC), n= 3. 
# The SEM for each individual biosensor strain in Figures 5.5 (a) did not exceed 0.001. 
# The SEM for each individual biosensor strain in Figures 5.5 (b) did not exceed 0.10. 
# Correlation coefficients between bioluminescence and absorbance readings were: lpp-lux R
2
 = 0.9717; 
tatA-lux R
2
 = 0.9554; ldc-lux R
2
 = 0.9746; lysS-lux R
2
 = 0.9899; spc-lux R
2
 = 0.9702 
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5.5.4 : Bioluminescence and Viable Counts of the Preservative-Free Negative Controls 
The mean + SEM bioluminescence expressed by the cultures, immediately after inoculation, was as 
follows: 6 + 0.002 log10 RLU/ml for lpp-lux; 5.4 + 0.006 log10 RLU/ml for tatA-lux; 5.23 + 0.002 log10 
RLU/ml for ldc-lux; 5.04 + 0.008 log10 RLU/ml for lysS-lux; and 5.644 + 0.01 log10 RLU/ml for spc-lux 
(Figure 5.6 (a). The bioluminescence expressed by the cultures decreased relatively linearly, by 
approximately 0.2 log10 RLU/ml  across 6 h and 24 h on incubation  immediately after inoculation up to 
1 day of incubation with no statistical differences between any of the strains. However, between 7 days 
and 28 days of incubation, the mean + SEM bioluminescence expressed by lpp-lux and lysS-lux 
decreased significantly from lpp-lux; 5.4 + 0.006; 5.04 + 0.008 log10 RLU/ml for lysS-luxto 3 + 0.023 
log10 RLU/ml (P ≤ 0.05, Tukey-Kramer post hoc analysis) whilst there was no statistical difference in 
the mean bioluminescence expressed by tatA-lux, ldc-lux and spc-lux although it declined significantly 
(P ≤ 0.05 in each case, Tukey-Kramer post hoc analysis). The bioluminescence levels remained 
significantly lower for both lpp-lux and lysS-lux than any of the other biosensor strains, after 28 d of 
incubation (P = 0.05, Tukey-Kramer post hoc analysis). 
 
 248 
 
 
 
Figures 5.6 (a): Bioluminescence, viable counts, and bioluminescence per cell (RLU:CFU) when the 
biosensor strains were incubated without preservative for up to 28 days, in triplicates n=3 
# The SEM for each individual biosensor strain in Figures 5.6 (a) did not exceed 0.15. 
 
The mean + SEM initial plate counts (CFU/ml) of the five biosensor strains, and also the wildtype 
ATCC 8739 strain, were 6.2 + 0.3 log10 CFU/ml (Figure 5.6 (b)). The viable counts of each of the 
cultures showed a small, but statistically insignificant, decrease after 7 days of incubation in each case.  
The mean + SEM viable counts of each of the E. coli strains had declined by approximately 1 + 0.5 log10 
CFU/ml after 14 days of incubation, and a further 0.5 + 0.01 log10 CFU/ml after 21 days of incubation. 
The mean + SEM viable counts for each of the strains remained above approximately 4.5 + 0.8 log10 
CFU/ml (Figure 5.6 (b). There were no significant differences between the viable counts of the five E. 
coli biosensor strains and the control strains at any given time point between inoculation and 28 days of 
incubation. 
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Figures 5.6 (b): Bioluminescence, viable counts, and bioluminescence per cell (RLU:CFU) when the 
biosensor strains were incubated without preservative for up to 28 days, in triplicates n=3 
# The SEM for each individual biosensor strain in Figures 5.6 (b) did not exceed 0.10 
 
The bioluminescence per cell (RLU:CFU) was the highest for lpp-lux at 0 hour (at a ratio of 1.00), and 
this was followed by spc-lux (at 0.44 ± 0.03), tatA-lux (at 0.25 ± 0.02), ldc-lux (at 0.16 ± 0.01), and lysS-
lux (at 0.10 ± 0.02). After 6 hours of incubation, the RLU:CFU for lpp-lux was 0.80 ± 0.03, whilst for 
spc-lux it was 0.41 ± 0.009, for tatA-lux it was 0.26 ± 0.01, for ldc-lux it was 0.16 ± 0.01, and for lysS-
lux it was 0.13 ± 0.02. After 1 day of incubation the RLU:CFU of lpp-lux was 0.66 ± 0.05, whilst for 
spc-lux it was 0.41 ± 0.04, for tatA-lux it was 0.26 ± 0.04, for ldc-lux it was 0.17 ± 0.01 and for lysS-lux 
it was 0.10 ± 0.06. From day 7 to day 28, the bioluminescence per cell expressed by lpp-lux and lysS-lux 
decreased significantly to 0.04 ± 0.03 and 0.013 ± 0.001 respectively (P ≤ 0.05 in both cases, Tukey-
Kramer post hoc analysis), whilst for ldc-lux, tatA-lux and spc -lux it was 0.1 ± 0.006, 0.17 ± 0.006, and 
0.35 ± 0.007 respectively (Figure 5.6 (c)). There was no statistical difference in the bioluminescence 
expressed by tatA-lux, ldc-lux and spc-lux although it declined significantly (P ≤ 0.05 in each case, 
Tukey-Kramer post hoc analysis). 
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Figures 5.6 (c): Bioluminescence, viable counts, and bioluminescence per cell (RLU:CFU) when the 
biosensor strains were incubated without preservative for up to 28 days, in triplicates n=3 
# The SEM for each individual biosensor strain in Figures 5.6 (c) did not exceed 0.1. 
0 
0.2 
0.4 
0.6 
0.8 
1 
1.2 
lpp-lux tatA-lux ldc-lux lyss-lux spc-lux 
B
io
lu
m
in
es
ce
n
ce
 p
er
 c
el
l 
 (
R
LU
:C
FU
) 
Biosensor 
0 hour 
6 hour 
Day 1 
Day 7 
Day 14 
Day 21 
Day 28 
C 
 251 
 
 
 
 
5.5.5 : Effect of Benzalkonium Chloride (BAK) on Bioluminescence, Viable Counts and ATP-
Chemiluminescence for the Five Biosensor Strains and also the Control Strains of E. 
coli ATCC 8739 in a Preservative Efficacy Test 
The bioluminescence expressed by the five biosensor strains (figure 5.7), and also the intracellular ATP 
levels (as demonstrated by the chemiluminescence assay) (figure 5.10) and the viable counts (figure 5.8) 
decreased significantly between inoculation and 6 hours of incubation when the cultures were exposed 
to high concentrations of benzalkonium chloride (0.0062%, 0.00031 and 0.00016%) (P = 0.008, 0.000, 
0.001, Tukey Post Hoc analysis) The bioluminescence per cell at between 0 to 6 h was (in ascending 
order); lpp (0.229 ± 0.02), tatA (0.028 ± 0.07), ldc (0.017 ± 0.04), spc (0.016 ± 0.04), lysS (0.0014 ± 
0.04) and remained zero at each of the time points tested up to 28 days of incubation, for the five 
biosensor strains (Figure 5.8). 
 
When exposed to BAK concentrations of 0.0016%, 0.00078% and 0.00039 %, the bioluminescence 
expressed by the lpp-lux biosensor strain had been reduced significantly by 5 orders of magnitude 
between 24 h to 7 d of incubation (P < 0.05, ANOVA) with no subsequent recovery in bioluminescence 
up to 28 days of incubation. The bioluminescence per cell was on average 0.00008 ± 0.0004  with no 
significant difference after 7 d for 0.0031%, 0.0016%, 0.00078%, and 0.00039% BAK.  
 
When exposed to a benzalkonium chloride concentration of 0.00078% BAK, the bioluminescence (log10 
RLU/ml) expressed by ldc-lux decreased significantly (P ≤ 0.05, ANOVA) by at least 3 orders of 
magnitude between 14 and 21 days from initial levels whilst bioluminescence readings expressed by 
lysS-lux decreased significantly (P ≤ 0.05, ANOVA) by at least 3 orders of magnitude between 7 and 14 
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days of incubation respectively. The bioluminescence expressed by both spc-lux and tatA-lux was 
reduced significantly by at least 2 orders of magnitude when these cultures were sampled at the 28
th
 day 
of incubation (P ≤ 0.05, ANOVA). In addition, the viable counts (log10 CFU/ml) and the ATP-
chemiluminescence (log10 RLU/ml) were only reduced significantly (P ≤ 0.05, ANOVA) by 1.77± 0.05, 
1.71± 0.12, respectively in orders of magnitude for the five biosensor strains from 0 h to 28 days with no 
statistical differences over 28 days between two methods. The bioluminescence per cell obtained at the 
reduction of more or at least 3 orders of magnitude for lysS and ldc were 0.004 ± 0.01 between 7 and 14 
days and 0.16 ± 0.01 between 14 and 21 days respectively at 0.00078%. Whilst the bioluminescence per 
cell for tatA and spc measured between 21 and 28 days of incubation were 0.24 ± 0.05 and 0.211 ± 0.06. 
At the point of 3 order of magnitude of bioluminescence reduction by the biosensors, the 
bioluminescence per cell expressed by tatA-lux and spc-lux were approximately 1000 times higher to 
bioluminescence per cell expressed by lpp-lux, 10 times higher to lysS-lux, and approximately  twice 
higher to ldc-lux. 
 
When exposed to 0.00039% BAK, the bioluminescence expressed by the spc-lux and tatA-lux biosensor 
strains was reduced significantly by at least 1.85 orders of magnitude after 28 d of incubation from 
initial bioluminescent readings (P ≤ 0.05, ANOVA). In contrast, the bioluminescence expressed by the 
ldc-lux biosensor strain was reduced significantly by at least 3 orders of magnitude between 14 and 21 
days of incubation (P ≤ 0.05, ANOVA) whilst the bioluminescence readings by lysS-lux was reduced 
significantly by at least 3 orders of magnitude between 7 and 14 days of incubation (P ≤ 0.05, ANOVA). 
The viable counts (log10 CFU/ml) and the ATP-chemiluminescence (log10 RLU/ml) were only reduced 
significantly (P ≤ 0.05, ANOVA) by 1.33, 1.31, respectively in orders of magnitude for the five 
biosensor strains from 0 h to 28 days with no statistical differences over 28 days between the methods. 
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The bioluminescence per cell obtained at the reduction of 3 orders of magnitude for lysS and ldc was 
0.06 ± 0.01 between 7 and 14 days of incubation and 0.10 ± 0.01 between 14 and 21 days of incubation 
respectively. Whilst the bioluminescence per cell for tatA and spc at 28 days of incubation, were 0.211 
±0.05 and 0.233 ±0.06.  
 
At the point of 3 order of magnitude of bioluminescence reduction by the biosensors, the 
bioluminescence per cell expressed by spc-lux and tatA-lux were approximately 100 times higher to 
bioluminescence per cell expressed by lpp-lux, 5 times higher to lysS-lux, ldc-lux and tatA-lux.  
 
The comparison between the biosensors revealed that bioluminescent and bioluminescent per cell 
readings by lpp-lux and lysS-lux were significantly lower (P ≥ 0.05, Tukey post hoc) compared to the 
bioluminescence and the bioluminescence per cell readings by ldc-lux, tatA-lux and spc-lux across all 
concentrations and all time points. Whilst no significant difference between bioluminescence readings 
exhibited by ldc-lux, spc-lux and tatA-lux when challenged with 0.0125%, 0.0062%, 0.0001 %, 
0.0016%, 0.00078% and 0.00039%  across the 28 days of incubation. 
 
Importantly, in each case when there was a reduction in viable counts of 3 orders of magnitude there 
was also a reduction in bioluminescence of at least 99.9% for each of the biosensor strains (Table 5.3). 
The correlation coefficients between the viable counts (log10 CFU/ml) and bioluminescence (log10 
RLU/ml) were generally very good significant; lpp-lux (R
2
= 0.603-1.00); tatA-lux (R
2
= 0.934-1.00); ldc-
lux (R
2
= 0.907-1.00); lysS-lux (R
2
= 0.896-1.00); and spc-lux (R
2
= 0.918-1.00) (Table 5.3). In addition, 
the correlation coefficients between the bioluminescence (log10 RLU/ml) and ATP-chemiluminescence 
(log10 RLU/ml) were generally very good; lpp-lux (R
2
= 0.651-1.00); tatA-lux (R
2
= 0.85-1.00); ldc-lux 
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(R
2
= 0.906-1.00); lysS-lux (R
2
= 0.851-1.00); spc-lux (R
2
= 0.838-1.00); E.coli [pBR 322.lux] (R
2
= 0.943-
0.992) and E.coli (R
2
=0.961-0.994) (Table 5.3). Table 5.3 illustrates the tabulation for suitability of the 
range of benzalkonium chloride tested in this study in accordance to European Pharmacopeia-A criteria. 
BAK concentrations of 0.0062%; and 0.0031% were found to be suitable for oral, parenteral, and topical 
pharmaceutical preparations, when the data were related to the EP-A criteria, whilst BAK concentrations 
of 0.00078% and 0.00039% were not found to be effective for any pharmaceutical preparations in the 
current experiments. The E.coli strains demonstrate the same level effectiveness against benzalkonium 
chloride concentrations (Table 5.3). 
 
The standard error of means for all the biosensor strains was lower for bioluminescence readings 
(0.106), compared to plate counts (0.156), and was slightly higher than ATP chemiluminescence 
(0.102). In addition, the F value obtained by ANOVA between the bioluminescence, viable counts and 
ATP chemiluminescence data was (159, 50, 0.05) = 0.59, does not exceed the F critical value of 1.57, which 
indicates no significance difference were found between whole-cell bioluminescent method compared to 
traditional plate count, and ATP chemiluminescence method over the PET time points and BAK 
concentrations. 
 
 
Additionally, there is no significant difference in bioluminescence per cell levels for lpp, ldc and lyss to 
expressions of tatA and spc in BAK PET test. 
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Figure 5.7: Bioluminescence expression (log10 RLU/ml) by the five biosensors when challenged with benzalkonium chloride (BAK) at 
concentrations, presented in ascending order (A to E) from left to right, of: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062% at  pH 7.0 over 
28 days of incubation. # Overall the SEM is 0.106 at 95% confidence interval 
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Figure 5.8: Viable counts (log10 CFU/ml) for the five biosensor strains and also the control strain when challenged with benzalkonium chloride 
(BAK) at concentrations, presented in ascending order (A to E) from left to right, of: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062% at  pH 
7.0 over 28 days. # Overall the SEM is 0.154 at 95% confidence interval 
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Figure 5.9: Bioluminescence per cell (RLU:CFU) for the five biosensor strains when challenged with benzalkonium chloride (BAK) at 
concentrations, presented in ascending order (A to E) from left to right, of: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062%  at  pH 7.0 over 
28 days  # Overall the SEM is 0.017 at 95% confidence interval 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
A B C D E A B C D E A B C D E A B C D E A B C D E 
Lpp-lux TatA-lux Ldc-lux Lyss-lux Spc-lux 
B
io
lu
m
in
es
ce
cn
e 
p
er
 C
el
l (
R
LU
:C
FU
) 
Biosensor 
0 hour 
6 Hours 
Day 1 
Day 7 
Day 14 
Day 21 
Day 28 
 258 
 
 
 
Figure 5.10: ATP chemiluminescence measurements (log10 RLU/ml) for the five biosensor strains and the control strain when challenged with 
benzalkonium chloride (BAK) at concentrations, presented in ascending order (A to E) from left to right, of: 0.000037%; 0.000078%; 0.00016%; 
0.00031% and 0.00062% at  pH 7.0 over 28 days. # Overall the SEM is 0.102 at 95% confidence intervals. 
0 
1 
2 
3 
4 
5 
6 
A B C D E A B C D E A B C D E A B C D E A B C D E A B C D E 
Lpp-lux TatA-lux Ldc-lux Lyss-lux Spc-lux E.coli ATCC 8739 
Lo
g 
A
TP
-C
h
em
ilu
m
in
es
ce
n
ce
 (
Lo
g 
1
0 
R
LU
/m
l)
 
Biosensor 
0 hour 
6 Hours 
Day 1 
Day 7 
Day 14 
Day 21 
Day 28 
 259 
 
 
Table 5.3: The viable counts, ATP-chemiluminescence, and bioluminescence from the biosensor strains when exposed to benzalkonium 
chloride, and an analysis of the suitability of this preservative for use in different pharmaceutical preparations in accordance with the 
guidelines set out in the European and British Pharmacopoeias 
Biosensor 
strain 
[BAK] (%) Incubation 
time required 
to achieve a 
reduction in 
viable counts 
of greater 
than 3 orders 
of magnitude 
(days) 
Incubation 
time required 
to achieve a 
reduction in 
ATP-chemi-
luminescence 
of greater 
than 3 orders 
of magnitude 
(days) 
Incubation 
time required 
to achieve a 
reduction in 
bio-
luminescence 
of greater 
than 3 orders 
of magnitude 
(days) 
% reduction  
in bio-
luminescence 
when the 
viable counts 
had been 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
Suitability of BAK 
for different 
pharmaceutical 
preparations 
#
 
lpp-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9          0.989 0.837 0.851 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.803 0.806 0.947 O,P,T 
 0.0016 14 14 6 Hr 99.9 0.603 0.955 0.651 O,P,T 
 0.00078 n/a n/a 7 99.9 0.873 0.965 0.758 Non-Effective 
 0.00039 n/a n/a 7 99.9 0.851 0.956 0.816 Non-Effective 
tatA-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.996 0.928 0.968 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.998 0.806 0.969 O,P,T 
 0.0016 14 14 14 99.9 0.983 0.955 0.997 O,P,T 
 0.00078 n/a n/a 28 n/a 0.934 0.965 0.8543 Non-Effective 
 0.00039 n/a n/a n/a n/a 0.929 0.956 0.996 Non-Effective 
ldc-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.998          0.928 0.973 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.985 0.806 0.963 O,P,T 
 0.0016 
 
14 
 
14 
 
 14 
 
99.9 0.907 
0.955 0.997 
O,P,T 
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Biosensor 
strain 
 Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of BAK 
acid for different 
pharmaceutical 
preparations, as 
determined from the 
Pharmacopoeia
#
 
 0.00078 n/a n/a 14 99.9 0.927 0.934 0.942 Non-Effective 
 0.00039 n/a n/a 21 n/a 0.989 0.965 0.906 Non-Effective 
          
lysS-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.992 0.928 0.969 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.896 0.806 0.972 O,P,T 
 0.0016 Day 14 Day 14 Day 14 99.9 0.968 0.955 0.851 O,P,T 
 0.00078 n/a n/a Day 14 n/a 0.841 0.965 0.986 Non-Effective 
 0.00039 n/a n/a Day 21 n/a 0.858 0.956 0.929 Non-Effective 
spc-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.918 0.928 0.970 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.991 0.806 0.961 O,P,T 
 0.0016 Day 14 Day 14 Day 14 99.9 0.969 0.955 0.995 O,P,T 
 0.00078 n/a n/a 28 n/a 0.983 0.965 0.891 Non-Effective 
 0.00039 n/a n/a n/a n/a 0.999 0.956 0.838 Non-Effective 
E.coli 
[pbr-322.lux] 
0.0062 6 Hr 6 Hr n/a n/a n/a 0.990 n/a O,P,T 
 0.0031 6 Hr 6 Hr n/a n/a n/a 0.992 n/a O,P,T 
 0.0016 Day 1 Day 1 n/a n/a n/a 0.963 n/a O,P,T 
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Biosensor 
strain 
 Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% reduction  
in bio-
luminescence 
when viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) 
between 
CFU and 
ATP 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
ATP 
 Suitability of BAK 
acid for different 
pharmaceutical 
preparations, as 
determined from the 
Pharmacopoeia
#
 
 0.00078 n/a n/a n/a n/a n/a 0.982 n/a Non-Effective 
 0.00039 n/a n/a n/a n/a n/a 0.943 n/a Non-Effective 
 0.0062 6 Hr 6 Hr n/a n/a n/a 0.994 n/a O,P,T 
E.coli ATCC 
8739 
0.0031 6 Hr 6 Hr n/a n/a n/a 0.996 n/a O,P,T 
 0.0016 Day 1 6 Hr n/a n/a n/a 0.968 n/a O,P,T 
 0.00078 n/a Day 1 n/a n/a n/a 0.986 n/a Non-Effective 
 0.00039 n/a n/a n/a n/a n/a 0.961 n/a Non-Effective 
# O, P and T indicate the effectiveness of BAK or use inOral, Parenteral and ophthalmic, and Topical preparations, determined in accordance with the pharmacopoeial guidelines 
n/a: not applicable
 according to  Pharmacopeia guidelines of
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5.5.6 : Effect of Benzalkonium Chloride (BAK) with the addition of 0.03% EDTA on 
Bioluminescence, Viable Counts and ATP-Chemiluminescence for the Five Biosensor 
Strains and the Control Strains of E. coli ATCC 8739 in a Preservative Efficacy Test 
 
The bioluminescence expressed by the five biosensor strains (figure 5.11), and also the intracellular ATP 
levels  determined by ATP chemiluminescence assay (figure 5.14), and viable counts (figure 5.12) 
decreased significantly between inoculation and 6 hours of incubation when the cultures were exposed 
to concentrations of benzalkonium chloride of 0.0062%, 0.0031% and 0.0016%, supplemented with 
0.03% EDTA (P= 0.000, 0.002, 0.000, Tukey Post Hoc analysis) (Figures 5.11, 5.12, & 5.14).  The 
average bioluminescence per cell between 0 and 6 h was (in descending order): lpp (0.13 ± 0.02); spc 
(0.018 ±0.05); ldc (0.006±0.04); tatA (0.004±0.07); lysS (0.004±0.04). The bioluminescence expressed 
by each biosensor strain in the presence of 0.0062%, 0.0031% and 0.0016%, BAK remained at 
effectively zero at each of the time points after 6 hours of incubation up to 28 days of incubation. 
 
When exposed to BAK concentrations of 0.0016%, 0.00078%, and 0.00039%, supplemented with 
0.03% EDTA, the bioluminescence expressed by the lpp-lux biosensor strain was reduced significantly 
by 5 orders of magnitude between 24 h to 7 days of incubation (P < 0.05, ANOVA) and showed no 
subsequent increase in bioluminescence. The bioluminescence per cell was on average 0.03 ± 1.41 
between day 7 and 28 d when exposed to 0.00078% and 0.00039% BAK, supplemented with 0.03% 
EDTA. 
 
When exposed to a benzalkonium chloride of concentration 0.00078%, lysS-lux, ldc-lux, tatA-lux, and 
spc-lux all showed a 3 orders of magnitude reduction in bioluminescence between the 6
th
 and 24
th
 hour 
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of incubation whilst the intracellular ATP levels and viable counts decreased significantly (P  ≤ 0.05, 
ANOVA) at the same time. 
 
When exposed to a benzalkonium chloride concentration of 0.00039% BAK, the bioluminescence (log10 
RLU/ml) expressed by lysS-lux decreased significantly by at least 3 orders of magnitude between 7 and 
14 days of incubation (P ≤ 0.05, ANOVA), whilst the bioluminescence expressed by ldc-lux decreased 
significantly (by at least 3 orders of magnitude between 21 and 28 days of incubation (P ≤ 0.05, 
ANOVA). Bioluminescence expression by spc-lux and tatA-lux was reduced significantly by at least 
2.11 magnitude after 28 days of incubation with 0.00039% BAK (P ≤ 0.05, ANOVA). 
 
The viable counts (log10 CFU/ml) and the ATP-chemiluminescence (log10 RLU/ml) were only reduced 
significantly (P ≤ 0.05, ANOVA) by 2.00 ± 0.15, 2.34± 0.11, respectively in orders of magnitude for the 
five biosensor strains from 0 h to 28 days with no statistical differences over 28 days between the 
methods at 0.00039% BAK. The bioluminescence per cell obtained at 3 orders of magnitude for lysS and 
ldc was 0.006±0.21 between 7 to 14 days and 0.005 ±0.03 between 21 and 28 days respectively. The 
bioluminescence per cell for tatA and spc at 28 days of incubation were 0.04 ±0.05 and 0.23 ±0.06 at 
0.00039% BAK.  
 
At 0.00039% BAK, the bioluminescence per cell expressed by spc were approximately 100 times higher 
to bioluminescence per cell expressed by lpp-lux, 5 times higher to tatA-lux and 10 times higher to lysS-
lux, ldc-lux.  
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The comparison between the biosensors revealed that bioluminescent and bioluminescent per cell 
readings 
Overall Tukey Post Hoc analysis revealed that there is a significant decreased (P ≤ 0.05, Tukey Post 
Hoc) between bioluminescence and bioluminescence per cell readings by lpp-lux and lysS-lux to ldc-lux, 
tatA-lux and spc-lux whilst no significant difference between bioluminescence readings exhibited by ldc-
lux, spc-lux and  tatA-lux when challenged with 0.0062%, 0.0031 %, 0.0016%, 0.00078% and 0.00039%  
with the addition of 0.03% EDTA  to each BAK concentration across the 28 days of incubation. Overall 
analysis revealed that bioluminescence levels were significantly lower expressed by lpp to lyss,ldc, spc 
and tatA 
 
Importantly, a reduction in viable counts of 3 orders of magnitude correlated significantly with a at least 
more than 99.9% reduction in bioluminescence for each of the bio-reporter strains (P ≤ 0.05, ANOVA) 
(Table 5.3). The correlation coefficients between the viable counts (log10 CFU/ml) and bioluminescence 
(log10 RLU/ml) were significantly good; lpp-lux (R
2
=0.75-1.00); tatA-lux (R
2
=0.904-1.00); ldc-lux 
(R
2
=0.87-1.00); lysS-lux (R
2
=0.87-1.00); and spc-lux (R
2
=0.94-1.00) (Table 5.4). In addition, the 
correlation coefficients between the bioluminescence (log10 RLU/ml) and ATP-chemiluminescence were 
significantly good (log10 RLU/ml) were; lpp-lux (R
2
=0.86-1.00); tatA-lux (R
2
=0.85-1.00); ldc-lux 
(R
2
:0.87-1.00); lysS-lux (R
2
=0.90-1.00); and spc-lux (R
2
=0.83-1.00); E.coli [pBR 322.lux] (R
2
=0.808-
0.991)  and E.coli  (R
2
=0.820-0.991) (Table 5.5). In table 5.4 illustrates the tabulation for suitability of 
the range of benzalkonium chloride with 0.03% EDTA tested in this study in accordance to European 
Pharmacopeia-A criteria. The effectiveness of 0.0062%; 0.0031%; 0.00016; and 0.00078% were suitable 
for oral, parenteral, and topical pharmaceutical preparations whilst at concentrations 0.000037% BAK 
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effective against topical pharmaceutical preparations. The E.coli strains demonstrate the same effect 
against benzalkonium chloride with 0.03 % EDTA concentrations (Table 5.4). 
 
The standard error of means for all the biosensor strains across all PET time points and BAK 
concentrations by the bioluminescence method was lower for whole-cell bioluminescence readings 
(0.095), compared to plate counts (0.164), and ATP chemiluminescence (0.107). The F value obtained 
(155, 54, 0.05) = 0.994, does not exceed the F critical value of 1.57, indicates no significance difference 
were found between whole-cell bioluminescent method and compedial methods. 
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Figure 5.11: Bioluminescence levels (log 10 RLU/ml) expressed by the five biosensor strains challenged with benzalkonium chloride (BAK) + 0.03% 
EDTA presented in ascending concentrations  (A to E) from left to right: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062% of each biosensor, 
pH 7.0 over 28 days. # Overall the SEM is 0.095 at 95% confidence interval 
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Figure 5.12: Viable counts (log10 CFU/ml) expressed by the five biosensors with benzalkonium chloride (BAK) + 0.03% EDTA presented in 
ascending concentrations  (A to E) from left to right: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062%. # Overall the SEM is 0.164 at 95% 
confidence interval 
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Figure 5.13: Bioluminescence per cell (RLU:CFU) for the five biosensor challenged with benzalkonium chloride (BAK) + 0.03% EDTA presented in 
ascending concentrations  (A to E) from left to right: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062% pH 7.0 over 28 days. # Overall the SEM is 
0.017 at 95% confidence interval 
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Figure 5.14: ATP chemiluminescence levels (log10 RLU/ml) of the five biosensors challenged with benzalkonium + 0.03% EDTA presented in 
ascending concentrations (A to E) from left to right: 0.00039%; 0.00078%; 0.0016%; 0.0031%; and 0.0062% pH 7.0 over 28 days. # Overall the 
SEM is 0.107 at 95% confidence interval 
0 
0.5 
1 
1.5 
2 
2.5 
3 
3.5 
4 
4.5 
5 
A B C D E A B C D E A B C D E A B C D E A B C D E A B C D E 
Lpp-lux TatA-lux Ldc-lux Lyss-lux Spc-lux E.coli ATCC 8739 
A
TP
 C
h
em
ilu
m
in
es
ce
n
ce
 (
Lo
g 
1
0 
R
LU
/m
ll)
 
0 hour 
6 Hours 
Day 1 
Day 7 
Day 14 
Day 21 
Day 28 
 270 
 
 
Table 5.4: Analysis of the viable counts, ATP-chemiluminescence, and bioluminescence from the biosensor strains when exposed to benzalkonium 
chloride with 0.03% EDTA, and an analysis of the suitability of this preservative for use in different pharmaceutical preparations in accordance with 
the guidelines set out in the European and British Pharmacopoeias 
Biosensor 
strain 
[BAK] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time 
required to 
achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescenc
e (days) 
% 
reduction  
in bio-
luminescen
ce when 
viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlatio
n  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) between 
CFU and 
ATP 
Correlation  
coefficient (R
2
) 
between RLU 
and ATP 
 Suitability of 
BAK+ 0.03% 
EDTA for different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
Lpp-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.996 0.992 0.993 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.997 0.992 0.99 O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr 99.9 0.996 0.860 0.863 O,P,T 
 0.00078 1 1      6 Hr 99.9 0.917 0.973 0.922 O,P,T 
 0.00039 n/a n/a 6 hr 99.9 0.754 0.990 0.758 T 
tatA-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.994 0.995 0.994 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.977 0.995 0.983 O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr 99.9 0.975 0.953 0.850 O,P,T 
 0.00078 1 1 1 99.9 0.979 0.904 0.991 O,P,T 
 0.00039 n/a n/a n/a 99.9 0.917 0.944 0.965 T 
ldc-lux- 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.994 0.987 0.988 O,P,T 
 0.0031 
 
6 Hr 6 Hr 6 Hr 99.9 
0.974 
0.980 0.986 
O,P,T 
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Biosensor 
strain 
 Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time 
required to 
achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescenc
e (days) 
% 
reduction  
in bio-
luminescen
ce when 
viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlatio
n  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) between 
CFU and 
ATP 
Correlation  
coefficient (R
2
) 
between RLU 
and ATP 
 Suitability of 
BAK+ 0.03% 
EDTA for different 
pharmaceutical 
preparations, as 
determined from 
the 
Pharmacopoeia
#
 
 0.0016 6 Hr 6 Hr 6 Hr 99.9 0.968 0.851 0.924 O,P,T 
 0.00078 1 1 1 99.9 0.871 0.952 0.872 O,P,T 
 0.00039 n/a n/a 28 99.9 0.934 0.978 0.973 T 
lyss-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.994 0.995 0.994 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.974 0.996 0.984 O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr 99.9 0.966 0.857 0.820 O,P,T 
 0.00078 1 1 1 99.9 0.87 0.960 0.841 O,P,T 
 
 
 
0.00039 
 
n/a n/a 28 99.9 0.891 
 
 
0.971 
 
 
0.900 
 
 
T 
spc-lux 0.0062 6 Hr 6 Hr 6 Hr 99.9 0.993 0.994 0.992 O,P,T 
 0.0031 6 Hr 6 Hr 6 Hr 99.9 0.982 0.993 0.991 O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr 99.9 0.978 0.863 0.877 O,P,T 
 0.00078 1 1 1 99.9 0.975 0.967 0.985 O,P,T 
 0.00039 n/a n/a n/a 99.9 0.948 0.978 0.911 T 
E.coli  [pBr-
322.lux] 
0.00062 
 
6 Hr 6 Hr n/a n/a n/a 0.993 
 
n/a O,P,T 
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Biosensor 
strain 
[BAK] 
(%) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
viable counts 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
ATP-chemi-
luminescence 
(days) 
Incubation 
time required 
to achieve 
more than 3 
orders of 
magnitude 
reduction in 
bio-
luminescence 
(days) 
% 
reduction  
in bio-
luminescen
ce when 
viable 
counts 
reduced by 
more than 3 
orders of 
magnitude 
Correlation  
coefficient 
(R
2
) 
between 
RLU and 
CFU 
Correlation  
coefficient 
(R
2
) between 
CFU and 
ATP 
Correlation  
coefficient (R
2
) 
between RLU 
and ATP 
 Suitability of BAK+ 
0.03% EDTA for 
different 
pharmaceutical 
preparations, as 
determined from the 
Pharmacopoeia
#
 
 0.0031 6 Hr 6 Hr n/a n/a n/a 0.993 n/a O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr n/a n/a 0.863 n/a O,P,T 
 0.00078 1 1 n/a n/a n/a 0.922 n/a O,P,T 
 0.00039 n/a n/a n/a n/a n/a 0.808 n/a T 
 0.0062 6 Hr 6 Hr n/a n/a n/a 0.994 n/a O,P,T 
E.coli ATCC 
8739 
0.0031 6 Hr 6 Hr n/a n/a n/a 
0.983 
n/a O,P,T 
 0.0016 6 Hr 6 Hr 6 Hr n/a n/a 0.820 n/a O,P,T 
 0.00078 1 1 n/a n/a n/a 0.991 n/a O,P,T 
 0.00039 n/a n/a n/a n/a n/a 0.965 n/a T 
+O, P and T denote the effectiveness of benzalkonium chloride according to Pharmacopeia guidelines of Oral, Parental and ophthalmic, Topical preparation 
n/a; not applicable 
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5.6 : Discussions 
5.6.1 : The Effect of Benzalkonium Chloride (BAK) on Biosensor and Control Strains 
Benzalkonium chloride (BAK) is a single positively charged quaternary ammonium compound and 
is classified as a monoquaternary ammonium compound (QAC). BAK is used as an active ingredient 
in disinfectants, and as a preservative in pharmaceutical antiseptics, cosmetics, oral, parenteral, nasal, 
and ophthalmic products. BAK is bactericidal when cells are exposed to sufficiently high 
concentrations, and/or it can also have bacteriostatic activities at lower concentrations preventing 
exponential increase of bacterial growth (Brown & Norton, 1965; Eriksen, 1970). As demonstrated 
previously, in chapter 4 of this thesis, whole-cell bioluminescence can be used to monitor E. coli 
viability in preservative efficacy tests and in MIC screening of weak acid preservatives. Since BAK 
acts by perturbation of lipid bilayer membranes, which is a different mode of action from weak acids, 
it was decided to test whether the biosensor strains could be used to determine the MIC of BAK and 
then subsequently to monitor the viability of the bacteria in a preservative efficacy test (Gilbert & 
Moore, 2005). Consequently, this would help to show the potential of the bioluminescent biosensor 
strains, employed in the current research, to monitor the viability of cells exposed to a diverse range 
of preservatives. 
 
It has been reported that disruption of the cell membrane by BAK leads to increased levels of highly 
reactive oxygen species, within the cell affected, which could affect the electron-transport chain 
(Bore et al., 2006). Accumulation of intracellular reactive oxygen species (R.O.S) has been 
demonstrated to cause depletion of NADPH (Bore et al., 2006), which is a requirement in the 
synthesis of aldehyde as a substrate for bioluminescence (Meighen, 1991). Consequently, there is a 
danger that perturbation of the cytoplasmic membrane could have a negative impact upon 
bioluminescence levels. However, there were significant correlations between the simultaneous 
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decrease in bioluminescence (RLU/ml), viable counts (CFU/ml) and ATP chemiluminescence 
(RLU/ml) that was observed in the work described in this thesis. 
 
Benzalkonium chloride exhibited strong antibacterial properties at concentrations from 0.05% to 
0.0016% since it was able to inhibit E.coli growth completely demonstrated by bioluminescence 
measurements.  The attraction of charges between BAK and the outer membrane of E. coli results in 
high binding affinity between the two. Binding of BAK leads to destabilisation of the cell membrane, 
resulting in a loss of proton motive force (p.m.f.) and leakage of cell contents in which leads to 
growth arrest (Gilbert & Moore, 2005). In this study, the MIC of BAK was determined to be 
0.0016% using bioluminescence as well as viable counts and optical density, which is very similar to 
previous estimates of the MIC of BAK against E. coli ATCC 8739 as being 0.0016% determined 
using optical density (Kamysz & Turecka, 2005). On the other hand, Bore et al. in 2007 found that 
the MIC of BAK against E. coli K-12 was much higher, at 0.008 - 0.009%, than in either the current 
study or that of Kamysz & Turecka (2005). However, the K-12 E.coli strain has adapted to BAK, 
and become more resistant to it than the ATCC 8739 strain, through increased expression of multi-
drug efflux pumps (Li & Nikaido, 2004; Tikhonova & Zgurskaya, 2004). Thus the E. coli ATCC 
8739 biosensor and control strains used in the study described in this thesis demonstrated a clear 
susceptibility to BAK by both bioluminescence and viable counts with an MIC of 0.0016%, which is 
comparable to the literature. 
 
Further analysis of the viability of the biosensor strains in preservative efficacy test (PET) assays 
demonstrated that the bioluminescence (log10 RLU/ml), viable counts (log10 CFU/ml), and ATP-
chemiluminescence (log10 RLU/ml) of the E.coli biosensor strains and also the control strains were 
all reduced significantly between inoculation and 6 hours of incubation when the cultures were 
exposed to BAK at concentrations of 0.0062%, 0.0031% and 0.0016% (Figures 5.7, 5.8, 5.9 and 
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5.10). This finding agrees with the results of the MIC and PET assays with benzalkonium chloride 
and E.coli ATCC 8739 published by Kamysz & Turecka (2005). Consequently, it is possible to 
determine the minimum concentration of BAK that is required for the preparation of ophthalmic, 
parenteral and topical products, following the recommendations set out in the Pharmacopoeias. 
Concentrations of 0.0062%, 0.0031%, and 0.0016% BAK all led to a reduction in the E. coli viable 
counts to undetectable levels  and a significant decrease in bioluminescence  for all biosensor strains 
between inoculation and the 6
th
 hour of incubation, which exceeds the European Pharmacopoeia-A 
requirements and so any of these concentrations would provide effective antimicrobial preservation 
for oral, topical ophthalmic and parenteral preparations. 
 
The bioluminescence expressed by the lpp-lux biosensor was reduced significantly by more than 5 
orders of magnitude after 7 days of exposure to BAK concentrations of 0.0016%, 0.00078% and 
0.00039%. This reduction in bioluminescence from lpp-lux occurred significantly quicker than it did 
for any of the other four biosensors (Figures 5.7 and 5.9). A similar effect was observed when lpp-
lux was exposed to BAK concentrations of 0.0016%, 0.00078% or 0.00039% when supplemented 
with 0.03% EDTA. It is possible that the lpp promoter is down regulation in BAK alone or in the 
presence of EDTA, as was also observed in this study in the presence of sorbic acid. Previous studies 
by Moen et al (2012) have demonstrated increased expression of osmB (lipoprotein) in non-resistant 
E.coli K12. expression of the OmpA, OmpF, and OmpT outer membrane proteins has been 
demonstrated in BAK-sensitive E. coli strains, whereas expression of OmpC was increased in BAK 
adapted strains (Bore et al., 2007; Ishikawa et al.,. 2002). This suggests that expression of lpp may 
have decreased to minimal levels whilst expression of the ompA, ompF, and ompT outer membrane 
protein genes was increased at BAK concentrations of 0.0016%, 0.00078% and 0.00039 % . 
However, direct evidence for down regulation of lpp was not sought in the current study, due to time 
constraints, and so further analyses using quantitative reverse transcription PCR comparing lpp 
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expression levels with that of other genes such as osmB, ompA, ompF and ompT could provide 
valuable insights.  
When exposed to low concentrations of BAK (0.00078% and 0.00039%), the viable counts (log10 
CFU/ml) and the ATP-chemiluminescence (log10 RLU/ml) were only reduced significantly (P ≤ 
0.05, ANOVA) by less than 2 orders of magnitude when exposed to 0.00078% and 0.00039% BAK 
for the five biosensor and control strains from 0 h to 28 days with no statistical differences over 28 
days between two methods. It is clear from the results that low BAK concentrations (0.00078% and 
0.00039%), were not effective for use in oral, topical ophthalmic and parenteral preparations since 
the reductions in viable counts and bioluminescence did not comply with the requirements of the 
Pharmacopoeias. Moreover, the low BAK concentration failed to cause perturbation in cells which is 
linked to a loss of osmoregularotory to cause cell death/arrest (Gilbert & Moore, 2005) and since 
BAK is known to disrupt the membrane it is possible that the potential involvement of the H
+
-
ATPase activity, whereby was able to pump protons out from the cell controlling sustaining the 
internal cytoplasm pH of E. coli. 
There was a reduction in the bioluminescence of the biosensor strains ldc-lux, lysS-lux of 3 or more 
orders of magnitude by 28 days of incubation in both the low concentrations. It is likely that the 
earlier loss of bioluminescence expression from these two strains in low concentrations of BAK was 
due to their weaker constitutive promoters leading to a loss of bioluminescence to base-line sooner 
than for tatA-lux and spc-lux. When exposed to 0.00078% BAK, the bioluminescence expressed by 
the ldc-lux and lysS-lux biosensor strains was reduced by 3 orders of magnitude between 7 and 14 
days; and 14 to 21 days of incubation, respectively. On the other hand it was not until between 21 
and 28 days of incubation in 0.00078% BAK that the bioluminescence expressed by the tatA-lux and 
spc-lux biosensor strains was reduced by 3 orders of magnitude. Previous work by Srikantha et al. 
(1995) has demonstrated that fusion of the lux operon to a weaker constitutive promoter resulted in 
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less transcription of the operon and so lower expression of bioluminescence which resulted in a 
quicker reduction in bioluminescence to baseline when the cells were metabolically challenged. This 
implies that lysS-lux biosensor strain represents the weakest promoter whereby the reduction of  3 or 
more orders of magnitude in bioluminescence in PET assays.  
 
The bioluminescence expressed by both the tatA-lux and spc-lux biosensor strains was reduced by at 
least 2 orders of magnitude when exposed to concentrations of 0.00078% and 0.00039 % BAK. The 
change in bioluminescence expressed by these two strains showed an excellent significant correlation 
with both the viable counts and the ATP-chemiluminescence indicating that these three measures 
yielded equilvalent results. The bioluminescence per cell expressed by both the tatA-lux and spc-lux 
biosesnsors was approximately twice that expressed by ldc-lux, approximately 10 times greater than 
that expressed by lysS-lux, and approximately 1000 times greater than that expressed by the lpp-lux 
biosensor strain. Consequently, this suggests that the biosensor strains tatA-lux and spc-lux would be 
particularly good candidates for further evaluation in “real-time” preservative efficacy testing, since 
a high level of bioluminescence expression per cell offers the potential for improved reliability in 
antimicrobial testing (Stewart, 1990). 
 
There was a low level of residual bioluminescence expression from all of the biosensor strains, even 
when there were no detectable viable counts from them at concentrations of BAK (without EDTA) 
of 0.0062% to 0.00039%. One possible explanation for this is that there may have been a small 
population of uninjured cells present, which was below the minimum detection limit (MDL) of the 
viable counting technique employed, mixed in with a much larger population of injured cells that 
were luminescing sub-maximally (Dodd et al.,1997). A second explanation for this observation is 
that there could be a small sub-population of VBNC E.coli present that could metabolise and 
bioluminescent at a low level (Rowan, 2004), but which could not be found by the viable counting 
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method employed. also observed when the biosensor strains were exposed to concentrations of 
benzalkonium chloride and also in sorbic acid PET. 
 
5.6.2 : The Effect of 0.03 % EDTA and EDTA on the Biosensor and Control Strains upon 
Bioluminescence, Viable counts and ATP-Chemiluminescence 
 
When the biosensor strains were challenged with BAK at 0.0062% and 0.0031% supplemented with 
0.03% EDTA in the PET assays, the bioluminescence , viable counts and intracellular ATP levels all 
decreased significantly between inoculation and 6 hours of incubation (P ≤ 0.05, ANOVA) (Figures 
5.11, 5.12 & 5.14). When benzalkonium chloride at concentrations of 0.0062% and 0.0031 % was 
supplemented with 0.03% EDTA, the reduction in the E. coli population density to undetectable 
levels, as demonstrated by bioluminescence, viable counts and ATP-chemiluminescence, between 
inoculation and the 6 hours of incubation was in excess of the requirements of the European 
Pharmacopoeia for preservatives to be used in oral, topical ophthalmic and parenteral preparations.  
 
When exposed to 0.00078% BAK supplemented with 0.03% EDTA, the time taken, after 
inoculation, for the bioluminescence expression by lysS-lux, ldc-lux, tatA-lux, and spc-lux to be 
reduced by 3 orders of magnitude was in agreement with the ATP-chemiluminescence and viable 
counts. Hence, the interactions of EDTA and BAK synergistically enhance the disruption of 
membrane layers is supported by Gilbert and Moore, (2005) as it lowers the minimum inhibitory 
concentration of BAK. The data presented in this thesis indicate that the MIC of BAK, when 
supplemented with 0.03% EDTA, was 0.00078% for all of the E. coli strains, whether the change in 
bioluminescence, viable counts or optical density was taken into account, which is significantly 
lower than the MIC of BAK alone by half. Previous studies have also noted similar synergistic 
effects for the combination of BAK and EDTA (Dantas et al.,2000). 
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It is known that EDTA is a chelating agent, which acts to destabilise the lipopolysaccharide outer 
membrane of E. coli by sequestering divalent cations, such as Ca
2+
 (Singer & Nicolson, 1972). 
EDTA contains four carboxylates  and two amines group consisting of three pairs of lone pair 
electrons (donor). This lone pair of electrons would attract an electron-pair acceptor for coordination 
bonding (Rao, 1982). The divalent cations found in lipopolysaccharides, such as Mg
2+
 or Ca
2+
, 
interact with the carboxylate groups of EDTA forming stable coordination compounds (Rao, 1982). 
The enhanced killing effect of 0.00078% BAK when supplemented with 0.03% EDTA, 
demonstrated  by reduction a in viable counts, bioluminescence and ATP- chemiluminescence 
readings of at least 3 orders of magnitude, suggests that loss of magnesium and calcium ions from 
the destabilisation of the outer membrane leads to a greater cell death with the formation of stable 
EDTA complex (Rao, 1982). Furthermore, Alakomi et al. (2006) have demonstrated, by using 
atomic force microscopy (AFM), the release of lipopolysaccharide from the surface of cells exposed 
to BAK supplemented with EDTA, at lower concentrations than when BAK was used alone, which 
resulted in large and irregular-shaped pits where the peptidoglycan layer was exposed. 
 
However, at 0.00039% BAK with the additional of 0.03% EDTA, a 2 order magnitude of was 
achieved in plate counts (log10 CFU/ml) and the ATP-chemiluminescence (log10 RLU/ml) for the 
five biosensor  and control strains from 0 h to 28 days with no statistical differences over 28 days 
between the methods, whilst bioluminescence expression by spc-lux and tatA-lux decreased 2 orders 
of magnitude from the 0 h to 28 days. The bioluminescence expressed by spc-lux and tatA-lux agreed 
with the two pharmacopeia certified method therefore signifies excellent choice of constitutive 
promoters for the evaluation of viability in BAK PET. However, the bioluminescence expressed by 
the tatA-lux biosensor was not statistically different from that expressed by the spc-lux biosensor 
when exposed to BAK alone, but when exposed to BAK supplemented with EDTA the expression of 
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bioluminescence by the tatA-lux strain was barely 20% of that from the spc-lux strain and this 
suggests that spc would be a better choice of constitutive promoter PET assays, certainly for BAK 
and EDTA, BAK, and sorbic acid. In contrast, the bioluminescence expressed by the lysS-lux and 
ldc-lux biosensor strains had decreased by 3 orders of magnitude before the 28 days of incubation 
had been completed, indicating that these promoters of the two strains were weaker than the spc-lux 
and tatA-lux biosensor strains. 
 
The addition of EDTA was found to enhance the antimicrobial activity of BAK. However it is 
known that EDTA can potentially act as a quencher for the ATP-chemiluminescence assay and 
therefore decrease the bioluminescence detected. Consequently, there is a danger that perturbation to 
the cytoplasmic membrane could have a negative impact upon bioluminescence levels.  
Nevertheless, there were significant strong correlations between  the changes in ATP 
chemiluminescence (RLU/ml) and both bioluminescence (RLU/ml) and viable counts for each of the 
tatA-lux, ldc-lux, lysS-lux, and spc-lux biosensor strains when they were exposed to 0.03% EDTA 
with significant correlation coefficient values of (R
2
: 0.82-1.00) indicating no divergent to the 
population (CFU/ml) and ATP chemiluminescence (RLU/ml) readings despite the depletion effect of 
BAK and BAK with 0.03% EDTA . Previous studies have found that concentrations of EDTA 
ranging from 0.05% to 0.58% decreasing ATP- chemiluminescence significantly (Wen et al., 2001). 
The concentration of EDTA used in combination with BAK in this study was 0.03%, and showed 
showed no significant quenching of the ATP-chemiluminescence, which concurs with Wen et al. 
(2001). This denotes the potential limitation of ATP chemiluminescence method in concentrations a 
more or at least 0.05% to 0.58% EDTA contained preservative system. In addition, the luciferin-
luciferase interaction with intracellular ATP extracted occurs extracellularly in which the effects of 
EDTA and other ions such as copper (II), zinc (II), calcium (II) (Wen et al., 2001) can act as 
quenchers thereby the utilizations of the concentrations are limited.  In contrast, the emission of 
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bioluminescence is intracellular within the genetically altered E.coli cells linked to metabolic activity 
and promoter expression which is less likely to be affected by quenchers as demonstrated by this 
study.  
 
It was not unreasonable to supplement the BAK with EDTA at a concentration of 0.03% in the 
current experiments, as this falls within the concentration of EDTA permitted to be added to eye care 
products (Furrer et al., 2001) and to food products (FSA). Moreover, it has become increasingly 
common for medicines to be formulated with a combination of preservatives to protect against 
microbial spoilage rather than to use just a single one (Denyer & King, 1988). The reason for this 
change in practice is twofold: firstly a single agent added to a product may not have a sufficiently 
broad spectrum of antimicrobial activity meaning that preservation can be incomplete; and secondly 
this makes it possible to reduce the concentration of the individual agents used without loss of 
efficacy overall. It is also necessary to achieve acceptable levels of product protection with only a 
relatively limited choice of agents available, and so efforts are being made to capitalise on potential 
synergistic interactions between preservatives, whilst at the same time cutting down on the 
concentrations used so as to minimise the risk of adverse reactions (Hodges et al., 1996).  EDTA has 
been demonstrated to act synergistically in combination with either benzalkonium chloride or 
potassium sorbate (Hart, 1984). EDTA has previously been reported to reverse the resistance of 
Gram negative organisms to some antimicrobial agents, and to enhance the effect of several cosmetic 
preservatives, such as the parabens, imidazolidinyl urea, and tert-butyl hydroxyanisole (Hart, 1984). 
Furthermore, EDTA is a safe, inexpensive, and effective product and its addition to cosmetic and 
toiletry formulations maintains clarity, protects the fragrance of the components, and stabilizes the 
coloring agents (Hart, 1984). Hence, by adding EDTA to benzalkonium chloride, this may prevent a 
lower concentration of BAK to be effective and hence demonstrating successful monitoring of 
viability by the biosensors. 
 282 
 
 
 
However, EDTA alone does not appear to inhibit E.coli growth since neither the cell density nor the 
bioluminescence of the biosensor strains was significantly altered in the presence of EDTA in the 
current experiments (Figures 5.5 a & b). Previous studies by Leive (1968) demonstrated that 
concentrations of EDTA between 5.8% and 17.5% were bactericidal to E.coli cells. However, since 
the concentrations of EDTA used in this study did not exceed 0.09% it is clear that they would have 
been unable to inhibit growth (Leive, 1968).  
 
Absorbance readings at 0.05% BAK (with and without EDTA) were significantly higher than 
0.025% BAK (with and without EDTA) in Figures 5.3 (a) & 5.4 (a) before and after 24 hour of 
incubation). It is most likely that this increase in absorbance is a result of the interaction of the 0.05% 
BAK halide anions (Cl
-
) with tryptone soy broth at these high concentrations causing slight 
precipitation of and thus cloudiness of the medium, leading to a false increase. This was reinforced 
by the high control absorbance readings without the addition of E.coli and checked by plate counts. 
However, the bioluminescence from the E. coli biosensor strains was minimal in 0.05% BAK, 
indicating that the E. coli had been inhibited. It is clear from these data that monitoring 
bioluminescence is more effective than attempting to determine culture density by absorbance when 
determine MIC of preservatives as absorbance remains as one of the oldest method in determining 
MIC. Spectrophotometry does not differentiate between live and dead cells, whereas 
bioluminescence does since it relies upon functioning metabolism in E. coli and thus should provide 
both a more sensitive and a more reliable method to monitor the effect of preservatives and other 
toxins upon cells.  
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5.6.3 :  Overall Comparison of the Bioluminescent Biosensors with the Viable Counts 
and ATP-Chemiluminescence Methods in Preservative Efficacy Testing 
 
The bioluminescence per cell (RLU:CFU) expressed by the spc-lux and tatA-lux biosensor strains 
was significantly higher at a reduction of a 3 or more magnitude reduction of bioluminescence than 
the bioluminescence per cell expressed by the ldc-lux, lysS-lux, and lpp-lux biosensor strains in the 
BAK PET assay. Furthermore, in the second series of PET assays when BAK was supplemented 
with 0.03% EDTA, the bioluminescence per cell expressed by spc was on average five times greater 
than that produced by tatA at the lower concentration of BAK tested (0.00078% and 0.00039%). 
Stewart, noted in 1990 that a high level of bioluminescence expression per cell offers the potential 
for improved reliability in antimicrobial testing, hence by validating the biosensors have concluded 
that spc represents the best biosensor as high bioluminescence per cell was yielded.  
 
It is possible that the statistically greater level of bioluminescence expressed by the spc-lux biosensor 
strain, as compared with the ldc-lux, lpp-lux and lysS-lux biosensor strains, is the result of a closer 
match between the spc-lux promoter regions and the consensus sequences for the -10 and extended -
10 regions, which would afford greater affinity for binding by RpoS (σ38/S) and RpoD (σ70/D). 
 
Under benzalkonium chloride stress, RpoS (σ38/S) and RpoD (σ70/D) both play important roles in 
combating the oxidative stress that can result from it (Bore et al., 2007; Martinez & Kolter, 1997; 
Martinez-Martinez et al., 2000) as similar roles were discovered in weak acid stress discussed in 
chapter 4. The major global regulatory gene, dps (DNA binding protein) is known to regulate the 
expression of a variety of stress-response genes when bacterial cells are challenged with BAK (Bore 
et al., 2007; Martinez & Kolter, 1997; Martinez-Martinez et al., 2000). Dps  has been shown to be 
regulated by OxyR, RpoS (σ38/S) and RpoD (σ70/D) (Altuvia et al., 1994, Azam et al., 1999; 
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Lomovskaya et al., 1994) which is involved in the  defence mechanism against oxidative damage by 
BAK (Almiron et al., 1992; Choi et al., 2000; Martinez & Kolter, 1997; Martinez-Martinez et al., 
2000).  
 
It is clear, therefore, that the nucleotide sequence of the promoter region is important as it can have 
an influence on the binding affinity of sigma factors as this is directly influence the expression of 
bioluminescence. Yet, a promoter that matches the consensus sequence for a promoter in all the 
conserved regions is undesirable because it actually reduces transcriptional activity for a promoter 
use as by having too many contacts impedes the transition from the open complex to promoter 
clearance and elongation (Grana et al., 1988) restricting opportunity for regulation. Furthermore, by 
recognizing the consensus sequence of a strong constitutive promoter, this can be implemented for 
promoter designing for future biosensor designs for monitor viability PET and MIC screening.  
Furthermore, the choice of a strong promoter with a good match to the consensus sequence would be 
advantageous in the design of future bioluminescent biosensors for both MIC screening and PET 
assays. 
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5.7 : Conclusions 
 
1) There was a strong correlation between the bioluminescence expressed by the spc-lux, tatA-
lux, lysS-lux and ldc-lux biosensor strains with both the viable counts and the ATP-
chemiluminescence methods, which are currently accepted by the Pharmacopoeias, when 
challenged with benzalkonium chloride with or without EDTA. 
2) EDTA acted synergistically with BAK to enhance its bactericidal activity. 
3) Expression of the lpp promoter was found to be down-regulated under BAK and BAK with 
EDTA conditions, since bioluminescence was significantly reduced after day 1 of exposure to 
low concentrations of BAK whilst the viable counts and ATP-chemiluminescence were 
unchanged. 
4) The bioluminescent biosensor incorporating the spc promoter is likely to be the best 
candidate for further development, since it led expressed greater levels of bioluminescence 
per cell than biosensors based upon the other four promoters, when challenged with 
benzalkonium chloride. 
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6 : General Discussion and Conclusion 
The microbiological analysis of food, cosmetics, and pharmaceutical products is an integral part of 
their microbiological safety management. However, both the conventional and current alternative 
microbiological testing methods used in these industries can require a long incubation time, highly 
skilled personnel, expensive reagents and expensive equipment to achieve useable results. A method 
which circumvents the undesirable traits of conventional and current rapid methods, but which 
retains their sensitivity and specificity, would be advantageous in rapid microbiological testing. The 
study described in this thesis investigates the application of five individual plasmid-borne biosensors 
constructed from constitutive Escherichia coli ATCC 8739 promoters in transcriptional fusion with 
the Photorhabdus luminescence luxCDABE operon which were then transformed into E. coli ATCC 
8739 challenged with two different kinds of preservative. 
 
6.1 : Whole-cell Bioluminescence as a Rapid Method 
A major benefit of the lux system is that it can act as a real-time reporter to monitor microbial growth 
and death kinetics. This was successfully demonstrated in the microbial growth and survival profiles 
of chapter 3, and during the preservative efficacy testing studies described in chapters 4 and 5. The 
decay of bioluminescence with time is a first-order process and reflects the rate of turnover of the 
luciferase enzyme and aldehyde substrate under the challenged conditions. The energy for the 
bioluminescence reaction is supplied via the oxidation of reduced FMNH2, consequently, the in vivo 
production of FMNH is an essential prerequisite for a bioluminescent phenotype. Since FMNH 
production is coupled in aerobic organisms to the electron transport chain via an NADH and FMN-
reductase couple, when given a non-limiting supply of the enzyme luciferase a limiting availability 
of FMNH will be reflected in variable and sub-maximal in vivo bioluminescence. Previous studies 
have suggested that stress responses that affect the production of intracellular FMNH, either directly 
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or indirectly, can be monitored in lux recombinant bacteria as changes in light output per cell 
(Ellison et al., 1994a &b; Hill., 1993; Steward, 1990, 1993,1997; Stewart et al., 1991, 1993, 1996, 
1997; Stewart & Williams, 1992, 1993). 
 
The naturally bioluminescent bacteria, Vibrio fisheri have proven and established their potential in 
toxicity testing (Kahru, 1993; Kahru et al., 1994; Loibner et al., 2004; Mortimer et al., 2008). Kinetic 
format of the V. Fisheri test (Microtox
TM
) – A Flash Away has been recently standardized (ISO, 
2010). In a comparative study of toxicity chemicals between V.fisheri and two bioluminescent E.coli 
strains; E.coli MC1061(pSLlux) and E.coli NC1061(pDNlux) found no statistical differences and 
reasonable correlation values obtained (Kurvet at al., 2011). In addition, studies from Deryabin and 
Aleshina, (2008) demonstrated the factors affecting luminescent expressions for bacterial strains; 
E.coli and V.fisheri were universal.  
 
Therefore, this establishes the five bioluminescent E.coli ATCC 8739 strains used in this study were 
in accordance to the standardized bacterium, V. fisheri. Furthermore, lux CDABE of V.fisheri is less 
thermostable as compared to P. Luminescence (Meighen, 1991), hence the novel E.coli strains could 
also serve as a improved replacement to V.fisheri for antimicrobial screening. 
 
The aim of this study was to investigate the potential of the bioluminescence method as a novel rapid 
method to replace traditional plate counting methods for use in preservative efficacy testing (PET). 
The five biosensor strains described in this thesis were challenged with two different preservatives to 
evaluate their potential for use in PET. Sorbic acid and benzalkonium chloride were the preservatives 
chosen for these preliminary studies because they have unique antimicrobial modes of action. 
Moreover, these preservatives are commonly used either singly or in combination with other 
preservatives in many food, cosmetic and pharmaceutical products.  
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Under sorbic acid and benzalkonium chloride challenge the whole-cell biosensors tatA-lux, ldc-lux, 
lysS-lux and spc-lux demonstrated high correlations with the two Pharmacopoiea-recommended 
methods (i.e. ATP Bioluminescence and conventional plate counting) for all of the concentrations 
tested and at all of the time points stipulated except for lpp-lux which has a significantly lower 
correlation coefficient values compared to the other four biosensors. This could imply that measuring 
the metabolic activity of cells is a desirable way of indicating cell viability and a quicker 
indication/prediction of viability status, a real time attribute of the lux CDABE genes as a bioreporter. 
 
Furthermore, the disadvantage of the ATP-chemiluminescence method lies in the reactions that occur 
with the firefly luciferase-luciferin assay. The reaction takes place outside of the cell and presence of 
salts, ions, and anions, interferes with the assays as demonstrated by Wen et al (2001). Moreover, the 
ATP extraction process requires a sterile environment to prevent contamination with exogenous 
ATP-rich cells, which can be difficult to maintain (Sharma & Malik, 2012). In contrast, the emission 
of bioluminescence is intracellular within the genetically altered E.coli cells linked to metabolic 
activity and promoter expression which is less likely to be affected by quenchers. In addition, the 
whole-cell bioluminescence does not require extraction process which is time and reagent 
consuming. 
 
Overall, the accuracy, precision and the linearity of their response to selected preservatives, have 
been successfully demonstrated for five E. coli biosensor strains which had a minimum detection 
limit of 10
3 
CFU/ml, a detection range of 6 orders magnitude of, and yielded equivalent results to 
methods currently recommended by the pharmacopoeias (British Pharmacopoeia Volume 5 SC IV L, 
European Pharmacopoeia 5.1.6). In comparison with the methods tested concurrent with 
bioluminescence in the work described in this thesis (i.e. ATP-bioluminescence, fluorescence 
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spectrometry, epifluorescence microscopy, and conventional plate counting) it is evident that the 
whole-cell bioluminescence method has significant advantages (Chapter 2) as  the response time of 
bioluminescence is short, it is cost effective, and less laborious. 
 
6.2 : Selection of the Best overall Constitutive Promoter 
Across the 28 days of incubation, the significant reduction in bioluminescence from initial incubation 
time is explained by a reduction in metabolic flux as the cells senesce.  Statistical analysis 
demonstrated that there is no significant difference between the bioluminescence readings, viable 
counts, adenylate energy charge (AEC) and plasmid copy number (PCN) supported with strong 
correlation values. 
However, lpp-lux demonstrated a significant reduction in bioluminescence expression as the 
population progressed further into stationary phase and the level of bioluminescence it expressed was 
significantly lower than any of the other biosensor strains in PET assays.  Moreover, the AEC was 
not significantly different between the 5 biosensor strains when compared at intervals through the 
growth curve. Consequently, it was hypothesized that the plasmid copy number for the lpp-lux strain 
had declined, since there have been reports of genetic instability in bioluminescent strains (Turdean, 
2011).  However, further analysis demonstrated that the PCN did not differ significantly through the 
growth phase, neither from its peak nor between the different strains.  Moreover, there was no 
significant difference between viable counts across all incubation time to biosensor strains.  
 
There is evidence in the literature that an alternative starvation outer membrane lipoprotein is 
expressed under stress conditions (Alexander & St John, 1999; Bore et al., 2007; Mates et al., 2007) 
which could correlate to the significant reduction in expression of lpp in late stationary phase or in 
the presence of the preservatives tested. In addition, a second promoter has been identified upstream 
of the lpp promoter obtained by the Regulon DB database. Originally, expression of the lpp gene was 
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considered to be constitutive (Nakamura and Inouye, 1982).  However, later workers have found that 
a σE promoter is located upstream of the lpp gene, and in the opposite orientation to the gene, which 
may lead to repression bioluminescence under stress conditions (Horton & Kanehisa, 1992) 
Furthermore, a CRP binding site located on the negative strand of the promoter within the -10 
regions (Score: 5.07) of lpp was found using virtual footprinting software indicating the effect of this 
CRP binding site is to repress transcription of the lux cassette. To the best of this author’s 
knowledge, this study presents the first evidence to hypothesize the down-regulation of the lpp 
promoter under the stressful conditions encountered in late stationary phase and in preservatives. 
However, this proposes future work in quantitating mRNA levels of lpp by reverse transcriptase 
qPCR. 
 
Indirectly, this suggests that the outer membrane lipoprotein, which serves as a defence system for 
E.coli, is of great importance to the cell. Alternative outer membrane genes are known to be 
expressed differentially to combat the various stressful conditions that a cell may encounter 
(Alexander & St John, 1999; Mates et al., 2007; Maurer et al., 2005). Consequently, it can be 
concluded that this promoter would be inappropriate for the construction of a constitutive biosensor 
since its expression could break down under stress conditions. 
 
Amongst the other four other promoters tested in the bioluminescent biosensor constructs, lysS was 
the weakest promoter in PET assay, as the bioluminescence expressions levels reduced  more than 3 
orders of magnitude significantly quicker than ldc, tatA and spc in PET and across the extended 
stationary phase. There are two CRP binding sites located on the negative strand of the lysS promoter 
sequence which could potentially act as a repressor which was found via virtual foot printing 
database and also contribute to the initial lower levels of bioluminescence expressed. Future 
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experiments to prove the presence of CRP within this region would be a new discovery to the 
claimed constitutive characteristic attribute of lysS (Clark & Neidhardt, 1990).  
 
The bioluminescent biosensor constructed with the ldc promoter exhibited approximately two-fold 
less bioluminescence per cell (RLU:CFU) compared bioluminescence expressions exhibited by 
biosensor constructed with spc constitutive promoter  when challenged  in sorbic acid, BAK, BAK 
with 0.03% EDTA PET assays.  However, previous studies have shown ldc expression is a RpoS-
dependent regulatory mechanism during stationary phase (Kikuchi et al., 1998; Van Dyk et al., 
1998). Never the less, bioluminescence per cell by exhibited by ldc-lux was significantly lower to 
spc-lux, hence, would not be the best candidate for PET assays in sorbic acid and BAK.  
 
The bioluminescence per cell expressed by the biosensor incorporating the tatA promoter was 
significantly twofold lower in sorbic acid PET assay than that expressed by the spc-lux biosensor in 
the PET assays. However, statistical analysis revealed no significant difference in the significance of 
bioluminescecen per cell for tatA and spc in BAK and BAK+ EDTA PET assays despite lower levels 
of levels bioluminescence per cell of tatA. Hence, the tatA-lux would not be suggested as the best 
candidate for PET assays due to the lower promoter strength tatA exhibits in acidic conditions. 
Nevertheless, there could be a potential use for tatA in testing of alkaline preservatives, since it 
expressed greater bioluminescence under the significant increase of pH 8.9 from neutrality alkaline 
conditions of extended stationary phase than the other biosensors. 
 
On the other hand, the bioluminescent biosensor incorporating the spc promoter exhibited 
significantly greater levels of bioluminescence per cell which was 10-1000 times greater than that 
exhibited by the other four biosensor strains under stress conditions. The plasmid copy number of the 
vector encoding spc-lux was similar to that for the other biosensor plasmids, therefore it is seems 
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likely that the strength of bioluminescence intensity was the result of the spc promoter. The spc-lux 
construct has great reliability and linearity with viable counts  over a very wide range of with and 
without preservative challenge, a sensitive range in detection whereby is able to response towards 
over a wide range of preservatives concentrations, robust in both acidic and alkaline conditions, and 
in addition was not found have any repressor sequences. Therefore, from the strains tested in this 
study, the spc-lux biosensor strain is the best candidate for further development as a bioluminescent 
biosensor to use in PET assays. 
 
Although the bioluminescence per cell for the other strains were significantly lower to spc-lux across 
the concentrations for use in PET assays, the other biosensor strains could prove useful as screening 
tools in some circumstances, since the strains are theoretically capable of reflecting growth as 
observed in the minimum inhibitory studies (MIC) after 24 hour incubation. However, the analysis 
duration of the lpp construct should be within the 48
th
 hour of stationary phase, as there was no 
significant difference between the bioluminescence expressions (Chapter 3).  
 
In addition, the comparison of the nucleotide sequences to the consensus sequences within promoter 
region demonstrated that the activity of the promoter is not reliant on any single particular conserved 
region, but the sum of the interactions between the RNA polymerase with all the conserved regions. 
In this study, the presence of a sequence similar to the consensus sequence in the extended -10 
region, -10 region of RpoD (σ70/D), along with A+T% about 40% in the UP regions and close to 
consensus spacer length between -35 and -10 regions, in spc could together have resulted in 
relatively high expression levels from this promoter over a 28 days of incubation, both under 
starvation and preservative stress. Promoters that have the consensus of the extended -10 regions 
have demonstrated strong  expression (Campbell et al., 2002), following the mutagenesis studies by 
Inouye and Inouye (1985) demonstrating increased expressions of promoters with the consensus of -
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10 region and Harley and Reynolds, (1987) demonstrated that inter region spacing of 16 and 18 bp 
should not affect the promoter activity compared to the consensus sequence which is 17 bp. These 
were promoter regions found to be important factors for greater bioluminescence expressions under 
stress conditions is potentially linked to the binging affinity to RpoD (σ70/D) and RpoS (σ38/S). In 
contrast, the small number of spacers, only 13 nucleotides between the -35 and -10 regions could 
have resulted in the low levels of bioluminescence expression by lysS-lux. It is important to 
appreciate the relationship of the conserved promoter regions with the level of gene expression in of 
the selection of a suitable promoter for an efficient whole-cell biosensor, where high levels of 
expression are required.  
 
Nevertheless, a fully consensus promoter is undesirable in several ways (Hook-Barnard & Hinton, 
2007). The numerous contacts actually reduce transcriptional activity for a promoter, because they 
prevent the transition from the open complex to promoter clearance and elongation (Grana et al., 
1988). 
 
However, some potential disadvantages have been suggested for whole-cell biosensors by Turdean 
(2011). Turdean (2011) stated that the disadvantages include a lack of genetic stability, requirement 
for long incubation times (usually more than 30 minutes), and sensitivity in bioluminescence 
intensity production in changing experimental conditions. Nevertheless, the results of the study 
described in this thesis show that genetic instability is unlikely to be a problem in the types of PET 
assays performed here since there is no significant loss of plasmids from the host cells throughout 
long-term stationary phase under alkaline conditions at the maximum of pH 8.9. Quantitative real 
time PCR (qPCR) was used to quantify plasmid copies present in the cells demonstrated that there 
was no significant plasmid loss in the long term stationary phase from 7 days to 28 days which 
proved that the bioluminescence expression expressed in the PET assays reflects the metabolic status 
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of the cell. There were no significant differences between adenosine groups and adenosine energy 
charge (AEC) levels between the whole-cell biosensors and control strains across 28 days 
demonstrating the genetically modification did not amend the metabolic activity of the biosensors. 
This signifies that the bioluminescence expressed in the PET assays were not significant to the 
metabolic activity, hence demonstrating a true reflection the effect of the preservatives.  In addition, 
bioluminescence per cell (RLU:CFU) exhibited by the tatA-lux, ldc-lux and spc-lux were relatively 
high across a very wide range of concentrations during the PET time frame and extended growth 
phase over 28 days of incubation.  
 
However, biosensors cells need to be grown to stationary phase, which takes at least 7 hours of 
incubation time. Never the less, this inconvenience can be avoided by lyophilized cells by freeze 
drying cells (Pellinen et al., 2004; Tauriainen et al., 1999).  In addition, genetically engineered 
biosensor cells as genetically modified organisms (GMOs)
, 
make them difficult to be commercialized 
due to official regulations in the European countries. 
 
6.3 : Future work 
To circumvent the incubation time of biosensor cells, lyophilisation of cells could be an alternative 
way to minimize incubation time, the utilization of nutrient broth, incubation space and possibly 
glassware. For the consideration of long shelf life of biosensors, a buffer could be added to 
lyophilized cells in multiwall plates to ‘activate’ the cells in specifically designed experiments for 
PET. Although lyophilisation and ‘activation’ of luminescent cells could not be tested in the current 
work due to time constraints, this could potentially be a fruitful area for further research. The whole-
cell bioluminescence method offers a speed of response and adequately monitored of 
bioluminescence bacteria to the action of antimicrobial which reinforce the prospect of real-time 
microbial assays for antimicrobials (Marincs, 2000; Stewart, 1989) and possibility as a commercial 
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kit.  Furthermore, the application of the whole-cell bioluminescent method could be used as a 
challenged microorganism in actual pharmaceutical products to evaluate the effectiveness of the 
product.  As majority of pharmaceutical product contains active ingredients could also be 
investigated for defining the limits for testing; this also includes optically dense or colored products.  
The development of the whole-cell bioluminescence method aims for complete rapid automation in a 
multi well plate for high throughput samples. This is directed to large capacity testing in labs or large 
companies in-house labs. The main advantage of this bioluminescent method is that it is simple and 
user-friendly in production and interpretation of the results. 
 
In addition, lpp was hypothesised to be downregulated with a few possible scenarios; the first is an 
alternative lipoprotein is expressed abundantly under stress and preservative exposure. The second is 
the presence of CRP binding sites within the -10 region of the promoter, and thirdly the speculation 
of another promoter which is transcribed in the opposite direction of transcription under stress 
response. In order to confirm all these theories this proposes reserve transcription- qPCR of targets 
on lpp and alternative lipoproteins, slp, pal, and osmB in quantifying expression levels in starvation 
and preservative stress. Secondly to target CRP binding sites by PCR under stress and preservative 
stress suggesting that potentially the regulation of CRP within the -10 promoter regions is be 
triggered by stress levels. Similarly, the promoter region of lysS was found to have two CRP binding 
sites. And lastly to identify the presence of the second lpp promoter. 
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6.4 : Conclusion 
In conclusion, the use of whole-cell bioluminescence as an alternative method to replace traditional 
viable counting in preservative efficacy testing has shown great potential. Bioluminescent biosensors 
proved to be more rapid, more sensitive and easier to operate traditional viable counts which are 
laborious, and time consuming with the results being delayed by several days. Amongst the five 
biosensors tested in the current work spc-lux would be the best choice of biosensors for sorbic acid in 
the range of 0.2% to 0.031%, at pH 5.0; for benzalkonium chloride in the range of 0.0062% to 
0.00039%, at pH 7.0; and also for BAK with the addition of 0.03% EDTA. 
 
Therefore, this concludes that by selecting the appropraite constitutive promoter, this reflects the 
ability of the whole-cell bioluminescence method in monitoring viability and growth in PET and 
MIC assays.  
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Recovery values 
of each dilution 
of 
Bioluminescenc
e and Viable 
Counts from 
Section 2.5.1
Genetically 
ModifiedE.coli 
Strains  
Dilution 
Factor (%) 
Recovery (%) in High Bacterial Suspension Recovery (%) in Low Bacterial Suspension 
Bioluminescence Method Conventional Method Bioluminescence Method Conventional Method 
Lpp-lux 75 70.77 (±0.09) 113.23(±0.0004) 77.14(±0.19) 121.34(±0.08) 
 50 70.02(±0.006) 109.03 (±0.01) 88.45(±0.008) 193.53(±0.10) 
 25 116.78(±0.02) 79.11(±0.03) 70.19 (±0.04) 124.72(±0.18) 
 10 91.14(±0.008) 97.03(±0.04) 99.27(±0.02) 108.78(±0.16) 
TatA-lux 75 116.61 (±0.006) 99.08(±0.04) 112.75(±0.003) 102.31(±0.04) 
 50 95.78(±0.03) 100.34(±0.05) 155.94(±0.061) 190.77(±0.07) 
 25 167.30(±0.009) 101.99(±0.02) 73.93(±0.035) 152.05(±0.04) 
 10 113.83(±0.05) 93.84(±0.07) 108.11(±0.01) 111.56(±0.14) 
Ldc-lux 75 70.26(±0.009) 86.21(±0.02) 70.61(±0.036) 98.82(±0.05) 
 50 70.17(±0.013) 92.58(±0.08) 70.89(±0.06) 169.18(±0.05) 
 25 99.52(±0.05) 82.91(±0.10) 104.99(±0.06) 137.83(±0.08) 
 10 106.89(±0.02) 88.90(±0.06) 71.03(±0.18) 109.42(±0.09) 
LysS-lux 75 183.74(±0.03) 81.78(±0.02) 70.24(±0.05) 97.13(±0.09) 
 50 85.91(±0.017) 85.61(±0.08) 78.13(±0.10) 136.11(±0.01) 
 25 132.74(±0.03) 83.10(±0.09) 96.32(±0.05) 124.47(±0.04) 
 10 138.37(±0.04) 77.91(±0.07) 70.14(±0.13) 99.85(±0.05) 
Spc-lux 75 179.36((±0.02) 117.18(±0.02) 72.89(±0.06) 117.18(±0.02) 
 50 199.75(±0.05) 112.61(±0.06) 72.49(±0.005) 177.63(±0.06) 
 25 190.43(±0.02) 110.02(±0.05) 89.49(±0.12) 104.82(±0.01) 
 10 161.10(±0.08) 11.02(±0.06) 91.94(±0.07) 102.60(±0.08) 
Pbr322-lux 75 n/a 138.78(±0.07) n/a 138.78(±0.02) 
 50 n/a 142.48(±0.09) n/a 113.13(±0.08) 
 25 n/a 113.3(±0.03) n/a 131.05(±0.05) 
 10 n/a 138.21(±0.03) n/a 136.51(±0.08) 
WildtypeE.coli 75 n/a 102.02(±0.019) n/a 104.49(±0.05) 
 50 n/a 107.91(±0.05) n/a 107.54(±0.06) 
 25 n/a 94.43(±0.11) n/a 94.19(±0.13) 
 10 n/a 100.74(±0.07) n/a 102.60(±0.07) 
Table 2.0: Recoveries values of 5 E.coli biosensors at dilution factors; 75%, 50%, 25%, and 10% 
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Table 2.1 (a): Statistical analysis of bioluminescence and conventional plate count method for the 
constructs 
Statistical Analysis between Recovery values from section 2.5.1 of bioluminescence and 
conventional plate counts 
No significant difference found 
Multiple Comparisons 
Tukey HSD   
Dependent Variable (I) Biosensor (J) 
Biosensor 
Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
lpp 
tatA -34.0550 .448 -108.6404 40.5304 
Ldc 2.0950 1.000 -72.4904 76.6804 
Lyss -21.8600 .765 -96.4454 52.7254 
Spc .6500 1.000 -73.9354 75.2354 
tatA 
lpp 34.0550 .448 -40.5304 108.6404 
Ldc 36.1500 .401 -38.4354 110.7354 
Lyss 12.1950 .958 -62.3904 86.7804 
Spc 34.7050 .433 -39.8804 109.2904 
Ldc 
lpp -2.0950 1.000 -76.6804 72.4904 
tatA -36.1500 .401 -110.7354 38.4354 
Lyss -23.9550 .709 -98.5404 50.6304 
Spc -1.4450 1.000 -76.0304 73.1404 
Lyss 
lpp 21.8600 .765 -52.7254 96.4454 
tatA -12.1950 .958 -86.7804 62.3904 
Ldc 23.9550 .709 -50.6304 98.5404 
Spc 22.5100 .748 -52.0754 97.0954 
Spc 
lpp -.6500 1.000 -75.2354 73.9354 
tatA -34.7050 .433 -109.2904 39.8804 
Ldc 1.4450 1.000 -73.1404 76.0304 
Lyss -22.5100 .748 -97.0954 52.0754 
CFU 
lpp 
tatA -.6000 1.000 -108.1271 106.9271 
Ldc 10.0750 .994 -97.4521 117.6021 
Lyss 20.0600 .935 -87.4671 127.5871 
Spc 11.6750 .990 -95.8521 119.2021 
tatA 
lpp .6000 1.000 -106.9271 108.1271 
Ldc 10.6750 .993 -96.8521 118.2021 
Lyss 20.6600 .929 -86.8671 128.1871 
Spc 12.2750 .988 -95.2521 119.8021 
Ldc lpp -10.0750 .994 -117.6021 97.4521 
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tatA -10.6750 .993 -118.2021 96.8521 
Lyss 9.9850 .995 -97.5421 117.5121 
Spc 1.6000 1.000 -105.9271 109.1271 
Lyss 
lpp -20.0600 .935 -127.5871 87.4671 
tatA -20.6600 .929 -128.1871 86.8671 
Ldc -9.9850 .995 -117.5121 97.5421 
Spc -8.3850 .997 -115.9121 99.1421 
Spc 
lpp -11.6750 .990 -119.2021 95.8521 
tatA -12.2750 .988 -119.8021 95.2521 
Ldc -1.6000 1.000 -109.1271 105.9271 
Lyss 8.3850 .997 -99.1421 115.9121 
 
Table 2.2: F value obtained between Bioluminescence and Viable counts in section 2.5.2 
a) Lpp-lux biosensor 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable: RLU 
F df1 df2 Sig. 
1.717 4 18 .018 
 
b) tatA-lux biosensor 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable: RLU 
F df1 df2 Sig. 
1.715 4 18 0.15 
 
c) ldc-lux biosensor 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable: RLU 
F df1 df2 Sig. 
1.849 4 18 0.12 
 
d) lysS-lux biosensor 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable: RLU 
F df1 df2 Sig. 
2.656 4 18 .009 
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e) spc-lux biosensor 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable: RLU 
F df1 df2 Sig. 
1.884 4 18 .10 
 
Table 2.3: Pearson Correlation Coefficients between RLU, CFU, TVC, ATP and RFU readings  
a) Outer membrane lipoprotein (LPP) 
 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation 1 .976** .993** .978** .976** 
Sig. (2-tailed) 
 
.000 .000 .000 .000 
N 8 8 8 8 8 
CFU 
Pearson Correlation .976** 1 .965** .936** 1.000** 
Sig. (2-tailed) .000 
 
.000 .001 .000 
N 8 8 8 8 8 
ATP 
Pearson Correlation .993** .965** 1 .995** .965** 
Sig. (2-tailed) .000 .000 
 
.000 .000 
N 8 8 8 8 8 
RFU 
Pearson Correlation .978** .936** .995** 1 .936** 
Sig. (2-tailed) .000 .001 .000 
 
.001 
N 8 8 8 8 8 
Epi 
Pearson Correlation .976** 1.000** .965** .936** 1 
Sig. (2-tailed) .000 .000 .000 .001 
 
N 8 8 8 8 8 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
b) Twin Arginine Translocase (TATA) 
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation 1 .988** .976** .948** .988** 
Sig. (2-tailed) 
 
.000 .000 .000 .000 
N 8 8 8 8 8 
CFU 
Pearson Correlation .988** 1 .954** .914** 1.000** 
Sig. (2-tailed) .000 
 
.000 .001 .000 
N 8 8 8 8 8 
ATP Pearson Correlation .976** .954** 1 .993** .954** 
Sig. (2-tailed) .000 .000 
 
.000 .000 
N 8 8 8 8 8 
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RFU 
Pearson Correlation .948** .914** .993** 1 .914** 
Sig. (2-tailed) .000 .001 .000 
 
.001 
N 8 8 8 8 8 
Epi 
Pearson Correlation .988** 1.000** .954** .914** 1 
Sig. (2-tailed) .000 .000 .000 .001 
 
N 8 8 8 8 8 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
c) Lysine decarboxylase (LDC) 
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation 1 .968** .957** .900** .968** 
Sig. (2-tailed) 
 
.000 .001 .006 .000 
N 7 7 7 7 7 
CFU 
Pearson Correlation .968** 1 .917** .856* 1.000** 
Sig. (2-tailed) .000 
 
.004 .014 .000 
N 7 7 7 7 7 
ATP 
Pearson Correlation .957** .917** 1 .988** .917** 
Sig. (2-tailed) .001 .004 
 
.000 .004 
N 7 7 7 7 7 
RFU 
Pearson Correlation .900** .856* .988** 1 .856* 
Sig. (2-tailed) .006 .014 .000 
 
.014 
N 7 7 7 7 7 
Epi 
Pearson Correlation .968** 1.000** .917** .856* 1 
Sig. (2-tailed) .000 .000 .004 .014 
 
N 7 7 7 7 7 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
d) Lysyl t-RNA Synthetase (lYSS) 
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation 1 .963** .955 .826* .963** 
Sig. (2-tailed) 
 
.000 .029 .022 .000 
N 7 7 7 7 7 
CFU 
Pearson Correlation .963** 1 .9239 .766* 1.000** 
Sig. (2-tailed) .000 
 
.038 .045 .000 
N 7 7 7 7 7 
ATP Pearson Correlation .955 .939 1 .884** .92 
Sig. (2-tailed) .029 .038 
 
.008 .0384 
N 7 7 7 7 7 
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RFU 
Pearson Correlation .826* .766* .884** 1 .766* 
Sig. (2-tailed) .022 .045 .008 
 
.045 
N 7 7 7 7 7 
Epi 
Pearson Correlation .963** 1.000** .92 .766* 1 
Sig. (2-tailed) .000 .000 .0038 .045 
 
N 7 7 7 7 7 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
e) Ribosomal Protein (SPC) 
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation 1 .971** .907** .884** .971** 
Sig. (2-tailed) 
 
.000 .005 .008 .000 
N 7 7 7 7 7 
CFU 
Pearson Correlation .971** 1 .881** .851* 1.000** 
Sig. (2-tailed) .000 
 
.009 .015 .000 
N 7 7 7 7 7 
ATP 
Pearson Correlation .907** .881** 1 .998** .881** 
Sig. (2-tailed) .005 .009 
 
.000 .009 
N 7 7 7 7 7 
RFU 
Pearson Correlation .884** .851* .998** 1 .851* 
Sig. (2-tailed) .008 .015 .000 
 
.015 
N 7 7 7 7 7 
Epi 
Pearson Correlation .971** 1.000** .881** .851* 1 
Sig. (2-tailed) .000 .000 .009 .015 
 
N 7 7 7 7 7 
 
f) E.coli [pBR322.lux] 
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation .a .a .a .a .a 
Sig. (2-tailed) 
 
. . . . 
N 7 7 7 7 7 
CFU 
Pearson Correlation .a 1 .848* .864* 1.000** 
Sig. (2-tailed) . 
 
.016 .012 .000 
N 7 7 7 7 7 
ATP Pearson Correlation .a .848* 1 .997** .848* 
Sig. (2-tailed) . .016 
 
.000 .016 
N 7 7 7 7 7 
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RFU 
Pearson Correlation .a .864* .997** 1 .864* 
Sig. (2-tailed) . .012 .000 
 
.012 
N 7 7 7 7 7 
Epi 
Pearson Correlation .a 1.000** .848* .864* 1 
Sig. (2-tailed) . .000 .016 .012 
 
N 7 7 7 7 7 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
a. Cannot be computed because at least one of the variables is constant. 
 
g) Wildtype E.coli  
Correlations 
 
RLU CFU ATP RFU Epi 
RLU 
Pearson Correlation .a .a .a .a .a 
Sig. (2-tailed) 
 
. . . . 
N 7 7 7 7 7 
CFU 
Pearson Correlation .a 1 .848* .864* 1.000** 
Sig. (2-tailed) . 
 
.016 .012 .000 
N 7 7 7 7 7 
ATP 
Pearson Correlation .a .848* 1 .997** .848* 
Sig. (2-tailed) . .016 
 
.000 .016 
N 7 7 7 7 7 
RFU 
Pearson Correlation .a .864* .997** 1 .864* 
Sig. (2-tailed) . .012 .000 
 
.012 
N 7 7 7 7 7 
Epi 
Pearson Correlation .a 1.000** .848* .864* 1 
Sig. (2-tailed) . .000 .016 .012 
 
N 7 7 7 7 7 
*. Correlation is significant at the 0.05 level (2-tailed). 
**. Correlation is significant at the 0.01 level (2-tailed). 
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Table 2.4: Tukey Statistical Analysis between Bioluminescence per cell to Biosensors at 24 hours 
 
Multiple Comparisons 
Dependent Variable:   Ratio   
 
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
Tukey  
lpp 
tatA 6.6000* .000 6.3040 6.8960 
Ldc 7.0133* .000 6.7173 7.3093 
Lyss 7.1000* .000 6.8040 7.3960 
Spc -1.6000* .000 -1.8960 -1.3040 
tatA 
lpp -6.6000* .000 -6.8960 -6.3040 
Ldc .4133* .007 .1173 .7093 
Lyss .5000* .002 .2040 .7960 
Spc -8.2000* .000 -8.4960 -7.9040 
Ldc 
lpp -7.0133* .000 -7.3093 -6.7173 
tatA -.4133* .007 -.7093 -.1173 
Lyss .0867 .865 -.2093 .3827 
Spc -8.6133* .000 -8.9093 -8.3173 
Lyss 
lpp -7.1000* .000 -7.3960 -6.8040 
tatA -.5000* .002 -.7960 -.2040 
Ldc -.0867 .865 -.3827 .2093 
Spc -8.7000* .000 -8.9960 -8.4040 
Spc 
lpp 1.6000* .000 1.3040 1.8960 
tatA 8.2000* .000 7.9040 8.4960 
Ldc 8.6133* .000 8.3173 8.9093 
Lyss 8.7000* .000 8.4040 8.9960 
 
lpp 
tatA 6.6000* .000 6.3996 6.8004 
Ldc 7.0133* .000 6.8129 7.2137 
Lyss 7.1000* .000 6.8996 7.3004 
Spc -1.6000* .000 -1.8004 -1.3996 
 lpp -6.6000* .000 -6.8004 -6.3996 
 
 350 
 
 
Table 2.5: Costing of the individual methods that was tested 
 
 
Fluorescence spectrometry  and  
Epifluorescence method 
ATP-bioluminescence method Plate count method Whole-cell bioluminescence 
                                                                   Reagents/kit; Cost (£) 
LIVE/DEAD Baclight kit;  
                                     £232 
Tryptone soy broth;      
                                   £42.2 
Buffered peptone  
Water:                        £28.5 
ATP Bioluminescence assay kit HS 
II;                              
                               £259.40 
Tryptone soy broth; £ 42.2 
Buffered peptone  
Water:                      £28.5 
Tryptone soy broth: 
                        £42.2 
Buffered peptone water; 
                       £28.5 
Tryptone soy agar;                                                            
 
                      £51.20 
 
Tryptone soy broth: 
                            £42.2 
Buffered peptone water;    
                            £28.5 
Total: £302.7 Total: £330.1 Total: £121.9 Total: £192.6 
Approximately 300 assays  Approximately 500 assays Approximately 1000 
assays 
Approximately 1000 assays 
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7 Sequencing output 
 
Sequence 1.0: Ribosomal Protein (SPC) 
 
ctgcgtatgcaggctgcaagtggccagctgcaacagtctcacctgttgaagcaagtgcgtcgcgatg
tcgcacgcgttaagactttactgaacgagaaggcgggtgcgtaatgaccgataaaatccgtactctg
caaggtcgcgttgttagcgacaaaatggagaaatccattgttgttgctatcgaacgttttgtgaaac
acccgatctacggtaaattcatcaagcgtacgaccaaactgcacgtacatgacgagaacaacgaatg
cggtatcggtgacgtggttgaaatccgcgaatgccgtccgctgtccaagactaaatcctggacgctg
gttcgcgttgtagagaaagcggttctgtaatacagtacactctctcaatacgaataaacggctcaga
aatgagccgtttatttTTTCTAcccatatccttgaagcggTGTTATAATgccgcgccctcgatatgg
ggatttttaacgacctgattttcgggtctcagtagtagttgacattagcggagcactaaaatgatcc
aagaacagactatgctgaacgtcgccgacaactccggtgcacgtcgcgtaatgtgtatcaaggttct
gggtggctcgcaccgtcgctacgcaggcgtaggcgacatcatcaagatcaccatcaaagaagcaatt
ccgcgtggtaaggtcaaaaaaggtgatgtgctgaaggcggtagtggtgcgcaccaagaagggtgttc
gtcgcccggacggttctgtcattcgcttcgatggtaatgcttgtgttcttctgaacaacaacagcga
gcagcctatcggtacgcgtatttttgggccggtaactcgtgagcttcgtagtgagaagttcatgaaa
attatctctctggcaccagaagtactctaaggagcgaatcatggcagcgaaaatccgtcgtgatgac
gaagttatcgtgttaaccggtaaagataaaggtaaacgcggtaaagttaagaatgtcctgtcttccg
gcaaggtcattgttgaaggtatcaacctggttaagaaacatcagaagccggttccggccctgaacca
accgggtggcatcgttgaaaaagaagccgctattcaggtttccaacgtagcaatcttcaatgcggca
accggcaaggctgaccgtgtaggctttagattcgaagacggtaaaaaagtccgtttcttcaagtcta
acagcgaaactatcaagtaatttggagtagtacgatggcgaaactgcatgattactacaaagacgaa
gtagttaaaaaactcatgactgagtttaactacaattctgtcatgcaagtccctcgggtcgagaaga
tcaccctgaacatgggtgttggtgaagcgatcgctgacaaaaaactgctggataacgcagcagcaga
cctggcagcaatctccggtcaaaaaccgctgatcaccaaagcacgcaaatctgttgcaggcttcaaa
atccgtcagggctatccgatcggctg 
 
REDrpsQ 
YELLOWrplN 
GreenrplX 
Blue -35 
Grey -10 
The orange nucleotides represent the -40 to -60 regions 
The green nucleotides represent the inter region of -10 to -35 
The purple nucleotides represent the -10 to +1 region 
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Sequence 2.0: Lysyl-tRNA synthetase (LYSS) 
 
cggcgcgggcggtcagcacgttaaccgtaccgaatctgcggtgcgtattacccacatcccgaccggg
atcgtgacccagtgccagaacgaccgttcccagcacaagaacaaagatcaggccatgaagcagatga
aagcgaagcTTTATGaactggagatgcaGAAGAAAAAtgccgagaaacaggcgatggaagataacaa
atccgacatcggctggggcagccagattcgttcttatgtccttgatgactcccgcattaaagatctg
cgcaccggggtagaaacccgcaacacgcaggccgtgctggacggcagcctggatcaatttatcgaag
caagtttgaaagcagggttatgaggaaccaacatgtctgaacaacacgcacagggcgctgacgcggt
agtcgatcttaacaatgaactgaaaacgcgtcgtgagaagctggcgaacctgcgcgagcaggggatt
gccttcccgaacgatttccgtcgcgatcatacctctgaccaattgcacgcagaattcgacggcaaag
agaacgaagaactggaagcgctgaacatcgaagtcgccgttgctggccgcatgatgacccgtcgtat
tatgggtaaagcgtctttcgttaccctgcaggacgttggcggtcgcattcagctgtacgttgcccgt
gacgatctcccggaaggcgtttataacgagcagttcaaaaaatgggacctcggcgacatcctcggcg
cgaaaggtaagctgttcaaaaccaaaaccggcg 
GreenprfB peptide chain release factor 
YellowLysSlysyl-tRNAsynthetase 
Blue -35 box 
Grey -10 box 
The orange nucleotides represent the -40 to -60 regions 
The green nucleotides represent the inter region of -10 to -35 
The purple nucleotides represent the -10 to +1 regions 
 
Sequence 3.0: Twin Arginine translocase (TATA) 
 
cattcttgttggtcagccgacctgaatgggggctgatgcccggctggttaatggcaggtggtctgat
cgcctggtttgtcggttggcgcaaaacacgctgattttTTCATCgctcaaggcgggccgtgtaACGT
ATAATgcggctttgtttaatcatcatctaccacagaggaacatgtatgggtggtatcagtatttggc
agttattgattattgccgtcatcgttgtactgctttttggcaccaaaaagctcggctccatcggttc
cgatcttggtgcgtcgatcaaaggctttaaaaaagcaatgagcgatgatgaaccaaagcaggataaa
accagtcaggatgctgattttactgcgaaaactatcgccgataagcaggcggatacgaatcaggaac
aggctaaaacagaagacgcgaagcgccacgataaagagcaggtgtaatcc 
YELLOW – tatA 
Grey -10 
Blue -35 
 
The orange nucleotides represent the -40 to -60 regions 
The green nucleotides represent the inter region of -10 to -35 
The purple nucleotides represent the -10 to +1 regions 
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Sequence 4.0: Outer membrane Lipoprotein (LPP) 
 
tattgcttttgtgaattaatttgtatatcgaagcgccctgatgggcgctttttttaTTTAATcgata
accagaagcaATAAAAAATcaaatcggatttcactatataatctcactttatctaagatgaatccga
tggaagcatcctgttttctctcaatttttttatctaaaacccagcgttcgatgcttctttgagcgaa
cgatcaaaaataagtgccttcccatcaaaaaaataTTCTCAacataaaaaactttgtgtAATACTtg
taacgctacatggagattaactcaatctagagggtattaataatgaaagctactaaactggtactgg
gcgcggtaatcctgggttctactctgctggcaggttgctccagcaacgctaaaatcgatcagctgtc
ttctgacgttcagactctgaacgctaaagttgaccagctgagcaacgacgtgaacgcaatgcgttcc
gacgttcaggctgctaaagatgacgcagctcgtgctaaccagcgtctggacaacatggctactaaat
accgcaagtaatagtacctg 
The orange nucleotides represent the -40 to -60 regions 
The green nucleotides represent the inter region of -10 to -35 
The purple nucleotides represent the -10 to +1 regions 
GreenpykF 
Yellowlpp 
Purple -35 (lpp)               
Dark green -10 (lpp)     
 
 
Sequence 5.0: Lysine Decarboxylase (LDC) 
 
cgtgttaagcactgaagatttaaaaaatcgtcgttatcagcgcctgatgagctacggttacgcgtaa
ttcgcaaaagttctgaaaaagggtcacttcggtggccctTTTTTAtcgccacggtttgagcaGGCTA
TGATtaaggaaggattttccaggaggaacacatgaacatcattgccattatgggaccgcatggcgtc
ttttataaagatgagcccatcaaagaactggagtcggcgctggtggcgcaaggctttcagattatct
ggccacaaaacagcgttgatttgctgaaatttatcgagcataaccctcgaatttgcggcgtgatttt
tgac 
Red – accA gene 
Yellow – ldcC gene 
Blue –35 
Grey -10 
The orange nucleotides represent the -40 to -60 regions 
The green nucleotides represent the inter region of -10 to -35 
The purple nucleotides represent the -10 to +1 regions 
 
 
 
 
 
 
 
 354 
 
 
 
 
 
Appendix Chapter 3 
The Comparisons of Bioluminescence, 
Growth, Adenylate Energy Charge (AEC), 
Plasmid copy number over extended period 
of time 
 355 
 
 
 
Table 3.1: Growth curve statistical analysis from Section 3.7.1 
No significance difference between biosensors across 48 hours for the 5 biosensor 
RLU 
 Biosensor N Subset 
 1 2 
Tukey HSD
a,b
 
ldc 50 7.1891  
lyss 50 7.2747  
tat 50 7.3217  
lpp 50  7.6922 
spc 50  7.7153 
Sig.  .149 .993 
 
Table 3.20: Tukey Analysis of bioluminescence readings of the five constructs across 48 hours 
 
No significant differences between bioluminescence of the five strains 
 
Multiple Comparisons 
Dependent Variable:   RLU   
Tukey HSD   
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
lpp 
tat .37044 .374 -.1941 .9350 
ldc .50306 .106 -.0615 1.0676 
lyss .41745 .254 -.1471 .9820 
spc .00429 1.000 -.5575 .5661 
tat 
lpp -.37044 .374 -.9350 .1941 
ldc .13263 .967 -.4319 .6972 
lyss .04702 .999 -.5175 .6115 
spc -.36614 .381 -.9279 .1956 
ldc 
lpp -.50306 .106 -1.0676 .0615 
tat -.13263 .967 -.6972 .4319 
lyss -.08561 .994 -.6501 .4789 
spc -.49877 .108 -1.0605 .0630 
lyss 
lpp -.41745 .254 -.9820 .1471 
tat -.04702 .999 -.6115 .5175 
ldc .08561 .994 -.4789 .6501 
spc -.41316 .259 -.9749 .1486 
spc 
lpp -.00429 1.000 -.5661 .5575 
tat .36614 .381 -.1956 .9279 
ldc .49877 .108 -.0630 1.0605 
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lyss .41316 .259 -.1486 .9749 
 
Table 3.3: Standard Mean error  RLU growth curve across 48 hours 
Grand Mean 
Dependent Variable:   RLU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
7.439 .065 7.311 7.566 
 
Table 3.4:  Standard Error CFU growth curve across 48 hours 
Grand Mean 
Dependent Variable:   CFU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
9.342 .083 9.179 9.504 
 
Table 3.5: F Values in comparison for RLU to CFU values across 48 hours for the five biosensors 
 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable:   RLU   
F df1 df2 Sig. 
3.888 228 21 .000 
 
Table 3.6: Standard error RLU in extended growth phase across 28 days for the five biosensors 
Grand Mean 
Dependent Variable:   RLU   
Mean Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
4.903
a
 .005 4.893 4.914 
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Table 3.7: Standard error for CFU in extended growth phase across 28 days for the five biosensors 
Grand Mean 
Dependent Variable:   CFU   
Mean Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
7.726
a
 .014 7.695 7.757 
 
Table 3.8 (a & b): Multiple comparisons of RLU, CFU. RLU: CFU, ATP, Time 
in extended growth phase across 28 days for the five biosensors 
 
Multiple Comparisons 
Tukey HSD 
Dependent Variable (I) biosensor (J) biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
lpp 
tatA -1.3061* .000 -1.5513 -1.0609 
Ldc -1.3261* .000 -1.5713 -1.0809 
Lyss -1.4989* .000 -1.7441 -1.2537 
spc -1.4683* .000 -1.7136 -1.2231 
tatA 
lpp 1.3061* .000 1.0609 1.5513 
Ldc -.0200 .999 -.2652 .2252 
Lyss -.1928 .190 -.4380 .0524 
spc -.1622 .350 -.4074 .0830 
Ldc 
lpp 1.3261* .000 1.0809 1.5713 
tatA .0200 .999 -.2252 .2652 
Lyss -.1728 .287 -.4180 .0724 
spc -.1422 .484 -.3874 .1030 
Lyss 
lpp 1.4989* .000 1.2537 1.7441 
tatA .1928 .190 -.0524 .4380 
Ldc .1728 .287 -.0724 .4180 
spc .0306 .997 -.2147 .2758 
spc 
lpp 1.4683* .000 1.2231 1.7136 
tatA .1622 .350 -.0830 .4074 
Ldc .1422 .484 -.1030 .3874 
Lyss             -.0306 .997 -.2758 .2147 
RLUCFU 
lpp 
tatA -.0219* .000 -.0241 -.0198 
ldc -.0141* .000 -.0163 -.0120 
lyss -.0052* .000 -.0074 -.0031 
spc -.0061* .000 -.0083 -.0040 
tatA 
lpp .0219* .000 .0198 .0241 
ldc .0078* .999 .0056 .0099 
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lyss .0167* .190 .0146 .0188 
spc .0158* .350 .0137 .0179 
ldc 
lpp .0141* .000 .0120 .0163 
tatA -.0078* .999 -.0099 -.0056 
lyss .0089* .287 .0068 .0111 
spc .0080* .484 .0059 .0102 
lyss 
lpp .0052* .000 .0031 .0074 
tatA -.0167* .190 -.0188 -.0146 
ldc -.0089* .287 -.0111 -.0068 
spc -.0009 .997 -.0030 .0012 
spc 
lpp .0061* .000 .0040 .0083 
tatA -.0158* .350 -.0179 -.0137 
ldc -.0080* .484 -.0102 -.0059 
lyss .0009 .997 -.0012 .0030 
CFU 
lpp 
tatA .0000 1.000 -.0234 .0234 
ldc .0000 1.000 -.0234 .0234 
lyss .0000 1.000 -.0234 .0234 
spc .0000 1.000 -.0234 .0234 
tatA 
lpp .0000 1.000 -.0234 .0234 
ldc .0000 1.000 -.0234 .0234 
lyss .0000 1.000 -.0234 .0234 
spc .0000 1.000 -.0234 .0234 
ldc 
lpp .0000 1.000 -.0234 .0234 
tatA .0000 1.000 -.0234 .0234 
lyss .0000 1.000 -.0234 .0234 
spc .0000 1.000 -.0234 .0234 
lyss 
lpp .0000 1.000 -.0234 .0234 
tatA .0000 1.000 -.0234 .0234 
ldc .0000 1.000 -.0234 .0234 
spc .0000 1.000 -.0234 .0234 
spc 
lpp .0000 1.000 -.0234 .0234 
tatA .0000 1.000 -.0234 .0234 
ldc .0000 1.000 -.0234 .0234 
lyss .0000 1.000 -.0234 .0234 
 
Multiple Comparisons 
Tukey HSD 
Dependent Variable (I) tIME (J) tIME Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
24 H 
48 H 1.1660* .000 1.1324 1.1996 
168 H 2.2687* .000 2.2351 2.3022 
336 H 3.0967* .000 3.0631 3.1302 
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504 H 2.6307* .000 2.5971 2.6642 
672 H 3.7973* .000 3.7638 3.8309 
48 H 
24 H -1.1660* .000 -1.1996 -1.1324 
168 H 1.1027* .000 1.0691 1.1362 
336 H 1.9307* .000 1.8971 1.9642 
504 H 1.4647* .000 1.4311 1.4982 
672 H 2.6313* .000 2.5978 2.6649 
168 H 
24 H -2.2687* .000 -2.3022 -2.2351 
48 H -1.1027* .000 -1.1362 -1.0691 
336 H .8280* .000 .7944 .8616 
504 H .3620* .000 .3284 .3956 
672 H 1.5287* .000 1.4951 1.5622 
336 H 
24 H -3.0967* .000 -3.1302 -3.0631 
48 H -1.9307* .000 -1.9642 -1.8971 
168 H -.8280* .000 -.8616 -.7944 
504 H -.4660* .000 -.4996 -.4324 
672 H .7007* .000 .6671 .7342 
504 H 
24 H -2.6307* .000 -2.6642 -2.5971 
48 H -1.4647* .000 -1.4982 -1.4311 
168 H -.3620* .000 -.3956 -.3284 
336 H .4660* .000 .4324 .4996 
672 H 1.1667* .000 1.1331 1.2002 
672 H 
24 H -3.7973* .000 -3.8309 -3.7638 
48 H -2.6313* .000 -2.6649 -2.5978 
168 H -1.5287* .000 -1.5622 -1.4951 
336 H -.7007* .000 -.7342 -.6671 
504 H -1.1667* .000 -1.2002 -1.1331 
RLUCFU 
24 H 
48 H -.0167* .000 -.0191 -.0142 
168 H .0008 .921 -.0016 .0033 
336 H .0028* .016 .0004 .0053 
504 H -.0244* .000 -.0269 -.0219 
672 H -.0066* .000 -.0091 -.0042 
48 H 
24 H .0167* .000 .0142 .0191 
168 H .0175* .000 .0150 .0199 
336 H .0195* .000 .0170 .0219 
504 H -.0077* .000 -.0102 -.0053 
672 H .0100* .000 .0076 .0125 
168 H 
24 H -.0008 .921 -.0033 .0016 
48 H -.0175* .000 -.0199 -.0150 
336 H .0020 .175 -.0005 .0045 
504 H -.0252* .000 -.0277 -.0228 
672 H -.0075* .000 -.0099 -.0050 
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336 H 
24 H -.0028* .016 -.0053 -.0004 
48 H -.0195* .000 -.0219 -.0170 
168 H -.0020 .175 -.0045 .0005 
504 H -.0272* .000 -.0297 -.0248 
672 H -.0095* .000 -.0119 -.0070 
504 H 
24 H .0244* .000 .0219 .0269 
48 H .0077* .000 .0053 .0102 
168 H .0252* .000 .0228 .0277 
336 H .0272* .000 .0248 .0297 
672 H .0178* .000 .0153 .0202 
672 H 
24 H .0066* .000 .0042 .0091 
48 H -.0100* .000 -.0125 -.0076 
168 H .0075* .000 .0050 .0099 
336 H .0095* .000 .0070 .0119 
504 H -.0178* .000 -.0202 -.0153 
CFU 
24 H 
48 H 2.0267* .000 1.9999 2.0535 
168 H 2.2367* .000 2.2099 2.2635 
336 H 2.2400* .000 2.2132 2.2668 
504 H 2.7233* .000 2.6965 2.7501 
672 H 3.3633* .000 3.3365 3.3901 
48 H 
24 H -2.0267* .000 -2.0535 -1.9999 
168 H .2100* .000 .1832 .2368 
336 H .2133* .000 .1865 .2401 
504 H .6967* .000 .6699 .7235 
672 H 1.3367* .000 1.3099 1.3635 
168 H 
24 H -2.2367* .000 -2.2635 -2.2099 
48 H -.2100* .000 -.2368 -.1832 
336 H .0033 .999 -.0235 .0301 
504 H .4867* .000 .4599 .5135 
672 H 1.1267* .000 1.0999 1.1535 
336 H 
24 H -2.2400* .000 -2.2668 -2.2132 
48 H -.2133* .000 -.2401 -.1865 
168 H -.0033 .999 -.0301 .0235 
504 H .4833* .000 .4565 .5101 
672 H 1.1233* .000 1.0965 1.1501 
504 H 
24 H -2.7233* .000 -2.7501 -2.6965 
48 H -.6967* .000 -.7235 -.6699 
168 H -.4867* .000 -.5135 -.4599 
336 H -.4833* .000 -.5101 -.4565 
672 H .6400* .000 .6132 .6668 
672 H 24 H -3.3633* .000 -3.3901 -3.3365 
48 H -1.3367* .000 -1.3635 -1.3099 
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168 H -1.1267* .000 -1.1535 -1.0999 
336 H -1.1233* .000 -1.1501 -1.0965 
504 H -.6400* .000 -.6668 -.6132 
 
 
Table 3.9: Multivariate Analysis of RLU, CFU, AEC, and PCN between the biosensors 
No significant difference between the parameters 
 
Tests of Between-Subjects Effects 
Source Dependent 
Variable 
Type III Sum 
of Squares 
df Mean 
Square 
F Sig. 
Corrected 
Model 
RLU 5.427
a
 4 1.357 .410 .800 
CFU .412
b
 4 .103 .048 .996 
PCN 22.686
c
 4 5.671 .016 .999 
AEC .001
d
 4 .000 .008 1.000 
Intercept 
RLU 1094.520 1 1094.520 330.947 .000 
CFU 2144.089 1 2144.089 990.423 .000 
PCN 40528.029 1 40528.029 115.112 .000 
AEC 14.716 1 14.716 492.080 .000 
Biosensor 
RLU 5.427 4 1.357 .410 .800 
CFU .412 4 .103 .048 .996 
PCN 22.686 4 5.671 .016 .999 
AEC .001 4 .000 .008 1.000 
 RLU 99.217 30 3.307   
 
Tables 3.20 (a) : Concentration  of genomic DNA (gDNA) and plasmid DNA (pDNA) was extracted  at the 
following time points; 0 hours, 4 hours, 6 hours, 24 hours, 168 hours, 336 hours, 504 hours, and 672 hours 
for all E.coli biosensor strains. 
Genomic DNA extract of Tat-lux Esherichia.coli 8739 
Samples 
(Hours) OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA conc 
(µg/ml) 
DNA Concentration 
(µg) 
0 1.292 0.91 0.767 0.531 1.605932 37.9 3.79 
4 1.104 0.851 0.702 0.472 1.647826 37.9 3.79 
6 1.492 1.518 1.061 0.41 1.701997 110.8 11.08 
24 2.352 2.943 1.942 0.54 1.71398 240.3 24.03 
168 2.064 3 1.8 0.584 1.986842 241.6 24.16 
336 1.1 0.882 0.624 0.32 1.848684 56.2 5.62 
504 1.263 0.845 0.696 0.5 1.760204 34.5 3.45 
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672 1.645 0.94 0.78 0.6 1.888889 34 3.4 
 
Table 3.2.1: Plasmid DNA extract of Tat-lux Escherichia.coli 8739 
time  OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA conc 
(µg/µl) 
DNA 
Concentration 
(µg) 
0 1.106 1.106 0.468 0.403 1.59633 17.4 1.74 
4 1.21 1.21 0.616 0.531 1.664063 21.3 2.13 
6 1.572 1.572 1.229 0.904 1.730337 77 7.7 
24 1.396 1.396 1.23 0.78 1.729335 106.7 10.67 
168 1.62 1.62 0.845 0.66 1.711538 44.5 4.45 
336 1.141 1.141 0.85 0.612 1.815068 53 5.3 
504 1.23 1.23 0.743 0.555 1.737255 44.3 4.43 
672 1.2 1.2 0.6 0.5 1.714286 24 2.4 
 
DNA molecules absorb UV light strongly at 260nm whilst aromatic amino acid present in protein absorbs 
UV at 280nm. To evaluate DNA purity by spectrometry, measurement of absorbance from 230nm to 320nm 
in order to detect other possible contaminants present in DNA solution. Strong absorbance reading at 230nm 
indicates that organic compounds or chaotropic salts are present in the purified DNA. A reading of 320nm 
indicated turbidity in the solution, another indication of possible contamination. DNA purity 
(260nm/280nm) ratio between 1.7-2.0 is generally accepted as representative of a high quality DNA sample. 
The ratio is calculated upon the subtraction of readings at 320nm 
 
Table 3.22: Genomic DNA extract of Ldc-lux Escherichia.coli 8739 
Samples 
(Hours) OD 230 OD 260 OD 280 OD 320 
DNA 
purity  
DNA 
conc 
(µg/ml) 
DNA 
Concentration 
(µg 
0 0.182 0.537 0.47 0.361 1.614679 17.6 1.76 
4 0.005 0.547 0.419 0.21 1.61244 33.7 3.37 
6 0.336 1.4979 0.902 0.166 1.809647 133.19 13.319 
24 0.167 0.657 0.373 0.012 1.786704 64.5 6.45 
168 0.174 0.877 0.554 0.124 1.751163 75.3 7.53 
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336 1.52 1.577 1.316 1.22 3.71875 35.7 3.57 
504 2.5 2.1 1.855 1.32 1.457944 78 7.8 
672 2 2.2 1.8 1.3 1.8 90 9 
 
Table 3.23: Plasmid DNA extract of Ldc-lux Escherichia.coli 8739 
Hours OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA 
conc 
DNA 
Concentration (µg 
0 0.374 0.913 0.839 0.731 1.685185 9.1 0.91 
4 0.291 0.85 0.692 0.478 1.738318 18.6 1.86 
6 0.07 0.632 0.444 0.233 1.890995 19.95 1.995 
24 0.748 1.55 1.103 0.566 1.832402 49.2 4.92 
168 0.385 1.108 0.773 0.352 1.795724 37.8 3.78 
336 0.058 0.671 0.475 0.238 1.827004 21.65 2.165 
504 1.244 2.215 1.653 0.933 1.780556 64.1 6.41 
672 1.544 1.397 1.2 0.879 1.613707 25.9 2.59 
 
Table 3.24: Genomic DNA extract of Lyss-lux Escherichia.coli 8739 
Hours OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA 
conc 
(µg/µl) 
DNA 
Concentration (µg 
0 1.188 0.567 0.469 0.322 1.666667 24.5 2.45 
4 1.393 0.758 0.637 0.443 1.623711 31.5 3.15 
6 2.053 1.3 0.905 0.4 1.782178 90 9 
24 2.1 1.776 1.193 0.5 1.84127 127.6 12.76 
168 1.661 1.125 0.804 0.42 1.835938 70.5 7.05 
336 2.304 1.145 0.969 0.75 1.803653 39.5 3.95 
504 1.6 1.2 0.8 0.325 1.842105 87.5 8.75 
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672 1.6 1.311 0.8 0.32 1.904583 99.1 9.91 
 
Table 3.25 Plasmid DNA extract of lyss-lux Escherichia.coli 8739 
Hours  OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA 
conc 
(µg/µl) 
DNA 
Concentration (µg 
0 0.977 0.303 0.242 0.152 1.677778 15.1 1.51 
4 1.466 0.744 0.63 0.457 1.65896 28.7 2.87 
6 1.603 1.68 1.036 0.22 1.789216 146 14.6 
24 2.739 2.965 1.953 0.403 1.652903 256.2 25.62 
168 1.999 1.72 1.136 0.319 1.71481 140.1 14.01 
336 2.281 2.249 1.465 0.335 1.693805 191.4 19.14 
504 1.772 1.312 0.863 0.306 1.806104 100.6 10.06 
672 1.319 1.2 0.519 0.353 5.10241 84.7 8.47 
 
Table 3.26 Genomic DNA extract of Spc-lux Escherichia.coli 8739 
Hours OD 230 OD 260 OD 280 OD 320 
DNA 
purity  
DNA 
conc 
(µg/ml) 
DNA 
Concentration 
(µg 
0 1.14 0.488 0.422 0.3 1.540984 18.8 1.88 
4 0.39 0.18 0.148 0.09 1.551724 9 0.9 
6 2.591 1.938 1.419 0.7 1.721836 123.8 12.38 
24 2.449 2.783 1.766 0.4 1.74451 238.3 23.83 
168 1.92 1.864 1.265 0.5 1.783007 136.4 13.64 
336 2.502 1.388 1.145 0.75 1.61519 63.8 6.38 
504 2.037 1.3 0.99 0.6 1.794872 70 7 
672 2.168 1.2 0.98 0.67 1.709677 53 5.3 
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Table 3.27 Plasmid DNA extract of Spc-lux Escherichia.coli 8739 
Hours  OD 230 OD 260 OD 280 OD 320 
DNA 
purity  
DNA 
conc 
(µg/ml) 
DNA 
Concentration 
(µg 
0 1.496 0.754 0.649 0.491 1.664557 26.3 2.63 
4 1.305 0.491 0.397 0.262 1.696296 22.9 2.29 
6 2.206 2.448 1.556 0.45 1.80651 199.8 19.98 
24 2.311 2.135 1.44 0.6 1.827381 153.5 15.35 
168 1.562 2.08 1.273 0.3 1.829394 178 17.8 
336 2.409 2.261 1.5 0.413 1.700092 184.8 18.48 
504 1.892 1.061 0.789 0.308 1.565489 75.3 7.53 
672 1.9 1 0.7 0.3 1.75 70 7 
 
Table 3.28: genomic DNA of lpp-lux Escherichia coli ATCC 8739  
Hours  OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA 
conc 
(µg/ml) 
DNA 
Concentration 
(µg 
0 0.671 0.264 0.213 0.141 1.708333333 12.3 1.23 
4 1.322 0.839 0.625 0.333 1.732876712 50.6 5.06 
6 1.643 1.661 1.059 0.306 1.799468792 135.5 13.55 
24 2.187 2.434 1.634 0.586 1.763358779 184.8 18.48 
168 2.127 2.335 1.464 0.277 1.733782645 205.8 20.58 
336 1.736 1.757 1.142 0.346 1.772613065 141.1 14.11 
504 2.22 1.65 1.145 0.49 1.770992366 116 11.6 
672 0.55 1.223 0.871 0.335 1.656716418 88.8 8.88 
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Table 3.29: Plasmid DNA of lpp-lux Escherichia coli ATCC 8739  
Hours  OD 230 OD 260 OD 280 OD 320 DNA purity  
DNA 
conc 
(µg/ml) 
DNA 
Concentration 
(µg 
0 1.671 1.29 1.164 1.011 1.823529412 13.95 1.395 
4 2.753 2.22 1.937 1.544 1.720101781 33.8 3.38 
6 2.539 2.3 1.964 1.484 1.7 40.8 4.08 
24 2 2.99 2.536 2.035 1.906187625 47.75 4.775 
168 1.805 2.3 1.553 0.59 1.775700935 85.5 8.55 
336 1.16 1.64 1.08 0.44 1.875 60 6 
504 1.293 1.6 1.15 0.6 1.818181818 50 5 
672 0.533 1.5 0.987 0.32 1.769115442 59 5.9 
 
 
Figure3.1 (a): Deoxy-D-Xylulose Phosphate (DXS) pcr product (113bp,1.0% gel) observed with total DNA 
from respective 5 biosensors and control. (Lanes 1&8; 100bp ladder, 2: Lpp, 3:Tat, 4:ldc; 5:Lys, 6: Spc, 
7:Pless 
Lane 1   2   3   4   5   6   7   8  
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 Figure 3.1 (b): Ampilicin (BLA) pcr product (81bp, 1.0% gel) observed with total DNA from respective 5 
biosensors and control. (Lanes 1&8; 100bp ladder, 2: Lpp, 3:Tat, 4:ldc; 5:Lys, 6: Spc, 7:Pless) At annealing 
temperature 58 degrees 
Calculations  
 
 
 
Tables 3.3 (a, b, c, d, and e): The tabulation of the plasmid copy numbers based on the copies of dxs and bla 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lane 1   2   3   4   5   6   7   8  
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Table 3.5 (a) : Tabulation of ct values, coefficient of variance, copies of target, and plasmid coy numbers 
(PCN) for Lpp-lux 
 
 
 
 
 
 
 
 
 
 
 
Hours  Target Standard curve 
Equations 
Correlation 
Coefficients 
Between 
copies and Ct 
values 
Ct 
values 
(n=3) 
Coefficient of 
variance (CV) 
Copies  Plasmid 
copy 
number 
(per cell) 
0 
Dxs y= -2.835x+ 42.649 0.88 22.67 0.029554 7.09E+06 35 
0 
Bla y = -2.53x + 42.28 0.89 21.07 0.003322 2.52E+08 
4 
Dxs y= -2.51x+ 44.927 0.98 23.1 0.007498 4.18E+07 27 
4 
Bla y=-2.711x+41.919  0.99 17.366 0.022989 1.14E+09 
6 
Dxs y=-2.863x+ 42.783 0.98 23.47 0.024505 5.57E+06 67 
6 
Bla y= -2.812x+ 44.094 0.97 20 0.022703 3.70E+08 
24 
Dxs y= --3.82x+ 45.983 0.994 21.3 0.015471 2.03E+06 54 
24 
Bla y= -3x+ 43.983 0.996 19.8 0.040404 1.09E+08 
168 
Dxs y = -3.121x + 38.31 0.92 22.3 0.013453 7.08E+07 26 
 
168 
Bla y = -3.247x + 41.8 0.99 21 0.071429 1.89E+09 
336 
Dxs y = -3.158x + 40.30 0.90 26.5 0.018868 1.11E+06 14 
336 
Bla y = -3.044x + 46.84 0.99 23.5 0.021277 1.53E+07 
504 
Dxs y= -3.4x+ 35.9 0.95 26.4 0.011858 1.82E+05 15 
504 
Bla y = -3.256x + 41.38 0.99 28.65 0.011517 2.65E+06 
672 
Dxs y = -3.329x + 43.21 0.93 26 0.023002 1.59E+07 16 
672 
Bla y = -3.4x + 45.364 0.95 28.45 0.015817 2.53E+08 
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Table 3.31 (b): Tabulation of ct values, coefficient of variance, copies of target, and plasmid coy nu(PCN 
 
 
 
 
 
 
 
 
 
 
Hours  Target Standard curve 
Equations 
Correlation 
Coefficients 
Between 
copies and Ct 
values 
Ct values 
(n=3) 
Coefficient of 
variance (CV) 
DNA Copies  Plasmid 
copy 
number 
(per cell) 
0 
Dxs y= -2.4332x + 43.46 0.95 22.87 0.003103 
1.51E+10 
38 
0 
Bla y= -2.5813x + 43.26 0.87 17.85 0.00855 
5.74E+11 
4 
Dxs y= -3.174x + 53.972 0.99 23.15 0.001247 
7.45E+08 
22 
4 
Bla y=-2.857x + 50.47 0.95 19.5 0.00782 
1.62E+10 
6 
Dxs y=-4x + 29.899 0.96 25.62 0.00137 1.18E+08 65 
6 
Bla y= -2.5105x + 32.16 0.9 21.24 0.023232 7.77E+09 
24 
Dxs y= -3.17x + 42.882 0.994 22.67 0.000509 
2.38E+06 
50 
24 
Bla y= -3.428x + 48.804 0.996 21.1 0.045116 
1.21E+08 
168 
Dxs y = -3.005x + 53.37 0.99 30.25 0.001252 
2.79E+08 
25 
168 
Bla y = -3.316x + 50.89 0.96 18.22 0.013458 
7.00E+09 
336 
Dxs y= -3.395x + 58.89 0.91 33.69 0.020627 
2.65E+07 
15 
336 
Bla y = -3x + 48.56 0.98 22.69 0.057278 
4.20E+08 
504 
Dxs y= -3.693x + 55 0.95 24.88 0.005052 1.42E+08 25 
504 
Bla y= -3.2x+ 43.478 0.92 19.4 0.005386 3.90E+09 
672 
Dxs y = -3.693x + 48 0.95 32.45 0.025447 5.42E+08 22 
672 
Bla y = -3.2x + 37.13 0.92 19.33 0.012746 1.19E+10 
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Table 3.32 (c) : Tabulation of ct values, coefficient of variance, copies of target, and plasmid coy numbers 
(PCN) for Ldc-lux 
 
 
 
 
 
 
 
 
Hours  Target Standard curve 
Equations 
Correlation 
Coefficients 
Between 
copies and Ct 
values 
Ct 
values 
(n=3) 
Coefficient of 
variance (CV) 
DNA Copies  Plasmid 
copy 
number 
(per 
cell) 
0 
Dxs y= -2.422x+24.86 0.97 24.77 0.026372 2.43E+05 41 
0 
Bla y= -2.628x+22.24 0.95 17.85 0.00855 1.00E+07 
4 
Dxs y= -3.01+38.6999 0.97 25.56 0.00984 1.49E+06 18 
4 
Bla y=-2.8+36.778 0.95 21.014 0.002892 2.68E+07 
6 
Dxs y=-2.64x+31.65 0.97 23.2 0.004336 1.62E+06 55 
6 
Bla y= -3.105x + 35 0.93 20.63 0.012788 7.85E+07 
24 
Dxs y= -3.17x + 42.882 0.994 23.21 0.006848 1.61E+06 49 
24 
Bla y= -3.387x +47.36 0.996 20.63 0.001454 7.85E+07 
168 
Dxs y= -2.752x +35.13 0.93 24.66 0.023755 8.51E+04 28 
168 
Bla y= -2.504x+ 33.30 0.94 20.14 0.002498 2.40E+06 
336 
Dxs y= -2.5x+ 30 0.99 25.66 0.009783 4.30E+05 16 
336 
Bla y= -2.54x+ 27.8 0.98 20.34 0.006412 6.85E+06 
504 
Dxs y= -3.23x+ 34 0.98 24.88 0.006901 1.42E+08 28 
504 
Bla y= -2.67x+ 30.784 0.90 19.4 0.023136 3.90E+09 
672 
Dxs y= -2.8x + 41.182 1 25.26 0.016565 7.01E+08 25 
672 
Bla y= -2.8x + 40.1 0.96 20.266 0.031723 1.75E+10 
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Table 3.33 (d) : Tabulation of ct values, coefficient of variance, copies of target, and plasmid coy numbers 
for lyss 
 
 
 
 
 
 
 
Hours  Target Standard curve 
Equations 
Correlation 
Coefficients 
Between 
copies and Ct 
values 
Ct values 
(n=3) 
Coefficient of 
variance (CV) 
DNA Copies  Plasmid 
copy 
number 
(per cell) 
0 
Dxs y= -2.568x+ 33 0.97 21.3 0.014085 9.77E+07 49 
0 
Bla y= -2.804x+ 34.97 0.95 17.45 0.020257 4.83E+09 
4 
Dxs y= -2.993x+ 33.1 0.97 23.78 0.003364 1.36E+06 22 
4 
Bla y=-2.473x+ 30.364 0.93 19.36 0.019107 2.95E+07 
6 
Dxs y=-3.315x+ 37.52 0.98 24.88 0.033811 2.83E+06 61 
6 
Bla y= -3.125x+ 38.34 0.92 20.85 0.012788 1.72E+08 
24 
Dxs y= --3x+ 42.75 0.994 23 0.007498 3.83E+06 53 
24 
Bla y= -2.95x+ 45.548 0.996 21.02 0.000951 2.06E+08 
168 
Dxs y = -3.041x + 46.66 0.99 24.85 0.003628 1.28E+07 22 
168 
Bla y = -3.446x + 46.60 0.94 17.5 0.028571 2.79E+08 
336 
Dxs y = -2.750x + 42.85 0.93 25.83 0.003067 1.56E+06 20 
336 
Bla y = -2.732x + 41.60 0.94 21.12 0.005682 3.14E+07 
504 
Dxs y = -3.596x + 50.74 0.99 22.1 0.006479 9.24E+07 20 
504 
Bla y = -3.41x + 53.167 0.98 21.54 0.025527 1.88E+09 
672 
Dxs y = -2.837x + 40.8 0.90 27.46 0.020086 1.32E+07 15 
672 
Bla y = -3.0x + 45 0.96 27.33 0.012075 2.05E+08 
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Table 3.34 (e): Tabulation of ct values, coefficient of variance, copies of target, and plasmid coy numbers  
(PCN) for spc-lux 
 
 
 
 
 
Hours  Target Standard curve 
Equations 
Correlation 
Coefficients 
Between 
copies and Ct 
values 
Ct values 
(n=3) 
Coefficient of 
variance (CV) 
DNA Copies  Plasmid 
copy 
number 
(per cell) 
0 
Dxs y= -2.585x+ 31.649 0.92 23.3 0.004453 4.19E+05 34 
0 
Bla y = -2.5x + 33.75 0.98 21.85 0.036697 1.46E+07 
4 
Dxs y= -2.56x+ 37.87 0.94 25.33 0.013028 5.32E+06 32 
4 
Bla y=-2.57x+ 36 1.0 19.55 0.028133 1.68E+08 
6 
Dxs y=-3.257x+ 38.68 0.99 25.02 0.001221 9.37E+05 67 
6 
Bla y= -3.22x+ 40.12 0.99 20.68 0.015965 6.32E+07 
24 
Dxs y= -3.322x+ 45.983 0.994 21.33 0.015471 2.84E+06 58 
24 
Bla y= -3x+ 43.983 0.996 19.33 0.017072 1.65E+08 
168 
Dxs y = -3.121x + 42.91 0.97 24.33 0.013564 9.01E+05 29 
168 
Bla y = -3.747x + 50.41 0.99 22.65 0.028481 2.57E+07 
336 
Dxs y = -3.458x + 40.30 0.95 22.4 0.013453 1.93E+07 10 
336 
Bla y = -3.544x + 41.5 0.99 19.5 0.046064 1.90E+08 
504 
Dxs y= -3.4x+ 37.75 0.97 25.24 0.026369 8.30E+05 22 
504 
Bla y = -3.256x + 42.88 0.99 26.55 0.004143 1.82E+07 
672 
Dxs y = -3.329x + 33.82 0.89 28.06 0.007036 2.18E+04 21 
672 
Bla y = -3.4x + 36.5 0.99 26.1 0.013814 4.63E+05 
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Tables 3.35 : Tukey Post Hoc test of PCN values  
 
Multiple Comparisons 
Dependent Variable:   PCN   
Tukey HSD   
(I) Time (J) Time Mean Difference (I-J) Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 Hour 
4 Hour -5.2000 .996 -27.9347 17.5347 
6 h -29.5333* .003 -52.2681 -6.7986 
24 h -19.2667 .158 -42.0014 3.4681 
168 h 7.8000 .962 -14.9347 30.5347 
336 h 18.8000 .181 -3.9347 41.5347 
504 h 12.0000 .723 -10.7347 34.7347 
672 h 13.8667 .556 -8.8681 36.6014 
4 Hour 
0 Hour 5.2000 .996 -17.5347 27.9347 
6 h -24.3333* .027 -47.0681 -1.5986 
24 h -14.0667 .538 -36.8014 8.6681 
168 h 13.0000 .635 -9.7347 35.7347 
336 h 24.0000* .031 1.2653 46.7347 
504 h 17.2000 .278 -5.5347 39.9347 
672 h 19.0667 .168 -3.6681 41.8014 
6 h 
0 Hour 29.5333* .003 6.7986 52.2681 
4 Hour 24.3333* .027 1.5986 47.0681 
24 h 10.2667 .852 -12.4681 33.0014 
168 h 37.3333* .000 14.5986 60.0681 
336 h 48.3333* .000 25.5986 71.0681 
504 h 41.5333* .000 18.7986 64.2681 
672 h 43.4000* .000 20.6653 66.1347 
24 h 
0 Hour 19.2667 .158 -3.4681 42.0014 
4 Hour 14.0667 .538 -8.6681 36.8014 
6 h -10.2667 .852 -33.0014 12.4681 
168 h 27.0667* .009 4.3319 49.8014 
336 h 38.0667* .000 15.3319 60.8014 
504 h 31.2667* .001 8.5319 54.0014 
672 h 33.1333* .001 10.3986 55.8681 
168 h 
0 Hour -7.8000 .962 -30.5347 14.9347 
4 Hour -13.0000 .635 -35.7347 9.7347 
6 h -37.3333* .000 -60.0681 -14.5986 
24 h -27.0667* .009 -49.8014 -4.3319 
336 h 11.0000 .802 -11.7347 33.7347 
504 h 4.2000 .999 -18.5347 26.9347 
672 h 6.0667 .991 -16.6681 28.8014 
336 h 0 Hour -18.8000 .181 -41.5347 3.9347 
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4 Hour -24.0000* .031 -46.7347 -1.2653 
6 h -48.3333* .000 -71.0681 -25.5986 
24 h -38.0667* .000 -60.8014 -15.3319 
168 h -11.0000 .802 -33.7347 11.7347 
504 h -6.8000 .982 -29.5347 15.9347 
672 h -4.9333 .997 -27.6681 17.8014 
504 h 
0 Hour -12.0000 .723 -34.7347 10.7347 
4 Hour -17.2000 .278 -39.9347 5.5347 
6 h -41.5333* .000 -64.2681 -18.7986 
24 h -31.2667* .001 -54.0014 -8.5319 
168 h -4.2000 .999 -26.9347 18.5347 
336 h 6.8000 .982 -15.9347 29.5347 
672 h 1.8667 1.000 -20.8681 24.6014 
672 h 
0 Hour -13.8667 .556 -36.6014 8.8681 
4 Hour -19.0667 .168 -41.8014 3.6681 
6 h -43.4000* .000 -66.1347 -20.6653 
24 h -33.1333* .001 -55.8681 -10.3986 
168 h -6.0667 .991 -28.8014 16.6681 
336 h 4.9333 .997 -17.8014 27.6681 
504 h -1.8667 1.000 -24.6014 20.8681 
 
 
Table 3.4 (a, b, & c): Concentrations of ATP, ADP, and AMP converted from chemiluminescence readings 
to mg/ml from the standard curve from Standards of Figure 3.13 in Section 3.7.4 
                                                         ATP concentrations (mg/ml) 
Time 
(Hour)  Lpp-lux tatA-lux  Ldc-lux  Lyss-lux  Spc-lux 
E.coli 
[pBR322.lux]  
E.coli 
ATCC 
8739  
0 
0.810402 0.810643 0.808429 0.806528 0.803313 0.835995 0.835995 
6 0.809812 0.809812 0.802895 0.802863 0.802302 0.802739 0.814619 
24 0.8478 0.841881 0.844011 0.842302 0.846406 0.848997 0.85364 
168 0.838705 0.843026 0.845035 0.848706 0.846469 0.836203 0.83724 
336 0.842399 0.848415 0.847054 0.844566 0.848207 0.843907 0.844651 
504 0.847412 0.847737 0.848309 0.849699 0.848054 0.847936 0.845769 
672 0.843692 0.846068 0.845583 0.846582 0.846485 0.847327 0.85163 
                                                     ADP concentrations (mg/ml) 
Time 
(Hour)  Lpp-lux tatA-lux  Ldc-lux  Lyss-lux  Spc-lux 
E.coli 
[pBR322.lux]  
E.coli 
ATCC 
8739  
0 0.835995 0.829081 0.826276 0.827064 0.826276 0.823868 0.848997 
6 0.750077 0.835995 0.831138 0.829813 0.829844 0.832178 0.830147 
24 1.06678 0.858377 0.855856 0.852507 0.857258 0.858042 0.85364 
168 1.006005 0.829086 0.833122 0.832018 0.832272 0.83246 0.835995 
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336 1.002912 0.834257 0.831652 0.829573 0.830391 0.828528 0.831545 
504 1.001922 0.838876 0.838275 0.836633 0.836998 0.836668 0.824743 
672 1.001435 0.830611 0.832267 0.830652 0.828286 0.829565 0.827187 
 
                                                          AMP concentrations (mg/ml) 
Time 
(Hour)  Lpp-lux tatA-lux  Ldc-lux  Lyss-lux  Spc-lux 
E.coli 
[pBR322.lux]  
E.coli 
ATCC 
8739  
0 0.845025 0.845318 0.845318 0.847534 0.845318 0.859639 0.859265 
6 0.845261 0.847546 0.847546 0.845075 0.848763 0.858217 0.858713 
24 0.862496 0.856191 0.858002 0.856939 0.859673 0.860503 0.860093 
168 0.839732 0.85135 0.846985 0.850576 0.855062 0.83634 0.839229 
336 0.848871 0.8523 0.847165 0.844677 0.848225 0.84321 0.846886 
504 0.848997 0.848233 0.8495 0.85343 0.849067 0.848149 0.846346 
672 0.84323 0.841916 0.845152 0.847844 0.847034 0.854938 0.852776 
 
 
 
Figure 3.7 (a): The ADP levels of five biosensors and control strains over extended period of time  
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 Figure 3.7 (b): The AMP levels of five biosensors and control strains over extended period of time  
 
Table 3.4: ANOVA analysis for ATP, ADP, and AMP readings  
No significance difference was found 
 
ANOVA 
 Sum of 
Squares 
df Mean Square F Sig. 
ATP 
Between 
Groups 
1359920183
6118.500 
6 
2266533639
353.084 
.419 .862 
Within Groups 
2271725765
01678.700 
42 
5408870869
087.588 
  
Total 
2407717783
37797.200 
48 
   
ADP 
Between 
Groups 
1178735920
499.357 
6 
1964559867
49.893 
.348 .907 
Within Groups 
2371945751
1671.790 
42 
5647489883
73.138 
  
Total 
2489819343
2171.145 
48 
   
AMP 
Between 
Groups 
7124123929
66.786 
6 
1187353988
27.798 
.663 .680 
Within Groups 
7519614253
864.255 
42 
1790384346
15.816 
  
Total 
8232026646
831.041 
48 
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Table 3.4.1: Standard mean error for ATP readings from Section 3.7.4.1 
Grand Mean 
Dependent Variable:   ATP   
Mean Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
3.929 .006 3.918 3.940 
 
Table 3.4.2: Tukey analysis for ATP readings from section 3.7.4.1 
 
No significance difference was found 
ATP 
Tukey HSD
a,b,c
   
Biosensor N Subset 
1 2 3 
wt 21 3.7886   
pless 21  3.8692  
Spc 21  3.9300 3.9300 
lpp 25   3.9524 
Lyss 21   3.9534 
tatA 21   3.9738 
Ldc 21   3.9895 
Sig.  1.000 .067 .078 
 
Table 3.4.3: Standard Mean error for AEC readings across 28 days 
Grand Mean 
Dependent Variable:   AEC   
Mean Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
.654 .003 .648 .660 
 
 
 
Table 3.4.4: Tukey analysis for AEC readings across 28 days 
 
No significance difference was found 
AEC 
Tukey HSD
a,b,c
   
Biosensor N Subset 
1 2 3 
wt 21 .6187   
lpp 21 .6304 .6304  
 378 
 
 
pless 21 .6490 .6490 .6490 
tatA 21  .6629 .6629 
Spc 21   .6645 
Ldc 21   .6648 
Lyss 21   .6695 
Sig.  .088 .054 .498 
 
Table 3.4.5: Tukey Analysis for time vs AEC values 
Multiple Comparisons 
Dependent Variable:   AEC   
Tukey HSD   
(I) Time (J) Time Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hr 
6hr -.06029* .015 -.1128 -.0077 
24 hr .11234* .000 .0598 .1649 
168 hr .29828* .000 .2457 .3508 
336 hr .31247* .000 .2599 .3650 
504 hr .31528* .000 .2627 .3678 
672 hr .32566* .000 .2731 .3782 
6hr 
0 hr .06029* .015 .0077 .1128 
24 hr .17263* .000 .1201 .2252 
168 hr .35857* .000 .3060 .4111 
336 hr .37276* .000 .3202 .4253 
504 hr .37557* .000 .3230 .4281 
672 hr .38595* .000 .3334 .4385 
24 hr 
0 hr -.11234* .000 -.1649 -.0598 
6hr -.17263* .000 -.2252 -.1201 
168 hr .18595* .000 .1334 .2385 
336 hr .20014* .000 .1476 .2527 
504 hr .20294* .000 .1504 .2555 
672 hr .21332* .000 .1608 .2659 
168 hr 
0 hr -.29828* .000 -.3508 -.2457 
6hr -.35857* .000 -.4111 -.3060 
24 hr -.18595* .000 -.2385 -.1334 
336 hr .01419 .980 -.0384 .0667 
504 hr .01700 .951 -.0356 .0695 
672 hr .02737 .675 -.0252 .0799 
336 hr 
0 hr -.31247* .000 -.3650 -.2599 
6hr -.37276* .000 -.4253 -.3202 
24 hr -.20014* .000 -.2527 -.1476 
168 hr -.01419 .980 -.0667 .0384 
504 hr .00281 1.000 -.0497 .0554 
672 hr .01318 .986 -.0394 .0657 
504 hr 0 hr -.31528* .000 -.3678 -.2627 
 379 
 
 
6hr -.37557* .000 -.4281 -.3230 
24 hr -.20294* .000 -.2555 -.1504 
168 hr -.01700 .951 -.0695 .0356 
336 hr -.00281 1.000 -.0554 .0497 
672 hr .01038 .996 -.0422 .0629 
672 hr 
0 hr -.32566* .000 -.3782 -.2731 
6hr -.38595* .000 -.4385 -.3334 
24 hr -.21332* .000 -.2659 -.1608 
168 hr -.02737 .675 -.0799 .0252 
336 hr -.01318 .986 -.0657 .0394 
504 hr -.01038 .996 -.0629 .0422 
*. The mean difference is significant at the 0.05 level. 
 
 
Figure 3.8: Growth rate of all seven E.coli  strains across 28 days 
Formulation of growth rate ;  
= 
                         
                 
    
=  v is CFU counts at the end of the time interval. 
= i is CFU counts at the beginning of the time interval 
No statistical differences were found across the E.coli strains 
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Appendix 4 
Whole-Cell Bioluminescence evaluation using 
Sorbic Acid
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Table 4.1: Tukey Post Hoc Analysis on Preservative-free vs Biosensors, Time in Section 4.6.3 
 
Multiple Comparisons 
Dependent Variable: RLU  
 Tukey HSD 
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
LPP 
tatA .1243 .005 -.1151 .3637 
ldc .4981* .000 .2587 .7375 
lyss .5129* .810 .2735 .7522 
spc -.0933 .000 -.3327 .1460 
tatA 
LPP -.1243 .595 -.3637 .1151 
ldc .3738* .000 .1344 .6132 
lyss .3886* .000 .1492 .6279 
spc -.2176 .002 -.4570 .0218 
ldc 
LPP -.4981* .000 -.7375 -.2587 
tatA -.3738* .000 -.6132 -.1344 
lyss .0148 1.000 -.2246 .2541 
spc -.5914* .000 -.8308 -.3521 
lyss 
LPP -.5129* .000 -.7522 -.2735 
tatA -.3886* .800 -.6279 -.1492 
ldc -.0148 1.000 -.2541 .2246 
spc -.6062* .810 -.8456 -.3668 
spc 
LPP .0933 .000 -.1460 .3327 
tatA .2176 .002 -.0218 .4570 
ldc .5914* .000 .3521 .8308 
lyss .6062* .000 .3668 .8456 
 
 
Time Analysis 
Multiple Comparisons 
Dependent Variable: RLU  
 Tukey HSD 
(I) TIME (J) TIME Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hour 6 hr -.0387 1.000 -.3457 .2684 
24 hr .0727 .991 -.2344 .3797 
7 days .5587* .000 .2516 .8657 
14 days .9780* .000 .6709 1.2851 
21 days .8700* .000 .5629 1.1771 
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 28 days 1.5713
* .000 1.2643 1.8784 
24 hr 
0 hour .0387 1.000 -.2684 .3457 
24 hr .1113 .926 -.1957 .4184 
7 days .5973* .000 .2903 .9044 
14 days 1.0167* .000 .7096 1.3237 
21 days .9087* .000 .6016 1.2157 
28 days 1.6100* .000 1.3029 1.9171 
48 hr 
0 hour -.0727 .991 -.3797 .2344 
6 hr -.1113 .926 -.4184 .1957 
7 days .4860* .000 .1789 .7931 
14 days .9053* .000 .5983 1.2124 
21 days .7973* .000 .4903 1.1044 
28 days 1.4987* .000 1.1916 1.8057 
7 days 
0 hour -.5587* .000 -.8657 -.2516 
24 hr -.5973* .000 -.9044 -.2903 
48 hr -.4860* .000 -.7931 -.1789 
14 days .4193* .002 .1123 .7264 
21 days .3113* .045 .0043 .6184 
28 days 1.0127* .000 .7056 1.3197 
14 days 
0 hour -.9780* .000 -1.2851 -.6709 
6 hr -1.0167* .000 -1.3237 -.7096 
24 hr -.9053* .000 -1.2124 -.5983 
7 days -.4193* .002 -.7264 -.1123 
21 days -.1080 .935 -.4151 .1991 
28 days .5933* .000 .2863 .9004 
21 days 
0 hour -.8700* .000 -1.1771 -.5629 
24 hr -.9087* .000 -1.2157 -.6016 
48 hr -.7973* .000 -1.1044 -.4903 
7 days -.3113* .045 -.6184 -.0043 
14 days .1080 .935 -.1991 .4151 
28 days .7013* .000 .3943 1.0084 
28 days 
0 hour -1.5713* .000 -1.8784 -1.2643 
24 hr -1.6100* .000 -1.9171 -1.3029 
48 hr -1.4987* .000 -1.8057 -1.1916 
7 days -1.0127* .000 -1.3197 -.7056 
14 days -.5933* .000 -.9004 -.2863 
21 days -.7013* .000 -1.0084 -.3943 
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Table 4.2: Standard Error for Bioluminescence (RLU/ml) readings in Sorbic acid  
Grand Mean 
Dependent Variable:   RLU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
2.389
a
 .011 2.363 2.415 
a. Based on modified population marginal mean. 
 
Table 4.3: Standard Error for population (CFU/ml) readings in Sorbic acid  
Grand Mean 
Dependent Variable:   CFU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
3.868
a
 .127 3.556 4.179 
a. Based on modified population marginal mean. 
 
 
Table 4.4: Standard Error for RLU:CFU  readings in Sorbic acid  
Grand Mean 
Dependent Variable:   RLUCFU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
.121 .012 .097 .146 
 
Table 4.1.4: Standard Error for ATP- Bioluminescence (RLU/ml) readings in Sorbic acid  
Grand Mean 
Dependent Variable:   ATP   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
3.278
a
 .056 3.141 3.416 
 
Table 4.5: Levene`s test between RLU and two compendia method  
Levene's Test of Equality of Error Variances
a
 
Dependent Variable:   RLU   
F df1 df2 Sig. 
1.404 258 35 .113 
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Table 4.6: Statistical analysis of RLU, CFU, ATP-chemiluminescence for biosensor stains 
Sorbic acid analysis in Sections 4.6.4 
 
Multiple Comparisons 
Tukey HSD   
Dependent Variable (I) Biosensor (J) 
Biosensor 
Mean Difference (I-J) Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
lpp 
tatA -1.1353* .006 -2.0391 -.2315 
Ldc -.9808* .026 -1.8847 -.0770 
Lyss -.7583 .146 -1.6621 .1456 
Spc -1.6186* .000 -2.5224 -.7147 
tatA 
lpp 1.1353* .006 .2315 2.0391 
Ldc .1545 .990 -.7493 1.0583 
Lyss .3770 .781 -.5268 1.2809 
Spc -.4833 .582 -1.3871 .4206 
Ldc 
lpp .9808* .026 .0770 1.8847 
tatA -.1545 .990 -1.0583 .7493 
Lyss .2226 .961 -.6813 1.1264 
Spc -.6378 .299 -1.5416 .2661 
Lyss 
Lpp .7583 .146 -.1456 1.6621 
tatA -.3770 .781 -1.2809 .5268 
Ldc -.2226 .961 -1.1264 .6813 
Spc -.8603 .071 -1.7641 .0435 
Spc 
Lpp 1.6186* .000 .7147 2.5224 
tatA .4833 .582 -.4206 1.3871 
Ldc .6378 .299 -.2661 1.5416 
Lyss .8603 .071 -.0435 1.7641 
CFU 
lpp 
tatA -.0030 1.000 -1.2593 1.2533 
Ldc -.0266 1.000 -1.2829 1.2297 
Lyss .0340 1.000 -1.2223 1.2904 
Spc .0279 1.000 -1.2284 1.2842 
tatA 
lpp .0030 1.000 -1.2533 1.2593 
Ldc -.0236 1.000 -1.2799 1.2327 
Lyss .0370 1.000 -1.2193 1.2934 
Spc .0309 1.000 -1.2254 1.2872 
Ldc 
lpp .0266 1.000 -1.2297 1.2829 
tatA .0236 1.000 -1.2327 1.2799 
Lyss .0607 1.000 -1.1956 1.3170 
Spc .0545 1.000 -1.2018 1.3108 
Lyss lpp -.0340 1.000 -1.2904 1.2223 
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tatA -.0370 1.000 -1.2934 1.2193 
Ldc -.0607 1.000 -1.3170 1.1956 
Spc -.0061 1.000 -1.2625 1.2502 
Spc 
lpp -.0279 1.000 -1.2842 1.2284 
tatA -.0309 1.000 -1.2872 1.2254 
Ldc -.0545 1.000 -1.3108 1.2018 
Lyss .0061 1.000 -1.2502 1.2625 
ATP 
lpp 
tatA -.0424 1.000 -.7565 .6717 
Ldc -.1086 .994 -.8227 .6055 
Lyss -.1183 .991 -.8324 .5958 
Spc -.1017 .995 -.8158 .6124 
tatA 
lpp .0424 1.000 -.6717 .7565 
Ldc -.0662 .999 -.7803 .6479 
Lyss -.0759 .998 -.7900 .6382 
Spc -.0593 .999 -.7734 .6548 
Ldc 
lpp .1086 .994 -.6055 .8227 
tatA .0662 .999 -.6479 .7803 
Lyss -.0097 1.000 -.7238 .7044 
Spc .0069 1.000 -.7072 .7210 
Lyss 
lpp .1183 .991 -.5958 .8324 
tatA .0759 .998 -.6382 .7900 
Ldc .0097 1.000 -.7044 .7238 
Spc .0166 1.000 -.6975 .7307 
Spc 
lpp .1017 .995 -.6124 .8158 
tatA .0593 .999 -.6548 .7734 
Ldc -.0069 1.000 -.7210 .7072 
Lyss -.0166 1.000 -.7307 .6975 
RLUCFU 
lpp 
tatA -.0292 .942 -.1352 .0768 
Ldc .0160 .994 -.0901 .1220 
Lyss .0677 .402 -.0383 .1737 
Spc -.1549* .001 -.2610 -.0489 
tatA 
lpp .0292 .942 -.0768 .1352 
Ldc .0452 .767 -.0609 .1512 
Lyss .0969 .091 -.0091 .2029 
Spc -.1257* .011 -.2317 -.0197 
Ldc 
lpp -.0160 .994 -.1220 .0901 
tatA -.0452 .767 -.1512 .0609 
Lyss .0517 .665 -.0543 .1578 
Spc -.1709* .000 -.2769 -.0648 
Lyss lpp -.0677 .402 -.1737 .0383 
tatA -.0969 .091 -.2029 .0091 
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Ldc -.0517 .665 -.1578 .0543 
Spc -.2226* .000 -.3287 -.1166 
Spc 
lpp .1549* .001 .0489 .2610 
tatA .1257* .011 .0197 .2317 
Ldc .1709* .000 .0648 .2769 
Lyss .2226* .000 .1166 .3287 
 
 
Table 4.7: Statistical analysis of RLU, CFU, ATP-chemiluminescence against time Sorbic 
acid analysis  
 
Multiple Comparisons 
Tukey HSD   
Dependent Variable (I) time (J) time Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
0 hr 
24 hr .9737 .003 -.1834 2.1308 
48 hr 1.2383* .027 .0812 2.3954 
168 hr 1.8397* .000 .6826 2.9968 
336 hr 2.2057* .000 1.0486 3.3628 
504 hr 2.5536* .000 1.3965 3.7106 
672 hr 2.7840* .000 1.6269 3.9411 
24 hr 
0 hr -.9737 .163 -2.1308 .1834 
48 hr .2646 .994 -.8925 1.4217 
168 hr .8660 .285 -.2911 2.0231 
336 hr 1.2320* .029 .0749 2.3891 
504 hr 1.5799* .001 .4228 2.7369 
672 hr 1.8103* .000 .6532 2.9674 
48 hr 
0 hr -1.2383* .027 -2.3954 -.0812 
24 hr -.2646 .994 -1.4217 .8925 
168 hr .6014 .716 -.5557 1.7585 
336 hr .9674 .169 -.1897 2.1245 
504 hr 1.3153* .015 .1582 2.4724 
672 hr 1.5457* .002 .3886 2.7028 
168 hr 
0 hr -1.8397* .000 -2.9968 -.6826 
24 hr -.8660 .285 -2.0231 .2911 
48 hr -.6014 .716 -1.7585 .5557 
336 hr .3660 .965 -.7911 1.5231 
504 hr .7139 .525 -.4432 1.8709 
672 hr .9443 .192 -.2128 2.1014 
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336 hr 
0 hr -2.2057* .000 -3.3628 -1.0486 
24 hr -1.2320* .029 -2.3891 -.0749 
48 hr -.9674 .169 -2.1245 .1897 
168 hr -.3660 .965 -1.5231 .7911 
504 hr .3479 .973 -.8092 1.5049 
672 hr .5783 .752 -.5788 1.7354 
504 hr 
0 hr -2.5536* .000 -3.7106 -1.3965 
24 hr -1.5799* .001 -2.7369 -.4228 
48 hr -1.3153* .015 -2.4724 -.1582 
168 hr -.7139 .525 -1.8709 .4432 
336 hr -.3479 .973 -1.5049 .8092 
672 hr .2304 .997 -.9267 1.3875 
672 hr 
0 hr -2.7840* .000 -3.9411 -1.6269 
24 hr -1.8103* .000 -2.9674 -.6532 
48 hr -1.5457* .002 -2.7028 -.3886 
168 hr -.9443 .192 -2.1014 .2128 
336 hr -.5783 .752 -1.7354 .5788 
504 hr -.2304 .997 -1.3875 .9267 
CFU 
0 hr 
24 hr 1.6824* .034 .0740 3.2907 
48 hr 2.1770* .001 .5687 3.7853 
168 hr 2.3434* .000 .7351 3.9518 
336 hr 2.5203* .000 .9120 4.1286 
504 hr 2.7325* .000 1.1242 4.3408 
672 hr 2.8352* .000 1.2269 4.4436 
24 hr 
0 hr -1.6824* .034 -3.2907 -.0740 
48 hr .4946 .970 -1.1137 2.1030 
168 hr .6611 .884 -.9473 2.2694 
336 hr .8379 .713 -.7704 2.4462 
504 hr 1.0501 .454 -.5582 2.6584 
672 hr 1.1529 .337 -.4555 2.7612 
48 hr 
0 hr -2.1770* .001 -3.7853 -.5687 
24 hr -.4946 .970 -2.1030 1.1137 
168 hr .1664 1.000 -1.4419 1.7748 
336 hr .3433 .996 -1.2650 1.9516 
504 hr .5555 .947 -1.0528 2.1638 
672 hr .6582 .886 -.9501 2.2666 
168 hr 
0 hr -2.3434* .000 -3.9518 -.7351 
24 hr -.6611 .884 -2.2694 .9473 
48 hr -.1664 1.000 -1.7748 1.4419 
336 hr .1769 1.000 -1.4315 1.7852 
504 hr .3891 .991 -1.2193 1.9974 
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672 hr .4918 .971 -1.1165 2.1001 
336 hr 
0 hr -2.5203* .000 -4.1286 -.9120 
24 hr -.8379 .713 -2.4462 .7704 
48 hr -.3433 .996 -1.9516 1.2650 
168 hr -.1769 1.000 -1.7852 1.4315 
504 hr .2122 1.000 -1.3961 1.8205 
672 hr .3149 .997 -1.2934 1.9233 
504 hr 
0 hr -2.7325* .000 -4.3408 -1.1242 
24 hr -1.0501 .454 -2.6584 .5582 
48 hr -.5555 .947 -2.1638 1.0528 
168 hr -.3891 .991 -1.9974 1.2193 
336 hr -.2122 1.000 -1.8205 1.3961 
672 hr .1027 1.000 -1.5056 1.7111 
672 hr 
0 hr -2.8352* .000 -4.4436 -1.2269 
24 hr -1.1529 .337 -2.7612 .4555 
48 hr -.6582 .886 -2.2666 .9501 
168 hr -.4918 .971 -2.1001 1.1165 
336 hr -.3149 .997 -1.9233 1.2934 
504 hr -.1027 1.000 -1.7111 1.5056 
ATP 
0 hr 
24 hr 1.0927* .008 .1785 2.0069 
48 hr 1.5063* .000 .5921 2.4205 
168 hr 1.5443* .000 .6301 2.4585 
336 hr 1.7070* .000 .7928 2.6212 
504 hr 1.7571* .000 .8429 2.6713 
672 hr 1.9070* .000 .9928 2.8212 
24 hr 
0 hr -1.0927* .008 -2.0069 -.1785 
48 hr .4136 .829 -.5006 1.3278 
168 hr .4516 .762 -.4626 1.3658 
336 hr .6143 .417 -.2999 1.5285 
504 hr .6644 .320 -.2498 1.5786 
672 hr .8143 .116 -.0999 1.7285 
48 hr 
0 hr -1.5063* .000 -2.4205 -.5921 
24 hr -.4136 .829 -1.3278 .5006 
168 hr .0380 1.000 -.8762 .9522 
336 hr .2007 .995 -.7135 1.1149 
504 hr .2508 .983 -.6634 1.1650 
672 hr .4007 .849 -.5135 1.3149 
168 hr 
0 hr -1.5443* .000 -2.4585 -.6301 
24 hr -.4516 .762 -1.3658 .4626 
48 hr -.0380 1.000 -.9522 .8762 
336 hr .1627 .998 -.7515 1.0769 
504 hr .2128 .993 -.7014 1.1270 
672 hr .3627 .901 -.5515 1.2769 
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336 hr 
0 hr -1.7070* .000 -2.6212 -.7928 
24 hr -.6143 .417 -1.5285 .2999 
48 hr -.2007 .995 -1.1149 .7135 
168 hr -.1627 .998 -1.0769 .7515 
504 hr .0501 1.000 -.8641 .9643 
672 hr .2000 .995 -.7142 1.1142 
504 hr 
0 hr -1.7571* .000 -2.6713 -.8429 
24 hr -.6644 .320 -1.5786 .2498 
48 hr -.2508 .983 -1.1650 .6634 
168 hr -.2128 .993 -1.1270 .7014 
336 hr -.0501 1.000 -.9643 .8641 
672 hr .1499 .999 -.7643 1.0641 
672 hr 
0 hr -1.9070* .000 -2.8212 -.9928 
24 hr -.8143 .116 -1.7285 .0999 
48 hr -.4007 .849 -1.3149 .5135 
168 hr -.3627 .901 -1.2769 .5515 
336 hr -.2000 .995 -1.1142 .7142 
504 hr -.1499 .999 -1.0641 .7643 
RLUCFU 
0 hr 
24 hr -.0161 1.000 -.1519 .1196 
48 hr -.0509 .923 -.1866 .0849 
168 hr -.0117 1.000 -.1474 .1241 
336 hr -.0089 1.000 -.1446 .1269 
504 hr -.0051 1.000 -.1408 .1306 
672 hr .0388 .979 -.0969 .1746 
24 hr 
0 hr .0161 1.000 -.1196 .1519 
48 hr -.0347 .988 -.1705 .1010 
168 hr .0045 1.000 -.1313 .1402 
336 hr .0073 1.000 -.1285 .1430 
504 hr .0110 1.000 -.1247 .1468 
672 hr .0550 .891 -.0808 .1907 
48 hr 
0 hr .0509 .923 -.0849 .1866 
24 hr .0347 .988 -.1010 .1705 
168 hr .0392 .978 -.0966 .1749 
336 hr .0420 .969 -.0937 .1778 
504 hr .0458 .953 -.0900 .1815 
672 hr .0897 .439 -.0460 .2255 
168 hr 
0 hr .0117 1.000 -.1241 .1474 
24 hr -.0045 1.000 -.1402 .1313 
48 hr -.0392 .978 -.1749 .0966 
336 hr .0028 1.000 -.1329 .1386 
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504 hr .0066 1.000 -.1292 .1423 
672 hr .0505 .925 -.0852 .1863 
336 hr 
0 hr .0089 1.000 -.1269 .1446 
24 hr -.0073 1.000 -.1430 .1285 
48 hr -.0420 .969 -.1778 .0937 
168 hr -.0028 1.000 -.1386 .1329 
504 hr .0038 1.000 -.1320 .1395 
672 hr .0477 .943 -.0881 .1834 
504 hr 
0 hr .0051 1.000 -.1306 .1408 
24 hr -.0110 1.000 -.1468 .1247 
48 hr -.0458 .953 -.1815 .0900 
168 hr -.0066 1.000 -.1423 .1292 
336 hr -.0038 1.000 -.1395 .1320 
672 hr .0439 .961 -.0918 .1797 
672 hr 
0 hr -.0388 .979 -.1746 .0969 
24 hr -.0550 .891 -.1907 .0808 
48 hr -.0897 .439 -.2255 .0460 
168 hr -.0505 .925 -.1863 .0852 
336 hr -.0477 .943 -.1834 .0881 
504 hr -.0439 .961 -.1797 .0918 
 
Table 4.8: Statistical analysis of RLU, CFU, ATP-chemiluminescence against Concentrations 
Sorbic acid analysis  
 
Multiple Comparisons 
Tukey HSD   
Dependent 
Variable 
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
0.2 
0.1 .9737 .163 -.1834 2.1308 
0.05 1.2383* .027 .0812 2.3954 
0.025 1.8397* .000 .6826 2.9968 
0.0125 2.2057* .000 1.0486 3.3628 
0.0062 2.5536* .000 1.3965 3.7106 
0.0031 2.7840* .000 1.6269 3.9411 
0.1 
0.2 -.9737 .163 -2.1308 .1834 
0.05 .2646 .994 -.8925 1.4217 
0.025 .8660 .285 -.2911 2.0231 
0.0125 1.2320* .029 .0749 2.3891 
0.0062 1.5799* .001 .4228 2.7369 
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0.0031 1.8103* .000 .6532 2.9674 
0.05 
0.2 -1.2383* .027 -2.3954 -.0812 
0.1 -.2646 .994 -1.4217 .8925 
0.025 .6014 .716 -.5557 1.7585 
0.0125 .9674 .169 -.1897 2.1245 
0.0062 1.3153* .015 .1582 2.4724 
0.0031 1.5457* .002 .3886 2.7028 
0.025 
0.2 -1.8397* .000 -2.9968 -.6826 
0.1 -.8660 .285 -2.0231 .2911 
0.05 -.6014 .716 -1.7585 .5557 
0.0125 .3660 .965 -.7911 1.5231 
0.0062 .7139 .525 -.4432 1.8709 
0.0031 .9443 .192 -.2128 2.1014 
0.0125 
0.2 -2.2057* .000 -3.3628 -1.0486 
0.1 -1.2320* .029 -2.3891 -.0749 
0.05 -.9674 .169 -2.1245 .1897 
0.025 -.3660 .965 -1.5231 .7911 
0.0062 .3479 .973 -.8092 1.5049 
0.0031 .5783 .752 -.5788 1.7354 
0.0062 
0.2 -2.5536* .000 -3.7106 -1.3965 
0.1 -1.5799* .001 -2.7369 -.4228 
0.05 -1.3153* .015 -2.4724 -.1582 
0.025 -.7139 .525 -1.8709 .4432 
0.0125 -.3479 .973 -1.5049 .8092 
0.0031 .2304 .997 -.9267 1.3875 
0.0031 
0.2 -2.7840* .000 -3.9411 -1.6269 
0.1 -1.8103* .000 -2.9674 -.6532 
0.05 -1.5457* .002 -2.7028 -.3886 
0.025 -.9443 .192 -2.1014 .2128 
0.0125 -.5783 .752 -1.7354 .5788 
0.0062 -.2304 .997 -1.3875 .9267 
CFU 
0.2 
0.1 1.6824* .034 .0740 3.2907 
0.05 2.1770* .001 .5687 3.7853 
0.025 2.3434* .000 .7351 3.9518 
0.0125 2.5203* .000 .9120 4.1286 
0.0062 2.7325* .000 1.1242 4.3408 
0.0031 2.8352* .000 1.2269 4.4436 
0.1 
0.2 -1.6824* .034 -3.2907 -.0740 
0.05 .4946 .970 -1.1137 2.1030 
 392 
 
 
0.025 .6611 .884 -.9473 2.2694 
0.0125 .8379 .713 -.7704 2.4462 
0.0062 1.0501 .454 -.5582 2.6584 
0.0031 1.1529 .337 -.4555 2.7612 
0.05 
0.2 -2.1770* .001 -3.7853 -.5687 
0.1 -.4946 .970 -2.1030 1.1137 
0.025 .1664 1.000 -1.4419 1.7748 
0.0125 .3433 .996 -1.2650 1.9516 
0.0062 .5555 .947 -1.0528 2.1638 
0.0031 .6582 .886 -.9501 2.2666 
0.025 
0.2 -2.3434* .000 -3.9518 -.7351 
0.1 -.6611 .884 -2.2694 .9473 
0.05 -.1664 1.000 -1.7748 1.4419 
0.0125 .1769 1.000 -1.4315 1.7852 
0.0062 .3891 .991 -1.2193 1.9974 
0.0031 .4918 .971 -1.1165 2.1001 
0.0125 
0.2 -2.5203* .000 -4.1286 -.9120 
0.1 -.8379 .713 -2.4462 .7704 
0.05 -.3433 .996 -1.9516 1.2650 
0.025 -.1769 1.000 -1.7852 1.4315 
0.0062 .2122 1.000 -1.3961 1.8205 
0.0031 .3149 .997 -1.2934 1.9233 
0.0062 
0.2 -2.7325* .000 -4.3408 -1.1242 
0.1 -1.0501 .454 -2.6584 .5582 
0.05 -.5555 .947 -2.1638 1.0528 
0.025 -.3891 .991 -1.9974 1.2193 
0.0125 -.2122 1.000 -1.8205 1.3961 
0.0031 .1027 1.000 -1.5056 1.7111 
0.0031 
0.2 -2.8352* .000 -4.4436 -1.2269 
0.1 -1.1529 .337 -2.7612 .4555 
0.05 -.6582 .886 -2.2666 .9501 
0.025 -.4918 .971 -2.1001 1.1165 
0.0125 -.3149 .997 -1.9233 1.2934 
0.0062 -.1027 1.000 -1.7111 1.5056 
ATP 
0.2 
0.1 1.0927* .008 .1785 2.0069 
0.05 1.5063* .000 .5921 2.4205 
0.025 1.5443* .000 .6301 2.4585 
0.0125 1.7070* .000 .7928 2.6212 
0.0062 1.7571* .000 .8429 2.6713 
0.0031 1.9070* .000 .9928 2.8212 
0.1 
0.2 -1.0927* .008 -2.0069 -.1785 
0.05 .4136 .829 -.5006 1.3278 
0.025 .4516 .762 -.4626 1.3658 
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0.0125 .6143 .417 -.2999 1.5285 
0.0062 .6644 .320 -.2498 1.5786 
0.0031 .8143 .116 -.0999 1.7285 
0.05 
0.2 -1.5063* .000 -2.4205 -.5921 
0.1 -.4136 .829 -1.3278 .5006 
0.025 .0380 1.000 -.8762 .9522 
0.0125 .2007 .995 -.7135 1.1149 
0.0062 .2508 .983 -.6634 1.1650 
0.0031 .4007 .849 -.5135 1.3149 
0.025 
0.2 -1.5443* .000 -2.4585 -.6301 
0.1 -.4516 .762 -1.3658 .4626 
0.05 -.0380 1.000 -.9522 .8762 
0.0125 .1627 .998 -.7515 1.0769 
0.0062 .2128 .993 -.7014 1.1270 
0.0031 .3627 .901 -.5515 1.2769 
0.0125 
0.2 -1.7070* .000 -2.6212 -.7928 
0.1 -.6143 .417 -1.5285 .2999 
0.05 -.2007 .995 -1.1149 .7135 
0.025 -.1627 .998 -1.0769 .7515 
0.0062 .0501 1.000 -.8641 .9643 
0.0031 .2000 .995 -.7142 1.1142 
0.0062 
0.2 -1.7571* .000 -2.6713 -.8429 
0.1 -.6644 .320 -1.5786 .2498 
0.05 -.2508 .983 -1.1650 .6634 
0.025 -.2128 .993 -1.1270 .7014 
0.0125 -.0501 1.000 -.9643 .8641 
0.0031 .1499 .999 -.7643 1.0641 
0.0031 
0.2 -1.9070* .000 -2.8212 -.9928 
0.1 -.8143 .116 -1.7285 .0999 
0.05 -.4007 .849 -1.3149 .5135 
0.025 -.3627 .901 -1.2769 .5515 
0.0125 -.2000 .995 -1.1142 .7142 
0.0062 -.1499 .999 -1.0641 .7643 
RLUCFU 
0.2 
0.1 -.0161 1.000 -.1519 .1196 
0.05 -.0509 .923 -.1866 .0849 
0.025 -.0117 1.000 -.1474 .1241 
0.0125 -.0089 1.000 -.1446 .1269 
0.0062 -.0051 1.000 -.1408 .1306 
0.0031 .0388 .979 -.0969 .1746 
0.1 0.2 .0161 1.000 -.1196 .1519 
0.05 -.0347 .988 -.1705 .1010 
0.025 .0045 1.000 -.1313 .1402 
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0.0125 .0073 1.000 -.1285 .1430 
0.0062 .0110 1.000 -.1247 .1468 
0.0031 .0550 .891 -.0808 .1907 
0.05 
0.2 .0509 .923 -.0849 .1866 
0.1 .0347 .988 -.1010 .1705 
0.025 .0392 .978 -.0966 .1749 
0.0125 .0420 .969 -.0937 .1778 
0.0062 .0458 .953 -.0900 .1815 
0.0031 .0897 .439 -.0460 .2255 
0.025 
0.2 .0117 1.000 -.1241 .1474 
0.1 -.0045 1.000 -.1402 .1313 
0.05 -.0392 .978 -.1749 .0966 
0.0125 .0028 1.000 -.1329 .1386 
0.0062 .0066 1.000 -.1292 .1423 
0.0031 .0505 .925 -.0852 .1863 
0.0125 
0.2 .0089 1.000 -.1269 .1446 
0.1 -.0073 1.000 -.1430 .1285 
0.05 -.0420 .969 -.1778 .0937 
0.025 -.0028 1.000 -.1386 .1329 
0.0062 .0038 1.000 -.1320 .1395 
0.0031 .0477 .943 -.0881 .1834 
0.0062 
0.2 .0051 1.000 -.1306 .1408 
0.1 -.0110 1.000 -.1468 .1247 
0.05 -.0458 .953 -.1815 .0900 
0.025 -.0066 1.000 -.1423 .1292 
0.0125 -.0038 1.000 -.1395 .1320 
0.0031 .0439 .961 -.0918 .1797 
0.0031 
0.2 -.0388 .979 -.1746 .0969 
0.1 -.0550 .891 -.1907 .0808 
0.05 -.0897 .439 -.2255 .0460 
0.025 -.0505 .925 -.1863 .0852 
0.0125 -.0477 .943 -.1834 .0881 
0.0062 -.0439 .961 -.1797 .0918 
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Figure 4.1: Virtual Foot printing analysis for Lpp sequences. Crp locus is found in the blue font color 
below 
tattgcttttgtgaattaatttgtatatcgaagcgccctgatgggcgctttttttaTTTAATcgataaccagaagcaATAAAAAATcaaat
cggatttcactatataatctcactttatctaagatgaatccgatggaagcatcctgttttctctcaatttttttatctaaaacccagcgttcgatgcttctttga
gcgaacgatcaaaaataagtgccttcccatcaaaaaaataTTCTCAacataaaaaactttgtgtAATACTtgtaacgctacatggagatta
actcaatctagagggtattaataatgaaagctactaaactggtactgggcgcggtaatcctgggttctactctgctggcaggttgctccagcaacgct
aaaatcgatcagctgtcttctgacgttcagactctgaacgctaaagttgaccagctgagcaacgacgtgaacgcaatgcgttccgacgttcaggct
gctaaagatgacgcagctcgtgctaaccagcgtctggacaacatggctactaaataccgcaagtaatagtacctg 
The light blue fonts are where the crp locus was identified based on the start and end positions. 
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Figure 4.4 : Virtual Foot printing analysis for LysS sequences. Crp locus is found in the negative 
strand, corresponding complement sequences were not found within the lyss promoter region. 
caggccatgaagcagatgaaagcgaagcTTTATGaactggagatgcagAAGAAAAAtgccgagaaac
aggcgatggaagataacaaatccgacatcggctggggcagccagattcgttcttatgtccttgatga
ctcccgcattaaagatctgcgcaccggggtagaaacccgcaacacgcaggccgtgctggacggcagc
ctggatcaatttatcgaagcaagtttgaaagcagggttatgaggaaccaaca 
The two crp locus were found to overlap within the positions indicated in blue fonts  
A second lpp promoter was located (RegulonDB) 
 
 
 
Figure 4.2: Lpp promoter obtained from Regulon DB indicates 2 promoters
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Appendix 5 
Evaluation of Whole-cell Bioluminescence 
in Benzalkonium Chloride 
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Table 5.1: Standard Error for Bioluminescence (RLU/ml) readings in Benzalkonium Chloride 
 
 
Grand Mean 
Dependent Variable:   RLU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1.699 .106 1.490 1.908 
 
Table 5.2: Standard Error for plate counts (CFU/ml) readings in Benzalkonium Chloride 
 
 
Grand Mean 
Dependent Variable:   CFU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
2.628 .154 2.325 2.932 
 
Table 5.3: Standard Error for ATP-Chemiluminescence (RLU/ml) readings in Benzalkonium Chloride 
Grand Mean 
Dependent Variable:   ATP   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
2.614 .102 2.413 2.814 
 
Table 5.4:  F test for RLU against CFU and ATP-bioluminescence 
 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable:   RLU   
F df1 df2 Sig. 
.958 159 50 .590 
 
Table 5.5: Overal SEM for RLU Benzalkonium Chloride +0.03% EDTA 
 
 
Grand Mean 
Dependent Variable:   RLU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
1.344 .095 1.157 1.530 
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Table 5.6: Standard Error for plate counts (CFU/ml) readings in Benzalkonium Chloride +0.03% EDTA 
Grand Mean 
Dependent Variable:   CFU   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
2.120 .164 1.797 2.443 
 
Table 5.7: Standard Error for ATP bioluminescence (RLU/ml) readings in Benzalkonium Chloride +0.03% 
EDTA 
 
Grand Mean 
Dependent Variable:  ATP   
Mean Std. Error 95% Confidence Interval 
Lower Bound Upper Bound 
2.101 .107 1.889 2.312 
 
Table 5.8: F test for RLU against CFU and ATP-bioluminescence readings 
 
Levene's Test of Equality of Error Variances
a
 
Dependent Variable:   RLU   
F df1 df2 Sig. 
.583 155 54 .994 
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Table 5.9: Tukey for bioluminescence, Viable Counts ATP-chemiluminescence, and 
bioluminescence per cell readings in BAK preservative 
 
Multiple Comparisons 
Dependent Variable:   RLU   
   
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
lpp 
tatA -.9418* .011 -1.6690 -.2146 
Ldc -.7265 .050 -1.4537 .0007 
Lyss -.5990 .056 -1.3262 .1282 
Spc -.8974* .016 -1.6246 -.1702 
tatA 
lpp .9418* .011 .2146 1.6690 
Ldc .2153 .560 -.5119 .9425 
Lyss .3428 .354 -.3844 1.0700 
Spc .0444 .904 -.6828 .7716 
Ldc 
lpp .7265 .050 -.0007 1.4537 
tatA -.2153 .560 -.9425 .5119 
Lyss .1275 .730 -.5997 .8547 
Spc -.1709 .644 -.8981 .5563 
Lyss 
lpp .5990 .500 -.1282 1.3262 
tatA -.3428 .354 -1.0700 .3844 
Ldc -.1275 .730 -.8547 .5997 
Spc -.2984 .419 -1.0256 .4288 
Spc 
lpp .8974* .016 .1702 1.6246 
tatA -.0444 .904 -.7716 .6828 
Ldc .1709 .644 -.5563 .8981 
Lyss .2984 .419 -.4288 1.0256 
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Multiple Comparisons 
Dependent Variable:   CFU   
Tukey HSD   
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
lpp 
tatA -.0025 1.000 -1.4747 1.4696 
Ldc -.0312 1.000 -1.5034 1.4410 
Lyss -.0402 1.000 -1.5124 1.4320 
Spc -.0175 1.000 -1.4897 1.4547 
tatA 
lpp .0025 1.000 -1.4696 1.4747 
Ldc -.0287 1.000 -1.5008 1.4435 
Lyss -.0377 1.000 -1.5099 1.4345 
Spc -.0150 1.000 -1.4871 1.4572 
Ldc 
lpp .0312 1.000 -1.4410 1.5034 
tatA .0287 1.000 -1.4435 1.5008 
Lyss -.0090 1.000 -1.4812 1.4632 
Spc .0137 1.000 -1.4585 1.4859 
Lyss 
lpp .0402 1.000 -1.4320 1.5124 
tatA .0377 1.000 -1.4345 1.5099 
Ldc .0090 1.000 -1.4632 1.4812 
Spc .0227 1.000 -1.4495 1.4949 
Spc 
lpp .0175 1.000 -1.4547 1.4897 
tatA .0150 1.000 -1.4572 1.4871 
Ldc -.0137 1.000 -1.4859 1.4585 
Lyss -.0227 1.000 -1.4949 1.4495 
 
 
                                                                     Multiple Comparisons 
Dependent Variable:   ATP   
Tukey HSD   
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
lpp 
tatA .0413 1.000 -1.0149 1.0975 
Ldc -.0891 .999 -1.1453 .9671 
Lyss -.0891 .999 -1.1453 .9671 
Spc .1158 .998 -.9404 1.1720 
tatA lpp -.0413 1.000 -1.0975 1.0149 
Ldc -.1305 .997 -1.1867 .9257 
Lyss -.1305 .997 -1.1867 .9257 
 402 
 
 
Spc .0745 1.000 -.9817 1.1307 
Ldc 
lpp .0891 .999 -.9671 1.1453 
tatA .1305 .997 -.9257 1.1867 
Lyss .0000 1.000 -1.0562 1.0562 
Spc .2049 .984 -.8512 1.2611 
Lyss 
lpp .0891 .999 -.9671 1.1453 
tatA .1305 .997 -.9257 1.1867 
Ldc .0000 1.000 -1.0562 1.0562 
Spc .2049 .984 -.8512 1.2611 
Spc 
lpp -.1158 .998 -1.1720 .9404 
tatA -.0745 1.000 -1.1307 .9817 
Ldc -.2049 .984 -1.2611 .8512 
Lyss -.2049 .984 -1.2611 .8512 
 
Multiple Comparisons 
Dependent Variable:   RLUCFU   
Tukey HSD   
(I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
lpp 
tatA -.0741* .015 -.1387 -.0096 
Ldc .0006 1.000 -.0640 .0651 
Lyss .0188 .930 -.0458 .0833 
Spc -.0414 .039 -.1059 .0232 
tatA 
lpp .0741* .015 .0096 .1387 
Ldc .0747* .014 .0102 .1392 
Lyss .0929* .001 .0284 .1574 
Spc .0328 .629 -.0317 .0973 
Ldc 
lpp -.0006 1.000 -.0651 .0640 
tatA -.0747* .014 -.1392 -.0102 
Lyss .0182 .937 -.0463 .0827 
Spc -.0419 .383 -.1064 .0226 
Lyss 
lpp -.0188 .930 -.0833 .0458 
tatA -.0929* .001 -.1574 -.0284 
Ldc -.0182 .937 -.0827 .0463 
Spc -.0601 .081 -.1246 .0044 
Spc 
lpp .0414 .039 -.0232 .1059 
tatA -.0328 .629 -.0973 .0317 
Ldc .0419 .038 -.0226 .1064 
Lyss .0601 .041 -.0044 .1246 
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Table 5.10: Tukey for bioluminescence, ATP-chemiluminescence, and bioluminescence per cell readings 
against time in BAK preservative 
 
Multiple Comparisons 
Dependent Variable:   RLU   
Tukey HSD   
(I) time (J) time Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hr 
6 hr 1.4470* .004 .3079 2.5862 
24 hr 2.0160* .000 .8769 3.1551 
168 hr 2.3331* .000 1.1939 3.4722 
336 hr 2.5484* .000 1.4092 3.6875 
504 hr 2.5803* .000 1.4412 3.7195 
672 hr 2.6687* .000 1.5296 3.8078 
6 hr 
0 hr -1.4470* .004 -2.5862 -.3079 
24 hr .5690 .752 -.5702 1.7081 
168 hr .8860 .241 -.2531 2.0252 
336 hr 1.1013 .065 -.0378 2.2405 
504 hr 1.1333 .052 -.0059 2.2724 
672 hr 1.2217* .027 .0825 2.3608 
24 hr 
0 hr -2.0160* .000 -3.1551 -.8769 
6 hr -.5690 .752 -1.7081 .5702 
168 hr .3171 .982 -.8221 1.4562 
336 hr .5324 .806 -.6068 1.6715 
504 hr .5643 .759 -.5748 1.7035 
672 hr .6527 .613 -.4864 1.7918 
168 hr 
0 hr -2.3331* .000 -3.4722 -1.1939 
6 hr -.8860 .241 -2.0252 .2531 
24 hr -.3171 .982 -1.4562 .8221 
336 hr .2153 .998 -.9238 1.3545 
504 hr .2473 .995 -.8919 1.3864 
672 hr .3356 .976 -.8035 1.4748 
336 hr 
0 hr -2.5484* .000 -3.6875 -1.4092 
6 hr -1.1013 .065 -2.2405 .0378 
24 hr -.5324 .806 -1.6715 .6068 
168 hr -.2153 .998 -1.3545 .9238 
504 hr .0320 1.000 -1.1072 1.1711 
672 hr .1203 1.000 -1.0188 1.2595 
504 hr 0 hr -2.5803
* .000 -3.7195 -1.4412 
6 hr -1.1333 .052 -2.2724 .0059 
24 hr -.5643 .759 -1.7035 .5748 
168 hr -.2473 .995 -1.3864 .8919 
336 hr -.0320 1.000 -1.1711 1.1072 
672 hr .0884 1.000 -1.0508 1.2275 
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0 hr -2.6687* .000 -3.8078 -1.5296 
6 hr -1.2217* .027 -2.3608 -.0825 
24 hr -.6527 .613 -1.7918 .4864 
168 hr -.3356 .976 -1.4748 .8035 
336 hr -.1203 1.000 -1.2595 1.0188 
504 hr -.0884 1.000 -1.2275 1.0508 
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Multiple Comparisons 
Dependent Variable:   CFU   
Tukey HSD   
(I) time (J) time Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hr 
6 hr 3.1692* .000 1.5680 4.7704 
24 hr 3.4042* .000 1.8030 5.0054 
168 hr 3.5472* .000 1.9460 5.1484 
336 hr 3.7170* .000 2.1158 5.3182 
504 hr 3.9082* .000 2.3070 5.5094 
672 hr 3.9826* .000 2.3814 5.5838 
6 hr 
0 hr -3.1692* .000 -4.7704 -1.5680 
24 hr .2349 .999 -1.3663 1.8362 
168 hr .3780 .992 -1.2232 1.9792 
336 hr .5477 .949 -1.0535 2.1489 
504 hr .7390 .815 -.8622 2.3402 
672 hr .8134 .737 -.7878 2.4146 
24 hr 
0 hr -3.4042* .000 -5.0054 -1.8030 
6 hr -.2349 .999 -1.8362 1.3663 
168 hr .1431 1.000 -1.4582 1.7443 
336 hr .3128 .997 -1.2884 1.9140 
504 hr .5040 .966 -1.0972 2.1052 
672 hr .5784 .935 -1.0228 2.1796 
168 hr 
0 hr -3.5472* .000 -5.1484 -1.9460 
6 hr -.3780 .992 -1.9792 1.2232 
24 hr -.1431 1.000 -1.7443 1.4582 
336 hr .1697 1.000 -1.4315 1.7709 
504 hr .3610 .994 -1.2402 1.9622 
672 hr .4354 .984 -1.1658 2.0366 
336 hr 
0 hr -3.7170* .000 -5.3182 -2.1158 
6 hr -.5477 .949 -2.1489 1.0535 
24 hr -.3128 .997 -1.9140 1.2884 
168 hr -.1697 1.000 -1.7709 1.4315 
504 hr .1912 1.000 -1.4100 1.7925 
672 hr .2657 .999 -1.3356 1.8669 
504 hr 
0 hr -3.9082* .000 -5.5094 -2.3070 
6 hr -.7390 .815 -2.3402 .8622 
24 hr -.5040 .966 -2.1052 1.0972 
168 hr -.3610 .994 -1.9622 1.2402 
336 hr -.1912 1.000 -1.7925 1.4100 
672 hr .0744 1.000 -1.5268 1.6756 
672 hr 
 
 
0 hr -3.9826* .000 -5.5838 -2.3814 
6 hr -.8134 .737 -2.4146 .7878 
24 hr -.5784 .935 -2.1796 1.0228 
     
168 hr -.4354 .984 -2.0366 1.1658 
336 hr -.2657 .999 -1.8669 1.3356 
504 hr -.0744 1.000 -1.6756 1.5268 
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Multiple Comparisons 
Dependent Variable:   ATP   
Tukey HSD   
(I) time (J) time Mean Difference (I-
J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hr 
6 hr 1.4234* .009 .2280 2.6188 
24 hr 1.9575* .000 .7620 3.1529 
168 hr 2.0349* .000 .8395 3.2303 
336 hr 2.2200* .000 1.0246 3.4155 
504 hr 2.5442* .000 1.3488 3.7396 
672 hr 2.5970* .000 1.4016 3.7925 
6 hr 
0 hr -1.4234* .009 -2.6188 -.2280 
24 hr .5341 .837 -.6614 1.7295 
168 hr .6115 .730 -.5839 1.8069 
336 hr .7966 .428 -.3988 1.9921 
504 hr 1.1208 .082 -.0746 2.3162 
672 hr 1.1736 .058 -.0218 2.3691 
24 hr 
0 hr -1.9575* .000 -3.1529 -.7620 
6 hr -.5341 .837 -1.7295 .6614 
168 hr .0774 1.000 -1.1180 1.2729 
336 hr .2626 .995 -.9328 1.4580 
504 hr .5867 .767 -.6087 1.7822 
672 hr .6396 .687 -.5559 1.8350 
168 hr 
0 hr -2.0349* .000 -3.2303 -.8395 
6 hr -.6115 .730 -1.8069 .5839 
24 hr -.0774 1.000 -1.2729 1.1180 
336 hr .1851 .999 -1.0103 1.3806 
504 hr .5093 .865 -.6861 1.7047 
672 hr .5621 .801 -.6333 1.7576 
336 hr 
0 hr -2.2200* .000 -3.4155 -1.0246 
6 hr -.7966 .428 -1.9921 .3988 
24 hr -.2626 .995 -1.4580 .9328 
168 hr -.1851 .999 -1.3806 1.0103 
504 hr .3242 .984 -.8713 1.5196 
672 hr .3770 .966 -.8184 1.5724 
504 hr 
0 hr -2.5442* .000 -3.7396 -1.3488 
6 hr -1.1208 .082 -2.3162 .0746 
24 hr -.5867 .767 -1.7822 .6087 
168 hr -.5093 .865 -1.7047 .6861 
336 hr -.3242 .984 -1.5196 .8713 
672 hr .0528 1.000 -1.1426 1.2483 
672 hr 0 hr -2.5970* .000 -3.7925 -1.4016 
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6 hr -1.1736 .058 -2.3691 .0218 
24 hr -.6396 .687 -1.8350 .5559 
168 hr -.5621 .801 -1.7576 .6333 
336 hr -.3770 .966 -1.5724 .8184 
504 hr -.0528 1.000 -1.2483 1.1426 
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Multiple Comparisons 
Dependent Variable:   RLUCFU   
Tukey HSD   
(I) time (J) time Mean Difference (I-
J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0 hr 
6 hr -.0109 1.000 -.0960 .0742 
24 hr .0539 .491 -.0312 .1390 
168 hr .0441 .717 -.0409 .1292 
336 hr .0520 .535 -.0331 .1371 
504 hr .0366 .861 -.0485 .1217 
672 hr .0423 .756 -.0428 .1274 
6 hr 
0 hr .0109 1.000 -.0742 .0960 
24 hr .0648 .264 -.0203 .1499 
168 hr .0550 .465 -.0300 .1401 
336 hr .0629 .299 -.0222 .1480 
504 hr .0475 .643 -.0376 .1326 
672 hr .0532 .508 -.0319 .1383 
24 hr 
0 hr -.0539 .491 -.1390 .0312 
6 hr -.0648 .264 -.1499 .0203 
168 hr -.0098 1.000 -.0949 .0753 
336 hr -.0019 1.000 -.0870 .0832 
504 hr -.0174 .997 -.1025 .0677 
672 hr -.0116 1.000 -.0967 .0735 
168 hr 
0 hr -.0441 .717 -.1292 .0409 
6 hr -.0550 .465 -.1401 .0300 
24 hr .0098 1.000 -.0753 .0949 
336 hr .0079 1.000 -.0772 .0930 
504 hr -.0076 1.000 -.0927 .0775 
672 hr -.0018 1.000 -.0869 .0833 
336 hr 
0 hr -.0520 .535 -.1371 .0331 
6 hr -.0629 .299 -.1480 .0222 
24 hr .0019 1.000 -.0832 .0870 
168 hr -.0079 1.000 -.0930 .0772 
504 hr -.0155 .998 -.1006 .0696 
672 hr -.0097 1.000 -.0948 .0754 
504 hr 
0 hr -.0366 .861 -.1217 .0485 
6 hr -.0475 .643 -.1326 .0376 
24 hr .0174 .997 -.0677 .1025 
168 hr .0076 1.000 -.0775 .0927 
336 hr .0155 .998 -.0696 .1006 
672 hr .0057 1.000 -.0793 .0908 
672 hr 
0 hr -.0423 .756 -.1274 .0428 
6 hr -.0532 .508 -.1383 .0319 
24 hr .0116 .02857 -.0735 .0967 
168 hr .0018 .02857 -.0833 .0869 
336 hr .0097 .02857 -.0754 .0948 
504 hr -.0057 .02857 -.0908 .0793 
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Table 5.10: Tukey for bioluminescence, ATP-chemiluminescence, and bioluminescence per cell readings 
against concentrations in BAK preservative 
 
Multiple Comparisons 
Dependent Variable:   RLU   
Tukey HSD   
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0.0062 
0.0031 1.1612* .001 .3392 1.9833 
0.0016 2.4880* .000 1.6660 3.3100 
0.0007 2.6013* .000 1.7792 3.4233 
0.0003 2.5956* .000 1.7735 3.4176 
0.0031 
0.0062 -1.1612* .001 -1.9833 -.3392 
0.0016 1.3267* .000 .5047 2.1488 
0.0007 1.4400* .000 .6180 2.2620 
0.0003 1.4343* .000 .6123 2.2563 
0.0016 
0.0062 -2.4880* .000 -3.3100 -1.6660 
0.0031 -1.3267* .000 -2.1488 -.5047 
0.0007 .1133 .999 -.7088 .9353 
0.0003 .1076 .999 -.7145 .9296 
0.0007 
0.0062 -2.6013* .000 -3.4233 -1.7792 
0.0031 -1.4400* .000 -2.2620 -.6180 
0.0016 -.1133 .999 -.9353 .7088 
0.0003 -.0057 1.000 -.8277 .8163 
0.0003 
0.0062 -2.5956* .000 -3.4176 -1.7735 
0.0031 -1.4343* .000 -2.2563 -.6123 
0.0016 -.1076 .999 -.9296 .7145 
0.0007 .0057 1.000 -.8163 .8277 
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Multiple Comparisons 
Dependent Variable:   CFU   
Tukey HSD   
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0.0125 
0.0062 .2076 .993 -.8546 1.2697 
0.0031 1.4966* .001 .4345 2.5588 
0.0016 4.2165* .000 3.1543 5.2786 
0.0007 4.2143* .000 3.1521 5.2764 
0.0003 4.2219* .000 3.1597 5.2840 
0.0062 
0.0125 -.2076 .993 -1.2697 .8546 
0.0031 1.2890* .008 .2269 2.3512 
0.0016 4.0089* .000 2.9468 5.0710 
0.0007 4.0067* .000 2.9446 5.0688 
0.0003 4.0143* .000 2.9521 5.0764 
0.0031 
0.0125 -1.4966* .001 -2.5588 -.4345 
0.0062 -1.2890* .008 -2.3512 -.2269 
0.0016 2.7199* .000 1.6577 3.7820 
0.0007 2.7176* .000 1.6555 3.7798 
0.0003 2.7252* .000 1.6631 3.7874 
0.0016 
0.0125 -4.2165* .000 -5.2786 -3.1543 
0.0062 -4.0089* .000 -5.0710 -2.9468 
0.0031 -2.7199* .000 -3.7820 -1.6577 
0.0007 -.0022 1.000 -1.0643 1.0599 
0.0003 .0054 1.000 -1.0568 1.0675 
0.0007 
0.0125 -4.2143* .000 -5.2764 -3.1521 
0.0062 -4.0067* .000 -5.0688 -2.9446 
0.0031 -2.7176* .000 -3.7798 -1.6555 
0.0016 .0022 1.000 -1.0599 1.0643 
0.0003 .0076 1.000 -1.0545 1.0697 
0.0003 
0.0125 -4.2219* .000 -5.2840 -3.1597 
0.0062 -4.0143* .000 -5.0764 -2.9521 
0.0031 -2.7252* .000 -3.7874 -1.6631 
0.0016 -.0054 1.000 -1.0675 1.0568 
0.0007 -.0076 1.000 -1.0697 1.0545 
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Multiple Comparisons 
Dependent Variable:   ATP   
Tukey HSD   
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
0.0125 
0.0062 .0428 1.000 -.6521 .7377 
0.0031 1.2286* .000 .5337 1.9235 
0.0016 3.0513* .000 2.3563 3.7462 
0.0007 3.1512* .000 2.4563 3.8461 
0.0003 3.2682* .000 2.5733 3.9631 
0.0062 
0.0125 -.0428 1.000 -.7377 .6521 
0.0031 1.1858* .000 .4908 1.8807 
0.0016 3.0084* .000 2.3135 3.7033 
0.0007 3.1084* .000 2.4135 3.8033 
0.0003 3.2254* .000 2.5304 3.9203 
0.0031 
0.0125 -1.2286* .000 -1.9235 -.5337 
0.0062 -1.1858* .000 -1.8807 -.4908 
0.00016 1.8227* .000 1.1278 2.5176 
0.0007 1.9226* .000 1.2277 2.6175 
0.0003 2.0396* .000 1.3447 2.7345 
0.0016 
0.0125 -3.0513* .000 -3.7462 -2.3563 
0.0062 -3.0084* .000 -3.7033 -2.3135 
0.0031 -1.8227* .000 -2.5176 -1.1278 
0.0007 .1000 .998 -.5950 .7949 
0.0003 .2169 .947 -.4780 .9118 
0.0007 
0.0125 -3.1512* .000 -3.8461 -2.4563 
0.0062 -3.1084* .000 -3.8033 -2.4135 
0.0031 -1.9226* .000 -2.6175 -1.2277 
0.0016 -.1000 .998 -.7949 .5950 
0.0003 .1170 .997 -.5779 .8119 
0.0003 
0.0125 -3.2682* .000 -3.9631 -2.5733 
0.0062 -3.2254* .000 -3.9203 -2.5304 
0.0031 -2.0396* .000 -2.7345 -1.3447 
0.0016 -.2169 .947 -.9118 .4780 
0.0007 -.1170 .997 -.8119 .5779 
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Multiple Comparisons 
   
Dependent Variable (I) Biosensor (J) Biosensor Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
lpp 
tatA -.4759 .124 -1.0843 .1326 
Ldc -.3910 .206 -.9994 .2175 
Lyss -.4425 .153 -1.0509 .1660 
Spc -.5713 .046 -1.1797 .0372 
tatA 
lpp .4759 .124 -.1326 1.0843 
Ldc .0849 .783 -.5235 .6934 
Lyss .0334 .914 -.5750 .6419 
Spc -.0954 .757 -.7038 .5130 
Ldc 
lpp .3910 .206 -.2175 .9994 
tatA -.0849 .783 -.6934 .5235 
Lyss -.0515 .867 -.6600 .5569 
Spc -.1803 .559 -.7888 .4281 
Lyss 
lpp .4425 .153 -.1660 1.0509 
tatA -.0334 .914 -.6419 .5750 
Ldc .0515 .867 -.5569 .6600 
Spc -.1288 .676 -.7373 .4796 
Spc 
lpp .5713 .046 -.0372 1.1797 
tatA .0954 .757 -.5130 .7038 
Ldc .1803 .559 -.4281 .7888 
Lyss .1288 .676 -.4796 .7373 
CFU 
lpp 
tatA -.0486 .926 -1.0830 .9858 
Ldc .0000 1.000 -1.0344 1.0344 
Lyss -.0486 .926 -1.0830 .9858 
Spc .0000 1.000 -1.0344 1.0344 
tatA 
lpp .0486 .926 -.9858 1.0830 
Ldc .0486 .926 -.9858 1.0830 
Lyss .0000 1.000 -1.0344 1.0344 
Spc .0486 .926 -.9858 1.0830 
Ldc 
lpp .0000 1.000 -1.0344 1.0344 
tatA -.0486 .926 -1.0830 .9858 
Lyss -.0486 .926 -1.0830 .9858 
Spc .0000 1.000 -1.0344 1.0344 
Lyss 
lpp .0486 .926 -.9858 1.0830 
tatA .0000 1.000 -1.0344 1.0344 
Ldc .0486 .926 -.9858 1.0830 
Spc .0486 .926 -.9858 1.0830 
Spc 
lpp .0000 1.000 -1.0344 1.0344 
tatA -.0486 .926 -1.0830 .9858 
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Ldc .0000 1.000 -1.0344 1.0344 
Lyss -.0486 .926 -1.0830 .9858 
ATP 
lpp 
tatA .0000 1.000 -.5325 .5325 
Ldc .0000 1.000 -.5325 .5325 
Lyss .0000 1.000 -.5325 .5325 
Spc .0000 1.000 -.5325 .5325 
tatA 
lpp .0000 1.000 -.5325 .5325 
Ldc .0000 1.000 -.5325 .5325 
Lyss .0000 1.000 -.5325 .5325 
Spc .0000 1.000 -.5325 .5325 
Ldc 
lpp .0000 1.000 -.5325 .5325 
tatA .0000 1.000 -.5325 .5325 
Lyss .0000 1.000 -.5325 .5325 
Spc .0000 1.000 -.5325 .5325 
Lyss 
lpp .0000 1.000 -.5325 .5325 
tatA .0000 1.000 -.5325 .5325 
Ldc .0000 1.000 -.5325 .5325 
Spc .0000 1.000 -.5325 .5325 
Spc 
lpp .0000 1.000 -.5325 .5325 
tatA .0000 1.000 -.5325 .5325 
Ldc .0000 1.000 -.5325 .5325 
Lyss .0000 1.000 -.5325 .5325 
RLUCFU 
lpp 
tatA -8.0286 .141 -18.7380 2.6809 
Ldc -4.3714 .421 -15.0809 6.3380 
Lyss -10.4857 .055 -21.1951 .2237 
Spc -9.8286 .072 -20.5380 .8809 
tatA 
lpp 8.0286 .141 -2.6809 18.7380 
Ldc 3.6571 .501 -7.0523 14.3666 
Lyss -2.4571 .651 -13.1666 8.2523 
Spc -1.8000 .740 -12.5094 8.9094 
Ldc 
lpp 4.3714 .421 -6.3380 15.0809 
tatA -3.6571 .501 -14.3666 7.0523 
Lyss -6.1143 .261 -16.8237 4.5951 
Spc -5.4571 .315 -16.1666 5.2523 
Lyss 
lpp 10.4857 .055 -.2237 21.1951 
tatA 2.4571 .651 -8.2523 13.1666 
Ldc 6.1143 .261 -4.5951 16.8237 
Spc .6571 .904 -10.0523 11.3666 
Spc 
lpp 9.8286 .072 -.8809 20.5380 
tatA 1.8000 .740 -8.9094 12.5094 
Ldc 5.4571 .315 -5.2523 16.1666 
Lyss -.6571 .904 -11.3666 10.0523 
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     Table 5.11: Tukey Analysis for BAK + 0.03 % EDTA in terms of RLU, Viable counts, ATP, RLU:CFU  
 
Tukey HSD   
Dependent 
Variable 
(I) Concentration (J) Concentration Mean Difference 
(I-J) 
Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
RLU 
0.0062 
0.0031 1.1399* .000 .4027 1.8771 
0.00015 2.0047* .000 1.2675 2.7419 
0.0007 2.5983* .000 1.8611 3.3355 
0.0003 2.6783* .000 1.9411 3.4155 
0.0031 
0.0062 -1.1399* .000 -1.8771 -.4027 
0.0015 .8648* .013 .1276 1.6020 
0.0007 1.4584* .000 .7212 2.1956 
0.0003 1.5384* .000 .8012 2.2756 
0.0016 
0.0062 -2.0047* .000 -2.7419 -1.2675 
0.0031 -.8648* .013 -1.6020 -.1276 
0.0007 .5935 .177 -.1437 1.3307 
0.0003 .6735 .091 -.0637 1.4107 
0.0007 
0.0062 -2.5983* .000 -3.3355 -1.8611 
0.0031 -1.4584* .000 -2.1956 -.7212 
0.0016 -.5935 .177 -1.3307 .1437 
0.0003 .0800 .998 -.6572 .8172 
0.0003 
0.0062 -2.6783* .000 -3.4155 -1.9411 
0.0031 -1.5384* .000 -2.2756 -.8012 
0.0016 -.6735 .091 -1.4107 .0637 
0.0007 -.0800 .998 -.8172 .6572 
CFU 
0.0062 
0.0031 2.5805* .000 1.4871 3.6740 
0.0016 4.1085* .000 3.0151 5.2020 
0.0007 4.6941* .000 3.6006 5.7875 
0.0003 4.7292* .000 3.6358 5.8227 
0.0031 
0.0062 -2.5805* .000 -3.6740 -1.4871 
0.0016 1.5280* .002 .4346 2.6215 
0.0007 2.1136* .000 1.0201 3.2070 
0.0003 2.1487* .000 1.0553 3.2422 
0.0016 
0.0062 -4.1085* .000 -5.2020 -3.0151 
0.0031 -1.5280* .002 -2.6215 -.4346 
0.0007 .5855 .579 -.5079 1.6790 
0.0003 .6207 .522 -.4728 1.7141 
0.0007 
0.0062 -4.6941* .000 -5.7875 -3.6006 
0.0031 -2.1136* .000 -3.2070 -1.0201 
0.0016 -.5855 .579 -1.6790 .5079 
0.0003 .0351 1.000 -1.0583 1.1286 
0.0003 
0.0062 -4.7292* .000 -5.8227 -3.6358 
0.0031 -2.1487* .000 -3.2422 -1.0553 
0.0016 -.6207 .522 -1.7141 .4728 
0.0007 -.0351 1.000 -1.1286 1.0583 
ATP 0.0062 0.0031 .7277* .005 .1576 1.2978 
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